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ABSTRACT 
Embryonic stem (ES) cells can differentiate into many different cell lines, 
including vascular smooth muscle cells (SMCs). The aim of this project is to 
characterize protein changes during this differentiation process. Mouse ES cells are 
pre-differentiated by withdrawal of the leukemia inhibitory factor-1 from the culture 
medium. Subsequently, stem cell antigen-1 positive (Sca-1) cells are sorted by 
magnetic labelling cell sorting with anti-Sca-1 microbeads and cultured in 
differentiation medium with or without platelet-derived growth factor (PDGF). Protein 
extracts of ES cells and Sca-1+ cells are separated by two-dimensional electrophoresis. 
About 300 protein species of each cell lines are analyzed by mass spectrometry. 
Proteome maps are available online (http: //vwvw. vascular-proteomics. com). After 
stimulation with PDGF for 5 passages, Sca-1+ cells differentiate into SMCs (esSMCs) 
with 95% staining positive for SMC markers such as smooth muscle a-actin, calponin, 
and smooth muscle myosin heavy chain. Protein profiles of esSMCs and mouse aortic 
SMCs are compared using the difference gel electrophoresis approach. esSMCs display 
decreased expression of myofilaments but increased oxidation of redox-sensitive 
proteins due to higher levels of reactive oxgen species (ROS). While immunoblotting 
reveals an upregulation of numerous antioxidants in esSMCs, enzymatic assays 
demonstrate lower glutathione concentrations compared to aortic SMCs despite a 3-fold 
increase in glutathione reductase activity. Mitochondrial superoxide measurement 
revealed the mitochondria-derived superoxide is the main source of ROS in esSMCs 
3 
and inhibition of electron transport chain complex III by antimycin A showed 
remarkable increase of ROS in esSMCs. Moreover, depletion of glutathione by diethyl 
maleate or inhibition of glutathione reductase by carmustine (BCNU) results in a 
remarkable loss of cell viability in esSMCs compared to aortic SMCs while adding 
2-mercaptoethanol increased esSMCs survival. These results indicate that esSMCs 
require additional antioxidant protection for survival and consequently, treatment with 
anti-oxidants could be beneficial for tissue repair from ES cells. 
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1 INTRODUCTION 
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1.1 Vascular Biology 
Vascular biology successfully brought together basic scientists and clinical 
investigators. It stimulated interactions and collaborations among researchers from 
multiple disciplines and developed new training opportunities. From these activities 
emerged the discipline of vascular medicine (Dzau, Gibbons et al. 1993). Vascular 
biology has grown and matured over the past 50 years to emerge as a major area of 
research with many potential therapeutic applications. 
1.1.1 Vasculature 
The vessel wall is an integrated functional component of the circulatory system 
which continually remodels in response to hemodynamic or biomechanical stress (Xu 
2000). Vessels are primarily divided into arteries and veins. Arteries are subdivided into 
large (elastic) arteries (such as aorta) and medium-sized (muscular, distributing) arteries. 
In general, veins are exposed to a lower blood pressure than arteries. Thus their wall 
structures are different from each other but both contain three layers: intima, media, and 
adventitia (Figure 1). 
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Figure 1. Structure of vessel wall 
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Figure 1. The arterial vessel wall has three layers: the intima with a lining of 
endothelial cells, the media, consisting of circular muscles between the internal and 
external elastic membrane, and the adventitia, embedded with vasa vasorum (supply 
vessels within the adventitia). The venous vessel wall is thinner and also has three 
layers: the intima, the media with less muscle cells, which lacks an elastic component, 
and the out layer, consists of fat cells. Large veins have valves to prevent blood flowing 
back under low blood pressure conditions. 
(http: //accessexcellence. org/AE/AEC/CC/images/vessel. gif) 
The term SMC is used within the vasculature to include any connective tissue cell 
that forms a coating around the endothelial tube (Mahoney and Schwartz 2005). In 
addition to contractile function, vascular SMCs have been shown to be a pleiotropic cell 
capable of phenotypic changes associated with the synthesis of many biologically active 
molecules that mediate cell growth, death, migration, matrix modulation and 
inflammation. These actions of vascular SMCs play important roles in physiological 
vascular functions (such as vascular remodelling) and pathological disorders (such as 
atherosclerosis). A cadre of endogenous biological mediators regulating smooth muscle 
23 
phenotype and function have been identified, including growth factors, pro-apoptotic 
factors, matrix glycoproteins, metalloproteinases, cytokines, chemokines, and adhesion 
molecules (Alexander and Dzau 2000). 
Moreover, SMCs in different parts of the vascular tree developed from different 
germ layers. For example, the descending aorta and most muscular arteries including the 
coronary arteries contain SMCs derived from the mesoderm, while the SMC 
compartment within the pulmonary trunc, the aortic arch and the ascending aorta 
originates from neuronal crest (ectoderm). Hence, a great variation has been observed 
among different SMC populations (Frid, Moiseeva et al. 1994; Frid, Dempsey et al. 
1997). 
The endothelium lines the inner surface of all blood vessels covering an area of 
approximately 1000 m2 and amounts to a total weight of 1 kg in humans. The quiescent 
endothelium forms not only a selective barrier between blood and tissue, but also 
provides an antithrombotic surface, inhibits leukocyte adhesion and SMC proliferation 
and regulates the vascular tone via synthesis of nitric oxide (NO). However, injury 
causes endothelial activation and leads to the loss of its antithrombotic and 
anti-inflammatory properties. Dysfunctional endothelium expresses adhesion molecules 
(Cybulsky and Gimbrone 1991) and coagulation factors (Libby and Simon 2001) and 
produces reactive oxygen species (ROS), resulting in a decreased bioavailability of the 
vasodilator causing paradoxical vasoconstriction (Cai and Harrison 2000). 
Robert Furchgott won the Nobel Prize for demonstrating endothelium-dependent 
vasodilatation (Furchgott and Zawadzki 1980). Endothelial cells have an obligatory role 
24 
in the relaxation of arteries by acetylcholine (ACh) and related muscarinic agonists by 
releasing a very labile (half-life 3-50 seconds) diffusible factor, endothelium-derived 
relaxing factor (EDRF), which acts on the adjacent smooth muscle cells to cause their 
relaxation. The chemical nature of EDRF was identified in 1986, when it was proposed 
that EDRF is nitric oxide (NO). 
Figure 2. Current scheme for endothelium-dependent relaxation 
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Figure 2. Agent A and receptor (R) of EC interaction activates Ca2+ influx. Increased 
intracellular Ca2+ activates NOS, generating NO from L-arginine. NO diffuses to 
adjacent SMCs where it activates G-cyclase, resulting increase in cGMP, which initiates 
processes leading to relaxation. L-NMMA and L-NAME are arginine derivatives, which 
inhibit NOS, and 02' and Hb02 are potent scavengers of NO. (GTP, guanosine 
triphosphate; G-cyclase, guanylyl cyclase; cGMP, cyclic guanosine monophosphate; 
L-NMMA, NG-monomethyl-L-arginine; L-NAME, Nw-Nitro-L-arginine methyl ester; 
Hb02, oxygenated hemoglobin) (http: //www. downstate edu/pharmacology/furch. htm) 
Most vasoactive stimuli such as shear stress mediate EC activities through the 
nitric oxide synthase (NOS)-derived NO. Three NOS enzymes are responsible for the 
production of NO, neuronal NOS (NOS1, nNOS), inducible NOS (NOS2, iNOS), and 
endothelial NOS (NOS3, eNOS), with eNOS to be important in the regulation of 
vascular compliance. eNOS is essential for neovasularization by enhance the 
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mobilization of stem and progenitor cells, so that contributs to impaired regeneration 
processes (Aicher, Heeschen et al. 2003). Massive generation of endogenous NO 
derived from iNOS overexpression leads to a marked apoptosis in vascular SMCs, 
suggesting an important role of NO as a proapoptotic factor for vascular SMCs in the 
process of vascular remodelling (Iwashina, Shichiri et al. 1998). 
NO relaxes vascular smooth muscle and inhibits platelet aggregation and adhesion 
via the elevation of cGMP levels. NO is destroyed only by oxygen and superoxide 
anions (OZ''). Its action both on vascular strips and on platelets is inhibited by 
hemoglobin and some redox compounds. Hemoglobin may have a complex action 
involving binding of NO, inhibition of guanylate cyclase and generation of 02' during 
auto-oxidation (Moncada, Radomski et al. 1988). 
In the vascular SMCs, the most predominant binding site for NO in the target 
tissues is heure group or iron-sulfur compound (Hobbs and Ignarro 1996). Herne plays a 
central role in eukaryotic metabolic pathways, as the prosthetic moiety of hemoproteins 
is involved in cell respiration and oxidative biotransformations, including hemoglobin 
and myoglobin, cytochrome P450, NOS and soluble G-cyclase. Herne oxygenase (HO) 
degrades heure to CO and biliverdin, which is further reduced to bilirubin. Two 
principal isozymes of HO have been identified, a constitutive isoform HO-2 and an 
inducible isoform HO-1, which is expressed at a low basal level in vascular ECs and 
SMCs and is induced by heavy metals, oxidative stress, inflammatory mediators and 
oxidized LDL. HO degrades heure to regulate hemoprotein levels and protect cells from 
the deleterious effects of free heure. 
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The vasodilator function ascribed to the heme-HO system relies on CO and 
biliverdin acting in a coordinated manner, with biliverdin/bilirubin as antioxidants. 
Importantly, biliverdin and bilirubin negate the pro-oxidant action of CO and thus 
enable the gas to effects vasodilation. The mechanism by which CO activates soluble 
guanylyl cyclase is similar to that of NO, and involves binding and dislocation of its 
heme-iron to induce a conformational change and activation of the catalytic site of 
guanylyl cyclase, resulting in elevated intracellular cGMP levels and leading to smooth 
muscle relaxation (Maines 1997). The heure moiety binds NO to form a 5-coordinate 
complex or bind CO to form a 6-coordinate complex. Although NO and CO modulate 
intracellular cGMP levels, platelet aggregation and smooth muscle relaxation, CO has a 
much lower affinity for soluble G-cyclase than NO (Stone and Marietta 1994). 
Decreased production or sensitivity to NO in atherosclerosis may be compensated for 
by an induction of HO-1, with bilirubin acting as a cellular antioxidant and CO as a 
vasodilator. CO and NO can also be generated in SMCs in response to atherogenic 
stimuli or pro-inflammatory cytokines, respectively. The metabolic and functional links 
between CO and NO suggest that vasodilator actions of CO may become important in 
atherogenesis, where endothelium-derived NO production is inhibited (Siow, Sato et 
al. 1999). As the heure moiety of NOS and soluble G-cyclase can serve as alternate 
substrates for HO, their activity may under certain conditions be downregulated. In 
addition, CO is able to bind to the heure moiety of NOS and thereby inhibit NO 
production (Maines 1997). (Figure 3) 
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Figure 3. Network of NOS-NO system and HO-CO system 
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Figure 3. HO metabolizes heure to generate the antioxidant biliverdin and CO, which is 
similar to NO, stimulates sGC resulting in increased intracellular cGMP. Atherogenic 
and pro-inflammatory mediators decrease eNOS activity while induce HO-1 and iNOS 
in SMCs. Diminished production or activity of NO by the endothelium in atherogenesis 
could be compensated for by induction of HO-derived CO, which can sustain blood 
flow. At the same time catabolism of heure and generation of biliverdin would attenuate 
cellular oxidative stress in atherogenesis. (L-Arg, L-arginine; eNOS, endothelial nitric 
oxide synthase; iNOS, inducible nitric oxide synthase; HO, heure oxygenase; 
sGC, soluble guanylyl cyclase) (Siow, Sato et al. 1999). 
It is well know that platelets play an important role in thrombosis and haemostasis, 
and in the maintenance of normal cardiovascular functions. Platelets express both iNOS 
and eNOS (Mehta, Chen et al. 1995). During platelets adhesion and aggregation, NOS 
is activated and generates NO. NO regulates platelets activation by inhibiting adhesion 
and aggregation. The L-arginine transport is rate-limiting for the NO production in 
uraemic platelets (Brunini, Yaqoob et al. 2003). NOS inhibitor 
N'G-monomethyl-L-arginine (L-NMMA) and N°-nitro-L-arginine methylester 
(L-NAME) inhibits NO production of platelets so that increased their activation and 
adhesion (Brunini, Mendes-Ribeiro et al. 2006). Platelets-derived NO may play a 
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significant role in the maintenance of vascular tone and blood flow (Zhou, Hellermann 
et al. 1995). 
NO inhibit the synthesis of platelet-activating factor by neutrophils, monocytes 
and ECs (Mariano, Bussolati et al. 2003). Increased transport of L-arginine is necessary 
to sustain NO synthesis in monocytes exposed to increased levels of circulating 
cytokines (Brunini, Roberts et al. 2002). 
1.1.2 Development of vascular system 
The embryo develops in the absence of vascularization at the earlies stages. When 
the embryo grows, the diffusion cannot provide sufficient nutrition for its development. 
The embryo rapidly transforms into a highly vascular organism, survival being 
dependent on a functional, complex network of capillary plexuses and blood vessels. 
The initial event in vascular growth is vasculogenesis, a process whereby vessels 
are formed de novo from EC precursors (angioblasts). During vasculogenesis, 
angioblasts migrate to discrete locations, differentiate in situ and assemble into solid 
endothelial cords, later forming a plexus with endocardial tubes, also known as the 
primary capillary plexus. The subsequent growth, expansion and remodeling of these 
primitive vessels into a mature vascular network is angiogenesis, characterized by a 
combination of sprouting of new vessels from the sides and ends of pre-existing ones or 
by longitudinal branching of existing vessels with periendothelial cells. Angiogenesis is 
important in the embryo to promote the primary vascular tree as well as an adequate 
vasculature from developing organs (Conway, Collen et al. 2001). 
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Both vasculogenesis and angiogenesis have been extensively studied in embryonic 
stem cells of mouse (Vittet, Prandini et al. 1996; Feraud and Vittet 2003) and human 
origin (Levenberg, Golub et al. 2002). 
1.1.3 Hemodynamics 
In vivo, there are two main hemodynamic forces acting on vascular cells: shear 
stress, the dragging frictional force on ECs created by blood flow, and mechanical 
stretch, or tension, a cyclic strain stress created by blood pressure (Davies, Polacek et al. 
1999). Shear stress is mainly sensed by ECs while all vascular cell types are exposed to 
stretch stress. 
Fluid shear stress represent an essential survival signal for ECs and potently 
inhibits EC apoptosis via phosphorylation of the serine/threonine kinase Akt (Dimmeler, 
Assmus et al. 1998), which subsequently mediates the activation of endothelial nitric 
oxide synthase (eNOS) leading to increased NO production and vessel relaxation 
(Dimmeler, Fleming et al. 1999). Fluid shear stress also modulates EC structure and 
function including the organization of F-actin microfilaments, the expression of 
adhesion molecules, and the attraction, activation and adhesion of leukocytes. 
Transcription and expression of a variety of genes encoding for growth factors, 
transforming growth factor, vasodilators, vasoconstrictors, and adhesion molecules 
appear to be regulated on shear stress stimulation (Lehoux and Tedgui 1998). 
Cyclic strain stress influences both ECs and SMCs. The maximum stretch of large 
diameter vessels (aorta, femoral and pulmonary arteries) in human is 9-12% under 
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normotensive conditions. A certain level of mechanical stretch is necessary to develop 
and maintain a differentiated and contractile phenotype of vascular SMCs (Lehoux and 
Tedgui 1998). Increased tension promotes the generation of vasoconstrictors and 
mitogenic factors such as endothelium-dependant contracting factors and 
platelet-derived growth factor (PDGF). If the cyclic strain stress is persistent and 
chronically elevated, SMCs may change structure supervention, beginning with 
hypertrophy (mainly seen in small vessels), hyperplasia (in large vessels) and cell 
migration, leading to gradual thickening of arterial walls, and subsequent hypertension 
and arteriosclerosis. 
The endothelium acts as a mechanotransducer that senses blood flow stress and 
converts these extracellular mechanical stimuli to biochemical signals (Davies 1995; 
Resnick and Gimbrone 1995; Davies, Barbee et al. 1997), which is important for both 
acute vascular regulation and chronic vascular remodelling. In vitro, fluid mechanical 
shear stress elicits acute endothelial responses that include activation of ion channels 
(Olesen, Clapham et al. 1988) and G proteins (Berthiaume and Frangos 1992; Gudi, 
Clark et al. 1996; Gudi, Nolan et al. 1998), mobilization of intracellular calcium (Shen, 
Luscinskas et al. 1992; Ando, Ohtsuka et al. 1993), and induction of protein kinase 
pathways (Tseng, Peterson et al. 1995). Subsequent transcription factor activation (Lan, 
Mercurius et al. 1994) and binding to shear stress response-related sequences of several 
flow-responsive genes (Resnick and Gimbrone 1995) results in important functional and 
structural changes in the cells including extensive topographic and cytoskeletal 
reorganization, cellular elongation, and alignment in the direction of shear stress 
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(Dewey, Bussolari et al. 1981; Remuzzi, Dewey et al. 1984; Barbee, Davies et al. 1994). 
Physical forces initiate signal pathways, especially mitogen-activated protein kinases 
(MAPKs), leading to vascular cell death and inflammatory response followed by SMC 
proliferation. Thus, mechanical stress, similar to cytokines or growth factors, can 
effectively activate signal transduction pathways, which can result in apoptosis and cell 
proliferation so that contribute to the development of arteriosclerosis (Mayr, Li et al. 
2000; Xu 2000; Mayr, Hu et al. 2002). 
1.1.4 Vascular remodelling 
Different physical forces lead to a different vessel remodelling. Blood vessels 
regress when not constantly perfused, they enlarge when chronically exposed to high 
flows, and their walls become thicker with high pressures (Heil and Schaper 2004). The 
adaptation and accommodation abilities of the blood vessel to long- and short-term 
hemodynamic condition changes are critical functions in cardiovascular homeostasis 
(Figure 4) (Gibbons and Dzau 1994). 
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Figure 4. The spectrum of structural alterations of blood vessels 
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Figure 4. In response to increased arterial pressure, the ratio of the width of the vessel 
wall to the width of the lumen is elevated by either an increase in muscle mass (A) or 
rearrangement of cellular and noncellular elements (B). Vascular stenosis increases 
shear stress and thereby induces an increase in the vessel radius to maintain a constant 
predetermined level of shear stress (D), such as arteriovenous fistula and aneurysm 
formation. Conversely, a long-term reduction in blood flow results in vascular mass and 
calibre reduction (C). The architecture of the vessel wall is also markedly altered in 
response to vascular injury, such as neointimal hyperplasia (E) and atherosclerosis (F). 
(Gibbons and Dzau 1994) 
Vascular remodelling involves cell growth, migration, apoptosis, extracellular 
matrix expansion or contraction, and activation or inhibition of specific protcolytic 
enzymes or glycosidases. it is dependent on a dynamic interaction between locally 
generated growth factors, vasoactive substances, and hcmodynamic stimuli. The 
remodelling response is usually a long-term adaptive process occurring in response to 
chronic changes in hemodynamic conditions, but it may subsequently contribute to the 
pathophysiology of' vascular diseases and circulatory disorders, such as atherosclerosis 
(Gibbons and Dzau 1994). 
Although all the vascular cells may participate in the remodelling process, the 
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endothelium is particularly suited to play a prominent part. The endothelium serves as 
dual function in the control of vascular tone, secreting relaxing factors such as NO, 
prostacyclin, endothelium-derived hyperpolarizing factor, and adenosine, in addition to 
constricting factors such as the endothelin and prostanoid. Vessel tone is dependent on 
the balance between these factors, as well as on the ability of the SMC to respond to the 
factors. 
Remodelling of pre-existing collateral arteriolar anastomoses is involved during 
arteriogenesis. During the course of collateral artery development, the collateral vessel 
wall is exposed to increased fluid shear stress, which initiates the interaction between 
monocytes and vascular endothelium. After that, growth factors are released from the 
matrix and monocytes, which not only activate mitosis but also influence the 
transcription of secondary growth factors, inactivation of the matrix-metalloproteinases 
(MMPs) inhibitor and down-regulation of elastin. SMCs are transformed from the 
contractile into the proliferative/synthetic phenotype. Monocytes/macrophages produce 
MMPs so that they can migrate from the intraluminal side of the collateral arteriole 
toward deeper vessel wall regions. The invasion of monocytes and proliferation of 
SMCs transform an arteriole with only 1-2 layers of SMCs into an artery of up to 
20-fold larger in diameter and 50-fold larger in tissue mass by SMCs proliferation. The 
increase of collateral vessel diameter reduces fluid shear stress, which is the signal for 
maturation and terminates the SMC proliferation. The arteriogenesis, which transform a 
small microvascular resistance vessel into a large conductance artery, is completed (Heil 
and Schaper 2004). 
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1.1.5 Vascular disease 
Cardiovascular disease is the principal death reason in western society and much 
of Asia. Alterations of hemodynamic forces have significant impact on the development 
of cardiovascular diseases. Excessive accumulation of SMCs has a key role in the 
pathogenesis of vascular diseases (Sata, Saiura et al. 2002) such as arteriosclerosis, 
atherosclerosis and graft arterial disease. 
1.1.5.1 Risk factors for atherosclerosis 
Several important environmental and genetic risk factors are associated with 
atherosclerosis (Table 1). 
Table 1. Risk factors for atherosclerosis 
Modifiable risk factors 
Hypertension Mechanical stress exerts the main influence on atherosclerosis as this 
disease only occures in arteries but not in veins. Atherosclerotic lesion 
favours areas of disturbed flow such as bifurcations, branch ostia and 
curves. These sites are often associated with structural modifications 
(intimal thickening, cellular rearrangement, SMCs proliferation and 
extracellular matrix deposition (Gibbons and Dzau 1994). 
Hyperlipidaemia Plasma lipid disorders are associated with an increased risk of 
atherosclerosis related disease, particularly coronary artery disease 
(CAD). Lipids are transported in the plasma as lipoproteins. There are 
three main categories of lipoproteins: high density lipoprotein (HDL), 
low density lipoprotein (LDL), and very low density lipoprotein 
(VLDL). LDL is the major carrier of cholesterol in the plasma and 
LDL-derived cholesterol is important in maintaining overall 
cholesterol homeostasis within cells. As cellular cholesterol increases, 
cellular cholesterol synthesis and synthesis of new LDL receptors are 
inhibited while scavenger receptors of macrophages and SMCs are 
not down-regulated, leading to foam cell formation in atherosclerotic 
lesions. Apolipoprotein E (ApoE) deficiency mouse provides an 
appropriate animal model for hypercholesterolaemia and shows 
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spontaneous atherosclerosis (Zhang, Reddick et al. 1992). Besides 
cholesterol, high plasma triglycerides are also associated with 
premature CAD, probably because they inhibit natural tissue 
plasminogen activator. 
Smoking There is a direct link between CAD and the number of cigarettes 
smoked. This risk declines to normal levels within 5 years of giving 
up smoking. Smoking increases free radical production and therefore 
oxidized-LDL. Carcinogens in the cigarette smoke cause DNA 
damage (Izzotti, De Flora et al. 1995; De Flora, Izzotti et al. 1997) 
therefore smoking contributes to endothelial injury as an early event 
in atherogenesis. 
Diabetes Complications of diabetes mellitus can be broadly considered as 
mellitus macro- and microvascular. Macrovascular complications (such as 
myocardial infarction, stroke and peripheral vascular diseases) are 
more common in patients with diabetes and improved glycaemic 
control cannot per se reduce the risk of them. Microvascular 
complications (such as retino-, nephro- and neuropathy) are hallmarks 
of diabetes mellitus. An attractive hypothesis suggests that elevated 
blood glucose levels cause glycosylation of various proteins, 
including lipoproteins. These products accumulate in atherosclerotic 
lesions and mediate cytotoxic effects on ECs. Improved glycaemic 
control minimizes and delays microvascular complications. 
Hemostatic Increased plasma levels of hemostatic factors (factor VII, factor VIIIC 
factors and fibrinogen) are associated with an increased risk of 
atherosclerosis. It is not known whether a reduction in these factors 
lowers incidence of angina and myocardial infarction. 
Weakly There is no clear evidence that the weakly associated factors can 
associated cause atherosclerosis. Physical activity may be beneficial on the 
factors circulation, or merely indicate a healthy constitution in those who 
make exercise. Persons with type A personality (aggressive, restless, 
ambitious people who are constantly anxious about deadlines) have 
more atherosclerosis than others. This may be due to an increased 
level of circulating catecholamines. The more alcohol the higher the 
risk, but no alcohol is also thought to lead to a higher risk. Alcohol 
intake below 50g per day seems to be protective for atherosclerosis 
(Kiechl and Willeit 1999). 
Virus Several reports showed a correlation between the incidence of 
atherosclerosis and the presence of infectious microorganisms, such as 
herpesviruses and C. pneumoniae. They are identified in atheromatous 
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lesions in coronary arteries and other organs but no direct evidence 
shows they can cause the lesions of atherosclerosis (Ross 1999). 
Non-modifiable risk factors 
Aging Although early lesions can be identified in young people, the 
incidence of atherosclerosis rises with age. Besides its intima- media 
thickening effects, aging predicts marked dilation of the vessel 
because of loss of elastic fibres, which is independent of elevated wall 
thickness and other determinants of vessel. Notably, structural aging 
is not an obligatory phenomenon but usually occurs once enhanced 
intima-media thickening indicates incipient wall pathology (Strong, 
Oalmann et al. 1984; Wissler 1992). 
Sex Atherosclerosis is more common in men than in women (Strong, 
Malcom et al. 1992; Strong 1995). After the menopause the incidence 
in women increases to approach that of men at the same age. The 
relative protection of women is attributed to female sex hormones. 
17ß-estradiol inhibits apoptosis in ECs (Alvarez, Gips et al. 1997). 
Additionally, women show a lower LDL levels and higher HDL levels 
than men. 
Genetics Premature vascular disease undoubtedly runs in families, but there is 
no established pattern. In the absence of other risk factors, a history of 
myocardial infarction increases the risk of ischaemic heart disease in 
offspring by 20-30%. Inherited metabolic disorders (such as lipopathy 
and homocystinemia) are associated with increased risk for 
atherosclerosis. 
1.1.5.2 Atherogenesis 
Atherogenesis is a slowly progressive process (Stary 1989). Depending on their 
size and composition, lesions are divided into fatty streaks, early stages of lesions, and 
advanced stages of atherosclerosis called plaques. Intima-media thickening of the vessel 
wall commonly precedes definite atherosclerosis. Such precursor lesions of 
atherosclerosis may occur as early as adolescence, but the frequency of definite 
atherosclerotic lesions remains low until age 40 in men and onset of menopause in 
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women. 
Pre-existing atherosclerotic lesions may experience one of two different types of 
disease progression (Kiechl and Willeit 1999). The first main type of plaque growth is 
described as nonstenotic atherosclerosis. It is characterized by slow and continuous 
plaque extension, which usually affects several plaques simultaneously and rarely 
causes lumen obstruction >40%. Nonstenotic atherosclerosis relies on a cumulative 
exposure to well-established risk factors. It is mediated by a variety of complex 
biological step-by-step phenomena such as lipid-induced atherogenesis or SMC 
proliferation. Diffuse dilative atherosclerosis may be assumed as a final stage of this 
type of disease progression. Compensatory enlargement of the artery at the site of active 
atherosclerosis effectively preserves a near normal lumen or is even over-compensatory 
in the early course of disease. Vascular remodelling in response to atherogenesis 
restores normal blood flow and delays the onset of clinical symptoms. The second main 
type of plaque growth is a focal disease, which usually develops at sites of high 
hemodynamic stress. Rapid plaque expansion and insufficient or lacking vascular 
remodelling act synergistically in producing a significant lumen compromise. 
Atherothrombosis seems to be the main underlying pathomechanism. Consistent with 
the concept of underlying plaque thrombosis, stenotic atherosclerosis is a domain of a 
procoagulant state without a significant age trend. The risk profile consists of clinical 
conditions known to interfere with coagulation and markers of enhanced thrombotic 
activity. Actually, both types of atherogenesis develop and proceed independently from 
each other. Similarly, the degree of arterial stenosis does not predict the likelihood of 
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myocardial infarction. Plaque fissuring which results in infarction mostly occurs in 
relatively minor atherosclerotic plaques. 
Atherosclerotic plaques contain three major cellular components: the SMCs, 
which dominate the fibrous cap, the macrophages, which are the most abundant cell 
type in the lipid-rich core region, and the lymphocytes, which have been mainly 
ascribed to the fibrous cap (Ross 1999). Vascular SMC migration, proliferation, and 
matrix synthesis within the intima of medium-sized and large vessels is though to play a 
major role in atherosclerosis development in adult human subjects (Ross 1993). 
The most popular model (Ross 1999) summarized atherogenesis as following four 
steps: (a) EC damage leads to endothelium dysfunction (increased permeability and 
endothelial adhesion molecules), allows leukocytes migration into the artery wall. (b) 
Fatty streaks initiate with lipid-laden monocytes, macrophages (foam cells) and T 
lymphocytes and further increase by SMCs migration and proliferation, T -cell activation, 
foam cell formation, and platelet adherence and aggregation. (c) As fatty streaks 
progress to intermediate and advanced lesions, a fibrous cap is formed to shield the 
lesion from the lumen. The fibrous cap covers a mixture of leukocytes, lipid, and debris, 
which may form a necrotic core. (d) Unstable fibrous plaques rupture from a thinning 
fibrous cap can rapidly lead to thrombosis. (Figure 5) 
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Figure 5. Atherogenesis model 
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Figure 5. (A) Endothelial dysfunction as an initial step of atherosclerosis. (B) 
Fatty-streak formation. (C) Formation of an advanced, complicated lesion. (D) Unstable 
plaques are generated. (Ross 1999) 
1.1.5.3 Arteriosclerosis 
The arteriosclerotic lesion is characterized by SMC hyperplasia or hypertrophy 
and matrix protein accumulations in the intima and/or media with or without lipid 
deposition, resulting in thickening and stiffness of the arterial wall (Schwartz 1999). 
Biomechanical stress effects on the vessel wall during the development of all types of 
arteriosclerosis (Zou, Hu et al. 1998). 
Abnormal or pathological remodelling in conditions such as hypertensive vascular 
hypertrophy, atherosclerosis, bypass graft disease, restenosis, and transplant 
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vasculopathy involves inappropriate cellular and extracellular changes leading to 
narrowing or occlusion of the lumen. Autologous vein grafts are the only surgical 
alternative for many types of vascular reconstruction, but occlusion of grafts is common 
after bypass operations. Three pathological processes are primarily responsible for vein 
graft occlusion: (a) thrombosis as an early postoperative event; (b) intimal hyperplasia 
after a few months to a few years; (c) arteriosclerosis occurs usually after at least 3 
years (Bourassa, Campeau et al. 1982). The lesions and the pathogenic processes of 
graft-induced arteriosclerosis appear to have unique features. For instance, an extensive 
loss of ECs in the intima and a significant loss of SMCs in the media of grafted veins 
were observed (Kockx, Cambier et al. 1994). In addition, the development of vein graft 
arteriosclerosis is rather rapid compared to arteries. Hypercholesterolemia has been 
shown to be a significant risk factor for the development of vein graft atheroma. 
Evidence indicates that the rates of obstructive atheroma in grafted veins were highly 
correlated to preoperative serum cholesterol levels, and that lesion development was 
predicted by higher levels of plasma VLDL and LDL. Accordingly, patients with 
familiar hypercholesterolemia exhibit a high incidence of late vein graft occlusion after 
bypass surgery. However, the molecular mechanism, by which hypercholesterolemia 
initiates, promotes or perpetuates vein graft atherosclerosis, is largely unknown. 
1.2 Stem cells 
Stem cells represent one of the most promising areas in biological and medical 
research. All stem cells are defined as having two basic properties: prolonged 
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self-renewal and the potential to differentiate in vitro, via "progenitor cells", into 
differentiated somatic cells of many tissue types. Stem cells include two broad 
categories: embryonic stem cells (ES cells) and adult (somatic) stem cells (Gepstein 
2002). 
1.2.1 Embryonic stem cells 
1.2.1.1 Mouse ES cells 
The term "embryonic stem cells" originated from the isolation of pluripotent stem 
cell cultures from early mouse blastocyst by Evans and Kaufman (Evans and Kaufman 
1981) and Martin (Martin 1981) independently. ES cells are characterized by their 
capacity for prolonged undifferentiated proliferation in culture while maintaining the 
potential to differentiate into every cell type of all three germ layers, including germ 
cells (Bradley, Evans et al. 1984). 
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Figure 6. Scheme of early mouse embryonic development 
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Figure 6. Scheme of early mouse development depicting the contribution of early cell 
populations such as ES cells to the development of the three germ layers. (Keller 2005) 
When co-cultured on confluent feeder layers (Evans and Kaufman 1981; Martin 
1981) or cultured in medium containing leukemia inhibitory factor (LIF) (Smith, Heath 
et al. 1988; Williams, Hilton et al. 1988), mouse ES cells can be maintained in the 
undifferentiated state, otherwise they will spontaneously differentiate into embryonic 
structures. Recent development allows mouse ES cells culture with defined factors, such 
as LIF and bone morphogenetic protein 4 (BMP4) in the absence of serum or feeder 
cells (Ying, Nichols et al. 2003). 
The ability to derive multiple lineages from ES cells opens exciting new 
opportunities to model embryonic development in vitro for studying the events 
regulating the earliest stages of lineage induction and specification. In addition, ES cell 
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differentiation system is considered as a novel and unlimited source of cells and tissues 
for transplantation for the treatment of a broad spectrum of diseases (Keller 2005). The 
ES cells have been used extensively for creating mouse mutants for more than a decade, 
but their application in cell replacement therapy remains in its infancy. 
1.2.1.2 Human ES cells 
The human ES cell lines were first derived from the "inner cell mass" of blastocyst 
stage embryos that developed in culture within 5 days of fertilization of the oocyte 
(Thomson, Itskovitz-Eldor et al. 1998). The human ES cells dramatically elevated the 
interest in the cell therapy aspect of ES cells and moved this concept one step closer to 
reality. 
The regulation of human ES cell growth is less well understood and differs from 
that of the mouse in that LIF and STAT3 (signal transducer and activator of transcription 
3) appears to play no role in their self-renewal. The use of inactivated fetal mouse 
fibroblast feeder cells is essential to inhibit the spontaneous differentiation of human ES 
cells in vitro and removing the feeder cells markedly enhanced their differentiation 
(Thomson, Itskovitz-Eldor et al. 1998; Reubinoff, Pera et al. 2000; Daheron, Opitz et al. 
2004). With current protocols, human ES cells can be maintained on feeder cells in 
serum-free medium supplemented with basic fibroblast growth factor (bFGF) (Amit, 
Carpenter et al. 2000). human ES cells can also be grown in the absence of feeder cells 
if cultured on matrigel- or laminin-coated plates in medium supplemented with mouse 
embryonic fibroblast conditioned medium (Xu, Inokuma et al. 2001), which is a 
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relatively easy maintenance of human ES cells. Further studies are needed to clarify the 
molecular mechanism that regulates human ES cell self-renewal (Keller 2005). 
1.2.2 Embryonic stem cell differentiation 
ES cells can differentiate into specialized somatic cells in vitro and have shown 
many early embryonic development processes (Gepstein 2002). It has been reported that 
ES cells display a remarkable capacity to form differentiated cell types in culture 
(Keller 1995; Smith 2001), e. g. cardiomyocytes (Doetschman, Eistetter et al. 1985), 
hematopoietic progenitor cells (Doetschman, Eistetter et al. 1985), ECs (Risau, Sariola 
et al. 1988; Hristov, Erl et al. 2003), skeletal muscle cells and SMCs (Rohwedel, 
Maltsev et al. 1994; Drab, Haller et al. 1997; Itskovitz-Eldor, Schuldiner et al. 2000), 
neuronal and glial cells (Bain, Kitchens et al. 1995; Brustle, Jones et al. 1999), 
pancreatic islet cells (Soria, Roche et al. 2000), yolk sac (Doetschman, Eistetter et al. 
1985), adipocytes (Dani, Smith et al. 1997), chondrocytes (Poliard, Nifuji et al. 1995), 
melanocytes (Yamane, Hayashi et al. 1999), primitive endoderm (Abe, Niwa et al. 
1996), and several other tissue types (Keller 1995). These highlighted totipotency and 
self-renewal make ES cells a promising source for regeneration medicine 
(Yurugi-Kobayashi, Itoh et al. 2003). 
When removed from the factors that maintain them as stem cells, ES cells will 
differentiate and, under appropriate conditions, generate progeny consisting of 
derivatives of the three embryonic germ layers: mesoderm, endoderm, and ectoderm 
(Keller 1995; Smith 2001). Three general approaches are used to initiate ES cell 
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differentiation. All of these approaches are effective and have specific advantages and 
disadvantages and have been used to generate a broad spectrum of cell types from ES 
cells (Table 2). 
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1.2.2.1 Mesoderm-derived lineages 
Mesoderm-derived lineages, including the hematopoietic, vascular and cardiac are 
among the easiest to generate from ES cells and have been studied in considerable detail. 
Besides, the ES cell system also can differentiate to the skeletal muscle (Rohwedel, 
Maltsev et al. 1994), the osteogenic (Buttery, Bourne et al. 2001; zur Nieden, Kempka 
et al. 2003), the chrondrogenic (Kramer, Hegert et al. 2000), and adipogenic (Dani, 
Smith et al. 1997) lineages. All these in vitro development recapitulated its development 
in vivo, indicating that these populations progressed through normal differentiation 
progress. 
1.2.2.1.1 Hematopoietic differentiation 
There are many studies focus on the hematopoietic differentiation using the ES 
cells (Burkert, von Ruden et al. 1991; Schmitt, Bruyns et al. 1991; Keller, Kennedy et al. 
1993; Nakano, Kodama et al. 1994) since the discovery of the hemoglobinized cells in 
embryoid bodies 20 years ago (Doetschman, Eistetter et al. 1985). To date, methods 
have been established for selectively expanding multipotential cell populations, 
neutrophils, megakaryocytes, master cells, eosinophils, dendritic cells, and definitive 
erythroid cells from ES cells in culture (Keller 2005). 
In optimized culture conditions following serum induction, ES cells will undergo 
hematopoietic differentiation in a highly reproducible and efficient way, which can be 
easily monitored by gene expression patterns, the appearance of specific cell surface 
markers, and the development of clonable progenitor cells, so that investigation of the 
regulation of hematopoietic commitment become possible. 
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The progenitor derived from ES cells known as blast colony-forming cell 
(BL-CFC) gives rise to hematopoietic and vascular progenitors in methylcellulose 
culture in the presence of VEGF (Kennedy, Firpo et al. 1997; Choi, Kennedy et al. 
1998), proved the hypothesis that the hematopoietic and endothelial lineages develop 
from a common progenitor, the hemangioblast. However, the BL-CFC does not express 
hematopoietic and vascular markers, such as CD31, VE-cadherin, CD34, or c-kit 
(Fehling, Lacaud et al. 2003), indicating this progenitor is in the earliest stage of 
hematopoietic commitment. Also the ES cell-derived hematopoietic cells express EC 
markers (Flk-1, VE-cadherin and CD41) before the hematopoietic-specific marker 
(CD45) which presents on most fetal liver and adult bone marrow cells. BMP4 together 
with VEGF can support hematopoictic differentiation of ES cells in serum-free 
conditions (Nakayama, Lee et al. 2000; Park, Afrikanova et al. 2004). The development 
of the BL-CFC and hematopoietic progenitors is positively regulated by bFGF (Faloon, 
Arentson et al. 2000), VEGF (Nakayama, Lee et al. 2000; Park, Afrikanova et al. 2004) 
and serum-derived factors. 
Several studies have documented hematopoietic development in human ES cell 
cultures either through co-culture with stromal cells (Kaufman, Hanson et al. 2001) or 
the generation of EBs (Chadwick, Wang et al. 2003; Cerdan, Rouleau et al. 2004). 
While differentiation was serum-induced, hematopoietic development was augmented 
in the EBs by the addition to the cultures of BMP4, VEGF, and a mixture of 
hematopoietic cytokines (stem cell factor, Flt-3 ligand, interleukin-3, interleukin-6 and 
granulocyte colony-stimulating factor) (Cerdan, Rouleau et al. 2004). Under this 
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condition, hematopoietic induction is slower than observed in mouse ES cell 
differentiation cultures. Only the hemoglobin pattern changes were detected within the 
ES cell-derived erythroid lineages but no distinct primitive or definitive erythroid 
population was identified. Similarly, human hematopoietic development also expresses 
EC markers (Flk-1, VE-cadherin, CD31) before their maturation to CD45+ cells (Wang, 
Li et al. 2004). The findings from this limited number of studies indicate that it is 
possible to generate hematopoietic cells from human ES cells in culture and that the 
sequence of developmental events may reflect the onset of hematopoisis in the early 
embryo (Keller 2005). 
1.2.2.1.2 Vascular differentiation 
It has been discussed that the vasculogenic potential of ES cells could be 
specifically of use in tissue engineering for the induction of tissue vascularization 
(Levenberg, Golub et al. 2002). Endothelial development can also be detected in early 
yolk sac blood islands of the embryo (Haar and Ackerman 1971) and ES cell-derived 
BL-CFC, suggesting that development of the endothelial lineage in vitro recapitulates 
its development in vivo. ES cells differentiate in vitro to ECs through successive 
maturation steps with sequential expression of cell lineage-specific markers: Flk-1, 
platelet endothelial cell adhesion molecule (PECAM) and tie-2, tie-1 and VE-cadherin, 
and EC specific antigens MECA32 (Hallmann, Mayer et al. 1995) and CD34/MEC-14.7 
(Vittet, Prandini et al. 1996). A similar pattern was also observed when isolated Flk-1+ 
progenitors were re-cultured on type IV collagen-coated dishes or on OP9 stromal cells 
(Hirashima, Kataoka et al. 1999). 
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The Flk-1+ cells derived from ES cells can differentiate into both endothelial and 
mural cells in response to VEGF and PDGF-BB selection respectively, so that to suffice 
a vascular progenitor cells (VPCs) (Yamashita, Itoh et al. 2000). VEGF is a major 
growth factor for developing ECs and lack of VEGF will result in embryo death during 
embryonic vascular development. Several growth factors have been implicated in SMC 
differentiation, including transforming growth factors (TGF) ßl, ß3, and PDGF-BB, 
(Nakajima, Mironov et al. 1997; Hirschi, Rohovsky et al. 1998; Hellstrom, Kalen et al. 
1999; Chen and Lechleider 2004). The combinatorial effects of Flk-1 and transcription 
factor T -cell acute lymphocytic leukemia 1 (Tal-1) regulate cell fate choice in early 
development into hernatopoietic, endothelial and smooth muscle lineage (Ema, Faloon 
et al. 2003). Flk-1'1" mouse embryo cannot form both hematopoietic and endothelial 
cells, suggesting they share a common progenitor. Although Tal-1 is dispensable for 
initial endothelial development, it is required for later vascular remodeling. In the 
absence of Tal-1, ES cells favour the vascular smooth muscle development pathway and 
are unable to generate endothelial and hematopoietic progeny, while when expressed, 
they differentiate to endothelial and smooth muscle cells. Interestingly, in the absence of 
Tal-1, cell-to-cell interactions play an important role in the generation and maintenance 
of ECs in vitro (Table 3) (D'Souza, Elefanty et al. 2005). 
Table 3. Flk-1+ cell fate under different condition 
Cell types Adherent Aggregate 
Tal-1*'* ECs (CD31+, F1k-1+, VEcad -30% -60% 
SMCs (SMA+) -50% ~5% 
HSC (Gata-1) -+ 
Tal-1'l' ECs (CD31+, F1k-1+, VEcad+) 0.5% ~27% 
SMCs (SMA+) -70% -18% 
HSC (Gata-1+) -- 
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The functional capacity of the ES cell-derived VPCs has been evaluated both in 
culture (Doetschman, Eistetter et al. 1985; Bautch, Stanford et al. 1996; Yamashita, Itoh 
et al. 2000) and in animal models following transplantation. They can organize into 
vessel-like structures or incorporated into newly formed vessel in vitro and in vivo, thus 
participate in neovascularization (Marchetti, Gimond et al. 2002; Yurugi-Kobayashi, 
Itoh et al. 2003). 
Endothelial differentiation has also been demonstrated in human ES cell 
differentiation cultures. The cells that develop in these cultures express endothelial 
markers, form tube-like structures* in matrigel in vitro, and generate capillary structures 
when transplanted into severe combined immunodeficient mice (Levenberg, Golub et al. 
2002). 
1.2.2.1.3 Cardiac differentiation 
Development of the cardiomyocytes lineage progresses in ES cell differentiation is 
similar to development of the lineage in vivo. The presence of cardiomyocytes can be 
easily detected by the appearance of contracting cells, expression of cardiac genes, and 
electrophysiological measurements (Maltsev, Rohwedel et al. 1993; Hescheler, 
Fleischmann et al. 1997; Boheler, Czyz et al. 2002; Banach, Halbach et al. 2003). 
Because few antibodies are available for the isolation of cardiac progenitors, ES cells 
were genetically modified to express either drug-resistance (Klug, Soonpaa et al. 1996; 
Zandstra, Bauwens et al. 2003) or fluorescent genes (Kolossov, Fleischmann et al. 1998; 
Muller, Fleischmann et al. 2000; Hidaka, Lee et al. 2003) under the control of 
stage-specific gene promoters of cardiac development to enable specific cell selection 
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within the lineage. 
ES cell-derived cardiomyocytes selected for a-cardiac MHC expression could 
incorporate and survive in the hearts of dystrophic mice after direct transplantation 
(Klug, Soonpaa et al. 1996), providing the source of transplantable cells for the 
treatment of cardiovascular disease. Expression of VEGF in the cardiomyocytes prior to 
transplantation into hearts of mice with myocardial infarction shows increased cell 
survival and enhanced neovascularization and improved cardiac function (Yang, Min et 
al. 2002). Cardiomyocytes differentiation and maturation have also been demonstrated 
in human ES cell differentiation cultures, which are similar to that reported in vivo (Nir, 
David et al. 2003). Although the human ES cell-derived cardiomyocytes do not undergo 
maturation to the stage of adult cardiomyocytes, cells with electrical properties of nodal, 
atril, and ventricular cells have been identified (He, Ma et al. 2003). Recently, human 
ES cell-derived cardiomyocytes have been used in xenogeneic transplantation as 
"biologic pacemakers" for the treatment of bradycardia (Kehat, Khimovich et al. 2004), 
but the arrhythmia effect should be concerned. 
1.2.2.2 Endoderm-derived lineages 
The generation of endoderm derivatives, in particular pancreatic ß-cells and 
hepatocytes, has become the focus of many investigators in the filed of ES cell biology. 
The interest of their development derives from their clinical potential for the treatment 
of Type I diabetes and liver diseases, etc. ES cells have been successfully induced into 
pancreatic islets, hepatocytes, thyrocytes, lung, and intestinal cells but several obstacles 
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still impair the progress of generating endoderm-derived cell types, such as very low 
frequency of differentiated cells, markers specifity, and lack of specific inducers. Only 
when large numbers of highly enriched progenitors are available, can these ES 
cell-derived endoderm cells be used in clinical applications (Keller 2005) 
1.2.2.3 Ectoderm differentiation 
Most of ectoderm differentiation studies focus on neuroectoderm commitment and 
neural differentiation. Each of the relatively pure populations of three major neural cell 
types (neurons, astrocytes, and oligodendrocytes) of the central nervous system can be 
generated when cultured under appropriate conditions (Okabe, Forsberg-Nilsson et al. 
1996; Barberi, Klivenyi et al. 2003). The ability to generate different types of neurons 
from ES cells has dramatically raised the interest in repair of nervous system disorders 
by cell replacement therapy, one of which is Parkinson's. 
In addition to somatic tissues, several studies have documented the development 
of germ cells from differentiated ES cells (Lawson, Dunn et al. 1999; Hubner, 
Fuhrmann et al. 2003; Clark, Bodnar et al. 2004). Before the models can be widely used, 
it will be important to define the regulators that induce germ cell development. 
1.2.2.4 Modelling embryonic development with ES cell 
The studies of earliest stages of lineage development in ES cell differentiation 
highlight the importance of understanding these early events, as the inducing molecules 
used in the differentiation cultures dramatically influence the cell populations that 
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ultimately develop and different cell fate needs different set of conditions. When ES 
cells were cultured without LIF, they will spontaneously differentiate to primitive 
ectoderm. The brachyury-expressing cells are shown as a hypothetical primitive streak 
consisting of both posterior and anterior populations. BMP4 is shown to induce 
posterior mesoderm and skin. Low concentrations of activin/nodal induce more 
posterior populations and high concentrations induce endoderm (derived from anterior 
primitive streak). FGF is shown to play a role in neural induction, whereas Writ, BMP 
and activin are all implicated as inhibitors of the early stages of this pathway (Figure 7) 
(Keller 2005). 
Figure 7. ES cell differentiation fate 
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Figure 7. After the withdrawal of LIF, the ES cells will spontaneously differentiate into 
primitive ectoderm. With BMP4 or FGF stimulation, it will differentiate to primitive 
streak or ectoderm, respectively. The primitive streak will give the rise to mesoderm 
lineages or definitive endoderm when high concentration of Activin/Nodal is present. 
(Keller 2005) 
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1.2.3 Adult stem cells 
Many adult tissues have also been found to harbour adult stem cell populations in 
recent years, including brain (Bjornson, Rietze et al. 1999; Clarke, Johansson et al. 2000; 
Galli, Borello et al. 2000), heart (Matsuura, Nagai et al. 2004), skeletal muscle (Jackson, 
Mi et al. 1999), bone marrow (Ferrari, Cusella-De Angelis et al. 1998; Petersen, Bowen 
et al. 1999; Pittenger, Mackay et al. 1999; Brazelton, Rossi et al. 2000; Lagasse, 
Connors et al. 2000; Mezey, Chandross et al. 2000; Sanchez-Ramos, Song et al. 2000; 
Jackson, Majka et al. 2001; Orlic, Kajstura et al. 2001), and umbilical cord blood. These 
adult stem cells have generally been regarded as having the capacity to form only the 
cell types of the organ in which they are found. Recently they have been shown to 
exhibit an unexpected versatility (Anderson, Gage et al. 2001) but still relatively limited 
transdifferentiation abilities (Gepstein 2002). 
It was reported that bone marrow cells (BMCs) substantially contribute to the 
pathogenesis of vascular diseases, e. g. postangioplasty restenosis, graft vasculopathy, 
and hyperlipidemia-induced atherosclerosis. One hypothesis is distant stem cells, e. g. 
BMCs, sensed the injury, mobilized by stem cell factor (SCF) and granulocyte-colony 
stimulating factor (G-CSF), migrate to the infarcted region, replicate, differentiate, thus 
promote structural and functional repair of the infarcted heart after injected (Orlic, 
Kajstura et al. 2001). One article demonstrated side population cells (CD34"/low, c-kit+, 
Sca-1+) of HSCs in bone marrow have the cardiomyogenic potential and could 
contribute to the formation of functional tissue so that benefit patients with myocardial 
infarction (Jackson, Majka et al. 2001). But another study shows the HSCs do not 
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transdifferentiate into cardiac myocytes in myocardial infarcts (Murry, Soonpaa et al. 
2004). Intravenous injection of HSCs or muscle-derived stem cells into irradiated 
animals results in the reconstitution of the hematopoietic compartment of the 
transplanted recipients, the incorporation of donor-derived nuclei into muscle, and the 
partial restoration of dystrophin expression. Transplantation of different stem cell 
populations using the procedures of bone marrow transplantation might provide an 
avenue for treating diseases where the systemic delivery of therapeutic cells throughout 
the body is critical (Gussoni, Soneoka et al. 1999). 
In contrast to HSCs, Sca-1+ cells in the adult murine heart do differentiate into 
spontaneous beating cardiomyocytes and may contribute to the regeneration of injured 
hearts (Matsuura, Nagai et al. 2004). This represents an alternative source of 
functionally intact cardiomyocytes for the treatment of cardiovascular diseases. 
Most published papers use the term progenitor cells to describe circulating and 
bone marrow-derived cells (Szmitko, Fedak et al. 2003). Accumulating data indicate 
that circulating "endothelial" progenitor cells and bone marrow progenitor cells can 
transdifferentiate into other types of cells (Quaini, Urbanek et al. 2002; Badorff, 
Brandes et al. 2003; Yeh, Zhang et al. 2003). Because the term progenitor cells are 
heavily used at present, most paper use both stem/progenitor cells to describe this 
population of cells rather than use more accurate term stem cells. 
1.2.4 Vascular progenitor cells (VPCs) 
A number of studies demonstrated that VPCs, including endothelial and smooth 
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muscle progenitors, which are present in circulating blood and BMCs, have the capacity 
to proliferate, migrate, and differentiate into mature SMCs and ECs (Asahara, Murohara 
et al. 1997; Rafii 2000; Simper, Stalboerger et al. 2002; Hill, Zalos et al. 2003; Sata 
2003; Szmitko, Fedak et al. 2003), thereby contributing to vascular repair, remodelling, 
and atherosclerotic lesion formation (Vasa, Fichtlscherer et al. 2001; Assmus, 
Schachinger et al. 2002; Hill, Zalos et al. 2003; Rauscher, Goldschmidt-Clermont et al. 
2003). 
Abundant progenitor cells (Sca-1+ cells) in the adventitia can differentiate into 
SMCs that participate in lesion formation in vein grafts (Hu, Zhang et al. 2004). These 
progenitor cells could be a source of SMCs in neointima and might contribute to 
circulating smooth muscle progenitor cells. Several studies of animal models suggested 
that both vascular and blood progenitor cells may contribute to the vascular diseases 
(Han, Campbell et al. 2001; Hillebrands, Matter et al. 2001; Li, Han et al. 2001; Saiura, 
Sata et al. 2001; Shimizu, Sugiyama et al. 2001; Hu, Davison et al. 2002; Sata, Saiura et 
al. 2002). 
The numbers of VPCs in blood negatively correlated with risk factors of 
cardiovascular diseases(Vasa, Fichtlscherer et al. 2001; Hill, Zalos et al. 2003; Rauscher, 
Goldschmidt-Clermont et al. 2003), highlighting the potential role of these cells in 
cardiovascular diseases (Assmus, Schachinger et al. 2002). Recently, Xu's group has 
provided evidence that both ECs and SMCs in atherosclerotic lesions and neointima in 
mice are derived from stem/progenitor cells presented in blood or the vessel wall, which 
can differentiate into vascular cells and thus contribute to pathophysiology of vessel 
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wall as well as generation of microvascular structures in adult neoangiogenesis (Hu, 
Davison et al. 2002; Hu, Davison et al. 2003; Xu, Zhang et al. 2003). These findings are 
crucial for understanding the pathogenesis and establishing new therapeutic strategies 
for vascular diseases, i. e. stem cell-based therapy. 
1.2.5 Stem cells contribution in atherogenesis 
During last 20 years, lots of studies demonstrated the SMC phenotype difference 
between media and atherosclerotic lesions. Traditionally, it was believed that SMCs can 
migrate from the media into intima after a transition in their phenotype (Campbell and 
Campbell 1994) in response to PDGF released by injured ECs and aggregated platelets 
(Ross, Glomset et al. 1977). However, the investigation of the role of SMC phenotypic 
switching has met a number of difficulties and deficiencies, such as lack of 
differentiation markers and regulation factors. Although the phenotypic modulation of 
SMCs in atherogenesis and vascular repair was widely accepted, no obvious evidence 
shows the essential role of such phenotypic modulation for atherogenesis. 
Recent studies demonstrated that stem/progenitor cells from blood (Saiura, Sata et 
al. 2001; Hu, Davison et al. 2002), bone marrow(Han, Campbell et al. 2001; Hillebrands, 
Matter et al. 2001; Shimizu, Sugiyama et al. 2001), and the vessel wall (Hu, Mayr et al. 
2002; Hu, Zhang et al. 2004) may be responsible, at least in part, for endothelial repair 
and SMCs accumulation in lesions, suggesting that SMCs in lesions may result from 
differentiation of stem cells. A new theory of atherosclerosis pathogenesis point out the 
importance of progenitor cells during this process (Figure 8) (Xu 2006). First, ECs on 
59 
the arterial wall were damaged in specific areas and regeneration is carried on by 
endothelial progenitor cells (EPCs). The differentiation of neoendothelial cells into 
mature state takes several days. During this period, LDL deposits in the intima and 
blood mononuclear cells adhere to neoendothelial cells and migrate into the 
subendothelial space. Progenitor cells are also the source of smooth-muscle 
accumulation in atherosclerotic lesions. Circulating or adventitial progenitor cells 
migrate into the intima and differentiate into neo-SMCs. All known risk factors for 
atherosclerosis can also exert their effects on the vessel wall partially via increase in 
endothelial turnover, inhibition of differentiation and promotion of SMC and 
macrophage accumulation. Thus, the progenitor cells comprise the main cell source 
responsible for the formation of atherosclerotic lesions. 
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Figure 8. Stem cell theory of atherosclerosis 
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Figure 8. (A) Dead ECs are replaced by EPCs allowing increased endothelium 
permeability for monocytes and platelets (B) Monocytes migrate into subendothelial 
area and differentiate into macrophages to take up oxidized LDL, forming foam cells. 
(C) Progenitor cell-derived ECs have a shortened lifespan due to locally generated 
cytokines, free radicals, and risk factors. Endothelial cell death results in loss of 
endothelium in certain areas and vascular progenitor cells might migrate into the fatty 
streak. (D) Angiogenesis within atherosclerotic lesions occurs. The microvessels 
transport vascular stem or progenitor cells from the adventitia into the lesion. They 
differentiate into neo-smooth muscle cells within atherosclerotic lesions, which differ 
from medial smooth muscle cells and further develop into atheroma. (EC, endothelial 
cell; EPC, endothelial progenitor cell; oxLDL, oxidized LDL; neo-SMC, neo-smooth 
muscle cell; SMC, smooth muscle cell) (Xu 2006) 
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SMC progenitor Vasa vasorum 
1.2.6 Tissue engineering 
Vascular and coronary diseases are treated surgically using bypass procedures, 
whereby grafts of principally autogenous tissue (internal mammary artery, saphenous 
vein) and synthetic prostheses (polyethylene tetraphthlate, polytetrafluoroethylene, 
expanded polytetrafluoroethylene) are used (Kannah, Salacinski et al. 2005). Graft 
failure happens due to the difference in elasticity between the native blood vessel and 
the graft, creating turbulence and damaging the endothelial lining, resulting in thrombus 
formation, SMC proliferation and intimal hyperplasia (Sales, Salacinski et al. 2005). 
Tissue engineering offers the prospect of being able to meet the demand for replacement 
of heart valves, vessels for coronary and lower limb bypass surgery. Human 
stem/progenitor cells have the ability for self-renewal and potential to differentiate, 
which may be used to create artificial vessels for the bypass surgery. Circulating EPCs 
and bone marrow cells have been applied for single- and two-stage seeding into 
synthetic prostheses before implantation (Tiwari, Salacinski et al. 2001; Shirota, He et al. 
2003), which may endothelialize in vivo so that prevent thrombus formation and 
significantly improve patency. Mesenchymal stem cells (MSCs) are also used for 
orthopaedic therapeutic applications, especially bone formation and cartilage tissue 
repairing (Tuan, Boland et al. 2003). Difficulties are associated with finding suitable 
numbers of cells with high quality and purity, especially under emergency 
circumstances. For these reasons, the study on stem cell differentiation is urgent for the 
basic medical researchers. 
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1.3 Proteomics 
1.3.1 Definition of Proteomics 
Because the genomic sequence or the transcriptional profile cannot be directly 
correlated with actual protein levels or protein function (Humphery-Smith, Cordwell et 
al. 1997) and cellular processes are largely attributed to posttranslational modifications 
(PTM) (Hart 1992; Faux and Scott 1996), measuring protein levels has become 
imperative. Proteomics, defined as "the entire PROTEin complement expressed by the 
genOME" of an organism at a given time-point (Wilkins, Pasquali et al. 1996), was thus 
developed to study cell functions at protein level (Wilkins, Sanchez et al. 1996). 
The dynamic range of protein expression and modification makes the proteomics 
more complex than genomics. The appearance of entire genomes of a number of 
organisms, unified protein sequence database, and more powerful computers, make 
proteomics one of the fastest developed research area in the past few years. Proteomic 
techniques are ideal for clarifying quantitative protein changes in physiological and 
diseased conditions (Lopez and Melov 2002; Huber, Pfaller et al. 2003; Loscalzo 2003; 
McGregor and Dunn 2003) but additional experiments are still needed to clarify the 
functional consequence of the changes in the proteome. 
A typical proteomic analysis includes experimental design, sample preparation, 
separation, identification and quantification of many proteins simultaneously from a 
mixture. To date, two-dimensional electrophoresis (2-DE) is the most preferred method 
to resolve proteins mixture from cellular lysate (Banks, Dunn et al. 2000; Dunn 2000). 
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Supported by high throughput mass spectrometry (MS) techniques, which allow rapid 
identification and characterization of very small quantities of peptides, 2-DE allows 
analyzing thousands of protein species at the same time. 
1.3.2 Sample preparation 
Efficient and reproducible sample preparation methods are key to successful 2-DE 
(Rabilloud 1999; Molloy 2000). An effective sample preparation should reproducibly 
solubilize proteins of all classes including hydrophobic proteins, prevent protein 
aggregation and loss of solubility during focusing, prevent post-extraction chemical 
modification, remove or thoroughly digest nucleic acids and other interfering molecules, 
yield proteins of interest at detectable levels. 
Because of the significant mask effect of the most predominantly expressed 
proteins (enzymes, cytoskeletal proteins, albumin and immunoglobulin G) to the lower 
abundant but more important co-migrating proteins (such as signalling proteins) in the 
whole cell lysate, some reduction in the complexity of samples is needed to display the 
majority of protein species on 2-DE gels. Sample pre-fractionation techniques aim to 
reduce the diversity and complexity of protein mixtures, thus increase the concentration 
of distinct subsets of proteins that can be resolved. Different pre-fractionation methods 
based on different protein properties are developed, such as differential extraction 
(relative solubility, hydrophobicity), subcellular fractionation (co-localization within the 
cell), chromatography (affinity), preparative isoelectric focusing (net charge), etc. In 
general, pre-fractionation methods should be kept as simple as possible, target different 
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molecular properties and employ downstream compatible solutions to minimize sample 
loss and the chance of degradation and artifactual protein modifications. 
1.3.3 Two-dimensional electrophoresis (2-DE) 
2-DE is a powerful and widely used method for the analysis of complex biological 
samples. It was first introduced in 1975 (Klose 1975; O'Farrell 1975) and has a 
renaissance in the past decade. 2-DE separates proteins according to two independent 
properties in two step: the first-dimension, isoelectric focusing, separates proteins 
according to their isoelectric point (pI) in pH gradient gels; the second-dimension, 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), separates proteins according to 
their molecular weight (Mr) (Patton, Pluskal et al. 1990) (Figure 9). 
Figure 9. Principles of 2-DE 
Figure 9. (A) First dimention, proteins are separated by isoelectric point under electric 
field in pH gradient gels, called isoelectric focusing. (B) Second dimention, proteins are 
separated by molecular weight in polyacrylamide gels. 
pH gradients for IPG strips are created with sets of acrylamide buffers, 
CH2=CH-CO-NH-R, where the R contains either a carboxyl [-COOH] or a tertiary 
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amino group [e. g., -N(CH3)21. These acrylamide derivatives are covalently incorporated 
into polyacrylamide gels at the time of casting and can form almost any conceivable pH 
gradient (Righetti 1990). According to both theory and experiment, the difference in pI 
between two adjacent isoelectric focusing-resolved protein bands is directly 
proportional to the square root of the pH gradient and inversely proportional to the 
square root of the voltage gradient at the position of the bands. Thus, narrow pH ranges 
and high applied voltages yield high resolution in isoelectric focusing. 
A default current limit of 50µA per strip is intended to minimize protein 
carbamylation reactions in urea sample buffers. If different strips are run at the same 
time, the electrical conditions experienced by individual strips will be different, perhaps 
exposing some strips to more current than desired. Thus, strip length, pH range and 
protein amount should be the same to get similar electronic resistant so that to produce 
similar protein pattern in 2-DE gels. 
The percentage of acrylamide referred to as %T (total percentage of acrylamide 
plus corsslinker, N, N-methylene- bisacrylamide, at a ratio of 37.5: 1) determines the 
pore size of a gel. Higher %T means smaller pore size. The pores of the polyacrylamide 
gel sieve proteins according to the size. Using piperazine diacrylamide (PDA) instead of 
bisacrylamide can reduce silver staining background and give higher gel strength 
(Wiersma, Dos et al. 1994). Polymerization is typically accomplished using a chemical 
reaction with ammonium persulfate (APS) and N, N, N', N'-tetramethylethylenediamine 
(TEMED), which are the initiator and the catalyst respectively (Figure 10). 
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Figure 10. Chemical basis of the polymerization of polyacrylamide gel 
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Figure 10. Acrylamide and bisacrylamdie 
are polymerized with the catalysis of 
aminum persulfate 
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Homogeneous (single-percentage acrylamide) gels generally give excellent 
resolution of sample proteins with a narrow Mr range. Gradient gels are cast with 
acrylamide concentrations that increase from top to bottom so that allow proteins with a 
wide range of Mr to be analyzed simultaneously and sharpen the spots. However, 
gradient gel cannot obtain the same resolution as single-percentage gels optimized for a 
narrow Mr range. A proteomics experiment might start out with an 8-16%T gradient for 
global comparison. After interesting regions of the 2-D array have been identified, a 
new set of single-percentage gels may be run to study a particular size range of proteins. 
In single-percentage gel, the migration rate of polypeptides in SDS-PAGE is inversely 
proportional to the logarithm of its Mr. In gradient gels, log(migration distance) is 
inversely proportional to log(Mr). 
It is highly recommended casting and running 2-DE gels in batches to ensure 
minimum gel-to-gel variation within one experiment. 
2-DE gels are high-resolution protein arrays suitable for the separation of complex 
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protein mixtures. Conventional one-dimensional IEF and one-dimensional SDS-PAGE 
can only resolve approximately 100 of the most abundant proteins in a heterogeneous 
sample. 2-DE theoretically can separate the product of the number of proteins separated 
by each technique because protein charge and molecular weight are independent 
properties. Because of this highly parallel nature of the technique, hundreds to 
thousands of proteins can be visualized simultaneously, i. e. a single large-format 2-DE 
gel will resolve 1000 to 3000 different polypeptide spots. A 2-DE gel is also an array of 
authentic proteins, which preserves protein charge, molecular weight, and PTMs (such 
as phosphorylation, glycosylation, and oxidation) during electrophoresis. This allows 
direct analysis of protein isoforms that may be involved in particular metabolic or 
disease processes. 2-DE gels present different PTM of one protein because the different 
PTM forms have slightly different molecular weight and/or pI. The glycosylation 
normally resulted in a series of spot chain in the 2-DE gels, which are easily recognized 
while the phosphorylation and oxidation only present horizontal shifting of spots with 
almost the same Mr but huge difference in pI. In addition, the quantitative differences 
between proteins in mixtures can be determined from the intensity of spots on 2-DE gel 
images by statistic analysis so that the differences of protein expression levels can be 
directly detected. 
A simple method to view more protein spots is using a series of complementary 
narrow pH-range immobilized pH gradient strips. Commercially available narrow-range 
and micro-range pH immobilized pH gradient strips can resolve proteins in 1 pH unit, 
most focus on acidic area. 
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Another way to get the information of low abundant proteins is to develop more 
sensitive detection method. The sensitivity that is achievable in staining is determined 
by the amount of stain that binds to the proteins, the intensity of the colouration, and the 
difference in colouration between stained proteins and the background (signal-to-noise 
ratio). Currently, there are no stains that can span the approximately 7 or 8 orders of 
magnitude dynamic range of cellular proteins. However, improved methods of protein 
detection by using fluorescent dyes offer a broader dynamic range and linear 
quantitative range of detection than silver staining. For example, SYPRO Ruby 
(Molecular Probes), a ruthenium-based fluorescent dye that binds non-covalently to 
proteins in gels, provides sensitive (1-10ng) and linear (over 3 orders of magnitude) 
stain with high signal-to-noise ratio, and compatible with MS and Edman sequencing 
(Patton 2000). It also allows detection of glycoproteins, lipoproteins, low Mr proteins 
and metalloproteins that are not stained well by other stains. The linear dynamic range 
of fluorescent dye, which covers the ranges of both Coomassie blue and silver stains, 
potentially increases accuracy of quantitative comparisons. Because all stains interact 
differently with different proteins (Carroll, Ray et al. 2000), replicate gels should be 
stained with at least two different stains for critical analysis. Normally the gels should 
be stained by Coomassie blue or a fluorescent stain prior to silver stain. 
Unfortunately, standard 2-DE gels do not reflect a true representation of 
hydrophobic, highly insoluble, very basic (pI >9.5), very small (<l OkDa) and very large 
(>lOOkDa), as well as very low abundance proteins. Very high molecular weight 
proteins do not easily enter the gels and should be separated using one-dimensional 
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SDS-PAGE, preferably following sample pre-fractionation to enrich the targeted 
proteins. Improved second-dimensional separation of very low molecular weight 
proteins can be achieved if the Tris-glycine buffer is substituted by the Tris-tricine-SDS 
buffer system in combination with high percentage gradient gels. Also more sensitive 
mass spectrometers are needed for identifying small proteins. The process of 
solubilization and subsequent separation of hydrophobic proteins in immobilized pH 
gradient strips have been improved by combining more effective reducing agents such 
as the uncharged agent tributyl phosphine with more powerful chaotropes such as 
thiourea and surfactants such as linear sulfobetaine-type zwitterionic detergents 
containing a carboxyamido group to improve urea tolerance. The development of basic 
immobilized pH gradients up to pH 12 will facilitate easy, reproducible analysis of 
alkaline proteins as soon as the problem of reverse electroendosmotic flow 
(anode-directed water flow) is fully solved. 
1.3.4 Difference gel electrophoresis (DIGE) 
Traditional 2-DE is a well-established technique and a relatively simple visual 
method for mapping differences in protein expression. There are certain limitations to 
the universal use of this technology, such as irreproducible between gels and has 
significant system variability, low detection sensitivity and linearity. It is hard to get 
highly confident result of protein expression changes by using traditional 2-DE. 
Recently, the difference gel electrophoresis (DIGE) (Unlu, Morgan et al. 1997) is 
invented and widely used in proteomics studies. With this technology, samples are 
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labelled with one of three fluorescent dyes (Cy2, Cy3 or Cy5) and run in a single 2-DE 
gel. DIGE displays two or more complex protein mixtures labelled with different 
fluorescent dyes in a single 2-DE gel, offers the opportunity of direct comparison of 
different samples, thus eliminating gel-to-gel variations inherent to comparative gel 
analysis. Fluorescent labelling also renders 2-D DIGE much more quantitative than 
colorimetric methods. It has a linear dynamic range of 4 or 5 orders of magnitude, by 
contrast with the approximately 1 or 2 order range of Coomassie and silver stains. As 
regards sensitivity, Ing of standard protein is detected with Cy3/Cy5 fluorescent 
labelling. The use of a pooled internal standard labelled with Cy2 will further improve 
the accuracy of quantitative comparisons in differential display experiments by 
normalizing quantitative expression data across multiple samples run on several 2-DE 
gels. 
The CyDye DIGE Fluor minimal dyes have an N-hydroxysuccinimide (NHS)- 
ester reactive group and covalently attach to the epsilon amino group of protein lysine 
residues via an amide linkage. When coupled to a lysine residue, the dye will replace 
the positive charge of lysine with its own positive charge so that does not significantly 
alter the pI of the protein. Their size and charge match properties insure that same 
labelled protein from different samples have the same relative mobility regardless of the 
dye used to tag them. Their fluorescent signals are relatively stable during the labelling, 
separation, and scanning. The excitation and emission wavelengths of these dyes are 
resolvable, which contributes to the accuracy of DIGE. (Table 4) (CyDye DIGE fluor 
Data File, 18-1164-84, GE healthcare) 
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Table 4. CyDye DIGE Fluor minimal dyes characteristics 
Fluor Fluorescence Max. absorption Max. fluorescence Added molecular 
colour wavelength (nm) wavelength (nm) weight (Mr) 
Cy2 Green 491 509 434 
Cy3 Orange 553 569 466 
Cy5 Red 645 664 464 
The workflow of three-dye DIGE system is as simple as traditional 2-DE. Samples 
are washed and lysed in special DIGE lysis buffer without primary amino reagent, 
which may interfere with DIGE labelling. After adjust the pH of protein extracts to 8.5 
(optimal pH for DIGE labelling), one of three fluorescent dyes is added to samples in a 
dye/protein ratio at 400pmol dye/50µg protein. In this condition, only 3% of total 
amount of each protein is tagged. Normally the same amount of two different protein 
extracts are labelled with Cy3 and Cy5 and also a randomized crisscross experimental 
design is used in which two extracts are each tagged with Cy3 or Cy5 to eleminate 
differences between dyes. The pooled internal standard, which contains equal amounts 
of each protein extract, is labelled with Cy2, and is included in all gels to normalize 
protein abundance measurements across multiple gel experiments. After labelling, 
protein extracts and the pooled internal standard are mixed together and resolved in a 
single 2-DE gel. Protein spot patterns are visualized by alternately illuminating the gel 
with the excitation wavelengths for each of the three fluorescent dyes by fluorescence 
scanner. The 2-D images are analyzed by specific software, such as DeCyder. The 
intensity of protein spots on the 2-D images of different protein extracts are compared 
with the pooled internal standard, which reduces variation between gels and enables 
automated and accurate spot quantitation, gel-to-gel matching and statistical analysis 
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(Figure 11). In order to maximize the amount of protein available for MS, the total 
protein should by visualized using a post-staining method (silver staining or SYPRO 
ruby) (Monteoliva and Albar 2004). 
Figure 11. Workflow of three-dye DIGE system 
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Figure 11. Two samples are labelled with Cy3 or Cy5. Pooled internal standard is 
labelled with Cy2. Mixtures are co-separated by 2-DE and separate images are acquired 
for each dye by a fluorescence scanner. Quantitative analysis is carried out by DeCyder 
software. 
(http"//www5 amershambiosciences com/aptrix/upp009I9 nsf/Content/Proteomics+DlG 
E-Proteomics+DIGE+Applications) 
1.3.5 Biological mass spectrometry 
Before biological mass spectrometry was invented, protein characterization was 
mainly undertaken by Edman degradation. However, this approach fails in the analysis 
of subpicomole (10-12 M) quantities or N-terminally blocked proteins (which are very 
common in eukaryotes). By contrast, biological mass spectrometry can provide an 
analytical sensitivity down to the subfemtomole (10-15 M) level and is not restricted by 
terminal modifications. 
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In the basic workflow for protein identification, mass spectrometric analysis is 
preceded by site-specific proteolysis (Shevchenko, Wilm et al. 1996). Trypsin normally 
is the best enzyme for unknown substrate, which can generate peptides between 1000 to 
2000 Da in mass (most convenient mass range for biological MS). Next, the peptide 
ions are produced by matrix-assisted laser desorption/ionization (MALDI) or 
electrospray ionization (ESI). Gas-phase ions are separated according to their mass (m) 
to charge (z) ratio (m/z) (Corthals 2000) in various mass analyzers, such as 
time-of-flight (TOF), quadrupole, ion trap, or Fourier-transform ion cyclotron resonance 
(FT-ICR) analyzers. The optional fragments of selected ion species are generated either 
by postsource decay (PSD) or by collision-induced dissociation (CID). The signal 
intensity of different peptides are recorded by the detector, obtaining a spectrum that 
displays ion intensity versus m/z values (Roepstorff 1997; Mann, Hendrickson et al. 
2001). Experimentally obtained peptide masses from the MS spectrum are subjected to 
database searches. There are several websites for database searching with mass 
spectrometric data (such as http: //www. matrixscience. com, http: //www. expasy. ch/tools ). 
The common aspect of all search engines is the generation of a protein ranking based on 
peptide mass matching probabilities using various computer algorithms, such as 
PROFOUND, MASCOT, MOWSE and SEQUEST. 
In MALDI-ToF MS, the laser ionizes predominantly singly charged peptides 
within a mixture of sample and matrix. Because in an electric field the time a peptide 
takes to hit the detector is proportional to its ratio of mass to charge (m/z), peptides with 
different mass spend different time to reach the detector. The ion signal intensity versus 
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its m/z (measured as time of flight) was ploted (Figure 12). The spectra were analyzed 
and the prominent intensity peaks were labelled and searched against protein databases. 
i. e. using the MASCOT program (http: //wwwmatrixscience. com) (Perkins, Pappin et al. 
1999). One specific protein has one set of defined peptide masses after tryptic digestion, 
so called peptide mass fingerprint (PMF). By comparing the observed PMF with the 
calculated PMF, the probability (P) of the proteins that the observed match is a random 
event can be calculated and shown as protein score, which is -10*Log(P). A higher 
score means lower possibility that the observed match is a random event. Scores > 59 
are considered significant (p<0.05). 
Figure 12. A representative MALDI-ToF MS spectrum 
Recently, tandem mass spectrometry (MS/MS) is commonly used to get partial 
peptides sequence information so that obtain highly confident protein identifications. A 
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Figure 12. Spectrum was recorded by Kratos Axima CFR MALDI-ToF MS and ploted 
as relative intensity versus m/z. The m/z values of predominant peaks were labelled and 
subjected to database search. 
peptide isolated in the gas phase of the first mass scanning stage is further dissociated 
by PSD or CID. The peptide will be broken at where the peptide bonds formed and B 
ions and Y ions are generated (Figure 13). The masses of the peptide fragments are 
determined in the second mass stage with the resulting data used for sequence analysis 
and database searching (Yates, Eng et al. 1995). MS/MS instruments include 
combination of MALDI-MS with PSD or ESI-MS coupled to triple-quadrupole MS or 
ion-trap MS. The latter is commonly regarded to be superior to MALDI-PSD MS/MS 
because of its greater sensitivity and less complex fragment ion spectra. Notably, 
MALDI MS is more tolerant to sample contamination and less time consuming than 
MS/MS. 
76 
Figure 13. A representative LCQ MSIMS spectrum 
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Figure 13. (A) Different ions (a and x, b and y, c and z ions) can be generated during 
the MS/MS. (B) Peptide ion spectrum obtained by LCQ Deca XP Plus MS/MS 
(Thermo). B ions and Y ions were recognized and labelled with red and blue colour, 
respectively. 
With rapid development during these years, mass spectrometers have emerged as a 
core technology for peptide and protein structural analysis, forensic analysis, 
metabolomics, and pharmaceutical drug discovery. Newly developed orbitrap (Hu, Noll 
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et al. 2005) and electron transfer dissociation (ETD) (Syka, Coon et al. 2004) provides 
the abilities of obtaining high mass accuracy and analysing posttranslational 
modification by MS/MS, which facilitates us in the protein modification 
(phosphorylation, oxidation and glycosylation) research and analysis of complex blood 
samples or biomarkers. 
1.3.6 Alternative non-gel based approaches 
Proteomic research lacks an amplification method, such as polymerase chain 
reaction (PCR) in genomic sequencing and is limited by the absence of technologies 
that can perform a fast and high-throughput analysis of complex protein distributions 
automatically (Fey and Larsen 2001). Despite the potential and resolution of 2-DE, it 
remains a labour-intensive technique that requires qualified personal to obtain 
reproducible results. Also because of its limitation with respect to the resolution of 
proteins with extrem properties, alternative gel-free approaches are developed to avoid 
these disadvantages, such as multidimensional liquid chromatography (MDLC) online 
with ESI-MS/MS. 
1.3.6.1 Multidimensional liquid chromatography (MDLC) 
As an alternative to 2-DE approach, initial efforts have focused on MDLC to 
decrease sample complexity coupled with MS for protein identification (Lopez and 
Melov 2002). In LC/MS-based approaches, complex protein mixtures are digested in 
solution and fractionated by one or several steps of capillary chromatography and 
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analysed in a data-dependent manner by MS/MS. 
A clear advantage is that most of these methods are very automation-friendly. 
However, exhaustive analysis of the sequence data obtained demands powerful 
computing facilities. The MDLC can minimize the bias toward larger proteins with 
more numerous peptides but it is not quantitative and the purified peptides are not all 
ionized, leading to underrepresentation of these proteins. 
Major limitation of LC/MS-based methods is the difficulty in performing 
differential display analysis. To date, several different chemical, metabolic and 
enzymatic labelling techniques are used to perform non-gel MS-based quantatitive 
proteomics, such as stable isotope labelling with amino acides in culture media (SILAC), 
isotope-coded affinity tags (ICAT), iTRAQ, etc. For the comparison between different 
experiments or for the absolute quantification, reference peptides need to be introduced 
into MDLC system. 
1.3.6.2 SI LAC 
SILAC (Ong, Blagoev et al. 2002) is a simple and accurate approach for 
MS-based quantitative proteomic methods. Two groups of cells are grown in culture 
media that are identical except one contains the light form (labelled with 
1H, 12C and 
'4N) and the other contains the heavy form (labelled with 2H, 13C and 15N) of a 
particular essential amino acid (e. g. L-leucine or arginine). After several times of cell 
doubling, the cell population replaces the original form of the amino acid with the given 
light or heavy form of the amino acid. In this way, the same proteins from two different 
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samples will show the same chemical behaviour but with a difference in mass detectable 
by MS. Peptide peak intensities can be used for relative quantification of these proteins 
(Figure 14A). 
Figure 14. Scheme of SILAC 
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Figure 14. (A) Worke flow of SILAC. Different samples are cultured in medium 
contain light or heavy amino acid. Cell lysates are combined, digested and quantified by 
MS. (B) Comparison between different labelling methods. SILAC labels samples at the 
cell level, which has high efficiency and minimum artificial error. 
The advantages of SILAC are that it incorporates with nearly 100% efficiency and 
does not require multiple chemical processing and purification steps, thus ensures the 
two different samples have been subjected to same conditions throughout the 
experiment and allows using any method of protein or peptide purification without 
introducing error into the final quantitative analysis. 
1.3.6.3 ICAT 
Isotope-coded affinity tags (ICAT) represented the first labeling strategy for 
protein expression analysis using LC/MS approaches that facilitated high throughput 
proteomics and enabled relative quantitation between two samples for proteins that 
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contain the amino acid cysteine (Gygi, Rist et al. 1999). 
In this elegant and straightforward approach, two samples are labelled with 
structurally identical tags that differ in isotopic composition and contain a thiol-reactive 
group, which covalently links to cysteine residues, and a biotin moiety. The samples are 
combined, digested, and the labeled peptides are selectively enriched via biotin-avidin 
affinity chromatography. They can be separated, quantitated and identified by MS/MS 
(Figure 15). 
Figure 15. ICAT strategy 
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Figure 15. Proteins from different samples are labelled with different ICAT tags and 
then combined, digested, affinity separated and analyzed by MS/MS. Relative intensity 
of the peptides from different samples indicates the relative abundance of the original 
proteins. Protein identifications are obtained by the sequence analysis of the peptide. 
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One of the main advantages of ICAT is that it selects for peptides that contain 
relatively rare cysteine residues, which significantly reduces the complexity of the 
sample and its resulting mass spectrum. At the same time, this is also one of its 
drawbacks because many important proteins, including those with PTMs, do not contain 
cysteine. As a result, several groups have described alternative labeling strategies that 
target lysine and tryptophan residues or peptide N- or C- termini. 
1.3.6.4 iTRAQ 
Recently, an improved approach analogous to ICAT has been developed called 
iTRAQTM. The technique is based upon chemically tagging the lysine sidechain and the 
N-terminus of peptides by one of four isobaric N-hydroxysuccinimide ester tags with 
different mass of reporter moieties. Labelled samples are then combined, fractionated 
by nanoLC and analyzed by MS/MS. Database searching of the fragmentation data of 
the peptides results in the identification of the labelled peptides. Measurement of the 
intensity of the reporter ions enables relative quantification of the peptides in each 
digest (Figure 16). 
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Figure 16. iTRAQ principles 
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Figure 16. Peptides from different samples are labelled with different iTRAQ tags and 
then combined, fractionated and analyzed by MS/MS. Protein is identified by the 
sequence analysis of the peptide and their relative abundance derived from the relative 
intensity of the reporter moiety. (http: //www. proteome. soton. ac. uk/iTRAO. htm) 
Both ICAT and iTRAQ techniques require proteins to be chemically modified 
before they are mixed so that these techniques have the potential to introduce artifical 
sample preparation biases. 
1.3.7 Vascular Proteomics 
In the early times, when the absence of immobilized pH gradients and powerful 
computer-based analysis software limited the reproducibility and accuracy of 2-DE, 
only the most obvious changes were detected, i. e. albumin, fibrinogen, immunoglobulin 
G alpha-I antitrypsin, transferrin, haptoglobin, ApoA-I and ApoA-II, which were 
originated from the plasma and accumulated in diseased vessels (Stastny, Fosslien et al. 
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1986). Later studies reflect the compromised endothelial barrier function of diseased 
and aged vessels (Song, Stastny et al. 1985; Stastny and Fosslien 1992). Even with 
recent improvements in 2-DE and the availability of sophisticated software packages for 
gel analysis, proteomic characterization of atherosclerotic lesions remains a challenge. 
Many variations will influence the reliability of the differences found in proteomic 
analysis, e. g. the biological variability between human, the variability between 
heterogeneous composition of atherosclerotic lesions and the experimental variability of 
proteomic analysis. To overcome the limitations of heterogeneity in cell composition, 
laser capture microdissection may be used. However, collecting sufficient material for 
proteomic analysis is time-consuming and it is difficult to identify proteins from very 
limited amounts of tissues. The most feasible alternative is to use cultured cells and to 
study proteomic changes in response to cardiovascular risk factors, such as high levels 
of glucose, cholesterol, and mechanical stress. 
An interesting alternative approach to study atherosclerotic plaques with 
proteomic techniques was performed recently (Duran, Mas et al. 2003). Normal arteries 
and carotid endarterectomy samples were cultured in protein-free medium and the 
supernatant was analyzed by 2-DE. Proteins involved in reverse cholesterol transport, 
apoptosis, protein degradation and antioxidants were found to be released from plaques, 
which fits well in the pathophysiological context of atherosclerosis. However, it remains 
to be clarified whether these proteins are really secreted by plaques or just because of 
the diffusion difference between plaques and normal arteries. 
Several SMCs proteome maps have been published recently (McGregor, Kempster 
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et al. 2001; Dupont, Corseaux et al. 2005; Mayr, Mayr et al. 2005). Proteomic changes 
in venous SMCs exposed to hemodynamic stress were observed for proteins of the 
gelsolin family and actin filament remodelling. These indicate that mechanical 
stress-induced protein changes favour the generation of contractile stress fibbers 
(McGregor, Kempster et al. 2004). Proteomic techniques are applied to several 
functional studies on arterial SMCs, such as SMC hypertrophy and hyperplasia 
(Holycross, Peach et al. 1993; Patton, Erdjument-Bromage et al. 1995), 
aging-associated effect on SMC differentiation (Cremona, Muda et al. 1995), SMC 
apoptosis and proliferation (Guevara, Kim et al. 1999; Taurin, Seyrantepe et al. 2002) 
and vascular SMC response to oxidative stress (Liao, Jin et al. 2000). In a recent study 
combined proteomics and metabolomics to investigate the mechanism of the neointima 
formation in vein graft of protein kinase C delta (PKCS)-deficient mice (Mayr, Siow et 
al. 2004). 
Similarly, annotated 2-DE map of proteins expressed in human umbilical vein 
endothelial cells (HUVECs) has been published (Bruneel, Labas et al. 2003; Bruneel, 
Labas et al. 2005) and is available on the web at http: //www. huvgc. com. Data were 
accumulated from separations conducted on 3-10,4-7 and 4-6.5 pH gradients and 
displayed more than 1,000 protein species and more than 200 have been identified, 
providing a representative overview about the most abundant proteins in this important 
cellular model. 
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1.4 Oxidative Stress 
Oxidative stress is the disturbance in the prooxidant-antioxidant balance in favour 
of the former (Sies and Cadenas 1985). It induces cellular redox imbalance and leads to 
potential tissue damage (or altered cell responses) (Sies 1991). Cellular prooxidants 
include reactive oxygen species (ROS), reactive nitrogen species (RNS), lipid 
hydroperoxides (ROOH), paraquat, adriamycin, etc. There are two kinds of antioxidants: 
enzyme systems (SODs, catalase, glutathione peroxidase, peroxiredoxins) and radical 
scavengers (ascorbic acid, a-tocopherol, GSH, thioredoxin, selenium, etc). Also there 
are mainly two kinds of redox pairs: thiol redox (GSWGSSC; protein sulphydryls), and 
pyridine nucleotide redox (NADPH / NADP+, NADH / NAD+). 
1.4.1 Source of ROS 
ROS come from both endogenous and exogenous sources, including mitochondria, 
cytochrome P450 metabolism, peroxisomes, and inflammatory cell (neutrophils, 
eosinophils and macrophages) activation (Inoue, Sato et al. 2003). The oxygen free 
radical is the ultimate source of many ROS, which is mainly generated by the 
mitochondria. The electron transport chain leakage (ubiquinone and several iron-sulphur 
clusters transfer electron directly to oxygen instead of to the next electron carrier, shown 
in Figure 17) will generate superoxide anion radical (02'"), which form hydrogen 
peroxide (H202) and hydroxyl radical (HO). SOD-2 and glutathione peroxidase (GPx) 
is the main scavenger of 02' and H202 in mitochondria, respectively. Thus 
mitochondria represent the main source of the intracellular oxygen radicals (02' and 
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H202) in mammalian organs. 
Figure 17. Mitochondrial electron transport chain and ROS generation 
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Figure 17. Mitochondrial complex I and II transfer electrons from NADH and succinate, 
respectively, to ubiquinone. The reduced ubiquinol will pass electrons to complex III 
and becomes ubisemiquinone. Antimycin A inhibits the recycle of ubisemiquione back 
to ubiquinone. Accumulation of ubisemiquinone will generate superoxide. Site of 
inhibition are indicated with boxes. DPI, diphenylene iodonium; SOD, superoxide 
dismutase; TTFA, thenoyl trifluoracetone. (Chandel, Maltepe et al. 1998) 
NAD(P)H oxidase is considered as major source of ROS in vasculature and SMCs. 
In neutrophils, high levels of ROS generated by NAD(P)H oxidase are used to kill 
invading microorganisms, while nonphagocytic cells only produce low levels of ROS. 
NAD(P)H oxidase comprises several subunits, p22phox, gp91phox, p47pnox, p40Phox, 
p67ph°", and Rac. When cells are stimulated with cytokines, growth factors, and 
hormones (Sauer and Wartenberg 2005) (such as interleukin, TNF-a, PDGF, TGF-ß 1, 
VEGF), the cytosolic subunits (p47, p40, and p67) will translocate to the membrane 
subunits (p22 and gp9l), resulting in NAD(P)H oxidase activation and the oxidative 
burst. 
Besides the above main source of ROS generation, there are several other 
endogenous or exogenous sources of cellular oxidants, shown in Table 5 (Klaunig and 
Kamendulis 2004). 
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Table 5. ROS and reactive nitrogen species generation in the cell 
Cellular oxidants Source Oxidative species 
Endogenous Mitochondria 02'', H202, HO' 
Cytochrome P450 02'", H202 
Macrophage/inflammatory cells Of, NO', H202, OCl" 
Peroxisomes H202 
Exogenous Redox cycling compounds 02'' 
Metals (Fenton reaction) HO' 
Radiation HO' 
1.4.2 Oxidative effects 
All macromolecules can be damaged by ROS and lead to various diseases: (a) 
nucleic acid damage cause mutation and carcinogenesis (Nakabeppu, Sakurai et al. 
2006); (b) membrane damage by lipid peroxidation (Girotti 1998); (c) protein damage, 
deactive enzymes, receptors and transporters (Davies 2005); (d) polysaccharide damage, 
hyaluronic acid degradation caused arthritis (Jahn, Baynes et al. 1999). 
Glutathione (GSH, L-y-glutamyl-L-cysteinylglycine), first discovered in 1920s, is 
present in millimolar concentrations within most eukaryotic cells and involves in 
various biologic phenomena. Cellular GSH comes from glutathione synthesis, reduction 
of oxidized glutathione (GSSG), and luminal and plasma GSH transportation. It is an 
important protective antioxidant against free radicals and other oxidants by oxidation of 
the thiol (-SH) group of its cysteine residue. The functions of different GSH-related 
enzymes (GSSG reductase, thioredoxin-thioredoxin reductase system, thiol transferase, 
and protein-disulphide isomerase) demonstrate GSH's capability of catalysing protein 
thiol-disulphide interchange for defence against oxidative stress. Hence, GSH plays an 
important role in enzyme activation and regulation of complex biochemical processes. 
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The ratio of GSH to GSSG (GSH/GSSG) is crucial in cells (Cotgreave and Gerdes 
1998). GSH depletion and altered GSH/GSSG ratios can signal the development of 
oxidant-mediated tissue injury (White, Mimmack et al. 1986; De Vecchi, Lubatti et al. 
1998) and malformations during embryogenesis (Trocino, Akazawa et al. 1995). 
Sustained low level of GSH/GSSG can cause cell death. 
Thiol antioxidant 2-mercaptoethanol (2-ME) has been reported to support 
lymphopoiesis and to maintain a variety of other cell lines in vitro, including enhancing 
leukaemia and lymphoma cells proliferation, stimulation of the proliferation of murine 
spleen cells by enhancing the transport of L-cysteine into the TCA-insoluble pool, and 
benefit for the optimal maintenance of colony formation, cell proliferation and 
differentiation of marrow osteoprogenitor cells in primary human bone marrow 
fibroblast cultures (Inui, Oreffo et al. 1997). The uptake of the essential amino acid 
cysteine and consequently the maintenance of intracellular glutathione levels are 
enhanced by 2-ME. Furthermore, 2-ME causes lymphocytes to release thiols into the 
culture medium, which may protect the cells from oxidative damage (Neumann, Zierke 
et al. 1998) 
Many proteins have been shown to be sensitive to thiol disulphide interchange 
reactions, including enzymes involved in central and peripheral metabolism, signal 
transduction, protein catabolism, and anti-oxidative enzymes (Cotgreave and Gerdes 
1998). The activation of many proteins is related with the modifications induced on 
thiols by redox changes while some proteins lose their function after these 
modifications. 
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The peroxiredoxin (PRX) family represents a special type of peroxidases, as the 
protein is the reducing substrate itself. According to the number of cysteine in the active 
site and the reaction procedure, they can be classified into typical 2-Cys peroxiredoxin 
(PRX-1, -2, -3, -4), atypical 2-Cys peroxiredoxin (PRX-5) and 1-Cys peroxiredoxin 
(PRX-6). Upon oxidative stress, the cysteine in the active site is either oxidized to 
cysteine sulfenic acid or overoxidized to cysteine sulfinic acid (Manevich, Sweitzer et al. 
2002; Wood, Schroder et al. 2003) (Figure 18). While the first modification is DTT 
sensitive and therefore undetectable in 2-DE gels, the latter modification is DTT 
resistant and results in a charge shift towards a more acidic pI (Wagner, Luche et al. 
2002). Peroxiredoxin 6 only has one cysteine in the active site and is more easily 
oxidized than other peroxiredoxins so that it can be used as an indicator for high level of 
ROS in cells. 
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Figure 18. Redox modification of reactive cysteine in proteins 
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Figure 18. The main target of proteins under oxidative attack is the cysteine residue of 
the protein. Under physiological pH, a reactive cysteine can exist as thiolate anion, 
which more easily undergoes reversible oxidation either by the reaction with ROS 
(S-hydroxylation), NO radical (S-nitrosylation), or GSSG (S-glutathiolation). The 
reaction products are Prot-SOH, Prot-S-NO, or Prot-S-SG, respectively. Prot-S-OH can 
be transformed into Prot-S-SG when GSH exists to protect the protein from further 
oxidation into sulfinic acid (Prot-S02H) or sulfonic acid (Prot-SO3H), which are 
irreversible modifications of cysteine. (Filomeni, Rotilio et al. 2005) 
Oxidized proteins are recognized by proteases and completely degraded to amino 
acids in mitochondria. In cytoplasm, nucleus and endoplasmic reticulum of eukaryotic 
cells, these biological reactions occurre in the proteasome complex. When exposed to 
high oxidative stress or in the presence of declined proteolytic capacity (aging or certain 
disease states), the oxidized proteins will accumulated and cross-link with one another 
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or form extensive hydrophobic bonds and further impair the normal cell functions. 
Protein synthesis inhibitors shunt intracellular cysteine from protein synthesis to GSH 
synthesis (Ratan, Murphy et al. 1994), which increases the resistance to apoptosis. 
During the 1980s, most studies focused on the detrimental effects of oxidative 
stress in biological processes, such as necrotic cytotoxicity. Now it is well known that 
oxidative stress take up a role in the regulation of many physiological processes. 
Change of intracellular redox state becomes an additional signal that can regulate 
proliferation, cell cycle and apoptosis. 
Oxidants and oxidant-mediated regulation is involved in both mitogenesis and 
apoptosis. Exposure to oxidative stress can induce a wide series of responses ranging 
from increased mitosis to transient growth arrest, transient adaptation, permanent 
growth arrest, apoptosis, and necrosis (Davies 1999). These effects depend on the cell 
type, source, species, intracellular oxidants concentration and duration of stress (Figure 
19). 
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Figure 19. Cellular responses to oxidative stress 
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Figure 19. For terminally differentiated cells (A), highly proliferative tumour or 
transformed cells (C), oxidative stress can induce apoptosis or necrosis. For mitotically 
competent cells, lower level of oxidative stress can stimulate cell proliferation, but at 
higher oxidative stress, cells will die by apoptosis or necrosis (B). (Aw 1999) 
1.4.3 Apoptosis 
Apoptosis is a common mechanism of cell replacement, tissue remodelling, and 
removal of damaged cells (Chandra, Samali et al. 2000). The most prominent protease 
families implicated in apoptosis are caspases. About 100 proteins are potential caspase 
substrates and caspase-mediated proteolysis is the essential step of most apoptosis 
events. Caspases are cysteine-containing, aspartate-specific proteases which exist as 
zymogens in cytoplasm, mitochondrial intermembrane space, and nuclear matrix of 
virtually all cells. The activity of caspases is optimal under reducing environments. 
There are three proposed models for caspase activation. First, apoptosis can be 
induced by ligation of cell surface receptors, causes assembly of death-inducing 
signalling complex (DISC) and activates caspase-8, caspase-3 and other caspases, 
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ultimately cleaves various substrates. Second, cytochromc c released from 
mitochondrial forms apoptosomc with apoptotic protcasc activating factor I (Apal-I) 
and activates caspasc-9, caspasc-3 and caspasc-7 (Figure 20). The third pathway is 
initiated by cytotoxic cells, which release per(orin to attack the target cells. Perforin 
permeahalizes target cells, allowing granzyme into the cytosol, where it activates 
caspas-3 and induces apoptosis in tumour cells and inlccted cells (Chandra, Saniali et al. 
2000). 
Figure 20. Intracellular ROS-mediated apoptotic pathways 
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Figure 20. Apoptosis can be induced by H202-induced upregulation of Fas-Fact- system, 
leading to activation of caspase-8 and downstream caspases, and ultimately cleaves 
various substrates. Another pathway focuses on H-, O, -caused release of cytochrome c 
from mitochondria into the cytosol, which forams apoptosome and activates caspase-9 
and caspase-3. H-, O2 also activates nuclear transcription factors and induced cell death. 
GSH and SODs are the main cellular defenses against ROS. (Chandra, Saniali et al. 
2000) 
A role for oxidative stress in apoptosis has been elucidated by several independent 
observations. Apoptotic cell death can be switched to necrosis during oxidative stress by 
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oxidation of active site thiol group of caspases and oxidative-induced mitochondrial 
energy production failure. Oxidative stress can inhibit caspases activity directly by 
modifying cysteines of the active site or indirectly by activating caspase inhibitors 
(Chandra, Samali et al. 2000). During the oxidant-induced apoptosis, oxidative stress 
causes a mitochondrial calcium influx, which activates mitochondrial nuclease to 
degrade all mitochondrial polynucleotides. It is possible that partially digested 
mitochondrial polynucleotides play a similar role as released cytochrome c in activating 
pro-apoptotic enzymes (Cadenas and Davies 2000). 
1.4.4 Oxidative stress in pathophysiology 
A lot of biological and pathological processes and various diseases are caused by 
oxidative stress, most of which are linked with apoptosis, such as aging, inflammation, 
ischemia-reperfusion, carcinogenesis, AIDS, Parkinson's (Chandra, Samali et al. 2000). 
1.4.4.1 Aging 
Aging is progressive and endogenous. This ultimately determines the rate of aging 
and maximum life-span potentials (MLSPs) of different animal species. (Barja 2002). 
Many recent studies support that free radicals, especially those of mitochondrial 
origin, are related to the basic aging process (Weindruch and Sohal 1997; Beckman and 
Ames 1998; Barja 1999). Most investigations showed that endogenous antioxidants are 
negatively correlated with maximum longevity without normalization by metabolic rate 
(Perez-Campo, Lopez-Torres et al. 1998), suggesting that the rate of oxygen radical 
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generation in tissues in vivo at normal conditions must be lower in long-lived than in 
short-lived species. Overexpression of GSH reductase in Drosophila melanogaster did 
not prolong their MLSP (Mockett, Sohal et al. 1999) and aging rate does not seem to 
change in SOD- or GPx-knockout mice (Banja 2002), indicated that antioxidants do not 
slow the intrinsic aging process. However, antioxidants can non-specifically protect 
against many causes of early death, normally exogenous oxidative stress, so that 
increase animal survival, especially under suboptimum conditions. These can be very 
important to prevent early death in human populations living in suboptimum 
environment. 
Various studies point to two parameters that can elucidate the connection between 
aging and oxidative stress. One parameter is the rate of generation of ROS by 
mitochondria, which correlates better than the metabolic rate with maximum longevity. 
Long-live animals have a lower ROS generation rate and lower antioxidants level 
correspondingly. On the other hand, the higher oxidative stress caused more damage in 
the mitochondrial DNA (measured as 8-OHdG) of short-lived than in that of long-lived 
animals, which will be accumulated during aging and result in mitochondrial 
malfunction (Cadenas and Davies 2000). The other parameter is the degree of fatty acid 
unsaturation of tissue cellular membranes, measured as the total number of fatty acid 
double bonds (double bond index, DBI). DBI is negatively correlated with body size in 
mammals, which is due to the endogenous desaturase activities in different species. 
Thus, the low DBI of long-lived animals would protect them against lipid peroxidation 
(Banja 2002). 
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1.4.4.2 Cardiovascular disease 
Cardiovascular diseases are associated with increased oxidative stress in blood 
vessels. ROS are regarded as one of the risk factors for the pathogenesis of various 
cardiovascular diseases, including hypertension, atherosclerosis, restenosis, cardiac 
hypertrophy, and heart failure. 
ROS generated from NAD(P)H oxidases expressed in ECs and SMCs have been 
demonstrated to be involved in artherosclerosis, hypertension, heart failure, and diabetic 
vasculopathy (Sauer and Wartenberg 2005). Vascular SMCs contain potent 
oxidant-generating systems, acting as major superoxide source in the normal vessel wall 
(Griendling, Minieri et al. 1994). NADPH-derived superoxide and H202 are intimately 
involved in SMC growth and apoptosis. In ECs, laminar shear results in a transient 
activation of NADPH oxidase, whereas oscillatory shear causes a sustained increase in 
their activity. Superoxide in the vessel wall will react with NO and form peroxynitrite, 
thereby impairing endothelium-dependent vasodilatation, oxidize LDL, increase 
adhesion molecule expression in ECs, and activate matrix metalloproteinases 
(Griendling, Sorescu et al. 2000). oxLDL has been shown to produce multiple 
functional alterations that are potentially involved in atherosclerosis (Steinberg, 
Parthasarathy et al. 1989). Low concentration of oxLDL stimulates SMC proliferation, 
while higher doses can induce apoptosis (Dietrich, Hu et al. 2000). Although ROS serve 
as short-term second messenger in vascular cells, the long-term effect of ROS induces 
cellular damage and lesion formation. Notably, over-expression of the uncoupling 
protein 1 promotes atherosclerosis by triggering mitochondrial dysfunction, depleting 
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energy stores and increasing superoxide production (Bernal-Mizrachi, Gates et al. 2005), 
which is in agreement with our observations (Mayr, Chung et al. 2005). Thus, there is a 
growing body of evidence that mitochondrial energy metabolism and oxidative stress 
are intertwined in cardiovascular disease. 
1.4.5 Antioxidant therapy 
The antioxidant therapeutic interventions, which reduce the generation of ROS, 
include vitamin E-like antioxidant, native SOD, SOD mimic, and ON00' 
decomposition catalyst. 
Protective and beneficial roles of SOD have been demonstrated in broad range of 
diseases. SOD effectively attenuates both acute and chronic inflammatory responses in 
animal models of human diseases. Bovine erythrocyte SOD-1 attenuated the 
inflammatory injury of the colons and showed promising therapeutic efficacy with 
rheumatoid arthritis, osteoarthritis, and side effects associated with chemotherapy and 
radiation therapy. However, they have several disadvantages: (a) H0' formation from 
SOD product H202; (b) short circulating half-time, antigenicity, bell-shaped dose 
response curves, high susceptibility to proteolytic digestion; and (c) they cannot 
penetrate cells or cross the blood-brain barrier (Cuzzocrea, Riley et al. 2001). 
A series of low molecular weight SOD mimics, such as manganese-based 
metalloporphyrin complexes, have been developed to overcome some limitations of the 
native enzymes. An important and unique property of these SOD mimics is that they are 
stable to dissociation and oxidation in the Mn(II) oxidation state. In addition, they are 
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not deactivated by ON00' or H202 but possess catalase activity, scavenge ON00' and 
inhibit lipid peroxidation. Mn(II)-based SOD mimics shows cardio-protective effects in 
isolated heart preparations and in the in vivo models of myocardial ischemia/reperfusion 
injury (Cuzzocrea, Riley et al. 2001). The most profound effects of metalloporphyrin are 
depressing the neutrophil influx and reducing nitrotyrosine formation. Although they are 
very effective compounds in a wide range of oxidative stress paradigms, its potency and 
efficacy can be quite variable. One general limitation is their poor blood-brain 
permeability that complicates their use in neurodegenerative diseases (Cuzzocrea, Riley 
et al. 2001). 
Peroxynitrite decomposition catalysts also have anti-inflammatory function. 
Fe(III)-porphyrin complexes show a peroxynitrite isomerase activity, which measurably 
reduces the lifetime of peroxynitrite under physiologically relevant conditions. It is 
likely that peroxidase enzymes might function additionally as endogenous peroxynitrite 
isomerase, such as mammalian heure haloperoxidases. An active drug will duplicate 
peroxidase reactivity at critical sites where these enzymes are not present in optimal 
quantities (Cuzzocrea, Riley et al. 2001). 
It is well established that ROS formation plays a critical role in the development 
of atherosclerosis (Griendling and FitzGerald 2003; Griendling and FitzGerald 2003). 
Oxidative stress has been implicated in development of potentially proatherogenic 
actions on SMC proliferation, inflammatory cell recruitment, and redox-sensitive gene 
expression. Results of antioxidant trials, however, were disappointing (Touyz 2004). 
Several explanations have been put forward including the fact that many oxidation 
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pathways are not effectively inhibited by certain antioxidants, that under certain 
conditions both vitamin E and C can exhibit pro-oxidant rather than anti-oxidant actions 
(Hazell and Stocker 1997; Podmore, Griffiths et al. 1998) and that doses of antioxidants 
that are effective in reducing systemic oxidative markers may not cause a significant 
reduction in oxidative injury in the site of interest (Touyz 2004). 
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RATIONALE 
SMCs are the key player involved in vascular modelling and vascular disease 
pathogenesis. Initially, it was thought that SMCs from the media migrated, 
dedifferentiation into the neointima thereby contributing to lesion development. There 
are now compelling data to suggest that smooth muscle progenitor/stem cells participate 
in atherogenesis. With regards to this novel hypothesis, the true contribution of 
stem/progenitor cells may be wholly established by understanding the mechanisms of 
vessel wall integration, specific recruitment signals, homing, differentiation and 
adhesion properties of these precursor cells. In addition, these mechanisms may provide 
new insight into therapeutic strategies such as vascular tissue engineering. 
Protocols to differentiate stem cells, more specifically ES cells into vascular SMCs 
have already been established by many labs. Using proteomics in conjunction with these 
protocols, we believe immense knowledge on stem cell differention may be obtained. 
First, by analyzing protein profiles including expression changes occurring at various 
stages during ES cell differentiation into SMCs, key proteins involved in molecular 
pathways governing this process may be highlighted. Second, the end stage proteomic 
profile may be used to confirm that a fully functional vascular SMCs similar to that 
present in native tissue can be successfully acquired by in vitro differentiation. 
Hence, within the field of stem cell vascular biology, proteomics can provide 
insight into the new atherogenesis hypothesis, and give new perspectives into 
therapeutic strategies for controlling this process in vivo. In addition, proteomics such as 
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that described here may be a potential tool to validify SMCs derived in vitro and 
subsequently used for vascular tissue engineering strategies. 
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AIMS AND OBJECTIVES 
As we now know, the ES cells have potential to differentiate into many kinds of 
other cell lines and replenish different tissue types. The two main ES cell lines currently 
available are human ES cells and mouse ES cells. Thorough studies of the mouse ES 
cells' functions and differentiation mechanisms will be fundamental for any future 
medical applications of human ES cells. Although ES cells and differentiated progenitor 
cells are already applied in medical therapy, the mechanism of ES cell differentiation 
toward a specific lineage and the protein expression changes involved are still not fully 
elucidated yet. 
In the present thesis, I will utilize proteomic techniques to study the ES cell 
differentiation and try to find some important protein changes and investigate their 
function in detail. 
Aim 1: There are no reliable ES cell proteome maps before I started my PhD, 
which is the fundamental reference if we want to compare the protein changes during 
their differentiation. Mouse ES cell were cultured and maintained in an undifferentiation 
state by using LIF-1 in the culture medium. The whole ES cell lysate were separated on 
a large format 2-DE gels and the proteins were identified by MS. Thus a reliable mouse 
ES cell proteome map was obtained. 
Aim 2: Mouse ES cells were induced to differentiate into SMC-like cells via the 
Sca-1+ progenitor cells. ES cells were predifferentiated by withdrawal of LIF-1 and 
Sca-1+ progenitor cells were then isolated by magnetic beads. Further culturing Sca-1+ 
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progenitor cells in differentiation medium supplemented with PDGF-BB will induce 
their differentiation into ES cell-derived SMCs (esSMCs), which express SMC markers 
and their purity was verified by FACS. The proteome map of Sca-1+ progenitor cells 
was also generated using the same protocols as the ES cell proteome map. 
Aim 3: Differences in protein expression of esSMCs and aortic SMC were 
directly compared by using DIGE approach. The majority of protein changes between 
these two cell lines were identified by tandem MS and verified by immunoblotting. 
Further comparison using enzymatic assay, cell viability experiment and treatment by a 
panel of inhibitors were carried on to find out some part of the mechanisms involved in 
ES cell differentiation. 
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2 MATERIALS AND METHODS 
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2.1 Cell culture and differentiation 
2.1.1 Mouse ES Cells Culture 
The clonal mouse ES cell line ES-D3 (CRL-1934, ATCC) was derived from 
blastocysts of a 129S2/SvPas mouse. ES cells were maintained as described previously 
(Vittet, Prandini et al. 1996). Briefly, ES cells were cultured in complete stem cell 
medium (see Appendix) in a humidified incubator with 95% air/5% CO2 at 37°C. The 
medium is buffered with 1.5 g/L sodium bicarbonate, which requires 5% CO2 to 
maintain the medium in the optimal pH range for cells (C02 + H2O -ý H2C03 H H+ + 
HCO3"). Undifferentiated ES cells were passaged into flasks coated with 0.04% gelatine 
(G1393, Sigma) at a ratio of 1: 6 to 1: 10 every 2 days to maintain an undifferentiated 
state. The addition of 2-mercaptoethanol provides an alternative source of -SH groups to 
regulates the redox level and protect cells from oxidative stress. 
2.1.2 ES cells differentiation to esSMCs 
To induce differentiation, ES cells were cultured on type IV mouse collagen 
(Trevigen) coated flasks for 3-4 days in basic differentiation medium (DM) (see 
Appendix) as described before (Hirashima, Kataoka et al. 1999). Sca-1+ cells were 
sorted from the cell culture by magnetic labelling cell sorting (MACS) with anti-Sca-1 
magnetic microbeads (Miltenyi Biotec) as described in our previous studies (Hu, Zhang 
et al. 2004). Briefly, cells were detached with 0.05% trypsin/0.02% EDTA solution 
(Invitrogen) from flasks and incubated with the antibody-conjugated/coated microbeads. 
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With occasional agitation for 15min at 4°C, the bead-bound cells were selected with 
magnetic cell separator (Miltenyi Biotec) and cultivated in collagen type IV coated 
24-well plate. After cultured with DM for 4 days, these cells were subcultured into 
collagen type IV coated 6-well plate with DM. These cells were called Sca-l+ cells, 
passage 0. After 2-3 days, Sca-l+ cells were subcultured and expanded in gelatin-coated 
flasks with DM and passaged every 2 days and change medium every day (Xiao, Zeng 
et al. 2006) Sca-l+ cells, passage 15, were harvested for proteomic analysis. 
Sca-1+ cells, passage 5-7, were stimulated with DM contains lOng/mL PDGF-BB 
(P4056, Sigma) in gelatin-coated flasks. These cells will express SMC markers after 5 
passages, so called ES-derived SMCs (esSMCs), passage 0. esSMCs were continuously 
passaged every 2 days in DM at ratio of 1: 2 to 1: 3 and change medium every day (Xiao, 
Zeng et al. 2006). esSMCs, passage 5-12, were harvested for proteomic analysis and 
immunoblotting. (Figure 2 1) 
Figure 21. Schematic illustration of ES cell differentiation procedure 
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Figure 21. Dissociated mouse ES cells were 
predifferentiated in collagen IV-coated dishes in basic 
differentiation medium (DM) without LIF-1. Sca-1+ 
cells were isolated with Sca-1 magnetic beads. When 
stimulated by IOng/mL PDGF-BB for 5 passages, 
more than 95% of these cells express smooth muscle 
cell markers, and were termed ES cell-derived SMCs 
(esSMCs). 
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2.1.3 SMCs culture 
Mouse mature vascular SMCs of C57BL/6J mice (Charles River, Sulzfeld, 
Germany) were cultivated from their aortas as described previously (Hu, Zou et al. 
1999). Briefly, mouse thoracic aortas were removed and washed with RPMI 1640 
(Invitrogen) medium. The Intima and inner two thirds of the media were carefully 
dissected from the vessel under an anatomic microscope, cut into pieces and planted 
onto a gelatine (0.02%) coated plastic bottle. The bottle was incubated upside down at 
37°C in a humidified atmosphere of 95% air/5% CO2 for 3 hours, and then primary 
culture medium (see Appendix) was slowly addes. Cells were incubated at 37°C for 7 to 
10 days and passaged by treatment with 0.05% trypsin/0.02% EDTA solution. The ECs 
will not survive during following cultures and no contamination was detected previously. 
Then these cells were cultured in the exactly same condition as the esSMCs. SMCs 
were cultured in 0.04% gelatine-coated flasks with DM in a humidity incubator with 5% 
CO2 at 37°C, passaged every 2 days at ratio of 1: 2 to 1: 3 with medium changes every 
day. SMCs were harvested at the same time as esSMCs for proteomic analysis and 
immunoblotting. 
2.2 H&E staining 
Cells were plated in 8-well chamber slides (Nalge Nunc) and cultured in complete 
stem cell medium or basic DM for 3 days then fixed and stained with H&E. Briefly, cell 
were stained in Harris' haematoxylin for 5min and in Eosin for 3min, followed by 
extensive wash in running water, then mounted with coverslip and left to dry. 
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2.3 Flow cytometry analysis 
The procedure was similar as described previously (Hu, Zhang et al. 2004). Briefly, 
cultured cells were incubated with dissociation buffer (Invitrogen) for 3min and blocked 
with diluted serum (the species of serum is the same as the secondary antibody) for 
20min on ice. The single-cell suspension was aliquoted and incubated with either 
isotype control or SSEA-1 (MAB4301, Chemicon), Sca-1 (553333, BD Biosciences), 
smooth muscle a-actin (C6198, Sigma), calponin (C2687, Sigma), and SMMHC 
(M7786, Sigma) antibodies for 30min on ice and incubated with rabbit anti-mouse or 
anti-rat immunoglobulin conjugated with FITC (DAKO). Cell suspensions were 
analyzed with FACS scan flow cytometer (Becton Dickinson Immunocytometry 
Systems). Data analysis was carried out using CeliQuest software (Becton Dickinson). 
2.4 Immunofluorescence staining 
The procedure was similar as described previously (Hu, Zhang et al. 2004). Briefly, 
cultured cells were labelled with mouse monoclonal antibodies to stage-specific 
embryonic antigen-1 (SSEA-1; clone MC-480; Chemicon) and Sca-1 (clone E-13-161.7; 
BD biosciences), and visualized with rabbit anti-mouse immunoglobulin conjugated 
with fluorescein isothiocyanate (FITC; DAKO Cytomation) or phycoerythrin (PE; 
DAKO). 4', 6-diamidino-2-phenylindole (DAPI; Sigma) was used as counterstaining. 
Cells were mounted in Floromount-G (DAKO) and examined under fluorescence 
microscope (ZEISS). 
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2.5 Molecular biology methods 
2.5.1 RNA isolation 
The RNA extraction was performed according to the RNeasy Mini Kit (Qiagen, 
Valencia, CA, USA) protocol for isolation of total RNA from animal cells. All steps of 
the RNeasy protocol were performed at room temperature. The cells were washed and 
scraped off in PBS and centrifuged at 13.2krpm for lmin. Cell pellet was disrupted by 
RLT Buffer (350µL for small flask, 600 gL for medium flask) and mixed by pipetting to 
make sure no cell clumps are visible. The lysate was transferred directly onto a 
QlAshredder spin column placed in a2 mL collection tube, and centrifuged for 2min at 
13.2krpm. Same volume of 70% ethanol was added to the homogenized lysate and 
mixed well by pipetting. 700 µL of the sample were applied to an RNeasy mini column 
placed in a2 mL collection tube and centrifuged for 15 seconds at 13.2krpm. The 
flow-through was discarded and another 700 gL of sample were applied if there was any. 
700µL of RW1 buffer was added to the RNeasy column and centrifuged for l5sec at 
13.2krpm to wash the column. 500µL RPE buffer was pipetted onto the RNeasy column 
and centrifuged for 15 seconds at 13.2krpm to wash the column and another 500 µL 
RPE buffer was added to the column and centrifugation for 2min at 13.2krpm was taken 
place to dry the RNeasy silica-gel membrane. The flow-through and the collection tube 
were discarded. Finally, the RNeasy column was transferred to a clean 1.5 mL 
collection tube. 50 µl RNase-free water was pipetted directly onto the RNeasy column, 
following by centrifugation for lmin at 13.2krpm to elute the RNA. The RNA 
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concentration was determined by measuring the absorbance at 260nm in a 
spectrophotometer and diluted with RNase-free water and ethanol to make a final 
mRNA concentration of 0.25 µg/µL in 75% ethanol. 
2.5.2 Reverse transcription PCR (RT-PCR) 
RT-PCR was performed using Improm-IITM RT kit (Promega, Madison, WI, USA) 
with RNase inhibitor (Rnasin, Promega) and random primers (Promega). Control RT 
reactions were performed without reverse transcriptase. Total RNA was used as a 
template for cDNA synthesis. 
RT reaction system was set up by drying 10µL mRNA (0.25µg/. tL) at 70°C and 
mixing with 0.2µL random primer (0.5gg/tL) and 9.8µL distilled water. The sample 
was incubated at 70°C for 5min and cooled down on ice for 5min. 1 0µL of 5x RT Buffer, 
6µL of 25mM MgCI2,2µL of 25mM dNTPs, 1µL of Rnasin (40U/gL) and 2µL of 
reverse transcriptase (200U/µL) were added to make a final volume 50µL. The RT-PCR 
was carried on in thermal cycler (TC-312 or TC-412, TECHNE) with following 
program: preheat lid at 105°C, initial denaturation at 25°C for 5min, elongation at 42°C 
for 1.5 hours and final extension at 72°C for 15min. 
2.5.3 Polymerase chain reaction (PCR) 
The expressions of cell markers were detected by PCR using cDNA from RT-PCR 
as templete. Oligonucleotide primer sequences were as follows (Table 6) (Hu, Zhang et 
al. 2004): 
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Table 6. PCR primers for SMC markers 
Gene Name Primer Cycles 
hl-calponin 30 
forward 5'-GAT ACG AAT TCA GAG GGT GCA GAC GGA GGC TC-3' 
reverse 5'-GAT ACAAGC TTT CAA TCC ACT CTC TCA GCT CC-3' 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 25 
forward 5'-GAT ACA AGC TTT CAA TCC ACT CTC TCA GCT CC-3' 
reverse 5'-CGG AGT CAA CGG ATT TGG TCG TAT 3' 
smooth muscle a-actin (SMA) 30 
forward 5'-ACG GCC GCC TCC TCT TCC TC-3' 
reverse 5'-GCC CAG CTT CGT CGT ATT CC-3' 
smooth muscle protein 22 (SM22) 25-30 
forward 5'-GCA GTC CAA AAT TGAGAA GA-3' 
reverse 5'-CTG TTG CTG CCC ATT TGAAG-3' 
smooth muscle myosin heavy chain (SMMHC) 35-40 
forward 5'-GAC AAC TCC TCT CGC TTT GG-3' 
reverse 5'-GCT CTC CAA AAG CAG GTC AC-3' 
Glyseraldehyde-3-phosphate dehydrogenase (GAPDH) is a catalytic enzyme 
involved in glycolysis. The GAPDH gene is constitutively expressed in almost all 
tissues at high levels and has been widely used as an internal control in conventional 
RT-PCR to normalize the expression of a target gene. 
PCR was performed using PCR kit (Invitrogen) following the manufacturer's 
112 
instructions and reaction system was prepared on ice as follows: 0.50µL DNA template, 
1.25µL dNTP (2mM), 1.25µL lOx buffer, 1.00µL primer, 1.00µL MgCl2 (50mM), 
0.10µL Taq Polymerase, and 7.40µL distilled water. The total volume is 12.50µL for 
each reaction. After prepared the reaction system, tubes were put into thermal cycler 
(Model TC-312 or TC-412, TECHNE) and the following programs were used: preheat 
lid at 105°C, initial denaturation at 94°C for 4min, then 25-40 cycles of denaturing at 
94°C, annealing at 55°C and elongation at 72°C, each step for 50 seconds. The final 
extension step is at 72°C for 5min and then PCR products can be stored at 4°C. 
2.5.4 Agarose gel electrophoresis 
Agarose gels (2%) were prepared by dissolving 3g agarose with 150mL TAE 
buffer (40mM Tris-acetate, 2mM Na2EDTA, pH 8.3) diluted from 50x TAE stock 
(EC-872, National Diagnostics) by heating in a microwave oven. Then, the gel was 
cooled and 7.5µL ethidium bromide (10 mg/mL) was added to the clear gel solution to a 
final concentration of 0.5µg/mL. After mixing, the gel was poured into a plastic mould 
with casting combs in place and allowed to solidify for 20-30min. The tape and the gel 
casting combs were removed and the gel was placed in a horizontal gel electrophoresis 
apparatus (GIBCO BRL, Horizon® 11.14, Catalogue No. 11068-012). TAE 
electrophoresis buffer was added to the reservoirs until the buffer covered the agarose 
gel. PCR products were mixed with 6x loading buffer (30% Glycerol or 15% ficoll 400, 
0.25% Bromophenol blue, 0.25% Xylene cyanole) and loaded into the wells together 
with 1kb DNA ladder. Agarose gel electrophoresis was performed for 45-60min with 
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constant current of 130mA. Finally, the target fragments were visualized on a 
transilluminator UV light box (254 nm) and pictures were taken. 
2.6 Protein concentration measurement 
The protein concentration was determined using the Bradford method (Bradford 
1976). For lysates in urea buffer, 2.8µL of samples was mixed with 2.8µL of 0.1 M HCI, 
22.4µL of distilled water, and 972 µL of diluted Protein Assay Reagent (1: 5 dilution, 
Bio-Rad) was added and mixed well. For samples without urea, 2µL of samples was 
mixed with 998µL of diluted Protein Assay Reagent. Absorbance at 595nm was 
measured by SmartSpecTM 3000 spectrophotometer (Bio-Rad) and protein concentration 
was calculated based on the BSA standard curve. 
2.7 Proteomic techniques 
Figure 22. Proteomics workflow 
Semple 
Preparation 
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Figure 22. The brief workflow of proteomics used in this thesis. Black line indicates 
normal 2-DE, silver staining and MALDI-ToF MS process. Red line denotes DIGE and 
MS/MS procedure. 
2.7.1 2-DE 
The protocol used for proteomics analysis is similar to that described previously 
(Dunn 1997; McGregor, Kempster et al. 2001). Cells were washed by 2-DE wash buffer 
(see Appendix) then scraped and centrifuged at 4°C, 13.2krpm, for 1min. Cell pellets 
were lysed in 2-DE lysis buffer (see Appendix) for 30min and centrifuge at 13.2krpm at 
20°C for 20min. Supernatant was divided into aliquots and protein concentration was 
determined, then stored at -80°C. Extracts were diluted with rehydration solution (see 
Appendix) or subject to an additional clean-up procedure by using 2-D PrepReady 
CleanUp Kit (Bio-Rad) to remove contaminants interfering with isoelectric focusing. 
Protein samples were loaded on 18cm nonlinear immobilized pH gradient strips, pH 
3-10 (Immobiline DryStrips, GE healthcare). One hundred micrograms total proteins 
were used for analytical gels and 400µg for preparative gels. After 24 hours rehydration, 
strips were focused in MultiphorTM II isoelectric focusing System (GE healthcare) at 
20°C with following protocol: 400V for 5min, 500V for 15min, 750V for 15min, 1250V 
for 30min, 2000V for 20min, 2500V for 15min, 3500V for 15min, then 3500V for 18 
hours. Once isoelectric focusing was finished, the strips were equilibrated in 
equilibration buffer (see Appendix) with addition of I% (w/v) DTT for 15min, followed 
by a further 15min equilibration in the same buffer containing 4.8% (w/v) 
iodoacetamide in place of DTT. SDS-PAGE was performed using 12%T (total 
acrylamide concentration), 2.6% C (degree of cross-linking) separating polyacrylamide 
gels without a stacking gel, running with EttanTM DALTsix vertical electrophoresis 
system (GE healthcare). The second dimension was carried out at 10°C with the 
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following protocol: for 6 gels, 600V, 400mA, 12W for 15min, 15W for 30min, 100W 
for 4.5 hours, using 2x running buffer in the upper chamber and 1x running buffer in the 
lower chamber, until the Bromphenol Blue dye front had migrated off the lower end to 
the gels. The lower power step at the beginning allows all proteins in the IPG strip enter 
the polyacrylamide gel before separation by the following high power step. 
2.7.2 DIGE 
The design of a DIGE experiment is shown as Table 7. esSMCs and aortic SMC 
were labelled with Cy3 and Cy5 and crisscross experimental design was used to 
eleminate differences between dyes 
Table 7. DIGE experiment design 
Strip No. Cy Dye Sample 
20372 Cy3 
Cy5 
esSMC-X2 p6 
20373 Cy3 Aortic SMC p13 
Cy5 
20374 Cy3 
Cy5 
20375 Cy3 
Cy5 
20377 Cy3 
Cy5 
20378 Cy3 
Cy5 
S \1 I 
esSMC-R1 p5 
Aortic SMC p 15 
pol' r, I 
esMC-X5.2 p 11 
Si III 
esSMC-X5.1 plO 
14Cp16 
esSMC-X1 p6 
20379 Cy3 Sea 1p 112 
Cy5 esSMC-R2 p5 
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Aortic SMCs and esSMCs were washed with DIGE wash buffer (see Appendix) 
and lysed in DIGE lysis buffer (see Appendix). After centrifugation at 13.2k rpm for 
20min, the supernatant containing soluble proteins was harvested and protein 
concentration was determined. The fluorescence dye labelling reaction was carried out 
at a dye/protein ratio of 200pmol/50gg. After incubation on ice for 30min, the labelling 
reaction was stopped by scavenging non-bound dyes with 10mM lysine (L8662, Sigma) 
for 15min. Fifty micrograms whole cell extracts of each sample were labelled with 
fluorescent dyes (Cy3 or Cy5) and mixed with internal pool standard (labelled with 
Cy2). Samples were mixed with 2x buffer (see Appendix) and loaded on immobilized 
pH gradient strips (18cm, pH 3-10, nonlinear). As in traditional 2-DE, after rehydration 
overnight, samples were separated using the same protocols. Fluorescence images were 
acquired using the Typhoon variable mode imager 9400 (GE healthcare), visualized by 
silver staining and scanned in transmission scan mode using a calibrated scanner 
(GS-800, Bio-Rad) for documentation. Detailed protocols can be downloaded from our 
website (http: //www. vascular-proteomics. com). 
2.7.3 Silver Staining 
Protein profiles of 2-DE gels were visualized by silver staining using the 
PlusOneTM Silver Staining Kit, Protein (GE healthcare) with slight modifications, i. e. 
only formaldehyde was used in developing solution but no glutardialdehyde or 
formaldehyde in other solutions (Yan, Wait et al. 2000), which is compatible with mass 
spectrometry. 250mL of solutions are needed per large format gel. All steps should be 
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performed with gentle shaking of the glass dish and all solutions are made in double 
distilled water. 
Gels were taken out from the glass plates carefully and fixed in fixation solution 
(see Appendix) overnight. On the next day, gels were sensitized for 30min in sensitizing 
solution (see Appendix) followed by silver reaction for 20min in 0.25% w/v AgNO3 
with 3x5min washing between these two steps. After brief washing for 2 times, the 
developing solution (see Appendix) was added and the gels were shaken until protein 
spots are observed and before background becomes over-developed. The developing 
solution was replaced by the stopping solutions (see Appendix). After shaking for 10min, 
the gels were washed 3x5min, sealed in bag and kept in 4°C. 
2.7.4 Analysis of 2-DE gels 
Three different software have been used for 2-DE gel analysis, PDQuest (version 
7.0 for Mac, Bio-Rad), ProteomWeaver (version 2.1, Definiens) and DeCyder (version 
6.5, GE healthcare). 
PDQuest is used for generating Mr/pI grid image. After identification of the 
proteins, Mr/pI Grid was made according to most confident Mr/pI pairs. The observed 
Mr and pI of proteins were derived from this Mr/pI Grid. 
ProteomWeaver detects spots on each gel and make a match matrix to compare 
these gels in a short time. After the matching process, an overlay picture of two gel 
images can be obtained, orange colour for bottom gel and blue colour for top gel. One 
image is distorted to make the matched spot exactly on the top of another image. When 
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the matched spots in two images are nearly the same size and intensity, the spot on 
overlay picture will appear black. Using this strategy, the difference between two gels 
can be easily found. 
DeCyder is the dedicated software for DIGE gels. It automatically detects spots 
using the standard gel image among the three images of one gel and does not allow 
artificial modifications on spots boundary. One DIGE gel has unique spots boundaries 
on three CyDye images, which can present the different protein expressions on the same 
gel directly. By matching and normalising the internal standard from different DIGE 
gels, samples from different DIGE gels using same standard can be matched and 
compared, and statistical analysis can be carried on. Average ratio of the intensity of 
each protein spots and p values between two groups were calculated. Spots showing a 
statistically significant difference (2 fold increase or decrease, p<0.05) in intensity were 
excised for in-gel tryptic digestion. 
2.7.5 In-gel tryptic digestion 
At the beginning, we used manual digestion according to a published protocol 
(Shevchenko, Wilm et al. 1996). Silver-stained spots were picked and washed with 
50µL 100mM ammonium bicarbonate (ABC, A6141, sigma) followed by 200µL 
acetonitrile (ACN, 27071-7, Aldrich) twice. After dried in Speed Vac for 5min, gel 
pieces were soaked in 50µL lOmM DTT (D9779, Sigma) in 100mM ABC for 30min at 
56°C followed by 50µL 50mM iodoacetamide (11149, Sigma) in 100mM ABC for 
30min at room temperature to reduce disulfide bond and alkylate cystaine residues. 
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After washed with 100µL 100mM ABC, 200µL ACN, 100µL 100mM ABC, 200µL 
ACN twice sequentially and dried in Speed Vac for 5min, gel pieces were treated 
overnight at 37°C with 50µL trypsin (20µg/mL in 50mM ABC, V5111, Promega). 
Peptide fragments were recovered by sequential extractions with 100mM ABC and 
extraction solution (see Appendix) twice, each for 20min. Extracts were combined 
together, lyophilized, and resuspended in 10µl 0.1% (v/v) trifluoroacetic acid (T0274, 
Sigma). The peptides solution was desalted with µC-18 ZipTip (Millipore) according to 
the manufacturer's instruction and spoted on MALDI plate (Kratos, Manchester, UK). 
Now the in-gel digestion was performed with an Investigator ProGest (Genomic 
Solutions) robotic digestion system according to published methods (Shevchenko, Wilm 
et al. 1996; Wilm, Shevchenko et al. 1996; Perkins, Pappin et al. 1999; Yan, Wait et al. 
2000). Briefly, silver stained gel slices were destained with 50µL of destaining solution 
(see Appendix) for 15min then washed with 100µL ddH2O 2x 10min then with 100µL 
25mM ABC for 10min. All solutions were purged by N2 and gels were dehydrated in 
50µL ACN and neutralized with ABC then shrinked with another 100µL of ACN. The 
gels were reduced in 30µL DTT (10mM in 50mM ABC) at 60°C for 10min and cooling 
for 20min then alkylated in 30µL iodoacetamide (50mM in 50mM ABC) for 15min. 
After washed with 40µL of 50mM ABC for 10min and shrinked with 50µL ACN for 
2x 15min, trypsin solution was prepared (see Appendix) and 15µL of trypsin solution 
was added to each well and digestion was carried on at 37°C for 7.5 hours, 10µL of 
ddH2O was added after 1.5 hours of digestion to cover the gels. After the reaction, 1 0µL 
of 25mM ABC, 20µL of ACN and 20µL of 10% formic acid were consequently added 
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and each incubation were 10min. after final extraction by 20µL ACN for 15min and 
30µL of ACN for 15min, all the solution were purged into collection plate and the 
digestion is finished. The plate was lyophilized and digestion products were 
resuspended in 15 µL of 0.1% formic acid and ready for MS. 
2.7.6 MALDI-ToF MS 
MALDI-MS was performed using an Axima CFR spectrometer (Kratos). The 
instrument was operated in the positive ion reflectron mode. 1µl of sample and 1µL of 
matrix (see Appendix) were applied to MALDI plate. The spectra were recorded and 
analyzed by Kompact software (version 2.3.4, Kratos) and the prominent intensity 
peaks were labelled and internally calibrated using trypsin autolysis products 
(monoisotopic masses at m/z = 842.51, m/z = 1045.56, and m/z = 2211.10). Their 
peptide masses were searched against SwissProt databases using the MASCOT program 
(http: //wwwmatrixscience. com) (Perkins, Pappin et al. 1999). One missed cleavage per 
peptide was allowed and carbamidomethylation of cysteine as well as partial oxidation 
of methionine were assumed. Protein scores greater than 59 were considerd significant 
(i<o. 05). 
2.7.7 Q-ToF MS/MS 
Mass spectra were recorded using a Q-ToF mass spectrometer (Micromass) 
interfaced to a Micromass CapLC capillary chromatograph. Samples were dissolved in 
0.1% formic acid, injected onto a 300µm x 5mm Pepmap C18 column (LC Packings), 
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and eluted with an acetonitrile/0.1 % formic acid gradient. The capillary voltage was set 
to 3500V, and data-dependent MS/MS acquisitions were performed on precursors with 
charge states of 2,3, or 4 over a survey mass to charge range of 540-1000. The collision 
gas was argon, and the collision voltage was varied between 18V and 45V depending on 
the charge-state and mass of the precursor. Initial protein identifications were made by 
correlation of uninterpreted tandem mass spectra to entries in SWISS-PROT and 
TREMBL, using ProteinLynx Global Server (V 1.1, Micromass). 
2.7.8 LCQ ion-trap MS/MS 
Following enzymatic degradation, peptides were separated by capillary liquid 
chromatography on a reverse-phase column (BioBasic-18,100mm x 0.18mm, particle 
size 5pm, Thermo Electron Corporation) and applied to a LCQ ion-trap mass 
spectrometer (Finnigan LCQ Deca XP Plus, Thermo Electron Corporation) interfaced 
with a Finnigan Surveyor autosampler (Thermo Electron Corporation). The peptides 
were eluted using an acetonitrile/0.1 % formic acid gradient. Acetonitrile concentration 
was increased gradually from 5% to 80%. Spectra were collected from the ion-trap mass 
analyzer using full ion scan mode over the mass to charge range 300-1800. MS-MS 
scans were performed on each ion using dynamic exclusion. Database search was 
performed using TurboSEQUEST program (BioWorks Browser v3.2, Thermo Electron 
Corporation) against UniProt database. Protein probabilities were calculated in the 
comparison of esSMCs and aortic SMCs. Following filter was applied: for charge state 
1, Xcon > 1.50; for charge state 2, Xoo, r > 2.00; for charge state 3, Xcon > 2.50. 
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2.8 Immunoblotting 
Immunoblotting was performed as described previously (Li, Hu et al. 1999; Li, Hu 
et al. 2000). Cells were washed with cold PBS and scraped on ice. After lysis in RIPA 
lysis buffer (see Appendix) for 30min at 4°C and centrifuged at 13.2krpm at 4°C for 
20min, supernatant was collected and the protein concentration was determined using 
Bradford method. Samples were stored at -20°C. Cell extracts were mixed with 1/4 
volume of 5x Laemmli buffer (see Appendix), denatured at 96°C for Smin and a quick 
spin was following. 50µg protein samples were loaded on each lane of Novex 
Tris-Glycine Gel (4-20%, 1.0mm x 10 wells, Invitrogen) and electrophoresed at 125V 
constant voltage for 2.5 hours. When the Bromphenol Blue dye front reaches the end of 
the gel, electrophoresis was terminated and proteins were electrotransferred from gel to 
nitrocellulose membrane at 25V constant voltage for 2.5 hours in transfer buffer (see 
Appendix). The membranes were labelled as appropriate and blocked with 5% 
PBS-milk for 1 hour at room temperature or overnight at 4°C. Specific primary (Table 8) 
and corresponding secondary antibody (both in 5% PBS-milk) were applied to the 
membrane in turn and incubated at room temperature with gentle agitation for 1 hour, 
wash with PBS for 3x5min between two incubations. After washing with 0.05% Tween 
in PBS for 3x5min, ECL Western Blotting Detection Reagents (RPN2209, GE 
healthcare) were applied for lmin. The membranes were drained from excess ECL 
solution and sealed in sample bags. Hyper film was exposed by membranes and 
developed in developing solution (Kodak GBX developer/replenisher, P7042, Sigma) 
and fixation solution (Kodak GBX fixer/replenisher, P7167, Sigma). 
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Table 8. Antibodies used in immunoblotting. 
Antibody Company Cat No Dilution 
Actin Santa Cruz sc-1616 1: 1000 
Catalase Abcam ab1877 1: 3000 
Crystallin a/ß (HSP20) Abcam ab13497 1: 1000 
Heat shock protein 27 (HSP27) Santa Cruz sc-1049 1: 1000 
Heat shock protein 60 (HSP60) Stressgen SPA-807 1: 400 
Heat shock protein 70 (HSP70) Stressgen SPA-810 1: 100 
Heat shock protein 90 (HSP90) Santa Cruz sc-7947 1: 300 
Herne oxygenase 1 (HO-1) Santa Cruz sc-10789 1: 200 
Herne oxygenase 2 (HO-2) Santa Cruz sc-11361 1: 1000 
Myosin light chain-1 (MLC-1) Abcam ab680 1: 1000 
Peroxiredoxin 1 (PRX-1) Lab Frontier LF-PA0001 1: 2000 
Peroxiredoxin 2 (PRX-2) Lab Frontier LF-PA0007 1: 2000 
Peroxiredoxin 3 (PRX-3) Lab Frontier LF-PA0030 1: 2000 
Peroxiredoxin 6 (PRX-6) Abcam ab16824 1: 1000 
Peroxiredoxin-S03 (PRX-S03) Lab Frontier LF-PA0004 1: 2000 
Peroxiredoxin 6-SO3 (PRX6-SO3) Lab Frontier LF-PA0005 1: 2000 
Superoxide dismutase [CuZn] (SOD-1) Santa Cruz sc-11407 1: 100 
Superoxide dismutase [Mn] (SOD-2) Upstate 06-984 1: 500 
a-Tubulin Abcam ab7750 1: 100 
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2.9 Total reactive oxygen species (ROS) measurement 
The oxidative fluorescent dyes dihydrorhodamine 123 (DHR123, D632, 
Molecular Probes) were used to evaluate in situ production of ROS by use of a method 
described previously (Miller, Gutterman et al. 1998). DHR123 are freely permeable to 
cells and are oxidized to hydrorhodamine in the presence of ROS and labels proteins in 
cytoplasm with green fluorescence. Cells were incubated with 10µM DHR123 for 1 
hour, washed with PBS and lysed in lysis buffer (see Appendix). The cell lysates were 
sonicated for 15 seconds then 30 seconds and centrifuged at 13.2krpm for 20min at 4°C. 
The supernatant were analyzed at excitation and emission wavelengths of 502 and 
523nm, respectively, by FusionTM universal microplate analyzer (Packard). Protein 
concentration was determined by the Bradford method. The fluorescence intensity was 
expressed as relative fluorescence units (RFU) per gg protein. 
2.10 Mitochondrial superoxide and ROS measurement 
MitoSOXTM Red mitochondrial superoxide indicator (M36008, Molecular Probes) 
is live-cell permeant and is rapidly and selectively targeted to the mitochondria. Once in 
the mitochondria, it is oxidized by superoxide but not by other ROS- or reactive 
nitrogen species (RNS)-generating system and exhibits red fluorescence. Hence it can 
be used for highly selective detection of superoxide in the mitochondria of live cells 
(http: //probes. invitrogen com/media/pis/mp36008 pd fl. Cells were cultured in 24-well 
plates, change medium after 24 hours. After 48 hours, cells were pretreated with normal 
medium, 20µg/mL antimycin A or 10µM rotenone for 3 hours and incubated with 
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2.5µM MitoSOXTM Red mitochondrial superoxide indicator and 10µM DHR123 in 
HBSS (14025-092, Invitrogen) for 30min. After washed with HBSS, plates were 
scanned on a fluorescence scanner (Typhoon 9400, GE healthcare), excitation/emission 
wavelengths 532nm/580nm for MitoSOX and 488nm/520nm for DHR123. 
Fluorescence intensity was quantified using the ImageQuant software (Molecular 
Dynamics) and normalized with aortic SMC control. 
2.11 ATP concentration measurement 
ATP concentration was determined by using a bioluminescence assay as described 
previously (Jenner, Ruiz et al. 2002). The ATP assay uses luciferase extract of firefly 
tails and depends on the detection of the bioluminescence produced by it in the presence 
of ATP. ATP levels in samples can be calculated because the amount of light produced is 
proportional to the amount of ATP. Cells were cultured on 6-well plate (2.5 x 105 
cells/well for SMC and 5X105 cells/well for esSMC), change medium after 24 hours. 
After 48 hours, cells were washed briefly with cold PBS twice. Cold trichloroacetic acid 
(TCA, 6.5% w/v) was added to each well (1mL/well) and incubated on ice for 10min. 
TCA extracts were transferred into eppendorf tubes. 10µL sample or acid ATP standard 
was added to 140µL of reaction buffer (see Appendix) and mixed with 50µL of firefly 
lantern extract solution (lmg/mL, F3641, Sigma). Bioluminescence was measured by 
luminescence plate reader (FusionTM universal microplate analyzer, Packard). Adherent 
cell protein was solublized by adding 1mL of 0.5M NaOH and incubating for 1 hour on 
ice. Protein concentrations were determined using Bradford method. ATP concentration 
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was adjusted for protein concentration and expressed as µmol per gram protein. 
2.12 GSH concentration measurement 
The fluorometric method for determination of GSH is described previously 
(Hissin and Hilf 1976; Jenner, Ruiz et al. 2002). The sample harvest procedure was the 
same as ATP measurement. 7.5µL of acid sample extract or acid GSH standard was 
added to reaction buffer (see Appendix) followed by 15µL of 0.1% (w/v) 
o-phthalaldehyde in methanol. After 25min, fluorescence was measured on a FusionTM 
universal microplate analyzer (Packard) by using excitation and emission wavelengths 
of 350nm and 420nm, respectively. GSH concentration was adjusted for protein 
concentration and expressed as µmol per gram protein. 
2.13 Glutathione reductase activity 
Glutathione reductase catalyzes the reduction of glutathione (GSSG) in the 
presence of NADPH, which is oxidized to NADP+. The decrease in absorbance at 
340nm is measured to determine the glutathione reductase activity. Cells were cultured 
on 6-well plates, medium was changed after 24 hours. After 48 hours, cells were washed 
briefly with PBS twice and lysed in lysis buffer (see Appendix). Cell lysates were 
sonicated for 30 seconds and centrifuged at 13.2krpm for 20min at 4°C. The supernatant 
were analyzed for glutathione reductase activities by using glutathione reductase kit 
(GR2368, Randox Laboratories Ltd) on Cobas Mira chemistry analyzer (Roche) 
according to the manufacturer's instruction. The glutathione reductase activities were 
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adjusted for protein concentration and expressed as IU per gram of cell proteins. 
2.14 Cell viability assay 
To investigate the GSH's influence on cell viability, GSH depletion reagent diethyl 
maleate (DEM) and GSH reductase inhibitor 1,3-Bis(2-chloroethyl)-1-nitrosourea, 
(carmustine, or BCNU) were administered. DEM is a commonly used electrophiles 
which leads to more rapid and more extensive depletion effect than that obtained with 
y-GCS inhibitors (Griffith 1999). It is relatively non-toxic and conjugates directly with 
GSH in a reaction catalyzed by the glutathione S-transferase system (16,17) (Weber, 
Duncan et al. 1990). The antitumor agent carmustine (BCNU) is unstable in aqueous 
solution, and will spontaneously degrade to reactive alkylating, 2-chloroethyl 
diazohydroxide, and carbamoylating intermediate, 2-chloroethyl isocyanate. The 
alkylating component is responsible for the antitumor effects, whereas the 
carbamoylating species inhibit carbamoylation of Cys-58 in glutathione reductase and 
carbamoylate glutathione (Becker and Schirmer 1995). 
Cells were cultured on 96-well plates (2.5x 103 cells/well for SMCs, 5x 103 
cells/well for esSMCs), medium was changed after 24 hours. After 48 hours, cells were 
incubated with different concentrations of diethyl maleate (DEM, D97703, Sigma) or 
2-mercaptoethanol for 24 hours, or with 100µM carmustine (BCNU, C0400, Sigma) for 
different time. After removal of medium, Ce1lTiter 96® AQ1e01S One Solution (Cell 
Proliferation Assay, Promega) was added with dilution ratio of 1: 6 in DMEM 
(Invitrogen). After 3 hours incubation, the optical density at 490nm was recorded by 
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photometer (Mayr, Mayr et al. 2002). The reagent concentration used was optimized in 
preliminary experiments. 
2.15 JC-1 staining 
A high mitochondrial membrane potential (M') guarantees the normal function of 
mitochondria. The fall in AT is one of the early events during the apoptosis. 
5,5', 6,6'-tetrachloro-1,1', 3,3'-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) is a 
lipophilic cationic dyes that exhibit potential-dependent accumulation in mitochondria, 
indicated by a fluorescence emission shift from green (-525nm) to red (-590nm) 
(Cossarizza, Baccarani-Contri et al. 1993). Consequently, mitochondrial depolarization 
is indicated by a decrease in the red/green fluorescence intensity ratio, which only 
depends on the AT and not on other factors (size, shape, density) (Salvioli, Ardizzoni et 
al. 1997). 
Cells were diassociated in PBS and treated with 51iM of JC-1 (T3168, Molecular 
Probes) with or without 50µM of carbonyl cyanide 3-chlorophenylhydrazone (CCCP, 
C2759, Sigma) for 30min at 37°C. Cell suspensions were analyzed by FACS scan flow 
cytometer (Becton Dickinson Immunocytometry Systems). Signals of FL-1 (green, 
525nm) and FL-2 (red, 590nm) channel were recoded and data analysis was carried out 
by CeliQuest software (Becton Dickinson). 
2.16 Metabolites measurement 
To evaluate the metabolites changes, a set of metabolites concentration in esSMCs 
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and aortic SMCs were measured by nuclear magnetic resonance (NMR) spectroscopy. 
Cells were cultured in big flasks (culture surface is 175cm2) for 48 hours, with medium 
change after 24 hours. Cells were washed by cold sodium chloride for 2 times after 
decanting the medium. Water-soluble metabolites were extracted in 6% perchloric acid 
(380083, Sigma). Adherent cells were scraped and transferred to ice cold centrifuge 
tubes. After centrifuged at 4000 rpm for 15min at 4°C, the supernatant was transferred 
to new tubes. The pellet was solubilized by adding 2mL of 0.5M NaOH and protein 
concentration was determined by the Bradford method. The supernatant was neutralized 
to pH 7 with IOM KOH and centrifuged at 4000 rpm for 15min at 4°C. The supernatant 
was collected, lyophilized and reconstituted in deuterium oxide (D20). Immediately 
before the NMR analysis, the pH was readjusted to 7 with perchloric acid or KOH. 
500µ1 of the extracts were placed in 5mm NMR tubes. 1H NMR spectra were obtained 
using a Bruker 600MHz spectrometer. The water resonance was suppressed by using 
gated irradiation centred on the water frequency. Sodium 3-trimethylsilyl-2,2,3,3- 
tetradeuteropropionate (TSP) was added to the samples for chemical shift calibration 
and qualification. 
2.17 Glucose concentration measurement 
D-glucose can be oxidized to gluconic acid by glucose oxidase releasing H202. In 
the presence of peroxidase, H202 reacts with o-dianisidine (colourless) to form a brown 
coloured product. Oxidized o-dianisidine reacts with sulphuric acid to form a more 
stable pink coloured product. The intensity of the pink colour measured at 540nm is 
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proportional to the original glucose concentration. 
Cells were cultured in 6-well plates. Medium from different time points was 
collected and gluocose concentration were measured by using Glucose (GO) Assay Kit 
(GAGO-20, Sigma). According to the manufacture's instruction, samples and glucose 
standard were added into 96-well ELISA plates. After addition of 100µl of the mixture 
of glucose oxidase/peroxidase/o-Dianisidine, the solution showed brown colour. After 
incubation in 37°C for 30min, the reaction was stopped by adding l00µ1 12N sulphuric 
acid. The intensities of each well at 540nm were measured and glucose concentrations 
were calculated. 
2.18 Statistical analysis 
Statistical analysis was performed using Student's t-test. Results were given as 
means ± SE. Mean = hic/n. Standard error of the mean (SE) = (F. (X-Xmean)2/(n'(n-1)))ý'. p 
value of less than 0.05 was considered significant. Number of different samples (n) used 
for different experiments were stated in each section of Results Chapter where 
applicable. 
131 
3 RESULTS 
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3.1 ES cells differentiation 
Mouse ES cells were pre-differentiated in collagen-IV coated flasks by withdrawal 
of LIF. Subsequently, Sca-1+ cells were isolated by magnetic labelling cell sorting 
(MACS) with anti-Sca-1 microbeads. Stimulation by PDGF-BB for 5 passages induces 
Sca-1+ cells to differentiate to ES-derived SMCs (esSMCs). At least 3 Sca-1+ cell 
cultures and 6 esSMC cultures were generated using this protocol and studied in this 
project. Aortic SMCs isolated from 2 C57BL/6J mice were used as control. Their 
phenotype was verified by using H&E staining, RT-PCR, FACS, and 
immunofluorescence staining. 
Sca-1+ progenitors and esSMCs displayed a monolayer in culture, while ES cells 
showed clusters in an undifferentiated status for more than 35 passages. Comparison of 
H&E staining pictures between mature and differentiated SMCs showed a 
morphological similarity (Figure 23). 
mRNA levels of SMC markers, e. g. smooth muscle a-actin, smooth muscle protein 
22, calponin, and smooth muscle myosin heavy chain, were very low in Sca-1+ cells. 
After stimulation with PDGF-BB for 5 passages, they were strongly expressed in 
esSMCs but slightly weaker than those in aortic SMCs (Figure 24). 
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Figure 23. H&E staining of ES cells, Sca-1+ cells, esSMCs and SMCs 
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Figure 23. ES cells, Sca-l+ cells, esSMCs and SMCs were cultured in chamber slides 
and stained with H&E staining. The ES cells showed clusters while other three cell lines 
displayed a monolayer. These four pictures were shown with same scale. Black bar 
indicates 50µm. 
Figure 24. RT-PCR results of ES cells, Sea-1+ cells, esSMCs and SMCs 
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Figure 24. mRNA of ES cells, Sca-l+ cells, esSMCs and SMCs were harvested and 
RT-PCR was utilized to detect the mRNA level of smooth muscle cell markers. The 
SMA, SM22, caponin and SMMHC were highly expressed in esSMCs compared to ES 
cells and Sca-l+ cells but slightly less than in aortic SMCs. GAPDH was included as 
loading control. (SMA, smooth muscle a-actin; SM22, smooth muscle protein 22; 
SMMHC, smooth muscle myosin heavy chain; GAPDH, glyceraldehyde- 3-phosphate 
dehydrogenase) 
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The flow cytometric analysis demonstrated that 96.5% of ES cells were stage 
specific embryonic antigen-1 (SSEA-1) positive (Figure 25A), which indicates that the 
ES cells were maintained in undifferentiated status and can be used in further 
experiments. FACS analysis also revealed that 94.3% of the Sca-1 + cells expressed stem 
cell antigen-I (Sca-1) marker (Figure 25A), proved that cell sorting with anti-Sca-1 
microbeads obtained a highly purified Sca-l+ population. More than 95% of esSMCs 
were smooth muscle a-actin-, calponin-, and smooth muscle myosin heavy chain 
(SMMHC)-positive cells, which were very similar as aortic SMCs (99%) (Figure 25B). 
Figure 25. FACS analysis of ES cells, Sca-1+ cells, esSMCs and SMCs 
(A) 
ES Cdb 
scor 
c. at 
(B) 
SMA Calponin SMMHC 
g ES cell 
1 to1 11 loo t°° 1°' to 1 1nß ,n , o' ,0 1°' 
FL, ý1 FL 141 FL+N 
8Ss 
nx +dý 
"sMc 
w° to, 1 ,o , o+ to , o' w? , o3 0' 
KZ H R, J/ FU-H 
ss$ 
-1x u-- jux 
ý sMc 
oe 
10 02 
FUN ILI H {t, -11 
Figure 25. Cells were dissociated and incubated with either isotype control (green line) 
or antibodies (red area) and analyzed by FACS. (A) ES cells specificly express stage 
specific embryonic antigen-1 but not Sca-1 while Sca-l+ cells only express Sca-l but 
not SSEA-1. (B) Smooth muscle cell markers of ES cells, esSMCs and SMCs were 
detected by FACS. The esSMCs showed similar cell marker expressions as aortic SMCs. 
(SSEA-1, stage specific embryonic antigen-l; Sca-1, stem cell antigen-l; SMA, smooth 
muscle a-actin; SMMHC, smooth muscle myosin heavy chain) 
Immunofluorescent staining of SSEA-1 and Sca-1 also showed that ES cells and 
Sca-1+ cells expressed SSEA-1 and Sca-1, respectively (Figure 26A). The 
immunofluorescent staining also confirmed that the esSMCs expressed SMA, calponin 
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and SMMHC (Figure 26B). 
Figure 26. Immunofluorescent staining of ES cells, Sca-i+ cells, and esSMCs. 
A 
B 
Figure 26. (A) Immunofluorescent staining showed SSEA-1 (green) expression in ES 
cells and Sca-1 (green) expression in Sca-l+ cells. Nuclei were counter-stained with 
DAPI (blue). White bar indicates 50µm. (B) Smooth muscle cell marker expressions of 
esSMCs were detected by immunofluorescent staining, including smooth muscle a-actin 
(red), calponin (red) and smooth muscle myosin heavy chain (green). Nuclei were 
counter-stained with DAPI (blue). White bar indicates 50µm. (SMA, smooth muscle 
a-actin; SMMHC, smooth muscle myosin heavy chain) 
All these results confirmed the undifferentiated stage of ES cells, high 
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homogeneity of the Sca-1+ progenitor cells, and SMC marker expressions of esSMCs 
after PDGF-BB stimulation. 
3.2 Proteome map of ES cells 
3.2.1 ES cell proteome map 
The proteome of ES cells was separated by 2-DE. On a large format 2-DE gel, 
there are about 2000 spots visible by silver staining. Comparison of different gels (n=6) 
by ProteomWeaver showed high consistency of the protein pattern between different ES 
cell cultures. A representative overlay picture is shown as Figure 27. Nearly 300 
proteins were picked and identified (Figure 28) by mass spectrometry, in a MM range 
from lOkDa to 130kDa, and a pI range from 4 to 9. The proteins were labelled and 
listed in Table 13 (see Appendix). The Mr/pI Grid map was generated by PDQuest 
software with internal calibration (Figure 29). 
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Figure 27. Overlay picture of two 2-DE gels of ES cells 
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Figure 27. Overlay of two 2-DE gels from different ES cell cultures were generated by 
ProteomWeaver software. The orange colour and blue colour indicate protein spots on 
different gels. Matched proteins with similar expression are shown in black colour. 
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Figure 28. Proteome map of FS cells 
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Figure 28.100µg of protein extract of ES cells was separated on a pH 
3-IONI. IPG strip, 
followed by a 12% SDS polyacrylamide gel. Protein spots were visualised 
by silver 
staining. Labelled spots were picked for protein identification. 
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Figure 29. Mr/pI grid picture of ES cell proteome map 
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Figure 29. The Mr/pI grid picture of ES cell proteome map was generated by PDQuest 
software, assuming that the observed Mr/pI of red spots were equal to the calculated 
value. The observed Mr/pI of other spots were read from this grid. Blue numbers are the 
spots numbers as in Table 13 (see Appendix). 
Figure 30. ES cell proteins category pie chart 
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Figure 30. Proteins category pie chart showed that enzymes, chaperones and cell 
proliferation-related proteins are most abundant proteins species in ES cells. 
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All 231 identified proteins were classified into 7 categories, antioxidants (3%), 
chaperones (21%), cell proliferation-related proteins (19%), enzymes (36%), signalling 
molecules (5%), structural proteins (13%), and others (3%) (Figure 30). The large 
proportion of the enzymes, chaperones and cell proliferation-related proteins may due to 
the high proliferation rate of ES cells. 
3.2.2 Brief comparison of proteome maps of ES cells and 
aortic SMCs 
Comparative analysis of ES cell (n=4) and SMC (n=4) proteome map were also 
performed. 30% of all identified spots in the same position were found containing the 
same protein (Table 9, Figure 31). This suggests that many spots containing high 
abundant proteins match on mouse ES cell and SMC gels. 
Table 9. Co-localization of proteins between ES cell and SMC maps 
No Protein Name 
UniProt 
Entry Name 
* SMC 
map No. 
ES cell 
map No. 
Al Actin, cytoplasmic 2 ACTG_MOUSE 50 50 
A2 Actin, cytoplasmic 1 ACTB_MOUSE 48 55 
A3 Actin, cytoplasmic 1 ACTB_MOUSE 83 97 
A4 Actin, cytoplasmic 2 ACTG_MOUSE 50 52 
A5 Aconitate hydratase, mitochondrial [Precursor] ACON_MOUSE 199 256 
A6 Fructose-bisphosphate aldolase A ALDOA_MOUSE 187 191 
A7 Fructose-bisphosphate aldolase A ALDOA_MOUSE 188 192 
A8 Annexin A2 ANXA2_MOUSE 165 176 
A9 ATP synthase alpha chain, mitochondrial [Precursor] ATPA_MOUSE 197 229 
A10 ATP synthase beta chain, mitochondrial [Precursor] ATPB MOUSE 32 36 
Cl Calreticulin [Precursor] CALK MOUSE 17 27 
C2 Cofilin-1 COF1_MOUSE 124 131 
D Dihydrolipoyl dehydrogenase, mitochondrial [Precursor] DLDH_MOUSE 229 230 
El Electron transfer flavoprotein alpha-subunit, ETFA MOUSE 168 169 
mitochondrial [Precursor] 
E2 Endoplasmin [Precursor] ENPL_MOUSE 32 
141 
E3 Alpha-enolase ENOA_MOUSE 249 210 
F1 Far upstream element binding protein 1 FUBP 1 MOUSE 204 246 
F2 Far upstream element binding protein 2 FUBP2 RAT 200 
255 
G1 78 kDa glucose-regulated protein [Precursor] GRP78_MOUSE 5 4 
G2 Glutamate dehydrogenase, mitochondrial [Precursor] DHE3_MOUSE 240 227 
G3 Glyceraldehyde 3-phosphate dehydrogenase G3P MOUSE 164 177 
G4 Glyceraldehyde 3-phosphate dehydrogenase G3P MOUSE 163 178 
G5 Guanine nucleotide-binding protein subunit beta2-like 1 GBLP_HUMAN 169 171 
H1 Heat shock cognate 71 kDa protein HSP7C_MOUSE 45 47 
H2 Heat shock cognate 71 kDa protein HSP7C MOUSE 7 9 
H3 Heat shock cognate 71 kDa protein HSP7C_MOUSE 11 21 
H4 Heat shock cognate 71 kDa protein HSP7C_MOUSE 153 156 
H5 47 kDa heat shock protein [Precursor] HSP47_MOUSE 192 216 
H6 60 kDa heat shock protein, mitochondrial [Precursor] CH60 MOUSE 219 63 
H7 Heat-shock protein beta-1 HSPB 1 MOUSE 144 145 
H8 Heterogeneous nuclear ribonucleoprotein L HNRPL_MOUSE 231 244 
H9 Heterogeneous nuclear ribonucleoproteins A2B 1 ROA2_MOUSE 160 179 
I Inosine-5'-monophosphate dehydrogenase 2 IMDH2_MOUSE 237 234 
L LIM and SH3 domain protein 1 LASP 1 MOUSE 183 183 
Ni NASCENT polypeptide associated complex alpha subunit NACA_MOUSE 68 70 
N2 Nucleoside diphosphate kinase B NDKB_MOUSE 127 127 
0 Ornithine aminotransferase, mitochondrial [Precursor] OAT MOUSE 220 64 
P1 Peptidyl-prolyl cis-trans isomerase A PPIA MOUSE 122 129 
P2 Peptidyl-prolyl cis-trans isomerase A PPIA_MOUSE 125 128 
P3 40 kDa peptidyl-prolyl cis-trans isomerase PPID_MOUSE 256 188 
P4 Peroxiredoxin 1 PRDX1_MOUSE 136 139 
P5 3-phosphoglycerate dehydrogenase Q8C603_MOUSE 215 219 
P6 Phosphoglycerate kinase 1 PGK1_MOUSE 190 207 
P7 Phosphoglycerate mutase 1 PGAM1_MOUSE 151 
154 
P8 Poly(rC)-binding protein 1 PCBP 1_MOUSE 259 
186 
P9 Profihin I PROM 
- 
MOUSE 120 124 
P 10 Prohibitiv PHB_MOUSE 85 86 
P 11 26S protease regulatory subunit 8 PRS8_MOUSE 253 
213 
P 12 Pyruvate kinase, M2 isozyme KPYM_MOUSE 235 237 
Si Stress-70 protein, mitochondrial [Precursor] GRP75_MOUSE 9 
11 
S2 Superoxide dismutase [Cu-Zn] SODC_MOUSE 114 120 
S3 Superoxide dismutase [Mn], mitochondrial [Precursor] SODM_MOUSE 138 
138 
Ti T -complex protein 1 subunit beta TCPB_MOUSE 
217 218 
T2 Transgelin 2 TAGL2_MOUSE 133 137 
T3 Transketolase TKT_MOUSE 233 245 
T4 Translationally controlled tumour protein TCTP_MOUSE 102 
103 
T5 Triosephosphate isomerase TPIS MOUSE 140 150 
V Voltage-dependent anion-selective channel protein 1 VDAC1 MOUSE 158 
172 
* The SMC No. come from the mouse arterial SMC map (Mayr, Mayr et al. 2005). 
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Figure 31. Overlay of SMC and ES cell 2-DE average gels 
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Figure 31. Overlay of average 2-DE gels of ES cells (blue, n=4) and aortic SMCs 
(orange, n=4) were generated by ProteomWeaver software. Matched proteins with 
similar expression are shown in black colour. Labelled spots were identified and 
revealed identical proteins in both cell lines, listed in Table 9, indicating the consistency 
of these proteins. 
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3.2.3 Differentially expressed proteins between ES cells and 
aortic SMCs 
Immunoblotting was carried out to verify differences in protein expression. For 
each protein, at least 2-3 Western blots were run with different cell lysates for 
comparison of protein expression between ES cells and aortic SMCs. Results showed 
that most heat shock proteins were more abundant in ES cells, e. g. HSP27, HSP60, and 
HSP90. However, crystallin a/ß (HSP20), which is known to regulate actin 
polymerization, was expressed at higher levels in SMCs (Figure 32). Another significant 
difference between these two cells is the antioxidants. The main oxidants such as 
catalase, peroxiredoxin 1 (PRX-1) and Cu-Zn superoxide dismutase (SOD-1) were all 
upregulated in ES cells while heure oxygenase 1 (HO-1) was decreased in ES cells 
compared to aortic SMCs (Figure 32). 
144 
Figure 32. Western blot comparison of protein expressions between ES cells and 
SMCs. 
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Figure 32. (A) Most heat shock proteins were upregulated in ES cells. However, 
crystallin a/ß (HSP20) is expressed at higher levels in SMCs because of the regulation 
role in actin polymerization. Higher expressions of antioxidants (catalase, peroxiredoxin 
I and SOD-1) were observed in ES cells, indicating altered oxidative stress in ES cells. 
(B) Bar graph show clear differences of the protein expressions between the two cells. 
The relative average intensity (Y-axis) of each sample in each blot was calculated by 
normalizing with the average of the stronger sample band of all blots. (HSP, heat shock 
protein; HO, heure oxygenase; PRX, peroxiredoxin; SOD, superoxide dismutase) 
3.3 Proteome map of Sca-1 + cells 
3.3.1 Sca-1+ cell proteome map 
After isolation from primitive differentiation culture by magnetic labelling cell 
sorting, Sca-l+ progenitor cells were cultured in gelatine-coated flasks for 15 passages 
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and harvested for 2-DE. Protein samples were separated before and after using a 
clean-up kit (Bio-Rad) and separated by isoelectric focusing on 18cm dry strips (pH 
3-10 nonlinear) and 12% SDS-PAGE (Figure 33 and Figure 34, respectively). 
Comparison of different gels (n=4) by ProteomWeaver showed high consistency of the 
protein pattern between different Sca-1+ progenitor cell cultures. A representative 
overlay picture of unprecipitated samples is shown as Figure 35. 
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Figure 33. Proteome map of Sca-1+ progenitor cells 
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Figure 33.400 µg of protein extract was separated on a pH 3-1ONL IPG strip, followed 
by a 12% SDS polyacrylamide gel. Protein spots were visualized by silver staining. 
Labelled spots were picked for protein identification (A). The highlighted areas are 
enlarged in inset B and C. 
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Figure 34. Proteome map of Sca-1+ progenitor cells after using clean-up kit 
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Figure 34.400 µg of protein extract was treated with clean-up kit (Bio-Rad) and 
separated on a pH 3-IONL IPG strip, followed by a 12% SDS polyacrylamide gel. 
Protein spots were visualized by silver staining. Labelled spots were picked for protein 
identification (A). The highlighted areas are enlarged in inset B and C. 
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Figure 35. Overlay picture of two 2-DE gels of Sea-l+ progenitor cells 
-low 
All 
40 
At 
4. 
It 
Mir 
"" S. ";, 
Figure 35. Overlay of two 2-DE gels from different Sca-l+ progenitor cell samples 
were generated by ProteomWeaver software. The orange colour and blue colour indicate 
protein spots on different gels. Matched proteins with similar expression are shown in 
black colour. 
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From approximately 2000 spots that were resolved on a single large format 
silver-stained gel, 300 were labelled and picked for mass spectrometry (Figure 33 and 
Figure 34). 241 spots were identified representing 173 unique proteins with a MM range 
from lOkDa to 100kDa and a pI range from 4 to 9. Fifty-nine spots (19.7%) remained 
unidentified. All identifications are listed in Table 14 (see Appendix). 
Overall, the spot patterns were very similar before and after clean-up and the 
clean-up procedure prevented streaking in the basic area. However, some spots 
disappeared after using the clean-up kit, mainly in the basic region (pI >8) and in the 
lower left corner of the gel (spots 44,73,74,81,85,89,109,144,166,175,181,188, 
190,224,230-232), while additional spots became detectable in the treated sample 
(spots 9-11,13,15-18,24,33,39,40,42,55,57,64,67,68,80,116,234,238,244, 
288). 
Among the total 241 identified proteins, the majority were enzymes (33%), 
followed by proteins involved in DNA maintenance, transcription and translation (18%), 
structural proteins (13%) and chaperones (20%). Interestingly, signalling molecules 
were more abundant in Sca-1+ progenitor cells (10%) than ES cells (5%) and adult 
arterial SMCs (Mayr, Mayr et al. 2005) (Figure 36). 
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Figure 36. Sca-1+ cell proteins category pie chart 
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Figure 36. Proteins category pie chart showed that enzymes, chaperones and cell 
proliferation-related proteins are most abundant proteins species in Sca-1+ cells. 
A direct comparison of the protein profile of Sca-l+ progenitor cells (n=4) with ES 
cells (n=4) and arterial SMCs (n=4) revealed that the percentage of differentially 
expressed spots (2 fold increased or decreased) was higher between arterial SMCs and 
Sca-1+ progenitor cells indicating that the proteome of Sca-l+ progenitor cells remained 
more similar to ES cells than arterial SMCs (Figure 37). 
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Figure 37. Percentage of differentially expressed spots in Sea-1+ progenitor cell gels 
compared with ES cell gels and SMC gels 
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Figure 37.2-DE gel images from Sca-l+ progenitor cells (n=4), ES cells (n=4) and 
SMCs (n^4) were imported into the ProteomWeaver software. Average gels were 
created from 4 single gels per group. Pie charts show the percentage of protein spots 
with 2 fold increased and decreased protein expression between Sca- l+ progenitor cells 
and ES cells (A) and between Sca-1+ progenitor cells and SMCs (B). 
3.3.2 Data presentation on the internet 
I maintain a website at htlp: //www. vascular-protcomics. com using Apache/ PHP/ 
MySQL, for our group presenting protocols, proteome maps, protein identifications, 
publications along with maps from mouse aortic SMCs (Mayr, Mayr et al. 2005) and 
other vascular cells (McGregor, Kempster et al. 2001; Dupont, Corseaux et al. 2005) 
published by other groups. The protein identifications were all saved in the MySQL 
database. After the users inquired the database through PHP language, the result was 
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displayed by Apache web server. The "SEARCH SPOTS" function allows the 
comparison of proteins across different maps and the detailed methods for 2-DE, tryptic 
digestion and mass spectrometry should be useful to other investigators. 
3.4 Comparison of esSMCs and aortic SMCs 
3.4.1 Proteomic analysis using DIGE approach 
To allow accurate quantification of protein expression in ES cell-derived SMCs 
(esSMCs) and aortic SMCs, the DIGE approach was utilized. In brief, proteins from 
esSMCs (n=6) and aortic SMCs (n=2) were labelled with either Cy3 or Cy5 and 
co-separated by 2-DE using a broad range pH gradient (pH 3-10 nonlinear) and large 
format 12% SDS gels. After normalization to the internal pooled standard labelled with 
Cy2, protein expression ratios and p values were calculated between these 2 groups by 
DeCyder software. Totally there were 146 spots showed a significant (p < 0.05) 2 fold 
change. A representative image with labelled numbers was shown as Figure 38. Among 
these, 128 spots (88%) were successfully identified by MALDI-ToF MS or LC MS/MS 
and listed in Table 15 (see Appendix). Because ES cells were cultured in complete stem 
cell medium to keep an undifferentiated stage, they were not included in present 
comparison. 
While cytoskeletal/myof i lament proteins and calcium binding proteins were less 
abundant in esSMCs than in aortic SMCs, chaperones such as heat shock proteins were 
increased along with proteins regulating DNA maintenance, transcription and 
translation. Notably, upregulation of the cytosolic antioxidant peroxiredoxin 6 (spot 50) 
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coincided with a downregulation of mitochondrial manganese SOD (SOD-2, spot 77,78) 
in esSMCs. 
Figure 38. esSMCs (green, n=6) and aortic SMCs (red, n=2) were compared using the 
DIGE approach. In the representative gel, protein lysates of esSMCs and aortic SMCs 
were labelled with Cy3 and Cy5, respectively and co-separated in large format 2-DE 
gels. Images were acquired on a fluorescence scanner and analyzed by DeCyder 
software. Spots with 2 fold increase or decrease (p < 0.05) between esSMCs and aortic 
SMCs were numbered, picked and identified by mass spectrometry. 
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Figure 38. A representative DIGE image of esSMCs and aortic SMCs 
Figure 39. An illustration of DeCyder software 
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Figure 39. An illustration of the DeCyder software. Protein expression increases (red 
circle) and decreases (blue circle) in SMCs compared to esSMCs are shown in the 
top-left panel on selected gels. The intensity of the protein spot in each gel is shown as 
one spot in the top-right panel. There are 6 spots in esSMCs group (yellow) and 2 spots 
in SMCs group (blue). Y-axis is the standardized log abundance compared to the 
internal pool standard. The average abundance of each group is shown as a cross (+) and 
connected by the blue line. A 3-D comparison of selected spot is shown in the 
bottom-left panel. The selected spot (purple circle) is SOD-2 with a 3.06 fold increase in 
SMCs compare to esSMCs, x. 00083, as shown in the bottom-right panel. 
3.4.2 Confirmation of differentially expressed proteins 
Some protein changes between esSMCs and aortic SMCs were verified by 
immunoblotting (Figure 40). For each protein, at least 2-3 Western blots were run with 
different cell lysates for comparison of protein expression between esSMCs and aortic 
SMCs. Cytoskeletal/myofilament proteins (actin, a-tubulin and myosin light chain) 
were less abundant in esSMCs than in aortic SMCs, while most chaperones were 
increased except crystallin a/ß (HSP20). Notably, upregulation of the cytosolic 
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antioxidant peroxiredoxin 1,2,6 and SOD-I were accompanied by downregulation of 
mitochondrial antioxidants peroxiredoxin 3 and SOD-2 in esSMCs. This inconsistency 
in antioxidant expression prompted us to study possible alterations in the subcellular 
redox state. 
Figure 40. Western blot comparison between esSMCs and SMCs 
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Figure 40. (A) The expressions of a panel of cytoskeletal proteins, heat shock proteins 
and antioxidants were detected by Western blot using corresponding antibodies. 
esSMCs showed decreased cytoskeletal proteins but increased heat shock proteins. 
Cytosolic antioxidants were increased in esSMCs but mitochondrial counterparts were 
decreased. (B) Bar graph showing clear differences of the protein expressions between 
these two cells. Relative average intensity (Y-axis) of each sample in each blot was 
calculated by normalizing with the average of the stronger sample bans of all blots. 
(MLC, myosin light chain; HSP, heat shock protein; PRX, peroxiredoxin; PRX-S03, 
oxidized peroxiredoxin; PRX6-S03, oxidized peroxiredoxin 6; SOD, superoxide 
dismutase; HO, heure oxygenase) 
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Besides revealing differences in protein expression, 2-DE gel also has the 
potential to display differences in posttranslational modifications. Peroxiredoxin 6 was 
encountered as doublet spots in 2-DE (Figure 41). The over-oxidation of peroxiredoxin 
6 is likely to be irreversible under biological conditions and de novo synthesis is 
required to counteract the annihilation of the peroxiredoxin-based antioxidant defence 
(Rabilloud, Heller et al. 2002). Consistent with the predominance of the acidic isoform 
in esSMCs, immunoblotting showed higher levels of oxidized peroxiredoxin 6 
(PRX6-SO3) (Figure 40), indicating an increased turnover of this antioxidant protein 
compared to mature SMCs. 
Figure 41. Overlay of 2-DE gels showing peroxiredoxin 6 shifting 
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Figure 41. Peroxiredoxin 6 showed 2 horizontal spots in 2-DE gels. In esSMCs, the 
oxidized form (red circle) was more abundant than the reduced form (blue circle) while 
the reduced form was present in higher amounts than the oxidized form in aortic SMCs. 
3.4.3 ROS production 
We therefore quantified total ROS and mitochondrial superoxide production by 
DHR123 and MitoSOX staining, respectively. Consistent with the increased oxidation 
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of redox-sensitive proteins in esSMCs, the fluorescent signal intensity for DHR 123 was 
higher in esSMCs compared to aortic SMCs (2133 ± 50 RFU/µg protein, n=3 vs. 1782 ± 
64 RFU/µg protein, n=3, p=0.002) (Figure 42). Notably, the increase in total ROS 
production was accounted for by a rise in mitochondrial superoxide production as 
indicated by a corresponding increase in MitoSOX staining. To further clarify the site of 
ROS generation, we treated SMCs with rotenone and antimycin A, a mitochondrial 
complex I and III inhibitor, respectively. Antimycin A but not rotenone augmented 
mitochondrial superoxide and total ROS formations in esSMCs, but did not 
substantially alter the fluorescent signal of aortic SMCs (Figure 43), providing 
additional proof that the observed increase in oxidative stress in esSMCs is 
predominantly from mitochondria and suggesting that complex III acts as the principal 
site of ROS generation. 
Figure 42. Total cellular ROS measured by DHR123 
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Figure 42. Aortic SMCs (n=3) and esSMCs (n=3) were incubated with DHR123 for 1 
hour and harvested for fluorescence signal measurement and protein concentrations 
were determined. Normalized RFU indicates the total reactive oxygen species level in 
these cells. esSMCs showed significantly increased ROS than aortic SMCs. (The error 
bar indicates SE of each group, ** denotes p<0.01) 
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Figure 43. Total IZOS and mitochondrial superoxide prodlictioll 
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Figure 43. MitoSOX (A) and DIIR123 (B) staining were used to assess total reactive 
oxygen species (ROS) and mitochondrial superoxide production in esSM('s (n -3) and 
aortic SMCs (n=3). csSMCs have a significant increase in mitocliondrial superoxide 
production. Changes in oxidative stress were analyzed after treatment with rotenone and 
antimycin A, a complex I and III inhibitor, respectively. Note that the complex III 
inhibitor antimycºn A resulted in a marked increase in mitochondrial superoxide 
production in esSMCs. (The error bar indicates SE of each group, ** 1)'-1). 0I compared 
to control) 
3.4.4 Redox balance 
The rise in mitochondrial ROS in csSMC's was paired with decreased expression 
of' ATP synthase beta chain (Table 15, see Appendix), a drop in cellular NIT levels 
(19.52 f I. 07µmol/g proteins in esSMCs, n 2, vs. 32.31 =f= II Oµmol/g proteins in aortic 
SMCs, n=2) (Figure 44A) and reduced concentrations of, glutathionc ((GSI1) (40.65 A- 
0.52µmol/g protein in csSMCs, 11==2, vs. 49.87 _1 1.34µmol/g protein in aortic SMCs, 
n=2) (Figure 44B). The reduction in cellular GSII, the major intracellular antioxidant, 
occurred despite a compensatory increase of glutathionc rcductase activity in csSMC's 
** 
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(107.6 ± 2.8 IU/g protein in esSMCs, n=3, vs. 33.5 ± 1.1 IU/g protein in aortic SMCs, 
n=3) (Figure 44C). 
Figure 44. Cellular ATP, GSH and glutathione reductase comparison 
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Figure 44. Cells were cultured in 6-well plates and harvested for measuring cellular 
ATP levels (n=2) (A), concentrations of reduced GSH (n=2) (B) and glutathione 
reductase activity (n=3) (C) in esSMCs and aortic SMCs. esSMCs showed lower ATP 
and reduced GSH levels but higher GSH reductase activity compared to aortic SMCs, 
indicating a higher ROS level in esSMCs. (The error bar indicates SE of each group, ** 
denotes p<0.01) 
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3.4.5 Cell viability 
In normal culture conditions (with 50µM 2-ME), esSMCs grew faster than aortic 
SMCs. Cells were cultured in 6-well plates and change medium after 24 hours. At 
different time point, cells were scraped and lysed in lmL 0.5M NaOH. Protein 
concentration was measured and plotted versus time (Figure 45). The slow down of the 
curve after 33 hours may be because shortage of nutritions in the medium. 
Figure 45. Growth curve of esSMCs and aortic SMCs 
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Figure 45. Cells were cultured in 6-well plates. Protein concentrations of cells from 
whole wells in different time points were measured and cell growth curve were made. 
esSMCs showed a much higher proliferation rate compared to aortic SMCs. 
esSMCs were more susceptible to cell death upon treatment with both diethyl 
maleate (DEM) (Figure 46A), a sulphydryl-reactive agent that results in rapid depletion 
of GSH followed by a drop in ATP (Mayr, Siow et al. 2004), and carmustine (BCNU) 
(Figure 46B), a glutathione reductase inhibitor. In contrast, esSMCs viability improved 
on addition of 2-mercaptoethanol to the culture medium (Figure 46C), highlighting their 
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need for additional antioxidant protection. 
DEM concentrations above 100µM are toxic. For the consist comparison with 
non-treated control, in this study DEM was directly added to DM containing 50µM of 
2-ME, which leads to a lower effective concentration of DEM. 
Figure 46. Cell viability after DEM, BCNU and 2-mercaptoethanol treatment 
100% 
% Z, 80% 
60% 
Ü 40% 
20% 
0% i.. . 
0 
A 
100% 
,. 80% 
a 
60% 
4O% 
20% -- 
-+ -SMC 
--t-esSMC 
-4-SMC 
r 
tesSMC 
0% 
_"___1_ß. _.. _., 
L. -. -. _. _---- 
1.... _... _.......... ý ................ ý.. 
A - . _. 
0136 24 
time (h) 
B 
140% - 
* 
120% 
100% 
. -. -SMC 
-r-esSMC 
80% .. _..... ___r_. _. _. ý. _.... __.. _. _... ý.. _.... _.. ........... ... __.... i....... ..... 
0 25 100 
C 2-ME concentration (1 M) 
Figure 46. Cell viability after depletion of GSH by treatment with DEM (n=3) (A) or 
inhibition of glutathione reductase by BCNU (n=3) (B). Increase in esSMCs survival 
upon addition of 2-ME to the culture medium (n=4) (C). (The error bar indicates SE of 
each group, * p<0.05 compared to baseline, ** p<0.01) 
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3.4.6 Mitochondrial depolarization 
JC-1 was used for detection of mitochondrial depolarization occurring in the early 
stage of apoptosis. The ratio of green (FL1) to red (FL2) fluorescence is dependent only 
on the membrane potential and not on other factors such as mitochondrial size, shape 
and density that may influence single-component fluorescent signals. The FL2/FL1 
ratios of esSMCs and aortic SMCs were 2 and 10, respectively (Table 10, Figure 47). A 
lower ratio means lower membrane potential of mitochondria, indicating loss of 
mitochondrial potential in esSMCs. After adding 50µM of CCCP, the potential of 
mitochondrial membrane was completely lost and the ratios dropped to 0.1 for both cell 
lines. 
Table 10. Fluorescence signal of JC-1 staining of esSMCs and aortic SMCs 
Sample with 10µM JC-1 FL-1 FL-2 FL-2/FL-1 
SMC control 90 900 10 
esSMC control 700 1400 2 
SMC + 50µM CCCP 300 30 0.1 
esSMC + 50µM CCCP 100 10 0.1 
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Figure 47. JC-1 staining of esSMCs and aortic SMCs 
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Figure 47. Cultured esSMCs and SMCs were dissociated in PBS and 10µM JC-I or 
extra 50µM CCCP were added. After 30min of incubation in 37°C, the fluorescent 
signal of the cells was acquired by FACS. The cell count chart of each channel of 
esSMCs and aortic cells were generated and compared with each other. The average 
fluorescent signal readings were listed in Table 10 and FLl/FL2 ratio were calculated. 
3.4.7 Metabolomic differences between esSMCs and SMCs 
To clarify the metabolic effects of the differences shown at the protein level, 
esSMCs (n=3) and aortic SMCs (n=4) were harvested for NMR. Metabolites were 
measured by high-resolution NMR spectroscopy and protein concentrations were 
determined. The NMR analysis demonstrated several metabolites concentration changes 
between esSMCs and aortic SMCs. Those with ratio greater than 1.2 or less than -1.2 
are listed in Table 11. 
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Table 11. Metabolites concentration changes between esSMCs and aortic SMCs 
Metabolites Concentration (pmol /g protein) Ratio p 
esSMC SMC 
Glucose Metabolism 
Lactate 64.599 ± 15.129 
Glucose 0.557 ± 0.509 
Myoinositol 12.864 ± 2.068 
Lipid Metabolism 
Acetate 15.718 t 1.598 
Carnitine 11.726 ± 2.519 
Acetone 4.470 ± 0.287 
Phospholipid Components 
Choline 0.346 ± 0.045 
Phosphocholine 
Glycolate 
Amino Acids 
Glycine 
Aspartate 
Glutamate 
Glutamine 
Taurine 
Energy Metabolism 
0.961 ± 0.228 
11.903 f 2.329 
21.933 ± 1.316 
35.531 ± 3.658 
201.396 f 8.205 
94.752 ± 6.606 
47.022 ± 5.93 9 
44.767 t 11.157 
3.888 f 1.936 
51.613 ± 4.689 
27.636 ± 7.385 
18.129 ± 4.901 
6.144 ± 1.478 
1.128 ± 0.570 
7.155 t 4.014 
21.723 t 5.537 
1.443 0.137 
-6.984 0.036 
-4.012 0.000 
-1.758 0.044 
-1.546 0.079 
-1.375 0.106 
-3.255 0.071 
-7.443 0.054 
-1.825 0.031 
74.716 t 16.046 -3.407 0.007 
15.557±4.217 2.284 0.001 
95.992 ± 18.938 2.098 0.000 
75.738 t 20.441 1.251 0.160 
92.998 f 35.210 -1.978 0.077 
Adenosine pool 42.392 ± 1.761 35.317 f 3.813 1.200 0.027 
Phosphocreatine 21.738 ± 1.464 28.793 t 6.523 -1.325 0.117 
Succinate 6.611 ± 0.391 10.117 f 1.999 -1.530 0.036 
Fumarate 0.452 ± 0.011 0.312 ± 0.194 1.448 0.245 
NAD+NADH 4.126 ± 0.520 2.659 ± 0.831 1.552 0.036 
The most significant changes were observed for glucose, myoinositol, glycine, 
glutamate and aspartate. The low concentration of glucose may explain the low ATP 
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level in esSMCs. esSMCs appear to consume more glucose to meet their higher 
energetic demand. Glucose concentration is lower not only within esSMCs but also in 
the culture medium after 24 hours culture compare to the aortic SMC culture (Figure 
48). Alternatively, their mitochondria may not generate ATP efficiently and they 
therefore need a higher rate of glycolysis. 
Figure 48. Glucose concentration in the culture medium of esSMCs and aortic 
SMCs 
1.2 
1.0 
J 
E 
C 
ä 0.6 
»r 
0.4 
8 
0.2 
0.0 
0 12 24 
Time (hours) 
--*-esSMC 
-U-- SMC 
Figure 48. Culture medium samples were taken from the 6-well plates at different time 
points from esSMCs (n=3) and aortic SMCs (n=3) and glucose concentration were 
measured. The glucose concentration of esSMCs showed a very fast drop during the cell 
culture. (The error bar indicates SE of each group, * denotes p<0.05 compared to 
baseline, ** p<0.01) 
In addition to ATP generation, mitochondria are also responsible for fatty acid 
oxidation. Notablely, metabolites involved in lipid metabolism and phospholipid 
components were all decreased in the esSMCs. Similarly, succinate, a supplementary 
carbon source in the citric cycle and in the electron transport chain complex II, showed 
a significant drop. Taken together, our proteomic and metabolomics data provide 
evidence for mitochondrial dysfunction in esSMCs. 
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4 DISCUSSION 
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4.1 Stem cells 
4.1.1 The differentiation potential of stem cells 
The remarkable differentiation potential of ES cells holds important research 
application including neoangiogenesis, stem cell-based therapies and tissue-engineering 
strategies, which may offer new clinical applications. ES cell differentiation is a 
complex process altering numerous proteins, not only at the transcriptional and 
translational level, but also by posttranslational modification. 
Three criteria should be considered when using ES cell model for lineage-specific 
differentiation. First, protocols need to be established that promote the efficiency and 
reproducibility of the development of intereted cell type. If possible, selection strategies 
should be combined with optimal differentiation schemes to isolate highly enriched cell 
populations. Second, lineage development from ES cells should recapitulate the 
development program that establishes the lineage in the early embryo. Third, the mature 
cell populations that develop in these cultures must display appropriate functional 
properties both in vitro and in vivo (Keller 2005). The third one remains to be the major 
challenges in the field today. 
The cellular heterogeneity is an intrinsic feature of the ES cell differentiation 
culture, which results in the pluripotent property of ES cells and makes the ES cell a 
considerable therapeutic potential source in the tissue engineering. However, the 
multiplicity is a major disadvantage of the ES cell differentiation culture when 
investigating cell type specific mechanism and teratomas can easily be formed when 
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injected in vivo (Martin 1981). In our studies, we used the positive selection (magnetic 
labelling cell sorting) of Sca-1+ cells and stimulation with PDGF-BB to obtain highly 
purified esSMC population, which expressed similar SMC marker as mature aortic 
SMCs (Figure 25). During the differentiation from Sca-1+ cells to esSMCs by 
PDGF-BB stimulation, the portion of SMC marker positive cells continuously 
increasing when treated with PDGF, from 50% at day 3 to 95% at passage 10. 
Additionally, esSMCs form vascular-like structures in vivo and no tumour-like tissue 
can be observed in the sections of cell grafts at 4 weeks (Xiao et al, unpublished data), 
indicating that esSMCs have angiogenesis activity and are safe for in vivo use. Another 
way to get highly purified SMCs is negative selection by puromycin on ES cell-derived 
SMCs with SM a-actin or SMMHC promoter controlled puromycin resistance gene 
(Sinha, Wamhoff et al. 2006). However, embryoid body differentiated up to day 28 still 
contained pluripotent cells. Thus, the highly efficient separation method is the critical 
requirement for the cell therapy and tissue engineering applications. 
Many laboratories, including us, used serum as a growth supplement and/or as a 
source of inducing factors and successfully developed various cell lineage from ES cells. 
However, the use of serum has several serious drawbacks that induce batch-to-batch 
variability and the lack of identity of the inducing factors contained in it. It will be 
important to use serum-free conditions (such as serum replacement) and defined 
molecules for differentiation study. Several recent studies have eliminated serum and 
have begun to identify factors required for lineage-specific differentiation (Nakayama, 
Lee et al. 2000; Ying, Nichols et al. 2003; Kubo, Shinozaki et al. 2004; Park, 
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Afrikanova et al. 2004). As more protocols incorporate these approaches, both mouse 
and human ES cell mutilineage differentiation will become an easy routine technology 
in many labs. 
4.1.2 Cell markers are not sufficient for differentiation 
Undifferentiated stem cells and cells in different stage during the differentiation 
express different combinations of surface antigens. These antigens can be routinely 
utilized to detect the existence of stem cells, progenitor cells, or differentiated cells by 
Western immunoblotting, reverse transcription-PCR, immunofluorescence staining, 
immunohistochemistry staining, or to separate specific cells from heterogeneous cells 
by fluorescence activated cell sorting (FACS) and magnetic labelling cell sorting 
(MACS). The full list of human cell differentiation molecules is a helpful reference 
when we study the stem cell differentiation (http: //www. hlda8. orM/). 
We used a panel of SMC markers which are widely accepted as sufficient to 
identify SMCs from heterogeneous cells, including SM a-actin and SMMHC, SM22, 
h-calponin. The SM a-actin and SMMHC expression within the developing embryoid 
body exhibited a high degree of SMC specificity/selectivity. In vivo, the SM a-actin 
promoter is expressed in all three muscle types during development but is restricted to 
smooth muscle by the time of birth (Mack and Owens 1999). The SMMHC promoter is 
more specific to SMCs and is only active in SMCs throughout embryogenesis and in a 
small subset of cardiomyocytes during very early development (Madsen, Regan et al. 
1998; Regan, Manabe et al. 2000). Normally the purified cells comprise various 
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subpopulations of SMCs (such as vascular, gut or other organ specific SMC lineages) 
and these cells are best suited to study the common mechanism for all SMCs (Sinha, 
Wamhoff et al. 2006). 
Although the esSMCs express a range of SMC markers, including two mature 
contractile SMC marker SM1 and SM2 (Xiao, Zeng et al. 2006), our proteomics 
comparison demonstrated that their ultimate phenotype and behaviour are profoundly 
different from mature vascular SMCs as revealed by the numerous differences between 
their proteome maps. Notably the esSMC 2-DE gel pattern is more like ES cells. 
Additionally, there are a lot of functional differences between these two cell types, 
especially their mitochondrial functions and their tolerance to oxidative stress. Similarly, 
ES cell-derived ECs also lack complete functional maturation in vitro (McCloskey, 
Smith et al. 2006). Mouse ES cell-derived ECs were compared with mouse aortic ECs. 
Although both cell types expressed EC markers (eNOS, Flk-l, Flt-1, VEcadherin, 
PECAM-1, CD34), ES cell-derived ECs showed a significantly lower levels of 
acetylated LDL uptake and von Willebrand factor and also their VEcadherin did not 
localize at the cell-cell junctions as in the mature counterpart. On the contrary, ES 
cell-derived ECs express much greater levels of the endothelial and hematopoietic stem 
cell marker CD34 and vasculogenic and angiogenic sprouting, indicating the immature 
stage of these differentiated cells. 
These findings indicate the expression of cell markers may be indicative but not 
sufficient to characterize stem cell-derived cells or stages of cell differentiations. Thus, 
other approaches are needed to characterize ES cell-derived cells and mature 
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counterparts. Otherwise, functional differences between which would have gone 
unnoticed by only relying on a classification based on a panel of cell marker proteins. 
Since the ultimate phenotype of a cell is reflected in their instantaneous proteomic 
profile, the advent of novel proteomic approaches may offer an opportunity to obtain 
not only a better understanding of cell differentiation, but also to progress towards a 
molecular classification of stem-cell derived cells based on comparative analysis of 
protein expression patterns with other vascular cell types. 
4.1.3 Mechanical stress and SMC maturation 
Previous studies demonstrated that lack of hemodynamic forces triggers apoptosis 
in vascular ECs (Kaiser, Freyberg et al. 1997) and low intra-luminal pressure (10mmHg) 
resulted in decreased contents of smooth muscle marker proteins h-caldesmon and 
filamin (Birukov, Bardy et al. 1998), both of which hint that mechanical forces are 
essential stimuli for the maintenance of blood vessels. Similarly, the reason for the 
immature state of esSMCs may be the lack of mechanical stress. ES cells were cultured 
in static environment from the beginning without mechanical stress, while mature cells 
underwent stress from the very beginning and the hemodynamic forces last during the 
entile development of the vascular system. The different original environment may be 
responsible for the different function of these two cells. Although they were cultured 
under exactly same condition afterwards and showed some similarities, many of their 
physiological functions are different. 
For tissue engineering, large numbers of proper functional and highly purified 
172 
cells will be needed to construct vessels. ES cells are easy to culture and have a high 
proliferation ability, which can be used to get enough cells in relatively short period. 
The purity of the ES cell-derived cells detected by FACS experiment is high enough to 
prevent the teratoma formation in vivo but the functions of these cells are very different 
from mature cells in vitro because of their immature stage. 
For the use of esSMCs in tissue engineering, additional treatment besides 
chemical stimulation (PDGF-BB), e. g. mechanical stress, may be needed to induce 
differentiation to mature SMCs. With presence of cyclic stretch, total expression of 
smooth muscle specific myosin heavy chain (SM-1 and SM-2) and myosin light chain 
kinases increased in cultured vascular SMCs but non-muscle myosin-A decreased 
compared to static condition (Smith, Tokui et al. 1995; Reusch, Wagdy et al. 1996), 
which demonstrated the stimulatory effect of cyclic stretch on cytoskeleton protein 
expression. Using the same method, we can culture esSMCs in a tube and apply ex vivo 
mechanical stretch between the two ends and gradually increase to normal blood 
pressure. After the stimulation by cyclic stretch, these esSMCs might become more 
similar to mature SMCs in function. 
4.1.4 Stem cell therapy 
Because of the outstanding differentiation performance of mouse stem cells, the 
introduction of human stem cells has received the most attention in recent years as a 
novel source of cells for cell replacement therapy and tissue engineering strategies. 
Diseases caused by the loss or dysfunction of one or a limited number of cell types 
173 
could benefit from ES cell-based therapies, including Type I diabetes, Parkinson's 
disease, stroke, arthritis, multiple sclerosis, heart failure, blood diseases, certain type of 
liver disease and spinal cord lesions (Wert Gd and Mummery 2003). Transplantation of 
specific ES cell-derived cells into pre-clinical models of human diseases is already 
underway. 
Although there is a promising future of the stem cell therapy, several important 
issues need to be addressed and settled before clinical practice. (a) The efficiency of 
establishing ES cell-derived cell lines has to be increased. Notably, apoptosis 
accompanying cell differentiation need to be resolved. If we discover the mechanisms 
and block the pathway of apoptosis during differentiation, we could increase the yield of 
purified progenitor/stem cells for implantation to injured tissue. (b) The compatibility of 
the donated embryos. Stem cell banks with a large numbers of ES cell lines would 
include a significant portion of the histocompatibility types in the population. Another 
trategy is to generate individualized ES cell lines through somatic cell nuclear transfer 
(SCNT), which would be genetically identical to the patient. (c) The purity of 
differentiated cell. Transplantation of undifferentiated ES cells can result in the 
development of teratomas (Thomson, Itskovitz-Eldor et al. 1998). With a combination 
of positive and negative selection, it should be possible to reproducibly generate grafts 
free of undifferentiated ES cells. (d) The number of cells to be transplanted. After the 
mechanisms controlling development of the desired lineage have been clarified, optimal 
conditions for the generation of the appropriate cell populations can be developed. (e) 
The delivery of the differentiated cells to the appropriate site, i. e. the homing of the 
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progenitor/stem cells. (f) The required stage of maturation depends to a large extent on 
the lineage under investigation. Relatively mature hepatocyte will be isolated and 
transplanted and end-stage of pancreatic ß-cells is needed before transplantation, while 
hematopoietic transplantation requires the most immature cells, i. e. HSC. Optimization 
of the differentiation stage of ES cells at transplantation is critically required to meet the 
challenge for cell therapy in regeneration medicine (Yurugi-Kobayashi, Itoh et al. 2003). 
Despite the potential benefit of using human ES cells in the treatment of disease, 
their use for research remains controversial and is currently high on the ethical and 
political agenda of many countries because they are derived from early human embryos. 
Although human ES cells can give rise to all somatic tissues, they cannot form 
extra-embryonic tissues which are necessary for complete embryo development, so that 
they cannot give rise to a complete new individual (Wert Gd and Mummery 2003). 
Messenchymal stem cells (MSCs) are highly attractive candidates for tissue engineering 
approaches in messenchymal tissue regeneration because they can easily be obtained 
and cultivated and are not ethically stigmatized. An ethical and practical limitation of 
SCNT is the requirement of enucleated oocytes. The development of oocytes from 
differentiated ES cells may provide one solution to this problem. 
4.2 Proteomics 
4.2.1 Gel-based or gel-free 
Currently, there are basicly two different workflows for proteomics. One is the 
conventional 2-DE separation following protein identification by MS. Another is based 
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on gel-free "shotgun" approach, which injects the digested protein complex directly into 
MS without prior 2-DE. 
Gel-based approach is very common due to the reasonable cost and is readily 
intergrated into other biochemical purification strategies. The high resolution can 
separate 2000 protein spots spontanously as shown in our proteome maps and all the Mr 
and pI information can be obtained. More importantly, some PTMs are also preserved, 
such as oxidation, phosphorylation and glycosylation. The drawback of gel-based 
approach is the time-consuming, labour intensive operation procedure, which demands 
qualified people to obtain reproducible results. 
While non-gel based approach is much faster and less time consuming. Because 
the separation is performed at the peptide rather than protein level, most of the solubility 
problems associated with large size, low abundance and hydrophobic proteins are 
obviated (Peirce, Wait et al. 2004). This approach offers considerable advantages for 
study membrane proteins. The disadvantage of most shotgun strategies is that 
computationally intensive analysis of the entire dataset is always required, even when 
only a few proteins display changes in expression levels. Moreover, no information on 
the pI or Mr of the intact proteins is obtained, and all connectivity between parent 
proteins and their digestion products is lost, which hinders characterization of PTMs. 
In this study, my subject is the proteome of ES cells and differentiated cells. The 
whole cell lysate is a very complex mixture of proteins. For quantification, mass 
spectrometry-based approaches are well suited to detect accurate differences in pairwise 
comparisons or few biological replicates. However, it remains a challenge to perform 
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comparisons across a large number of samples. Attempts are undertaken to perform 
label-free quantitation, but complex LC is required. Otherwise, quantitative differences 
in label-free LC-MS runs are influenced by co-eluting peptides as highly abundant ions 
suppress the ionization of less abundant ions. Undersampling of the mammalian 
proteome is another problem. For these reasons, the gel-based proteomic approach was 
used in this study although it is labour-intensive and requires more training. In addition, 
post-translational modifications such as the shift between the oxidized and reduced 
isoform of peroxiredoxin 6 would have gone unnoticed in a gel-free approach. However, 
this was a crucial observation and lead to all the functional studies into oxidative stress 
associated with the differentiation to esSMCs. 
Gel- and non-gel based approaches provide closely related but distinct information 
about proteins, suggesting that they are complementary, or at least supplementary, 
methods, but not a replacement for gel-based proteomics (Monteoliva and Albar 2004). 
With the development of all related techniques during these years, advanced LC system 
can easily resolve mixtures of 1000 different proteins and also new fragmentation 
methods on mass spectrometers such as- electron transfer dissociation (ETD) can be 
utilized to detect different PTMs. Thus, the shotgun approach also can be used for our 
future studies. 
4.2.2 Silver staining or DIGE 
Even within a same batch of 2-DE gels, silver stained gels still show a large 
variation because the dry stips and polyacrylamide gels are still not totally identical. 
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Gel-to-gel variation is the biggest problem for the reproducibility of our early studies. It 
is recommended that for a single biological replicate at least 9 different gels are required 
(3 different gels of three different samples of the same biological state) to overcome the 
gel-to-gel or intrinsic biological sample variations (Monteoliva and Albar 2004). It is 
very hard to use silver stained gels to study a large number samples and gel analysis is 
very time-consuming. 
Compared to the traditional silver stained gels, 2-D DIGE eliminates gel-to-gel 
variation by running different samples in one gel. This greatly reduced the work. Silver 
staining only allows a comparison between two similar samples, i. e. the same cell line 
before and after treatement, because a similar spot number or density is required for the 
normalization between silver stained gels. It is less suitable for comparing totally 
different cell lines, i. e. esSMCs and aortic SMCs, as they might have a different number 
of overall spots. By using the same internal pooled standard across different gels along 
with high sensitivity and wider linear dynamic range of the fluorescent dyes, highly 
accurate quantatitive analysis can be performed even between very different samples. 
Despite the relatively expensive equipment and consumables, the DIGE approach is 
much more reliable than silver stained gels. 
There were also some compatiblity issues when we transferred from silver stained 
system to DIGE comparison. DIGE lysis buffer contains Tris but not DTT. Tris can keep 
the DIGE lysis buffer in a stable pH of 8.5 for optimized labelling efficiency but 
introduced higher ion strength into the isoelectric focusing system. DTT will interfere 
with DIGE labelling and must be avoided in the lysis buffer before labelling. However, 
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the protein subunits or protein complex combined by double sulphate bond will not 
totally disaggregate in the lysis buffer without DTT. These component differences lead 
to potential differences in the spots pattern between 2-DE gels and DIGE gels. 
Hydrophobic protein lysis from cellular compartment for 2-DE remains to be an 
unconquered problem in proteomics today and can presently only be accomplished in 
part with the help of specifically different isolation protocols (Klose 1999; Ramsby and 
Makowski 1999). Moreover, the precipitation step during cleanup procedure will cause 
protein loss because some of the precipitated proteins cannot be resolubilized back into 
the solutions at the final reconstitution step. Also the extended exposure to the low pH 
trichloroacetic acid solution may cause some protein degradation or modification, which 
may influence the protein pattern of 2-DE gels. However, the clean-up can remove most 
of the contaminants some of which may interfere with the isoelectric focusing and cause 
a loss of spots or even vertical empty gap across the gels. For these reasons, we use a 
sample clean-up and ran the 2-DE gels as a complementary map for the proteome map 
of the Sca-1+ progenitor cells. 
By using the internal calibration with the Mr/pI pairs of identified proteins, a grid 
map can be generated (Figure 29). Because the real observed Mr/pI of identified 
proteins may not exactly equal to the calculated one, a less bias method could be used. 
The best one is using external calibration, i. e. using Mr marker to calibrate Mr and 
using pH gradient shape of IPG strip from manufacturer for adjusting pI. 
With more powerful computers, 2-DE gel analysis programs are also 
countinuously being developed and improved but image analysis remains a 
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time-consuming process. For DIGE experiments, DeCyder is the specially designed 
software for DIGE gels. It contains three modules, difference in-gel analysis (DIA), 
biological variation analysis (BVA) and extended data analysis (EDA). DIA module 
detects protein spots and directly compares the protein expression of the samples within 
one gel. BVA matches multiple images from different gels and calculates the relative 
ratio and statistical data of protein spots between multiple groups by normalizing and 
matching the internal pooled standard. The newly developed EDA module offers 
advanced statistical analysis in a simple-to-user format, uncovering patterns in 
expression data and relationships using multivariate analysis and sophisticated 
clustering methods. DeCyder provides statistical confidence and minimal user-to-user 
variation and reduces hands-on analysis time. 
Direct comparison between esSMCs and aortic SMCs using the DIGE approach 
revealed reliable differences in protein expression (Table 15, see Appendix), which will 
give us further insights into the functional role of the identified proteins (Yin et al, 2006, 
Proteomics, in press). The DIGE experiment showed that the expressions of 
myofilaments and associated proteins (such as actin, lamin, myosin light chain, 
tropomyosin and vimentin), calcium-binding proteins (annexin, caldesmon 1, 
calreticulin, and transgelin), are lower in esSMCs, which indicates an early 
differentiation state of esSMCs. In contrast, proteins related to DNA maintenance, 
transcription and translation showed increased expression in esSMCs, e. g. 
heterogeneous nuclear ribonucleoprotein, translation initiation factor, elongation factor, 
which are consistent with the higher proliferation rate of esSMCs. Other differences in 
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signalling proteins may implicate certain receptors and signalling pathways in 
regulating stem cell differentiation. 
HSPs are known to play an important role in chaperoning by transiently 
associating with nascent polypeptides to facilitate correct folding in the cytoplasm and 
nucleus. Notably, nearly all chaperones expressed at higher level in esSMCs than in 
aortic SMCs. This may due to the proliferation-related higher polypeptides synthesis 
rate in esSMCs. HSP 47 is known as molecular chaperon that specifically recognizes 
procollagen in the endoplasmic reticulum and is required for the maturation of type-IV 
collagen (Matsuoka, Kubota et al. 2004). The decreased expression level of HSP 47 
(spot 115 and 116) in esSMCs may be due to the previous initiation of differentiation in 
collagen IV coated flask, which did not demand high rate of collagen IV synthesis to 
form the basement membrane. Interestingly, stress-70 protein showed two pair of spots 
with the same Mr but different pI. The acidic form (spot 4 and 13) were both decreased 
while the alkali form (spot 5 and 15) were both increased in esSMCs compared to aortic 
SMCs. The pI shift may indicate phosphorylation or acetylation (Kim, Sprung et al. 
2006). The two forms of stress-70 protein with or without PTMs must perform different 
functions in esSMCs and aortic SMCs, which should be clarified by further study. 
The DIGE gel also showed SMCs specific marker, such as transgelin-2 (spot 76 
and 79), transgelin (SM22, spot 80), calponin (spot 93), which were decreased in 
esSMCs. Increased oxidized peroxiredoxin 6 (spot 50) and decreased SOD-2 (spot 77 
and 78) in esSMCs were also identified by DIGE gels, leading us to further investigate 
the redox status in esSMCs. Decreased ATP synthase B fragment (spot 22,31,32 and 63) 
181 
as well as increased VDAC (spot 88-91) suggested the mitochondrial dysfunction in 
esSMCs. 
There are still some spots, which are relatively difficult to obtain reproducible 
results because of low protein concentrations, low quality of MS spectra, too small to 
get enough peptide peaks to be identified, or unavoidable keratin contamination of 
samples during manual spot picking and tryptic digestion. 
4.2.3 Proteomics and differentiation 
To understand complex biological systems such as cell differentiation, a more 
comprehensive approach is needed. Proteomics offers the possibility to simultaneously 
assess the expression of multiple proteins and will help to get a better understanding of 
stem/progenitor cells differentiation in vitro and in vivo. 
There are several reports on stem cell and differentiation studies using proteomics 
technique. For example, proteome databases of murine R1 ES cells (Elliott, Crider et al. 
2004) and human mesenchymal stem cells (hMSCs) (Feldmann, Bieback et al. 2005) 
were established by using 2-DE and MS. The hMSCs and differentiated osteoblast were 
compared and membrane proteins were identified by using the subcellular fractionation 
and LC/MS/MS techniques (Foster, Zeemann et al. 2005), including many low abundant 
signalling proteins and cell markers. A proteomic approach was also used to compare 
cytosolic proteins differentially expressed in HSCs (CD34+ cells) and mature CD15+ 
myeloid cells from human umbilical core blood (Tao, Wang et al. 2004). Although 
proteomics were applied to many stem cell studies, it has been hampered by the lack of 
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physiologically relevant cell models that can be expanded to generate enough of 
material required for proteomic studies. 
Before we can analyze protein differences between different differentiation stage 
in detail, reliable and applicable reference protein maps of each stage during ES cell 
differentiation must be established. In addition to a protein map of mouse ES cells 
(Figure 28), we utilized the potential of proteomic techniques and provide a detailed 
map of proteins derived from Sca-l+ progenitor cells (Figure 33 and 34) (Yin, Mayr et 
al. 2005), the early differentiation step from ES cell to SMCs. All these data are 
available in our website. 
Vimentin is the most ubiquitous intermediate filament protein and the first to be 
expressed during cell differentiation. All primitive cell types including bone marrow and 
cord blood derived non-hematopoietic (mesenchymal, stromal) progenitor cells express 
vimentin, also in our Sca-1+ progenitor cells. Therefore vimentin is a key protein to 
identify progenitor cells of mesodermal origin (Feldmann, Bieback et al. 2005). 
Vimentin is one of the most prominent phosphoproteins. A charge train of spots in 2-DE 
gels may imply a series of phosphorylated proteins with different number of phosphate 
residues. SMC specific markers like h-caldesmon, a-actin, transgelin, and tropomyosin 
are commonly detectable in SMC 2-DE gels but less expressed in ES cells or Sca-1+ 
progenitor cells. 
Beside the intracellular protein differences, the membrane proteins are also 
important for the full function of esSMCs. Recent studies showed that the integrin a4PI 
(VLA-4) promotes the homing of circulating bone marrow-derived progenitor cells to 
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the a4ß1 ligands, VCAM, and cellular fibronectin, which are expressed on actively 
remodelling neovasculature (Jin, Aiyer et al. 2006). The expression of the similar 
membrane proteins as the mature SMCs will enhances the mobility of the esSMCs and 
facilitates their homing to the injured area in the cell therapy. 
As membrane proteins are normally very large hydrophobic proteins, new 
approaches are investigated by our lab to identify and quantify membrane proteins from 
SMCs (Sidibe, Yin et al. 2006, submitted), which combines cell surface labelling with 
Cy dye and biotinylation. After enrichment by the affinity capture with avidin and 
separation by 1D gradient SDS-PAGE, the Cy dye labelled proteins contained the 
majority of membrane, membrane-associated proteins and extracellular matrix proteins. 
Using this protocol, membrane proteins can be easier distinguished from co-purified 
intracellular contaminants. 
4.2.4 Bioinformatics for proteomics 
Currently increasing interest emerges in the validation of peptide identifications, 
the use of statistical methods to analyze results across multiple samples, the need to link 
mass spectrometric data to a multiplicity of genomic sequence entries, and the 
development of common standards for the dissemination of proteomic results. All these 
promote the development of proteomic bioinformatics. 
As proteomics study will generate large amount of data, including gel images, 
protein spots position on the 2-DE gel, mass spectrometry raw data and spots 
identifications, many 2-DE gel database have been set up, including SMCs, HUVEC, 
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serum, mitochondria (httl2: //www. exl2asy. oriz/ch2d/2d-index. html). Proteomic databases 
have been proven to be effective tools in basic and applied cell research (Resing 2002). 
The knowledge of the cellular proteome also provides a useful instrument for the 
assessment of differential protein expression changes under disease conditions, for the 
analysis of functional protein interactions and the clinical treatment protocols. For these 
reasons, we built our own website http: //www. vascular-proteomics. com. Our gels show 
excellent resolution and represent a variety of proteins and different PTM. The 
identifications through all these proteome maps are highly consistent, which may be 
beneficial for other researchers. Future guidelines for publication of protein 
identifications (Carr, Aebersold et al. 2004; Wilkins, Appel et at. 2006) may require 
access to raw file of mass spectrometry, for which the website would provide an ideal 
platform. 
4.3 Oxidative stress 
One of the remarkable features of esSMCs was their high level of oxidative stress 
in esSMCs as indicated by the presence of oxidized antioxidants pointing towards a 
potential role for oxidative stress in stem cell differentiation. 
4.3.1 Oxidative stress in stem cells differentiation 
ROS are ideally suited as signalling molecules because they are rapidly generated, 
highly diffusible, and have a short half-life inducing signal transduction cascades of 
numerous pathways, which regulate biological effects such as differentiation toward 
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certain cell lineage (Sauer, Wartenberg et al. 2001; Poli, Leonarduzzi ct al. 2004). 
Compared with undifferentiated and dedifferentiated cells, differentiated cells 
generally exhibit higher rates of cyanide-resistant respiration, cyanide-insensitive SOD 
activity, peroxide concentration and lower levels of GSH (Sohal, Allen et al. 1986). 
Metabolic gradients in developing organisms are believed to influence development 
(Allen and Balin 1989) by resulting in differential oxygen supplies to tissues directing 
developmental events. 
During embryoid body differentiation, embryoid bodies displayed significant 
endogenous production of ROS, accompanied by the expression of NADPH oxidase 
subunit p67Ph0", 10--100nM of H202 significantly enhances cardiomyogenesis in 
embryoid bodies, whereas higher concentrations exceeding 1 µM exhibits inhibitory 
effect. Continuous elevation of intracellular ROS is deleterious for cardiomyogenesis 
(Sauer and Wartenberg 2005). 
PDGF is essential for the ES cells differentiation into SMCs. At the same time, 
PDGF is well known to increase ROS in a variety of cells (Kreuzer, Viedt et al. 2003; 
Weber, Taniyama et al. 2004) and involves Rac activation in its signal transduction 
cascade (Chiariello, Marinissen et al. 2001). Although PDGF-BB had been withdrawn 
for several passages at the beginning of the differentiation, the increased oxidative stress 
may not be overcome by the cell redox system. Antimycin A inhibition resulted in a 
great increase of mitochondrial superoxide generation in esSMCs (Figure 43), 
indicating that complex III is responsible for the marked ROS increase in esSMCs. 
It has recently been shown that adult EPCs have increased antioxidant protection 
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(Dembach, Urbich et al. 2004), that oxidative stress accelerates EPC senescence 
(Imanishi, Hano et al. 2005) and that glutathione peroxidase deficiency mice have 
dysfunctional EPCs with impaired ability to promote angiogenesis (Galasso, Schiekofer 
et al. 2006). Our data presented in this study provide solid evidence that esSMCs 
encounter increased oxidative stress due to a rise of mitochondrial-derived ROS and 
displayed higher levels of antioxidants, indicating that esSMCs share some similarities 
with adult progenitor cells. 
The balance of the antioxidant and the ROS is very important for cell survival. It 
seems this balance is very fragile in esSMCs They are more susceptible to oxidative 
stress-induced cell death despite a compensatory increase in their endogenous 
antioxidant defence capacities and require exogenous antioxidant (2-mercaptoethanol) 
for survival. Thus, differences in protein expression relate to their altered cell function 
and maintaining the balance between ROS generation and antioxidative scavenging will 
be essential for the longevity of esSMCs and their potential use in tissue engineering. 
4.3.2 Oxidative effects 
In our study, peroxiredoxin 6 was mainly present as reduced isoform in aortic 
SMCs, but was predominantly oxidized in esSMCs (Figure 41), indicating a higher 
level of ROS in esSMCs, which is confirmed by the total ROS measurement with 
DHR123. In human blood vessels, the membrane-associated NAD(P)H oxidase is 
thought to be the principal source of superoxide and functionally related to 
cardiovascular risk factors (43,44). Besides its predominant role in the respiratory burst 
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oxidation of inflammatory cells, NADPH oxidase is also responsible for excess ROS 
production in vascular SMCs (45). But unlike mature SMCs, mitochondria appear to be 
the major source of excess ROS in esSMCs. The difference of mitochondria-derived 
superoxide was even more prominent between esSMCs and aortic SMCs (Figure 43), 4 
fold increase at basal condition and 10 fold increase after treated with antimycin A, the 
mitochondrial complex III inhibitor, suggesting the mitochondrial complex III is 
contributing to a marked increase in mitochondria-derived free radicals. 
In esSMCs, we observed lower levels of GSH than in aortic SMCs but higher 
GSH reductase activity. This may indicated that there is a higher consumption rate or a 
lower synthesis of GSH in esSMCs. Because of the drop in GSH, GCS activity needs to 
be measured. It has been reported that protein synthesis inhibitors shunt intracellular 
cysteine from protein synthesis to GSH synthesis (Ratan, Murphy et al. 1994), which 
increases the resistance to apoptosis. On the contrary, high protein synthesis activity 
also may cause cysteine shortage, leading to GSH depletion as observed in esSMCs. 
4.3.3 Redox imbalance induces mitochondrial dysfunction 
4.3.3.1 Mitochondria are more susceptible to oxidative stress 
Because mitochondrial components are exposed to a relatively high flux of 
superoxide and H202, the oxidative damage is more significant in mitochondria. 
The level of oxidized bases in mitochondrial DNA (mtDNA) is 10- to 20-fold 
higher than nuclear DNA without histone protection nor efficient DNA repair as their 
nuclear counterpart (Cadenas and Davies 2000). The hydroxyl radical (HO) derived 
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from the respiratory chain can easily add onto the deoxyguanosine of DNA to form 
8-hydroxydeoxyguanosine (8-OHdG) and induce gene mutations (Giulivi, Boveris et al. 
1995). 
02'', H202 and HO' exert quite different patterns of enzyme inactivation (Table 12). 
Overall, mitochondrial enzymes are all susceptible to inactivation by HO' but rather 
resistant to the effects of H202 exposure (Zhang, Marcillat et al. 1990). This is 
consistent to our observation that esSMCs is less susceptible to relatively higher 
concentration of H202 treatment (data not shown). 
Table 12. The different inhibition effects of oxidative stress to enzymes. 
Enzymes HO' HO' + 02' 02'' 11202 
NADH dehydrogenase High High High Partially 
NADH oxidase High High High Partially 
Succinate dehydrogenase High High Mildly - 
Succinate oxidase High High Poor - 
ATPase High High High - 
Cytochrome oxidase Resistant Resistant Resistant Resistant 
Cytochrome c oxidase Resistant Resistant Resistant Partially 
Notably, esSMCs showed a depletion of mitochondrial ROS scavenging enzymes, 
but a coordinated up-regulation of cytosolic ROS scavenging enzymes. However, this 
coordinated rise in cytosolic antioxidative defence capacity was unable to compensate 
for the loss of mitochondrial antioxidants as esSMCs remained more susceptible to 
oxidative injury. While the increased cytosolic antioxidants may be an adaptation to 
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PDGF-induced ROS production, the sustained high level of mitochondrial ROS are 
likely to impair mitochondrial antioxidants and functions by mutating mtDNA or 
inhibiting the synthesis of antioxidants enzymes. More importantly, 
mitochondria-derived 02'' can be only eliminated by SOD-2. Prolonged mitochondrial 
dysfunction causes a drop in ATP level compromising survival. 
4.3.3.2 SOD-2 is essential for maintaining normal cell function 
The pathophysiology of mitochondrial diseases has been attributed to decreased 
ATP production and toxicity resulting from increased mitochondrial ROS generation. 
Under normal condition, 0.4%-4% of the oxygen consumed is converted to 02'- during 
the oxidative phosphorylation and reduced to H202 by SOD-2. Mice that genetically 
lack of SOD-2 die by day 10 after birth. Notably, SOD-2 was decreased only in esSMCs 
but is similar between ES cells and aortic SMCs (data not shown). 
SOD-2 knockout mice have 30% less GSH when compared with wild-type mice 
and exhibit inhibition of electron transport chain complex I and II, inactivation of 
aconitase, development of a urine organic aciduria in conjunction with a partial defect in 
3-hydroxy-3-methylglutaryl-CoA lyase, and accumulation of oxidative DNA damage 
(Williams, Van Remmen et al. 1998; Melov, Coskun et al. 1999). The SOD-2 deficient 
mice also showed 1.3 fold decrease of succinate in state 3 than wild type mice, which is 
consistent with our NMR data, indicating the dysfunction of the citric acid cycle might 
be a result of low SOD-2. SOD-2 deficiency mice showed no changes in cytosolic 
enzymes compare to wild-type mice. The increased cytosolic enzymes in esSMCs may 
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be passed on from the ES cells because Western blot show a similar expression of 
SOD-1 in ES cells and esSMCs (data not shown). 
4.3.3.3 Citric acid cycle dysfunction causes GSH drop 
The L-glutamate level is twice as high in esSMCs as in aortic SMCs; while the 
succinate concentration is 1.5 folds decreased in esSMCs. Succinate is the key 
intermediate in the citric acid cycle, which comes from the a-ketoglutarate and is 
oxidized into fumarate and generates FADH2 at the same time. It is also involved in 
electron transport chain complex II to transfer electrons to ubiquinone. In the presence 
of low level of ROS, aconitase will be completely inactivated but a-ketoglutarate 
dehydrogenase is still functional. Glutamate becomes a key metabolite driving a 
segment of citric acid cycle with the final product being aspartate. When the ROS levels 
are increased, a-ketoglutarate dehydrogenase is also partially inhibited, resulting in an 
impaired respiratory capacity and decreased NADH production (Tretter and Adam-Vizi 
2000). The high concentration of glutamate and aspartate and low levels of succinate in 
esSMCs indicated impaired citric acid cycle by increased ROS production in these cells. 
The glutathione synthesis using L-glutamate may be inhibited because the L-glutamate 
is diverted to drive the citric acid cycle. This may be another reason for the low GSH 
concentration in the esSMCs. 
4.3.3.4 Electron transport chain dysfunction 
We tried several inhibitors for ROS-generation enzymes, including apocynin, 
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oxypurinol, N°-monomethyl L-arginine (L-NMMA), rotenone and antimycine A, which 
are the inhibitors for NAD(P)H oxidase, xanthine oxidase, iNOS/eNOS, electron 
transport chain complex I and III, respectively. The first 3 inhibitors did not show 
significant decrease of cell viability with treatment up to 400µM (data not shown). The 
rotenone and antimycin A lead to dramatic drop of cell viability at low concentration 
(5µM for rotenone, lOµg/mL for antimycin A) and cell death was higher in esSMCs 
compared to aortic SMCs, indicating that esSMCs are more susceptible to disruption of 
the mitochondrial electron transport chain. 
The major net energy conversion catalyzed by the mitochondria is: 
NADH + H+ + V202 + ADP +Pi -+ NAD+ + ATP + 2H2O 
That means the ATP generation depends on the NADH concentration. The low 
level of ATP in esSMCs demands higher rate of oxidative phosphorylation. There are 
two source of the electron in the electron transport chain, from complex I and complex 
II. Both are largely activated and used up all the NADH as well as succinate (as shown 
in NMR data). From the cell proliferation experiment, we indirectly got the information 
that the reductant potential (NADH + succinate) is lower in esSMCs than in aortic 
SMCs. Low NADH level would result in less ATP production, compromising the supply 
of energy in esSMCs. 
The complex I and II and aconitase defects are caused by the ROS-induced 
oxidation of iron-sulfur clusters, which release Fe 2'. This iron can participate in the 
Fenton reaction, generating hydroxyl radical (HO) and leading to further oxidative 
damage. Fibroblasts from complex I-deficient patients have increased mitochondrial 
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derived ROS production when compared with control. In addition, their fibroblasts have 
impaired mitochondrial function, as reflected by depolarized mitochondrial membrane 
potential (Michelakis, Hampl et al. 2002), which are similar as our FACS results of JC-1 
staining. 
Complex III is one of the major sites of superoxide radical formation by 
one-electron transfer to molecular oxygen. Inhibition of mitochondrial complex III by 
antimycin A will block the pathway from ubisemiquinone to ubiquinone (Figure 17) 
(Chandel, Maltepe et al. 1998). The ubisemiquinone accumulates and keeps converting 
02 to 02'" so that superoxide levels increase. In SMCs, the superoxide can be converted 
to H202 by SOD-2 but the insufficiency of SOD-2 in esSMCs cannot antagonize all the 
superoxide and esSMCs show a higher fluorescent signal in the MitoSOX experiments. 
Complex III is the most important part of the electron transport chain because it 
connects the upstream complex I and complex II and the downstream complex IV and 
ensures the electron transport pathway. If complex IV is blocked, alternative electron 
acceptors (such as fumarate) could maintain a minimal electron transport chain activity 
(Hohl, Oestreich et al. 1987). 
During the development, mitochondrial activity increases in cardiomyocytes. It 
may be the compensation of the increased energy demand or essential step of the 
maturation process. Addition of antimycin A (complex III inhibitor) completely blocked 
heart cell development, whereas neither TTFA (complex II inhibitor) nor KCN 
(complex IV inhibitor) blocks the differentiation, suggesting that specifically function of 
complex III of the electron transport chain rather than mitochondrial ATP production is 
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necessary for ES cells differentiation to cardiomyocytes (Spitkovsky, Sasse et al. 2004). 
The interference of the antimycin A with the heart cell differentiation indicates that 
some specific signalling pathways associated with mitochondrial complex III are 
important during the cardiomyocyte differentiation. 
At the same time, the SM a-actin expression was detected in embryoid bodies with 
presence of antimycin A, indicating the SMC differentiation was not inhibited by this 
specific mechanism (Spitkovsky, Sasse et al. 2004). However, the concentration of 
antimycin A (50nM) is 20-fold lower than usually to exclude side effects as much as 
possible. Higher concentration of antimycin A led to an increase of 
mitochondrial-derived superoxide, demonstrating that mitochondrial complex III 
appears to be responsible for the marked increase in mitochondrial free radicals in 
esSMCs, which may impair the survival of the esSMCs. ROS derived from different 
intracellular sources (mitochondrial or cytosolic) may have different effects on 
downstream signalling cascades that are responsible for ES cell differentiation. 
4.3.3.5 Energy metabolism 
Oxidative metabolism serves as an important signal for adaptive responses to 
hypoxia. Prolonged hypoxia causes an inhibition of oxidative phosphorylation, leading 
to important adaptive increases in glucose transport (Mann, Yudilevich et al. 2003), 
especially GLUT1. ECs cultured under hypoxia conditions for 4 days exhibited 
increased rates of glucose transport and generated more lactic acid than normoxic cells. 
All these are coincident with our observation that the oxidative phosphorylation of 
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esSMCs was impaired, which generated more superoxide but less ATP, esSMCs 
consumed more glucose and the lactate was elevated in esSMCs (Table 11), and 
esSMCs deplenish all the glucose in medium after 24 hours (Figure 48), which relies on 
highly efficient glucose transport system. One explaination is esSMCs grow very fast, 
so that there may be not sufficient oxygen supply for their growth, i. e. they may face a 
hypoxia microenvironment. Another possibility is the esSMCs were depleted for energy, 
e. g. ATP production. Anaerobic glycolysis is the fastest way to generate ATP. At the 
same time, a large quantity of NADH is oxidized by reducing pyruvate to lactate. This 
reaction is carried out by lactate dehydrogenase (LDH). 
The proton potential between inter membrane space and mitochondrial matrix are 
the determining factor for the ATP synthesis. If the electron transport chain cannot 
accumulate enough protons during the electron transport, there will be not enough 
energy for the mitochondria to generate enough ATP for cell metabolism. At the same 
time, the electron may be transfer directly to 02 to form 0f rather than to the next 
electron carrier in the electron transport chain. Thus, a low level of ATP synthesis rate is 
always coupled with higher superoxide in mitochondria. The constantly high level of 
superoxide will cause mitochondrial component damage and further lead to 
mitochondrial dysfunction. 
Spontaneous contraction of the differentiated heart cells with embryoid bodies was 
not affected by inhibition of electron transport chain, suggesting that early heart cell 
function is sufficiently supported by anaerobic ATP production (Spitkovsky, Sasse et al. 
2004). In contrast, alteration in mitochondrial redox status in esSMCs was associated 
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with cellular ATP level change. 
4.3.4 Apoptosis 
In the esSMCs, some cells generate relatively lower level of ROS and show a 
proliferation property while some other cells genereate more ROS exceeding their 
antioxidant ability resulting in apoptosis or necrosis. 
Apoptosis is observed during the differentiation of ES cells into esSMCs. The 
results from our lab showed that esSMCs had a higher rate of both spontaneous and 
ROS-induced apoptosis and necrosis. FACS analysis of apoptosis using annexin 
V/Propidium iodide (PI) double-labelling indicated that more dead and apoptotic cells 
in esSMCs compared to aortic SMCs, when cultured in DM. The main population of 
dying cells underwent apoptosis in esSMCs after treatment with H202 or serum 
starvation. Furthermore, caspase-2 activity in esSMCs had approximately a two-fold 
increase compared to aortic SMCs. Cytochrome c and caspase-3 in esSMCs were 
markedly elevated compared to that in aortic SMCs (Figure 49). When inhibiting 
caspase-2 with Z-VDVAD-fmk, Sca-1+ cells will direct toward differentiation direction 
instead of apoptosis (Xiao et al, unpublished data). These results indicate the apoptosis 
in esSMCs is mainly induced by the oxidative stress, which influenced the 
mitochondrial function and caused cytochrome c release. It could be interesting to 
further study the molecular mechanisms for regulating the balance between apoptosis 
and differentiation in stem cells. 
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Figure 49. ('vtochrOmc c and caspasc-3 expression in esSNl('s and aortic SM('s 
SMC esSMC 
Cytochrome c "W-" - --ý 
Caspase-3 --- - l 
Ii-actin ýMmft I mm ___ 
Figure 49. Western blots showed cytochrunie and caspasc-3 were highly cxprcssud III 
esSMCs (n--2) compared to aortic SM( (n 2), Imiicatin higlher apoptosis level in 
esSMCs. 
Our studies would suggest that inhibiting pools of' St l)Cl-oxiclc prod uictloll, it. in 
mitochondria by improving cellular IllctaholiSill, or targeting shccil e cell types, i. e. 
stem cells to facilitate tissue repair, may he a better therapeutic strategy than globaal 
antioxidant interventions. 
4.4 Conclusions and Potential Future Studies 
\Vc present the first protcomic conipairisun ot- niw-inc aortic SMCs and csSM('s 
demonstrating that there is a requirement to define stem cell populations by protcomics 
löt- a systematic understanding of changes occurring during dicv'clohnicnt. "I'hc high 
ROS lcvcl accomf)ailicd with the diffcrcntiation process is a challcnwc in 11-oint us and 
need more cffört to resolve this problem so that obtain stable cclls iör cell therapy. We 
expect that our identification of differentially expressed proteins during stem cell 
differentiation may have proftunci implications in stem cell therapy and tissue 
cinginccring. 
Since the ROS will impair the function Of dliflcrcntiatcci stein cclis and induce 
apoptosis, we want to know whether this high KOS level is necessary br the stem cell 
197 
differentiation or just a hazardous by-product of PDGF stimulation. If we add 
antioxidants and induce cell differentiation, by comparison with cells differentiated 
without antioxidant, we will know whether the antioxidants inhibit cell differentiation or 
prevent the differentiated cells from apoptosis. 
Moreover, mechanical stress can also induce stem cell differentiation. Some 
studies from our lab demonstrated that shear stress might induce mouse ES cells 
differentiation into ECs (Zeng, Xiao et al. 2006). Other kinds of stress may also be 
responsible for the SMC differentiation, i. e. by culturing ES cells on membrane and 
subjecting them to mechanical stretch. Furture studies will show where by combining 
chemical and mechanical stimulation, the differentiated esSMCs may acquire more 
similar behaviour as the aortic SMCs. 
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APPENDIX 
Recipes 
Cell culture 
Complete stem cell medium 
DMEM (ATCC) containing 1Ong/mL recombinant human leukaemia inhibitory 
factor (LIF, LIF1010, Chemicon), 10% fetal bovine serum (FBS, ATCC), 0.1mM 
2-mercaptoethanol (M7522, Sigma), 2mM L-glutamine (Invitrogen), 100U/mL 
Penicillin (Invitrogen), and 100µg/mL streptomycin (Invitrogen) 
Basic differentiation medium (DM) 
Alpha-minimal essential medium (a-MEM, Invitrogen), supplemented with 10% 
fetal calf serum (FCS, Invitrogen), 50µM 2-mercaptoethanol (Sigma), 2mM 
L-glutamine (Invitrogen), 100U/mL Penicillin (Invitrogen), and lOOpg/mL 
streptomycin (Invitrogen) 
SMC primary culture medium 
DMEM (Invitrogen) supplemented with 20% FCS (Invitrogen), 2mM L-glutamine 
(Invitrogen), 100U/mL penicillin (Invitrogen), and 100µg/mL streptomycin 
(Invitrogen) 
2-DE 
2-DE wash buffer 
250mM sucrose, 10mM Tris, pH=7 
2-DE lysis buffer 
9.5M urea, 2% w/v CHAPS, 1% w/v DTT, and 0.8% w/v Pharmalyte (pH 3-10) 
Rehydration solution 
8M urea, 0.5% w/v CHAPS, 0.2% w/v DTT, 0.2% w/v Pharmalyte (pH 3-10), and 
trace Bromophenol blue 
Equilibration buffer 
6M urea containing 30% v/v glycerol, 2% w/v SDS and trace Bromphenol blue 
DIGE 
DIGE wash buffer 
5mM Magnesium acetate, 10mM Tris, pH=8 
202 
DICE lysis buffer 
8M urea, 4% w/v CHAPS, 30mM TrisCl, pH=8.5 
2x buffer 
8M urea, 4% w/v CHAPS, 2% w/v DTT, 2% v/v Pharmalytes (pH 3-10) 
Silver staining 
Fixation solution 
40% v/v methanol, 10% v/v acetic acid 
Sensitizing solution 
30% v/v methanol, 0.2% w/v sodium thiosulphate, 0.5M sodium acetate 
Developing solution 
2.5% w/v sodium carbonate, 0.0148% w/v formaldehyde 
Stopping solution 
1.46% w/v EDTA-Na2.2H20 
In-gel digestion 
Extraction solution 
5% v/v formic acid, 50% acetonitrile 
Destaining solution 
15mM potassium ferricyanide, 50mM sodium thiosulfate 
Trypsin solution 
10µg trypsin in 600µL of 2mM HCl / 10% ACN, then add 900µL 25mM ABC 
MS 
Matrix for MALDI-ToF MS 
10mg a-cyano-4-hydroxy-cinnaminic acid in 3O0µ1 0.1% v/v trifluoroacetic acid 
and 700 µ1 acetonitrile 
Western blot 
RIPA buffer 
150mM NaCl, 65mM Tris Base, 1% v/v Nonidet P40,0.25% w/v Deoxycholate 
Acid (Sodium Salt), 10mM EDTA, pH=7.4 
RIPA lysis buffer 
1mL RIPA buffer, 5µI sodium orthovanadate, 5µl NaF, 1µl leupeptin, 1µl pepstatin, 
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lµ1 aprotinin and 2.51t1 PMSF 
Laemmli buffer 
250mM Tris, pH=6.8,100mM DTT, 10% w/v SDS, 50% glycerol, trace 
Bromohpenol Blue 
Transfer buffer 
12mM Tris, 96mM Glycine, 20% v/v methanol 
Others 
Lysis buffer for GSH reductase activity measurement 
containing 50mM Tris and 5mM EDTA (pH 7.5) 
Reaction buffer for GSH concentration measurement 
275µL of 80mM KH2PO4 (pH 8.0) containing 5mM EDTA 
Reaction buffer for ATP concentration measurement 
1: 1: 1 mixture of 80mM MgSO4.7H2O / 10mM KH2PO4 / 100mM Na2AsO4 (pH 
7.4) 
Lysis buffer for ROS measurement 
0.1% CHAPS, 50mM K2HPO4 (pH 7.0), and 0.1 mM EDTA 
204 
a cq3 
CL 
ca E O 
: 
O" 
H 
O 
v 
O 
`, 0.0 
ý- O 
y aý 
"- o 
Ca 
0- 
IL H 
Od 
u_ 
e}" 
"-ý MO ýD .0N . --i - 
N*NNN 
V9 
MNN 00 
00 r- ý r- rn 
CJ 
r eo ^ M d pe oo ao O O; dM Ö 
00 V1 00 0 00 Oý Ný NNN0 
Vi w V) %n MM Vl NN 
Ici >--O p" 
r" ý; ýo 0 0o cý vý ry ry c'1 ýn oý cý cý oý o vý 
y^ vi ýn vi c o0 06 vn Vn vi ýt et vý kn vi 
Na !ý ýC ýt ý1 N et ýD llý et V1 V1 
ONN 
. 
N-ý 
. 
ir, --+ N r-1 oý rq (D r4 ei 'r i/1 
MMM 
_w i 
u^0NMM0ee 01 -MN ON 0. NNN NN (D O 00 NNMMMNN 00 o0 ID IlO Vi 
N U1 ee 00 00 00 - 
V) 
-dVh 
V1 ýY -? - =ä 
[ý rý ; D` O o0 00 0o O M 
t+ M r+ --ý ON l- I- MN 00 0 00 N OO 00 ýp . -ý . "r pý NOM vi ON Vl v1 M 
U 
. -+ et V1 Vl NO L/1 00 
MN o\ o> NNM 
NN- . -+ NNN', eMMM et of en MN 
+r ä- V' vl 
evÖNONNNS0N NNAiý1' 
6' 3O 
en M ON 
en 
00 
-d CD pü 
ý' 
10 ö 00 ONO 
0 
Vet 
en 
\o c> 
ON 
.t 
KA 
M0 ýD o 
a ao ääääw aaaa. oa aaa 
Wwww 
wwN vwi w vý cý www 
oÖÖOOÖÖ0O vii 
ÖÖ vý ýn O 
oZ ea II>III10>-I': >iN 
cy 
>, 
C' XU , 
OUIÄ ý 
ry F-t 
>>ä 
ro) 22 ooo919 ýrb aýcn 2z aa uz 
0ä 
wZxx -° 
o00 
ýööuöö0 
Zo aý aý 4" .u .p 
k4 1. 
ýÜÜaVV 
a k4 G "- v 
ii 
uuv 
NN Q) cu Cl Q Rý 
tý 
N Vl V) -4 . -fir 
0 
+u u ,b 
N V1 
pppa 
'c d "2 "2 
00bF., 9° 0000 
00.; ;d 'v "° "° 00u4, Ö +. 
Näqä 
üvaö7a 
iý i'ýc 'Yý oo p 4) 
Qb 
. 4) 00 ea 4) o .ý 4) o +y+ ppNu E~! oo C'ýi vN a~i aýi vv vvi 
öää cn vý vý a: äöxxwä v° xxzzz 
Q w' ýlc 00 00 o 00 Oy 4)o aý o N'" <0--- . 
M. --U- en 
4)v 4v 
tr '4)o 
**« 
NN 
--- 
f- 
SMM 
V1 M ýO 4MM 
V) l- l- 
* *V 
NOO O\ '7 *M 00 . 
O\ 00 00 10 _ 00 I- I- v 00 N O\ G1 Iý ""r r+ . -ý Oý O> "-ý "-ý 
ýD "-" "-ý 
*** 
-4 C> 
rn 140 
eý NMNNNM ý7 ý`1 , 
ý_, NMNNN M 
ýT 
NNN 
^ý N 'ýf NM ýt MNNN NNMN le 
00 (- 4n Kl G> - v1 M Cý M 00 ri l,: 'D r"ý 00 O et .r "r 00 
Cý '11: Vi ri cl ri 
%J ýQ 
ýt v vi ý"i v ýi ýn oo %c ýo C ýc ýo ýo ýo oo 
"-" cý ýo co cry ovv, oý oo cý oo v, r, tý v, ý", 'ý, 
o o' ff` Vi r, 
NO l- N- oö v1 C1 
MN oö lh v c> Oý ONN r+ en v'1 
Ö V) M 
MMNNN -+ -- NNNMMMMMMMe -e ýf 'Q 
t' t VI V) VI 
ýo en l- t- l- 00 NMN as %Q G1 [- Oý C7,01 
ýo 
.-N00 . -ý 
Ö 
IID N V1 h Vi OO r-: a 00 O ýO %0 N %. o ýO ýO ýo NN %4q 
Tr rr vi Wn oo oö 
CC 
v'1 NOOO r'^ It O iý 00 ýNM vl oo . -+ .ý.. oo 
00 d' 
N 00 00 V CN 
00 ýo r4 NNO Oh vl ON ýc en Oh OA 00 O, MMM -it 'V' 
V1 NO 10 NN 
N Wi 00 00 00 sMN 00 OO Vl o' ON :r 00 00 00 V1 
V1 M Iý Vi V1 
oÖ It ON OA ON ý-O ,T Cs et Oý ýt ýi ý6 lý OÖ0 
00 
et It 
en 
NNNNN-- vl en et N IN MMMMMMM 
14! r wl tn W) 
MOOONN 00 g 
NNp 00 OMÖÖ Öý "w, ! 'ý] 
N r4 
ONN [N- ecn 
MU ýn p 00 
p Oý Oý O, NNO º`ýi pOO 
. --- N ,O ýO eee 
00 O> MMp 00 Oý ýp v> o'N Oý O> C% ýD 00 00 4-1 . -. 
o: ýG 
A-4 0waaawaa0aa0 CO Z. aaaa CO aaaaa 
O' a 
W 
Uxxw 00 
UÖÜ0Aqdýw 
pry", 
awaaaý.. ý 
`aý O' vxw rý awa Eý E-ý 
0 
x äää ý o E-- o ,no0ööö U- ýt oääaaaao 
. 
to 93 
eeý 
qwO "ý 
OOO0 
ev 
f%ý OÖUwwOoa, ý+ 
4ý 
... M "- Nvu .ýaVu0 
on on VHV -" 
.5 : io 
o vp{ p .Opp 
iý bA pppp 
ýO 
y 
o0 
ed ^ ýn ýn 
ý1 
rn vý mp2m ed IM N+ 
aý vo'o .oöö 
o 
CJ 
wpw. - t. 0 
pää .c .4äääQQö0 
ö¢ 
to oo0oAAo oA on CG 
24229 
vý .r do UpNNU G) p°N r- 
I. wwääw °v N2xxZaxxxHZQWaWa9 
N vl ONM v1 -4 - -e 01 v) %0 
O> M l- O_ v1 00 
NN 
O O. NMM <T V1 bN oo 00 00 OOOONNNN 
rý t- 00 .r- -4 ,... 1 -4 ,. - -4 -4 -" .. . -+ . -+ 
NNNNN 
lý 
O 
N oo N 
O rf) 
v1 
" 
N V) 
V) 
M 
N 
N 
M N 
ýO 
M 
O 
v'1 
* 
* 
N 
. [- 
eý 
O 
M 
* e7' 
v1 
"-+ 
N- 
0 
N 
M N 
x 
* 0 en - 00 
IZ ý 
N Q\ . -r r+ 00 M N C 
Oý lý ýO ýO O O o0 M et Qý et ýC et O 
lM 
et v% 
O 
- M 
0q 
et N N ýO $A V1 
IIR 
N gt 
. -+ . -+ r+ . -- . -4 N - -+ N - M - N M - M M - - N N - N ý+ - 
ýo l- (: 'V c) e 0% I- "" 00 . -ý .r at ýf; "" "ý Ký t7 et 4i Vi v1 lD A 
ýD t0 
--ý 
ýC 
lý 
ýG 
Qý 
ýO 
00 
ýO 
Oý 
ý/i ýt v1 V1 v1 vj v1 ey v1 v1 Vi vý Vi vi 
v1 
h 
tý 
Vi 
r" 
vi 
00 
vi 
ti O 1,0 e ýO et en N N Ö Ö N O> Oh M ý} V1 00 O 
140 N S N l- 00 Cý 00 S fS tN 5 N N ýO i %0 wl v'1 %0 O %0 vi ýo 
v) v) vi M M (D O N M lit N N N N . --ý - tN . -" N - ý-+ - N - 00 N "D ýD ID rý lý Cý cý In: "i N O M M Oý O O 01 ti M Gý 00 N 
p 
M 
ýe 
M 
e 
M O 
lý 
O 
ýD 
O O 
e 
en 
vi 
. -4 
ýt 
ýO 
vi 
N 
vi vi 
- 
vi 
- 
H 
00 
v1 
Co 
vi ý/i 
00 
v1 
l 
vý 
N 
h 
h 
v1 
oo 
vi 
- 
vý 
00 
vi 
GO 
vý 
e 
N N N t 't 
v) 
- 
00 
"-+ 
00 
00 
. -" 
00 
O 
l- 
ýt 
N 
`Q 
N 
ý7 
h 
00 
I- 
00 
N 
vl 
N N 
't7 
N 
vl 
N 
00 
it 
Cý 
v1 
Q 
N 
ýn 
N 
o0 
N 
Vl 
N 
ýO 
N 
ýO 
S S ti (D CD rf) 5 
P 
r-i 5 5 S S N N N h h 
00 
0 ßi 
ä 
00 
0 Ri 
ä 
00 
22 
ä 
00 
011 
V 
00 
ä 
p 
. 
ý7 
ä 
Ci 
r7 
ä 
N 
00 
ä 
ä 
0 
Ö' 
ý_ 
00 
ä 
N 
S 
ä 
N 
S 
ä 
r- 
O 
M 
ä 
r, 
O 
M 
ä 
r- 
00 
ä 
r 3 
CO 
ä rn 
c> N 
S 
r, 4 ä 
r `3 
Co 
ä 
O 
ä 
M 
O 
ä 
M 
O 
ä 
; 
ä 
r, 
O 
ä 
et 
'. O 
ä 
d 
MO 
00 
ÖÖÖ 
CD 
Ö O% 
w o. ooý 
ö, öý w 
ýWWWWWWWWWWWWN 
V) cn V) En En En CA rn En En 
C)O OOOOOOOOOOO 
IIIIIII iii 
2IIiý 
C'4 00 
, 
tea Wý Ir- NNNNNNNN Cý Cý 
NN 
CIO CL4 
awooxxooooxUUoxo 
öeH 
w º. OO 
vu 
wwww 
00ouuº: ° :: a a° .. a 
UU 'U 
ý+ a+ w-r w. + r+ w rr ý+ ýN rr --i N P. NNUUOO0mu(0.. w0 11 
r2 
aaa e4 as 
llý 
obb99 ,a .c 'ate, "b aý u 'a .o 
co 
DOM 
03 ö ^. ., 
°J y 
A fA aaaÖUN ýq 
.ýyOOb 
4- 
0OOU. 
. 
U. U F" NNOOO 'y 
yrG «' tz 
0ää0V p" a' öaaw . ýye aaa . ýe a . ýe a ,c uUub b U°y öO ö, o 0o coo .c .coov Upp200 ß ß, 4Q 
qm Am 
l 
. Il) (fin 
y,, 
pM 
tv . -y 
y FFCTT 
00 
xxxw wýý wLx i° r- xx En En r- vii xZZ vii x cn a 
U 
.ýa eq en -t ýo en tn 00 0 . I- "T tt e. "d 'N v1 = i- "F- "I- 0-N R1 ul 00 Oý O-NM qt NNNNNNNNU .4NM er 00 Os -- -- -- ^" NNNNN 
v1 l- M** 
eý 
1F 00 
OOO* 00 M*N0M*N ON 
* 
IM+ "~, 
N 
tT ýO 
N_ 
oho . ". NN C\ ON o0 N 00 as "-" " 00 N ýo o0 -4 C\ 
e1. -N V1 MM ^ý 
N-O l- MN OÖ 00 rn eOeO oÖ MM r' vM v) V) V) 
MNNNNN ý-+ "-+ to -N . --ý N "-+ -- en CO) en mt N-----M 
kn 00 "-" vl . -. . -, oo r- 00 h C; O O) OOO NO et M o0 
w1 vi !/f V1 U1 d v1 V1 "D oÖ oÖ oÖ 
': YN"r r+ V'I 't l. 00 [. ý O, 'o N ýt ýl 00 Vl O 01 ýD Q, 00 M 
00 O\ .- oÖ V1 oÖ OMO vi .N CIO QS MN It r'+ V1 16 iý N vl 
ON 
W) V1 ýo v1 W-1 V1 -'i Rt M Vl 't 'ýP MNNNN-NNNNNMM K1 "t 
Cý NM (ON "t gM t- ON l- - t- - 00 OA (7, ýo 00 00 NO I'- I- l- l- gO 
O0 N ["i ei MNM Cý M Cý O0 Cý Cý N vl v1, r' G) MMMM Cý 
V7 et 'ýt 'ýt `ýt ý/ 
i 
ýY U1 v1 N1 v1 N1 ýI 1V1 ýi V'1 00 W) to V1V1 OÖ 
N 
Oý v) ýt ýC p vl - tý In .z t/1 
NN 
co NNNNN 
N ýt 01 'ci I- O O, l- 
_ 
lo c 
oo 
V1 lNNýd90 
V: C: t: r -4 a', oo . -, 00 Oý 00 ýO "I: MO o0 00 00 00 00 . --ý vii 
ýD Ö [- t- (14 oo t- O l- OOÖO ýo ýo ýo O', c" 4 en oo c) 
0OÖ oo 
v1 ýO It vn CN "T IT [- v') l- NC [- 1ý0 v1 v1 v1 - ýo NNN [- I- l- I- "T "t 
ý en 
N 0000 . -i O- 
000 ,' 
--r . 
fir p- r- 00 r- 00 
140 
M-MwNNN vii 
%D 
r4 
O vgl 
ý 
-ý ýýr 
-0 tý 
00 
r14 
N 
N eV O -0 OOOOaNNO ý+ ''a NOOOOM lý .r of Qý, 00 NMmMMMM C> t- [- MN 
ON 'e7 NMMMMN O> 
cy . -ý r+ OO (> ,eO ýo %D YO 1,0 NN 140 """ 
O', -I v1 VV %0 "-, 
awaaa O' aaaaaaa O' aaaavaaaaP. O' a 
WWWWWWW En 
W 
rJ2 W U2 W Z) u2 U2 W V2 cQ cWn Ln 
Ln 
U2 u2 Gn cn cn 
CD C) CD C) 0 ZD C) CD 
C C) 0 u2 Ul p C) CD ZD 0ÖÖp000ÖpÖ oo 
II 
>I >I z5 >I 
11I 
C >I C 
e, 
ý>I 
IIIIIIIIIIIN 
r, I- I ýc IU r" U1UIwý UWU r- o t, obI 
r- W CZ N 
r- r- r, 
r- Ä ;Dv E-ý Qa ä Eý aýaýaý oý 
ýwýa 
aý a a, aaa 
äHÜäw 
aA. 
ÜxäxÜxÜ CY ää E-ý 
x 
C7 ZWxxxxa. Z. ' 
00 
0 
aUU H 1^. ý u ºý.. N Q. 1 iý. ý 
N 
w ý. y wdº. ý Oý a^ 
+ 
ca 
wU C) U E) U C) UUC, Fr . Cý' 
w 
ý+ a+ ." +' , 'ý M4oº: o° 0°° ri moUö .Eo000 
ýc 
,e 
Po e 
KDW 
2 92.1 1-4 -. 99 U) Ici , Z. öö . ýo 0Eoo 0ö °' E- iNn " 
..... 
00 
'S7 . 
4: 'O Abpbp=p .Obbb 'i, ' 
0COOOOb r" 
UU 
0) 
QU"U 
+N,, 4) 4) 4) 
uA2-. + 
OH Cý Ow 
ä° 
cad 
Cl Ow ? ý4 
y 
Chi 
o00 4r' 
ýý", NNda, ° 
a E-2 UawaUax %o x ýo ääwF. x cD xwxxxx °' 
N v1 e 
-1 %D n 00 O> N en N"-M V1 MN 00 O, o-M V1 V'1 Vl ýO 00 
0- 
NNNNNMee if) ve .0t, 00 00 00 .. r . -- --- .- -w 
---N 
M V1 N0NN* . -r O** . -9 * !t 41 *M** 
`Q' N Vl 00 * 41 00 ýO N* nt \o -* l- -* .r*** 
NN 00 M-- 00 (> N r4 r+ In -MMM 
yý M* O\ MN K1 
tS M V'1 N" M IlO c+2 O Oý 
MNNMN ON lV MN-MN v) vi NM -e 
Vl V1 ý! 1 4r N1 N V1 V1 ýI1 '7 th Vý VýÖ: V1 V1 ýd %G \d 1. O «t V) 
25 -`ý. , 
may 1 
li-! O vn OC %0 1. O 00 NNNNM 00 nt 
[t . -ý V1 NNNc V1 eý eý NNN Oý N-- yj v vi V) v1 h Igt of et et MMMNNNNN 
00 N 00 O OC Olý Oý O\ 00 . "r ON Oh t- "-" NM `t (> N 00 . 
-4 00 
Oý \p N ýT -i 19 00 -: "i "i V1 -i -i M [t 'q7 1. D 
ý/i V1- v1 -t v ýD ýD t ýr U1 vy v-l N 
MÖN ýV ÖpÖ vgl 
\NNN ýO 
Öý 
. 
ý-ý QO 
`ct NM 00 N O\ OO 00 ýO M '/1 00 
000 N 
N1ZÖ 
M 00 1. O kn In NMN 'V M 'D Oý t, -i 
r t- ÖN l- l- ýG "MG [- 1G 
M 
oö N 00 N 01 O0N "-+ 1. 
D 
Vl ýO ýD [f 'n Vl ýt 'h V'1 'ýf MM U1 NN vl NN- "--ý 
... ...., O v1 O 
"d r, 00 NMOO v1 v\ O oo yj 00 
j 
Gý 
. -. ... ., NN oeý0 0o N 00 In oG 0 00 p., 
0 
ii ; 
ýý 
00 ÖÖ 
\G 
3 ; 31- Im ^" AAN 00 V-b 
ÖÖÖO 
pý 0ý1 Cý . 
Nr 
le ON 
00 ä 00 00 äÖ äää ääV CYN In ää CN 0% ä In d O' aaaa 
ww 
wwww wýý w wý ýý wNwý vý vý v, w `i' wO vý OOp `ý ýw OO CD OäO OOOOOOO CD Oapp (Zöc oo> oýop oo o 
aas Ný t7ý i äl al aýý aas öl 
tAI 
vvvH as oa äa 00 vii 
ý c7 
to 
E-ý HF vý cý rx QdaQOOdaQ º-a 
a 
.0Sö 
1 Nö 0öpoo 'r 00 
äääo aý av 
-ji Za 
. JD r. 
plo 
, aý aý Nt.;; 4 
ääöööö0 
2 
O= 0 Saaa .ýowy on ya ." 
. -ý . -ý .ýöOOUUUOUpUO 
Ei 
. 
Ei 
.a .aää. 
I C) ön bb ,i"äö'.. u ýu 
45 cu >b 
00 'n fn ti 
> cu 00 
FH Iti V) xxdQ `O 
QÖ 
ºý p4 off. 'mQHÜ 
00 140 o1. O eý 
`O 
"MM"O ýf L/1 1. p 00 N 00 In 1. C SMN 
Oý OÖ "ý-ý "--ý 
NNNNWMMMM en ee l- 5 r° 00 01. cý ---~ 
C' 
0 
N 
iF pý i1 v) ýo MNNM*-M* 00 le 
00 00 
iF ýr MMNM l1 . ý}" O ýF M V1 
O Qý `ýf ""ý 1F Oý 0ONN0 
N 
00 
!f . -°ý 00 . °ý "-"ý "-ý ""r ýO "r ýO OA - OQ 00 00 -NN 
C1 
~Nn 
00 
Ö 
MMO aý NM ON t, t, V'1 -t N"0NNNMMMN 
r-1 r- 
N 
00 
N vi M "O v1 N IO N lt -4 le M "-+ M et 
~ 
M ýO ýD M [ý O Oý NN l-ý t-ý "t Oý t-ý ýO et ýD O O; N Kl 
00 NNv1 r-; 
ýc 06 ýn ýo 1e ýo C In ýa C o6 0ö kn C ýo od o6 C 
N 'ý 00 MOC, 9 Oý OO 01 O """ý fit' 00 O 00 'lt V1 
O 4'1 
V. ) N I- OÖ OÖ l- 
-Mh V'i v1 vi N ýo r- %d 01 N -i .rNMmM 
V) 
. -i rr . -+ . "+ -4 -4 NNNNNNNNNNN 
(4 mmMMMMMM 
H oo r- HN v) '. O O> e v% '. O N- 00 SÖNNNý 
v) 
oN0 
M OO 00 OO 00 
"-+ 
M ýT MMO ý+ N 
Illý 
tý ýc r; ýc oö ýc oö ýo 00 00 oö v od oö 
ýO o0 0MOO 0i' NO 00 00 0'. 
(N 
M Oý r- "-+ 00 00 ON O l`" Oý ýO l oo M 
ýO O I- [- 41 
et O 4t 14O Rt m 
ýO cV oo rl o0 00 [ý I": MO Vi v1 00 l- mot' oo vl vl 
OOM ýO 14ý ID 
-; \O vi vi vi 
M. 
. 
r, 
-ý . 
N-ý 
NN ýt NNNN 
06 vi t--Z r- cý 
NNNNMMMMMMMMI. 
" VI V) 
ýe 
00 .,.., v) 
3 
%0 o0 00 
ri dN' `O 
v Nd Nri90NO 
vi V) o% =n oO 00 
CD it'. 
N- nn o°o 
ä 0' -NnöAA VV A; N 
rn öe 
rn c> o'. o'. o'. rn -, o' o 
in. ää 
Ö' wäää O' aaaaa Co Co Co Co Oacaaaa O' 
ww ww vi 
] vWi W vwi vwi `n WW Ul mNN Z) 
ZE 
OOOAAAÖ Z) 
ÖpAAOOpOOAAo 
ýý d 
p4 1iQ 
qqHOdAaAao. 3 r, wää äý wAQa 
xzäzä IM-4 ý 
Ln 
äwýää 
0 
U 
et 0 
ý 
,äý vOi 
m 
u 
Ny 
Ö 
Co u 
-+ O ºy 
Ö 
d<yÖg 
tyd 
e 
.dNVVVN cºyýr ONN fy 
v'OOH 
il 
10"C 
OOO Qcd Lý' m 
vOi 
~ÖOd 
.C ý7 
?, $äbäbb n° : :röö 
:ýö 
Co 
,A (A 
JM 
°U°° 
.Oää' on a; u °' ý° 'v 'd vb v°' -0 92. -0 CL. P. E20 
cu cl ce 
TJ °' °"-' V C) 
, 
gyp & &) u 
°' pb 
-' uOvv0 NÜaVa0ööao0oüoO 
%D 
ZNN .ý .ý< 
ZUP. w 
ä¢ 
äädFEäädwää r° wa4d 
. -+ h ýo t- 00 C\ "t7 N ýo 00 OA 0N WT v1 
l- 00 - en Os C 'n N 
00 
po 
ýýýý fi ýýp CN (14 
. 
Nr 
-4 ----- I" . 
N+ 
. -+ . -ý . -ý .+ .r 
`D. 
-r . -ý . -ý . 
ý. 
. -ý .ý . "r 
ýD 
00 
M 
M 
N 
Oý 
M 
O v1 
N 
N N Oh gti - V% 
00 
N l C 
,t 
N 
IO 
N 
N 
M 
- 
M 
v) 
M 
- 
N 
,O 
N 
v1 
d' 
O 
N 
N 
7 ý-4 M 
00 
- 
N O 
el N 
0 
.r 
fi N 
N 
e M N et 
^" 
O` 
"'" 
00 ON "-4 M -4 - _A (- 00 of o0 -i O N "-" "-, N ri V1 Oý -+ N lIC ýG 
Öý 000 
rý 
000 
od 6 
ýV 
ý 
N 
e "O 
-i vl 
r 
et ýG 
OÖ 
M 
e 
vl 00 
C 
O N 
e 
ý/1 
O 
O 
e 
M 
10 
O 
00 
ý+ 
oÖ 
ýt 
e 
Oý 
l- 
m 
N 
M 
. fý 
M 
N 
M 
, [S 
M 
Oý 
M 
Oh 
M 
Ch 
M d' 
N 
'nP 
O O 
et 
ý 
'e 
1- 
le 
IZ 
Irr 
V'i 
'e 
\O 
V) 
M 
V1 
N 
v1 
- 
In 
M 
In 
M 
In 
M 
N 
N 
In 
vi 
In 
cý 
h 
O 
v1 
1,0 
O 
. 
.- 
.++ 
O 
0 
d 
00 
N 
In 
N 
(D 
ýT 
00 
vI1 
N 
N 
O 
d 
00 
In 
N 
N 
ýD 
M 
e 
Ö 
C O 
In 
(ý 
%0 
Ö 
O 
ý 
In 
lý 
p 0 
O 
N 
Qý 
-. + 
M 
00 
0 
v 
v 
0% 
O 
en 
t- 
O 
D 
00 
. - 00 00 
N 
V1 
C 
0 
Vlb 
O 
ýt 
e 
M 
lý 
O 
O 
.O M 
O -5 
O 
. 
-- 
N 
v 
" 
00 
vi 
N 
ýO 
O 
N 
N 
c 
en 
00 
V) 
N 
%0 
` vi 
00 
V) 
Ö 
00 
` M 
M 
N 
00 
- 
v 
t- 
N 
Oý 
` In 
rý 
0Ný, 
C 
- 
N 
- 
lt 
-! 
M le M M M 't 'cl' le e 'e t 
4 
't d' -e v') V'1 'n ýo in In h In 
ýt 
00 
ä 
~ 
Ü 
V 
O 
Vl 
iZ 
ýG 
O 
In 
ä 
ýO 
O 
vl 
ä 
N 
N 
ä 
"r 
N 
Vl 
ä 
.r 
0 
vl 
ä 
00 
Ö 
00 
00 
Ö 
et 
M 
N 
ä 
N 
c> 
Kei 
vi 
it 
. --ý 
-4 et 
Cý 
a°. 
N 
- 
lý 
- 
N 
- 
N 
ä 
\O 
ON 
-4 N 
P. 4 
p 
Ü 
Ö' 
c> 
M 
"r 
p" 
00 
[ý 
ä 
. -- 
ä 
M 
ýýýDDD 
ä 
pip 
ri (> 
ä 
N 
M 
ä 
r- 
00 
ö 
01 
V 
WWWW 
WÖ 
iý dddI 
ýI ýI 
ý ýI 
of xA IÄÄÄÖ VQ-ý N 
Qdddw@ 0a Q 
WWWW 
O 
CD CD 0 CD : CD 
1> 
rI 
Ni I1ýI 
=I IN 
... 
I dd ool 
IZV W>2 Qq 
äII ä äöä¢ää 
M 
OnO 
N V1 Q 
.oQ V1 
H 
cad UU 
_ý 
öQ Cl 
nO 
NäO 
ý' 
Q¢ 
ý' 
_p 
uI° 
cn 2u uu 
ý 
rcu öwü 
CA 0 Ln 51 
o0o aý a; ýý-V "0 "0 t~ 
cý~ 
2 
N. 
UyN" i^'1 uyH Ney 
eý 
= Q) 
Ud ce cu 
cq v 
v' 'ýi b C7 
b, 
qo evý 
25 ++ .. y"'' 
t'"' ed is O2 'L7 to >, v >, v .4 " 'C7 
t4 g: 4 c2.4: 4 
am9 
124 ;5 -9 
e 
CA 
;j00O 
-ý ý, vu>, 000 
p .Cybo>, 
w tý ., 
y 
vU, vUi 
ºý >, p 
,qkk a> 
>, 
. 54 _U ve 0 '0 CU -0 e 
vý oo0 
oQ0Q 
Cl 
y a 
Cl 9aao cn oasrbu 10 c7 vh 
¢A 
Aa¢¢ cam, ri a¢C, 03 vwww¢¢¢ cam, Eh, 44 r 
N 00 O-N nt 00 Oh NM \O N 01 OM O> -M ýD N 00 
O\ 0 '- 
OO--ýNNNNNNN 00 00 
-g ^" 
- _A - 
-4 
0 
NNNNNNNNNNNNN 
NO ýt NMM .ý V1 N . -r N- v1 M V1 "N 
. "r O\ M . "-i . -1 .-- -4 e -4 "N Oý N ý"-i mt N- it r" 00 Q: 
N 
00 
\o . 
M-ý 
000 
0o Nv et 'n M ýO Iý ý" NM .r. 
M c> -O NN ý-+ MNO 
ý--ý NN Kl NN "-+ -NN- ý-"ý (> NNN V) NMNN 
N 01 Irt M l1: v1 lýO et Cý N 00 v1 'qt . -; N Vi -i et N Vi 00 
9e vi 'm 
C oö 1o Vn v, výeeCe Yi ai C 00 (> tý M --ý V1O lý tt hN V1 ýt vl a O\ dOM 00 oq 
V1 vl O\ OC N V) V1 Oý M C- MNNN ') ý -1 v'1 00 - 'e: N 
v1 v1 v1 of Ir IC 110 \O NN l- Q1 et MNNNNMM 'e 
\o MNNOMNN r+ 
N 
et M 00 pý Nm C\ OO N- en 
00 llý 111: MN Oý ""ý t- OOOMN 
1,0 oo e oö Z -- vi vi vi ee oö e !e 
Oý V1 Oý "O ýo Iz O 00 pO 00 CN M 00 O Oý NN v'1 r- 
-4 - 00 vl vl 4n MNON 
'O 
NM -e N mf 1" I( N mm en 
19 o0 0ý lý lý 14O v1 C Oý et O O; O .r 
N vi vl NN of l- Ö0N vi ÖOv o0 
NÖ o0 0ö r+ Oý 
Ö 
V) v1 vi vi V') \O [N 00 l- 00 00 "MMNNNNMN Ul 
(> 00 WW OON9N0 IN l- c% 
8M 
to 00 
! ''2 't C) r, 1 IV "0 rn 
NNE Cp 
m 
ý} 
vli N 
Oý 000 
2ý} CU CY 
öUUZ 
00 ýo ýC O', 00 '0 0 C% O, N O: C, 00 %Z '0 
äwä ää äw aa aao a aaaa. aaaa a 
wwwW 
c 00 
ul vii cn cn 
OäAU9wWz Ö' ä im 
em 
vn 
ýý 
aw CD Ada>v: x a, UU 
c cu 44 aaa 0 
M 
25 
11 1.0 91 N r--+ b -4 rn ý. 
0 
Newoöo. ä 
0 to 
924 t24 6uoo0ym-a1.0 
%c V 
t24 0 r4 Z 
a, ä `n `r NNo 
CA .8 
CU '- K C7 4' 2oö 
_ý 
UaaV 
-" 
uöv it) o00dU 'w EU 
ýd 
AAöäN 
cn w g5 =öoo VV 0 
-- ö `n a- ei - 'r!, yy0o0UU .ýb aý 
A 
p. ý ýäa 
r3 e 311 U vý aw cZ Ea Et v¢ddH vý aawyac 
N d' vn N 00 -4 v1 00 O d' 'D IN O\ 
e l- N0 00 M b0 
MMMMM 'V' <7 -t in k1 vi V1 v1 '' O\ NOO %%00 .-N 
NNNNNNNNNNNNNCe k/'> Q. . -- . -4 -4 - 
1º *w In * ýy" * rM 00 N-*O ý}" *0M-* 
00 NO v1 * ýD *OMN ýt Oý * . -+ C*NNO* v1 *** 
O IN 00 - -4 . -4 \O N '. O - -4 . -4 p> - .4- . -i ý+ . -. - 00 MM le 
N 
N* V) C) 
* 
'ý 
* 
00 
M "0 eC '. O . -+ M %6 N 'p el 00 en CÖ N '. D 
-"' N C. v1 r4 00 ýt 
M 
ý- NNM- ''1 - '. O -NN eil ý"^"ý NNNNNN le -- 
Oý - 
CD ri ri 111: .ý 00 MM 
ý. i cri ý"i vi CCC `O ýo vi vi ýn vi v; vi vi ýn ýn vi vi V) - oýj ýn oý v ýr ýo v '. o O v, O vi cý oo ýo oý "ý o cý o 
10 00 tG et 'i N cV -4 v1 
e '. o 'o 00 it 
vN "-" "-ý .rpOO "-+ 
MNNN-NNMM VI %D 'o 'n 'n 'n 'd' 14T MMM 
NO v1 NNOON ý-+ N. +. "ý .r 00 '. O 10 Ob 
Oý t+1 Q> C\ 
O .+ -i 00 NNONNMNN l- NN 
v, .c vi 'n ýr ftCC `o vi vi vi ýr vi g. 
r+ Oý Nr+ Oý O\ ýO d' 'n Yl If N V) NMM 
O\ MMN 
en 0. . -i vý N o0 NN Cý -: N lIO lIO 14ý v1 Kn [- [- 
r- lý I 
-NMMNNNM'. O 
ý %0 ýo 
10 ýo VO V) vi " Kr lt et [t 
M 
MNN ýt if Oý 
NN -4 
O 
r- rý C -4 MMM ýt NNOOO00NOO 
NNN Q% MMMNNO 
ÖNM c> 
all "0 
0 Ný 
-4 . 
-. 
r -4 0 
01 0 
Ný\o 
fw) 0 00 
C) CD 
140 ýo 
Va O' O' a P., O' a O' aaaaaaaaaaa O' as 
ww 
WwWwwwwwwwwww vý vý WWqqqqq cn cn ýn vý vý vý vý 
CD 0 CD ööö ö> ööööööö ö>, ööM 
c7 A0 
äcýýääa a ¢¢¢¢¢a¢¢ 
0) 
N 0) 
Ný 
e b 
aý 
92 
cý 
ýN 
Öy 
yö' 
ýi .n 
ý5aN Ui py .+Ü VI N ý=`i NJ ý w 
ýp, 
bQ 
ýi C) Z. 
-. 
Uy FWri GWYi ºO 
ovOO. 0 
9) UNO pp 
º'º p .4 . -4 N r+ Ü . -+ 
CU CU Ei g' uu cu 
CA 
Aý 
41 '0 *0 *0 'A Ný 
oaa04 .ý .ý--°E-- 
a40vä aa) 
Z. ö00000r. 
15: 1 :. 51 51 oyUqoaäU2, i'-``o1 
EI 
öab :ooaeä aý - aý -9 -9 aö H55¢¢¢¢¢H¢¢ 
N 
00 ON _A 
Oý 0-40 M. '1- N "" N -+ O. " NM 'pm O r+ NC 
-4 r4 (Z e ý- V) 00 
00 00 
Q* 10 M 00 r . -4 ** r41 of 
00 . -- *ONM- . -- *-M. N 00 G- try -- . -r ('- - . -w eNN .r -q o0 
r, 00 
on oo ýO oMoo tt N 
-0 N (: cr ýo 'NT M 10 MNN gt e N- 
tt 'It 00 n V1 N Vi 1-h tlý OO of ßr1 00 00 
uj vj -f - oý oÖ oÖ 0a 00 00 !Q 
. -ý 00 Cý 00 00 V: lq N ON V/1 
00 V1 M ýo qt'f OÖ 00 .-OM ý6 M P- 
NNN----NMMM If N (- r- 
. -- O, NCO OG ýO O V1 M-- /O M 00 MN 00 W) W') NN It W1 W7 NN 00 
d ý7 00 00 00 06 00 
1 ID 
-14 
ý M I- O, O' c 00 00 vl ý Vl O, ý M 
Oý M" Oý NNN ON V1 dNtN ýo r- 
ID 
It [- 00 ýf MMhONhN Oý 
. -. . -i p 'O et 00 00 N (14 00 v1 It O*l ON m 
'R7 'tt Y) "- - -4 ýNMM It Vl I-T ID 00 
9N r- 00 
ON "0 00 MOd w) C4 -OO O 
NS 
10 
O\ NNýpM 
I- W) ~ 
ý-- O r4 00 00 10 
_. 
0O "--ý pop N 00 en C) 
aaaP. as O' O' a in., aaV 
0101 en 
1 %0 1 1ý -4 
U ýq 
ÖÖdw [ý 
ý 
L40 
w vn w QQ E-ý aUu a> 
ý 
IIIIIIIIIII 
IIIIIIIIIII 
00 M -T l- ---! ND l': "-! -1 v1 I,, ý 
rr ýi to v ti Wn kn nvv -ý i; ö= vööi; 
eq <D %0 
1.0 W) W) 
3 
en 
00 'o 'T 
MMMMN 
IIIIIIIIIII 
IIIIIIIIIII 
IIIIIIIIIII 
N 
0 
aý 
U 
N 
Q 
H 
N 
U) 
ä 
0 
9 
Ü 
Q 
^' 
tA 
ä 
o 
`', 
u Q 
EI 
U 
aý 
= 
E-ý 
'b 
u re, 
ä 
ö 
>, 
w 
o 
a 
ö 
U 
ö 
U 
cý 
to 
E-ý 
U 
C 0 
c0 
U 
ä 
°' v' 
1 ä 
> 
aý 
ý 
2 
> 
Y 
° 
ä 
ýi, 
¢ w 
' 
. 25 $" 
vý 
'ý 
w 
d 
E Lr FV 
`ý 4 
tr, 
b 
e 
ü 
;v 
b w 
;v 
b 
;v 
b 
! 
ä 
;o 
b w 
;v 
b w 
;v 
10 
ä 
;b 
b w 
;v 
d 
;b 
b 
ä 
; zi 
b 
ä 
;c 
U 
00 
l r- 00 
c% . - 
N 
M 
M 
M 
n 
r- - N N 
N Kn vi N 
;o 
ßr7 t - 
M 
ei' 
mil N N 
N 00 N Oý 
IRT 
N 
tt81111111111111 11 
IIIIIIIIIIIIIiI1 
11 
OONO 00 v? W) M ýo Cs en M- ID 
v vi vd vi vi 4! ýJ oo 
6 Cý oö oÖ 
O, 00 ý-r MM I- M ý7 Oý 00 ý--ý CýV: ýO 
NN v1 cV [N lt 00 NNÖ "-" ". " "-i O., v'i oö 
NNNN4 -4 ^" - ^4 MMMMM et 'tt r- 
I 
I101101001111011 11 
I1141111111816111 
IIIIIIIIIIIIIIIII 
vvbbbvvvvbb -d UUUU 
"d 
aý aý aý aý aý aý aý uu aý aý aý aý u aý ý aý 
10 "0 Ici 10 = 10 2222282EE22 
--MNMoN ýD NM 
.~ 
(N rn fi ýo 1,0 
- --4 -4 -4 --ý .r .w-NNN 
. -: o' 
O C/) O 
b F; c 
. rb Äb 
". 
0 
10 
.ä 
rA 
ä .a E 
a) .ýO 
2 
Co p w 
cý 
Äz 
* 
+- ** 
ýn 
N 
a 
E 
a? E 
O 
O 
C2W 
.. r 
y 
u 
O 
C? 
O 
I. 
C, 
C' 
u 
O 
a? 
O 
.0 H 
H 
O a. U I.. o 
v 
ü 
on 
d 
vöv 
u 
bý 
CU a 
a 0 
d p-, 
ea ä 
U 
C; 
4 oa 
C v) 
rý7 ü 
d 
b 
W d' 
o ea 
a 
c 
d E 
eý 
z 
w C I. a 
ie 
ýo N to MN r" 
CN 
M kn 
00 CA MhN 
Ae c> (D o -e vi 
vi Cý ri 't Kr) nt vi 
O o0 
-M 
"m .- ýo O o0 M v1 l, ý 
vi vý vi %N 00 00 1n NNN r1 O 
. -ý to nNNNN et 
wl et --NNNN 
(A NMNM0 
""ý 
NMÖ 
. -4 - 00 MN- .r rr . -4 N 
z 
t0 tt OM U1 v'1 v1 N 
-4 
M 
r+ NMM ý- N ý-+ 
11t 
1-4 
oo - en v to wn In 11 
ýi et Vi vi ýn ýn ýn ýn kn vl In 
Ö C7, ýt 
MÖ 000 MM1 
"t M rV NO 
Ö' ^ to et M 
O*, 00 N l- t- l- l- l- ýo ýG 'D 
S -4 MM0', O %O (14 M t7 NNNN-- . -+ 
('N - 
V1 OONNNbOOMM 01 O' Qý lýº 
Oý 
Vý V1 00 OÖ 06 h V1 'rt ýI1 Ln W) to v1 to 
v1 Vl 
W) 
NNC 
--ý 
NN 
. 
--ý 
. 
--ý 00 00 00 . 
-. 
i 00 
O 
00 00 "-. N 
en 00 t- C, 4 cq (14 N 
(14 
0 147 1: 000 Ono V1 4i VNl 000 V1 .. r 
00 
r 
10 v 
. -" 
i Vi N4\NÖÖ r1 
MÖM 
" "-4 N4NNN Oý C ON l- l- [- [- l- 
[- r- l- r- 
oo a 00 00 
ýNNNOSÖ 
-4 N 
Ni 
- 
00 
SS CO 
NN -'" ^' 
1.0 rN, 
ONO ONO ON Vl Vý1 00 C7ý rl 
00 00 00 
O 00 en 00 
a pYä ääääÖa °w ääääää en 
ä en 
WWWW En W En 
rW 
vWi V) V) V) En En cQ C' En V) 
0000000000000000000 
II :I 
:1 :I, :1ý.: 1 UI UI 
:I :I: 
vI 
: 
VI tn tn W-1 ÄÄq ýG ýpG >C 
ºý. ý 
ýýýäää 
cý 
ä °ý a q0 
(n rn W in, 
OOäa0,0 0xx000x0 
ö 
U 
Fei ýýý 
~~HHH 
h'i 
N b. "d NNN f°A t°/1 NN 
ova 00 äää C7 ä 14 a) a) aý ui u 
4a cý 
öö 
NNääcäää e° c 
Nppo00 C) Ö 
'--r °y eßä cam- .r . -i 
ÖÖÖo 
ii 
or vvIA " 
gl. E- E0ýN 
(n --4 . -4 
ep Et uCýöÖÖ0 
=bbbWV cý vv9. ww Lz 
0 0° 000 'a 0 .2 .4 .w . 
14 aa a° 
v o C) C) C) öMu0oco tom Nyy -, 
r 
'N 
o00y "y a nfd n! 
d "y "y V/ of 
cl ö° äääo0 0° 
-wo ä . ýý .ý cu 
tu u 
J: 1 b IV 
cIn pw vý ;ww 
, 
o., x c- xx Gn u2 Gn 
oa 
rn :4- M . -r 
ý 
. 
ý+ -e 
-i' V1 
7p . -w M ýT 
V1 
ei M !t -4 - . -. -0 - . -+ 
U-Mr- In 00 0% Z 
N 
,t 'D M 'n Q .ä eý . 
ýC O ^v N as , ,iO 
Oý Q 43 pp [- 
Dý W-1 8 "T 
d, 
ZO 
N 1, 
.N 00 Oý 25 en r- ON CN 00 t- ON 00 
00 
"T -4 ., .4 
C-4 
Cl Cl Cl Cl ce 12 
NNOM l- 't O- 00 .., O t- t- \O Vb GN ý. 
v) MM vi 00 p rn eN 
-g c1 ., NNM . -ý N Oý ýy V1 
N 
. -i M 00 V) M 
00 -NM 
fn C, 4 -4 
et ý-" pý oo vl of -I -, "I IO O) OOO ýq ýq 
q t-ý O o0 r, ý 00 tý 
V1 ý/ 1 ýI i v1 ýt 'IT th d v1 vl U1 v1 Vl 10 ()0 oÖ ý/ 
1vt ýO ýD 00 Y1 vi v1 
M Vl -: -i; ' 00 v'1 O) -1 O Q, 'd; Oý tt h 00 
I-i 00 Iý M 00 Oi 
CC C\ Z& 01 oÖ Yl -4 00 O Cs N et ý t/i %, O N 1ý: OÖ 01 ON -+ 
V1 O% ýO lý " V'1 
W) vl, Wn v1 v'1 ýD e1' et MM-NNNNNNNNMMM 'tt "T 
IRt Ii' 
- .rN -o Cý 't en M t- C\ - 00 00 NONN 00 ON 
Cý NNNOO tN -ý 
Cý Q, O O., l- [- MMM Lý Oý Vl Vl O, MM 00 Cý Oý Cl Cl Cý C1 ýO 
M Cý 
V1 t! 1 kn tn V1 ýI1 v1 V1 OÖ V1 V1 V1 V1 V1V1 'T7 d' "1 "I W. '17 to * 0ý 10 
*I 
ri l- '1 Nl 00 .ý it V1 V1 N co ZO v'1 t) "-; v1 ., l tt . -ý 
!O \O 
-M 
W) W) NNN O\ C l- V1 et O-N I- hNN P- l- V'1 ON 
O [l W1 
O\ 01 tt Vl ý-ý et ON Oý 00 O\ NMO 00 00 00 \D 'O 00 
00 V1 Vl M 00 Cs 
rq en 0 r- 
6 C; C; 
vii ONi 1 It 'ei 
NNN 
vii Vet 
NN 
'T cf of 
NO 
00 00 O\ t- MM "--ý "-ý NM 00 ýO N 01 NNMMNN~d `o r- 00 M 
<D (Z 
MN 
-0 NNO-O-'. O NOONNOO 
'4 M t- C) CD 
MMS 00 ON 00 ch le M 01 c+1 N 01 't NMM 01 NNM en pll 
M en en 
'. D '. O NMOO ý--ý -4 %M O '. D -9 O> - V1 '. G '. O O% NN 
%0 '. O 011 
aawaaaaaaaaVaaaa Co aaaa OY a0a 
WwwwwWWWWWWW vWi vWi vwi 
f4 4W 
vWi vWi 
WWWWWWW 
ÖÖOOO 
C) 
ÖÖOOpOOOOOOOOOOOOOOOpN 
U r, of N r. .., a, UUUUmrouo c, cý w cý N cý a` 
`äää `- ä= 
uuocnp.. Wuu x 
A4 ý P. 4 P. 
P. 
xwxxäääxxÄxöxu 
h01.1 
wp di {y 
0 
pUa,, 
0. a ý+a ýeNp Phi "ý ,ý ºa. 
º" 
y9 
'J Cc) 
OO tu wOW Cý ZRÖ rn MOO 
a) `, ; 
9aa EL p a, ast, as in, ý öUäöý, yU ra 0.1 
.ý .ý 
02u 'm ;Z 0 z! 5o °Fy 00öö 
v§ iii °° ä, 
;j20 
r1. 
°' N 
ON °' ppy'7v 
vU 
"O"K0 
ä00O 
t«, e; e.: oo an ýooN vý vi QOGvV FUi G+ VUU- "-+ UU ý0. ý. Q. U ++ 
ä 
;ý "ý . SE vOi . sE 
'ý . ýG . ýE ýE vOi vOi .! 4 ý. 
O". i! v 
UVv eý 101 0 Muu 
y .5Q. 
9b-5 
2Ä 
(1 (1 
cu UUi E" aýi 
qUUo0o c0i acui v 
, ýo ýo r- LA wwUUxw \o x (D xwxxawaxZ. 
At E°' x `'o 
.. 3 l- oo cý O V) OOO 't 
tN 
N 00 r+ Mh1,0 Co M ýO MN-- in N 00 
O "-r MMMM 
--N r4 NNN et t* v1 e ý-+ . -+ -- r'" 
NNNNNN 
- 'm M -ý 
t 0 
V'i 000 
N MN 1-1 m pV1p 00 -. 0m 0 t0 M O: 000 000 
12 ^N cl 
Cl 
ch 
ý 
N f 
- 
N 
M N 
N 
M 
V1 
N 
et 
M 
m 
N 
N 
- 
v) 
N 
O 
N 
N 
N 
c 
- 
oo 
N 
c 
_A 
N 
N 
O 
M 
M 
N 
M 
M 
O 
M 
N 
N 
O 
M 
121 
N 
00 
M 
ý . N 
. 
N. N 
00 ýo ýo N N o r2 ýr N N v ry oo ... c`l c'2 'ý c? O oý v, 0 N. r ýn i 
vi 
tý 
vi - N Y N v. O vý 
o 
-i O cý 
v -i 
ýO O 
vi 
Oý 
n 
et 
n 
ýt 
ýr a ýt 'd 
Vi 
n -e 
er 
V1 
ýt 
." 
f 
"-ý 
v vi 
ýD 
ýn 
00 
Kri 
i 
vi V'b vl ýp N ýp N 'r et er e t M M M M 
M M 
N N 
N 
M 
N 
. --ý 
N 
00 
00 
C. 9 
V\1 
00 
N 
ýO 
N 
N 
`1 
et 
N 
ýO 
O\ 
Oý 
kn 
r+ 
N 
/O 
N 
00 
V) 
O\ 
ýt 
Ilt 
o0 
Oý 
N 
V 
d 
M 
00 
N 
e 
O 
M 
b 
O 
d 
oO 
cN 
00 
V1 
N 
ýD 
M 
N 
00 
'r 
N 
C; 
O 
N 
M 
\1 
'O 
N 
O\ 
M 
V\1) 
; 23 
N 
(2) 
Oý 
O 
N 
N 
00 
O 
01 
N 
M 
V`1 
O 
M 
N 
M 
M 
V`1ý 
S 
O 
N 
N 
'`V 
o0 
N 
M 
d 9 
Q 
0o 
00 
11 
N 
1G 
Vt 
O 
'O 
n 
N 
v" 
e 
p 
ýO 
V1 
N 
V'? 
`, V 
M 
%0 
ZO 
Vz 
vi 
00 
fý 
ý` N 
M 
V-1 
4! 1 
N 
v1 
O 
N 
00 
N 
N 
O 
N 
00 
Ö 
IN h 
O% 
v1 
%O 
wä 
Ö 
ýo 
N 
vl 
O 
ýO 
N 
,O 
l- 
v1 
Ö 
00 
O 
v) 
O 
v1 in 
r- 
-' 
v1 
et 
00 
M 
M 
M 
N 
M 
N 
M 
N 
M 
M 
N 
00 
N _. e 
d 
N 
aý 
N 
cý 
N 
r. O 
P., a 
M 
000 
s 
n 
[N 
N 
a 
n 
c% 
a 
e 
M 
000 
a 
oo 
M 
000 
w 
;O 
00 
O 
a 
r- 
rl 
oo 
CD 
s 
Z 
CY 
(j 
a 
n 
O, 
w 
n 
O, 
a. 
$ 
ýo 
a 
rl' 
(j% 
ýO 
a 
"i 
r 
a 
Mt = 
Cý 
A 
a 
rD 
N 
Oý 
a 
O 
0 
ri 
ä 
M 
m 
Oý 
ä 
M 
l` 
O% 
ä 
^ý' 00 
ä 
00 
w 
ýo 
U 
aý 
a 
V) 
N 
ö 
r- 
00 
lN 
w 
N 
N 
ä 
CD CÖÖÖÖ 
NI 
ýI wl 
WI 
I äl 0N 
a 
a 
ÖÖ 
C) 
ÖM En En En ÖÖÖÖ 
00 
a 
ö 
0 
M5yNyuN 
cu 0 
A al 
2NyM `ý OO `n NpOý; O LL ed q Qi a CA .2pa- e(C .2r. MyO0 cy cn O Rj 
t' OOwU ed 9N 
t-. 0ä1öäru 
°1' 
.0 vii 
3C 
.. O 
ýi' 
cv oA ji N ,n "w c~d eý end b cl, .U [\ 
"-ý 
Ö" 
-ý .ý . --i cn .. N _ý 
Cri ONU.. 
% 
a a. aaUäaoo ýa ° ý' Hö °° a 
'd 
-- :'... o oý, wo 
n 
en o0oaaew., .. 
oo00 "' `V o° 
9 
H(A uvUö00ö0 
ä E2 äH Eý Eý 
Hxxxx °v ZZZäWP. ä. 
et 
et 1-7 le 'lV 
' t- 
00 M07 ýO N [- O ýD Iý r- Vl 
c> 
vi %0 olý 00 Oý NNNNNNNNNNANMMM vT 
M 
00 
. -. -0 
et 
N 
00 
O 
N 
O 
N 
Oý 
ýO 
-h 
00 c-o O> M O> -4 ,., 
N 
(- N . _, 
('n M ON 
vi 
ON 
!ý 
ýv 
e 
l- 
;3 
", 
" 
rn 
vi 
M rn 
M 
.n 
%0 
e 
r- O (D 
r, 1 
fn 
00 
"-+ 
r, 
M 
M 
N 
M 
ýP 
tt 
N 
N 
ýt 
N ý-+ N 
M 
N 
v1 
ý-+ 
N 
M 
N 
N 
O 
^; 
M 
M 
'ýi 
N 
N 
N 
ý/1 
N -4 rq N 
M 
N 
rq 
N 
r4 
N 
"" M - - - 
O; 
N 
N 
N 
O; 
N 
. - 
N 
-+ 
00 
v1 
Vi 
V1 
- 
e'ý 
Vl 
Oý 
- 
O: 
Oý 
- 
N 
Ký 
oo 
N 
N 
ý 
'ýt 
N 
M 
e+ý 
o0 
M 
M 
00 
N 
%0 
M 
h 
N 
r- 
M 
10 
a 
00 
M 
et 
Vi 
C 
M 
"r 
b 
O 
et 
"-+ 
V. 
N 
x7 
00 
V1 
N 
K7 
CT 
O 
d' 
C; 
V) 
[ý 
;4 
V) 
ry 
M 
v) 
N 
V1 
'ýf 
. 
V1 ýO tý 
ýt 
CT 
M 
ýO 
N 
ý! 
Z ýo "t 
- 
l- 
vl 
ýIt 
25 N 00 
N 
00 
O 
V1 
.ý 
0 
l": 
- 
N 
O 
C O> 
M 
- 
M 
IS 
00 
O 
vi 
N 
Vl 
N 
O 
r- 
OO 
M 
Oý 
00 
!' 
00 
%0 
O 
O> 
ýi' 
N 
M 
(> 
O; 
M 
O> 
fý 
O\ 
v'1 
N 
O> 
en M 
00 
O 
M 
"O 
00 
O% 
eP 
N 
M 
. -" N 
vi 
00 
O> 
\C 
M 
Q% 
10 
c 
-4 
M 
00 
O 
M 
.O 
N 
00 
v1 
tý 
`ýi' 
.O 
N 
C 
00 
lt 
vi 
eý 
d' 
^" %D 
V 
vi 
M 
o0 
M 
' 
NN 
t. 
O 
00 
!1 
0 
00 
N 
Q> 
e 
oho 
v1 
00 
%0 
O 
O\ 
" 
Nt 
ýO 
Oý 
M 
N 
V) 
2 
N 
ýO 
N 
0 
h 
N 
00 
Q> 
e 
et 
ýO 
M 
e 
ýO 
N 
N 
O 
3 
ýO 
N 
O 
v 
N 
O 
2 
00 00 NMM 
gt l- ON V) 0 v- 0NN co Mt r`1 
0 
°° 00 00 
Ö 
r- NM =Vý 
ýM 
r- V) ýt C) rn C> 0 
ZO ON ei NWW ý] M 
ß'r1 ; Lj N 00 OOO 
00 
V 
rkA 
CD CA (D 
1 000 
Ö 
Omi 
0C rn o 
oo rM oho 
ir 
00 00 00 le 14 ýo ýo 
aaaa oßä oo as aaaaaa o as as aaa 
wwwwwwwwwwwwww wwww (A "' cn vwi 
u 
Ln UD vl v2 VD G vl r/2 u2 Ln v2 GO2 ööö0 u2 u2 u2 CD] 0 C) C) ööööööpööoööö 
0000o00000 z5 >>>> °` 
i00 ý9 aýFxd ý4 as 
ai 
U 
UN 
ý 
x 
ý ý ý Ä x x ý a a a 
2 ,. 
ä 
0 
0 
2 
0 
0 
0 
0 
0 
0 
ö 
o 
0 0 
v ä 
° 
ýy 
° 
ä 
° 
N 
w 
ö 
r.. 
a 
-°' 
°~' 
ram 
0 
r, - U 
0 MM 
' '` 
0 
ý 
ä 
¢ 
o 
v 
p 
v 
p 
p 
= 
.C 
^ , 
0 
V 
ö 
, v 
0 
ö 
~ U 
0 
ö a 0 o 0 r. 0 m 
a 0 
j q ö 
u 
ö o g J ö . ° ° N .., ,., .9 .9 p " 
8 ä * 
,ý o º. ý, p 
ö 
. on 
E" 
b 
0 
v 
ö 
ä a s 
ä 
o 
ý' o a 
°n a° 
:ý :ý a a a o ö y 
o 0 
, 
. :i :i :1 
9 
91 
ß. 2 ,1 '° 53 -2 v 
:1 3 ä 
. b. ö 
;g U a $ ° 
° ; = u z ° v 0 0 ä °' ä v o .m ö ö ° z o°'n own äo o u o o n 
O 
N N N 
Ö 
N 
a Q N q 6) E) 'ý .° 
° y U U 
H a W 
0 
N x x z x w x 
, , 
HH x ¢ x x w as W ä x x x 
xt 00 
Ö 
N 
M M 
00 000 
0 Ö cy% 
0 -t - r- 00 -- 't N N N N N 
41 
N 4n N Vi N N 
00 N 
N 
p\ (> "-ý "-+ "--ý "-ý . -r _ -, r. 4 N N N NN 
V) 
-4 .D .a -4 .G . 
firJD 
MNM .- ^"00 ýý 
00 - 00 
O\ N -4 -4 M N1 -MM- 00 ... - 1-M- 
eý0 
ýN 
eý0 ^ý c Cl eia Cl 
ýN ed 
MaN f- NM it en M %0 ON O'. 00 N en M 
O\ O\ NMM- 
.rMMN O\ NNMMM ý" 
ýp N. Oh ei 10 
't NM. 
ý 
-- -M- r- CD v M- 
"i -i .. i et -i M Vi V1 N o0 oo . -, -" 
O -1 IO 'O en NO "C O) 
v) vý vi vi vi vi t vv VI vi v, vi CC oö vi vQ !. Vet 'ýt 00 MO 0o0 Q> C% O\ ýO tp 00 'O N lý M 00 ýt 'D M Oý 
ýD NN OK Iý 'NNN O' %. D MN `ýt t l- n oo 00 r 
00 v1 v1 ýt et et MMMNNNNN------NN 
. -ý NM tt ýt pý v% -4 o0 et o0 
1N 00 00 00 -q Ný O\ O\ 00 v) CN 
-M 'tt 'd; '. O N_O 
00 00 o 00 00 10 M 
n !! 2 
0 
vi vý V' ýn C ýr v ýt vi ri !iC e4 
.., p'. ON N '. p °'. 1-4 .r o0 NO Co 
OMOO'. O 
(D 00 %0 V) 00 . -ý r+ 
S 
[- cý MOe'. D 'i' ýt '. o M fir 
N s, 
MONd 
ýt ff) '. D ON 00 ri 00 00 r"ý 
5 
vl v r- N 14O N 00 N Oý ýC ONNC 
p'. v1 in e'f v1 Vl MM In NNN Vl N 
M (> I' NNNNO N 
°O° °O° 
nN 
°O 
CD -e 0ö in ev ß2. 
NQ o0o Q oNo in 
NNNNö 
N v, r- I tý Q 00 ZI 
3vUAN °O 
ww in pY ä pY pY ä pY c CY ä CY ý, äää CO -äVä 
wwWwwwwwwww En cn v, En wwww v2 vý c) v2 cn v2 NO v2 vý vý v2 wvZ ZD 0 rD O OO C) OOOO Z) cp O Op ZD pý OOZ ZD Z) C) OO°OOo °> OOOCOOOOOON 
WH2ä0. QZ Ln rA ýaX9aaaV 
.ý°¢ N OO H 
GL OUw 
oa 
oä° 
ö00 
Lýr 
to º. N v' °a W V1 xN 
°a-2ä8 44 )4 
9wdäUONU 
(1 
ýau aý ýn 
U U, "0 
CI 
uwu7, u aý uuo, u a' u, 1 
4- ý0 
in 
ryHn 
OA aU.. 
0 g2, vUpUUaoUppy .+a. Uo ,ýo. 
it 
Gn KA (n 6- ýA 
OOa +U 
aöö 
yayOppO °ý. y 
vý HVU 
o Cl cy 'Je 
.aO 
cii ýC *2 
b. -ý ¢° ¢Aa2aiw a¢ i *> UZwZaa¢ E 
O'. Nt in r- 
0MMM 
CN kn cý r- v oo c> v) (: cý C) r- r-4 r-4 r9 
NWMMMM nt vv ýC lý r- 00 aý O\ 
ý-+ 
ýD C 0ý0 0ý0 
lýNr 
1-4 
C 
It 00 00 eq NM-M i' NNM 
Niý 
W) 
O) llý "O 'V; llO OM 
-0-0 00 1ý 09 M Vý V1 V1 Ul I` Iý '. O ON - 
NNNNNNN fV NNM 
00 00 00 .rOM 00 8 ýo en 
N 
Omi 
Ny 
0 
. 
ý+ 000 . 
ý7i 
.... 
00 CA W) 
#A %0 th -e NN Ch N CD r-A 
MMNN-MMMNNNN 
Oý N 00 lý N V1 ý Oý ý 1"ý 'ý7 00 "-ý "-ý 
00 00 00 00 
ÖN 
ýn 
M 
ti vi 0o0 0o0 
r-1 NMMM V1 rz r- 
MMMMMMMMMMMMMM 
N v1 C, O, kn vi oho O 
eq ÖN ýD O, v1 v'f NOOOOO, ýO W) 
If MMOO ý--ý lý lý ýt d o0 I: rt Vt 
O v1 M lý 
00 06 oö cN ýc oö 00 00 
- 00 0ö 06 
° "0 00 
."O. 
ý Ol0 -4 
O+ IMnl 
NT 
T o` 
M lN- 00 00 
c 
ýO 0l I- 
00 vl N W) wl %n NN 'o NNN-N 00 00 °o .rý 
NMO In v1 OR N IT MO tn O v1 OM ýO ýO 'O m: r 
NNN ýo vl O 
v'1 l- l- ýo O% 00 W) I- W) O1, tri Rt Mt W) W) Vi 
ýo Cý Cý Cý Ö Cý l-: ý6 
NN IT NNNNNN1NMMM en en en en en en 
en M tf en 1, 'RP 
U 
N r. 1 nnö '-' 
ýo 00 .Ü U o0 
d- -- °ZA 10 M c, 
ä ö, awwaaöaýaa 
Me'e 
w0 w0 - 
0 3 \O ,N 0(4 
-4 
0O 
V1 
Ne 
v) 
M1 
v \O VOl v01VOlV 000 
N V) 
aOOON-O Vl Oe-- 
PM aaaaaP. san. a 
W 
ZD ZOOp 
,nQ Q `nr 
P. 4 
äWP., 
Wäw 
a 
O 
UU O 
.ý 
WWNwW vWi vWi tip U2 vwi 
Gn 
CI2 
0oo 05'7 5 u2 
ul Ö C) 
ÖÖÖÖÖr,. 
0 c) c> 0 
iii 
-I ¢I Qi 
<ii 
Z p. 
Än 
M1 ¢ÄÄxz 
EVa-ý 
º. a 6Qd 
Ir 
ý 
.O vOceýi 
Heq 
ö00 
aý o in 
4. ) u r- . "0 22 cm 10 10 Ö0ýý 
. 
0.. 
. 
Ov pÖÖý eyd Gý 
i+' 
U 
Ni Vl U 
y 4. 
. 
°n 
ou° 
a) 
QH 
mo o 
°., ' :: 
0.41 
to to 921 924 to b 
öaaý, ýe 
ää 
.äbvbv 
:ö :nvbä :ý 009 ao o o° w .,.. a G7 "c CZ 00 cd tý 0b ýn py+: w co ^" vUi vUi vUi e0 ÖU 
tNd eNC 
U 
tad 'r °0 tu 
° k. +, - . t7 
OO 
Ua, 0UUoUUU . gat a 
ääd Eý 
HäädwC, äwNdwww 
ý-+ 00 MOÖÖpÖ". 
+ t, 
00 ýt ýo [ý 00 ONM In \0 
VI VI t41 %o 0 o 00 00 m cý c> 
-4 - , "", ---n,,., ,.,,,, ----- . -+ r4 .--NNNNNNN 
NNNO Oý NON c7% ýetr 
~r N-r ~r N 000 
M 
1N-4 
eC 
V) 0 v1 - 00 Iý In 0O VI N- O\ sM ýt Oý 00 N en 00 qt 
ýt NM- r+ NMNNNN r+ -- N- 'a; N N 4n 
-+ n oo ."d; oq .. r NO ."N tý v1 fý 9i' Vi llD lO Iý Oý Oý et 1 
C `O D CC 00 'n eev ýc eee No '0 ýo CC 
. -ý v1 O et 'O MN Vn N Vl OM 00 N In ý"ý Oý r' 
Oý N ý/ 1ÖÖ -- ýD 
MN 
. -+ V1N tý Ul V1 Vl 
M" C\ 
M et `e "t -If le `t In Vl V1 N 'V' %m ýO Y1 V1 Y1 vi Yl In vl 
In N 00 - O\ 0N 0% 'G G0 l- MN ýO N0 tN ^' ;0Ö en N 
r4 - 00 Vgl 
Öý ýO t:: ee 00 00 
. -ý 1.0 NNM 
00 In In O f00 N o0 vl O 00 IN N-O 
-4 M 
000 \ 
vl MN 00 0 In - 00 O> M 00 -N 'n 
-- Oý ýO \o -i Irt 111: MO vi N V) vi O V1 - 
C% N" -y ýO 00 M C% (ý 
'0 '-h e vl ' qt 00 NNeNNÖ C N In 
- In t-: 
'c7 et 't nt d' V) in in vi 
;3N 
In In vi \o In vl 
.ý ý0 d \O efi N -4 00 N en O' co -N ºý-ý '4 
NM 
O O> M Vl -N 00 OMMM 00 aanO 
00 
N oý 00 en o, -'t N-' -r Na-x3 
Ö 00 00 ' le 
ÖN- 
000 
U r- 
vi 
r- 
co 
oall 00 0NN V) 
P., OOaaaaaa Co aaaa Oy oaaaa Co a 
O CD OOO 0] 0000000000000ON 
00 en, EV-ý `'aI 
x Q' ÖxÖA ý'' 
a 
wý 
OzUxUA.. a z `a ýC UQ O 00 d C7 wä , z, A O, A cn 
cl 
ö ööM 
,b oÜ Gý V 
OO0 
ýý ýN r+ 
pn 
NqyOw 
ci Uy vOi 
9 
ý+ w 
pro cý o r., w 
äawNb 
ei 
o ýq 
Yö5 `, ö° on 
= °' 
r; Q2g ca ai uÖUp°e 
aö 10 
No !dkN 
ýY 
oyyy 
-4 
ö4y wy 
tu 
b> 
yy 'G ýOM +ýU+ H 
12 u 
M, cqj 
Eh -ý pöa, 
`U 
pOvýOeG 
pa 
ÄQ a' 
cu 0 . 
ý4 
wby, w ý' cd oA 'O '`ý 0QqQ. aý Vw 
NMOON¢p bA NOpOp c0 v1 .. 
ý, N 
cýý O Cl 0ÖOp CL 
b 
mot- aý 
p 
'ý .ý~N 
eia 
r. wU "O ýn 
O >+ y 'ý rý Ug O 
Q 53 ;j cl (2 U2 + Q+ ¢NG Ni NNQG Pr O¢M rý Q fn ¢ ß. uWA º-I U º- 
'G 0 -+ NM'. O N 'n NONeN 00 eý -NMN 
00 O\ 
ý--ý NNNNNNrn ýt v'- wä v1 "1 v1 O %0 N [- NNNNr 
NNNNNNNNNNNNNNNNNNNNNNN 
M 
.. ý 
M 
N 
0 00 
Oý 
.r 
Zo M 
. -+ tý 
W) ýo 
ýD 
.0 
U1 Itt r- 00 
ýo 
Vl 
00 
N 00 ýO 
N 
l`ý "" 
00 
ýO INS 00 W) -4 f r1 
en 
M 
en 
en 
N 
en 
N 
N 
- N 
- - 
00 o0 
kn 
I"I 
N 
M 
N N - - N - 
N 
N 
N en 
N 
N M 
N 
00 V1 <1 el 't; N ýt V1 IO Qý M IO N r" O ý7 "-+ "r "-ý v1 
"-, 
pp 
"--: 
pp 
-t O 
In 
'1: 
tz 
N 
00 
h 
ýp 
'Rt 
ýI 1 
ýO 
10 
10 
O M 00 
ýC 
00 
V1 
O 
ýD 
V1 
ý/ 1 
ý--ý 
V1 
t 
u) 
N 
ý/ 1 
V1 
Y1 
QN 
'li 
ON 
v1 
't 
in 
ýt 
vl ý7 
01 
vl 
en 
v1 
en 
vl 
V1 
10 
O\ 
%lO 
N 
tN 
en 
IN 
N 
C\ 
V1 
"t 
V1 
N 
00 
N 
r 
M 
of 
en %6 ch ýo Yl 
qt 
QN 
00 
ýG 
N 
en 
ý6 
M 
00 
N 
V1 
N N 
K1 
N N - 
N 
et 
'O 
v 
N 
h 
in 
N 
N 
00 
"-" ýO 
N 
Vn 
In 
N 
N 
en 
v1 
N 
Q) 
in 
en 
N 
O 
M 
/O 
l- 
ý-Q 
tN 
ý-+ 
%D 
0 
O 
Oý 
O 
00 
00 
O 
OÖ 
et 
'n 
00 
- 
O 
C1 
00 
N 
O 
O 
00 
t 
N 
1.0 
C71% 
M 
N 
Oý 
- 
N 
In 
N 
Oý 
M 
0 
ýt 
ýG 
cý 
In 
00 
N 
0 
d 
ýo 
fý 
In 
-4 
c0 
N 
N 
N 
00 
V1 
ýO 
N 
. -ý 
en 
- 
ýO 
ýo 
Rt 
C\ 
C 
Oý 
N 
M 
C 
WY 
ýO 
In 
N 
N 
V1 
N 
N 
ýo 
Cý 
11, 
N 
v1 
In 
N 
- 
V1 
N 
In 
en 
in 
in 
N 
00 
W) 
0 
- 
N 
M 
* 
Oý 
v1 
. -, 
00 
M 
N 
v1 
S 
00 
^' Cý 
(D 
M 
ýe 
ý--ý 
ý--ý 
N 
M 
en 
N 
O 
ýl 
. -ý 
N 
N 
W) 
Vi I 
ýD 
Oý 
v1 
M 
N 
N 
vt 
N 
O 
11t 
M 
N 
tn 
Oý 
Oý 
ýc 
O 
N 
'IT 
00 
O t- vi r -- O l- b 
N2 
ceg -4 'ý Ok0 r- 
ýn oý O ýt Oý 
c> r- 
oo 
a. oýawaaoa 
w 
i1 äi >i 1 öi We i 
¢ aha 
00 
00 °- ö 
.. r 
00 w a 
cý 
a 
00 w a 
rn 
a 
00 v M 
00 
a 
rq 
o' 
i° 
ö 
oo 
a 
w 
ý 
rn 
a 
DO 
ý ý 
N 
ä 
p, 
ý 
ä 
a 
O OO le n q M 9 ~ 1,0 
~ M Ö N 
" - 
8 
vl v1 C4 
(: 0 C r- a le (> 0 7 
00 °' ä ä ä, 
a 
Ö' ä 
a 
8' 
a 
NwwwwWWWWW 
OOOOOOOOOO en 
i 
ii :::: 
i i: i i: N 914 
Öý 
ýxwOä 
U p; vý 
w w 0 
0 
üpý 
ÖfJ 
C 
öäa 
tea"' r+ cd 
W 
bA ? 
wW °' oo ou 6-4 Jý'a ä+ ý' ýi ° aai ¢, 
C~ 
. 
°o aM a' NýU ti ß' 0 0 (Z r4 w 
.= 
10 
gf ou EI *,; 3 
ý .2 "0 'ä .2 -2 Z5e r3 
aý .ýäuzV0 " is Nd 
cu x, uCr. P. 
'' üAM°-pä. '2wE 
'y v C7 y r' 
C 
ý 
u co 
ßßßo Mcn yyy °°2 18 ''va °Op, u 
IM, 
ö 
C? 
ü vý Cl) oo aý Q aý 
cu 
p% 
n 
a rn ¢E c7 dd E- y vý aa Hº a- vý 
x F" x 
ý. cl Q OM O-N v) Oý vi e oo v1 N \O OM Ilt bp0 .ý 00 00 00 00 00 c> 
NNNNNNN0 le ^Vlb 
r- en 
"ý -4 
"w 
r4 
N 
V1 Ný vi 
v) r- r- 00 °N 
0O 
N 
eC - ýo N 
00 
- 
M 
N o0 N 
M 
ýO 
l- 
Qý 
M 
00 
N 
- rr 00 
e 
Q 
r4 
- 
v1 
, 
-. 
rq 
e - 
". 
c> - 
- 
pN 
a 
. -- 
0 
- 
"0 
P-9 
"D 
t 
N 
- 
N 
4 
O 
. -r 
00 
N 
ýD 
N 
12 
N 
Oý 
- 
M N N ýO O O e CO O N N 
00 
N 
oo reý 
M 
12 
(D 
N 
- 
%0 
N 
N m vý 
N 
02 
V) 
eY 
N Ch 
N 
V') 
N 
p 
N 
- 
O 
et 
N 
1t 
ýO 
N 
oo 
N" 
N 
O 
N" 
M 
C> 
l": 
Cý 
C> 
M 
ýO 
- 
e 
M 
r+ 
et 
M 
00 
Vi 
 
C\ 
'ýt 
O 
,O 
N 
N 
.r 
.-N 
000 Cý 
ý} 
D 
e Oý 
e 
N 
ýG 
e v1 
M 
N 
Oý 
O 
10 
N 
v1 
ýO 
ýQ 
!Q 
Iý 
ýD 
v 
d; 
V1 
00 
oÖ 
V1 
r+ 
!Q 
Oý 
ýO 
h 
.. r 
- 
ýO 
tt 
N 
.I 
vi 
^+ 
ýC 
lt 
!Q 
v vi 
N 
le 
. -ý 
ý! 1 
N 
qt 
ry 
v1 
V V 
ýi 
«t 
t1 
V1 
Cý 
"-ý 
Mt 
M 
O 
Nd 
N 
O 
dN 
N 
O 
. --n Ö 
N 
O 
N 
M 
lNý, 
' 
M 
Ö 
O 
N 
00 
. -4 
N 
v1 
ý- 
'. O 
M 
O 
m 
M 
N 
O 
h 
ý 
M 
N 
O 
'. C 
V'1 
nt 
If) 
vi 
00 
fi 
N N 
N 
M 
N 
O 
C 
N 
00 
ei 
N 
N 
N 
r~", ' 
vD 
146 
'. O 
-i 
ýG 
ýd 
%0 
^"' 
~ 
vO 
14O 
'. O 
Ö 
vl 
If) 
N 
00 
NO 
tt 
VÖ 
vi 
v) 
Ö 
v) 
V'1 
N ~ 
M 
O 
N 
ý oo 00 00 ý 00 r- 
00 
öi °QOO3 CO 
Q 
-ö-3-4 
-4 
3 3N3 9tlele°ö°O ýCD 
ääääw pY pI ä äääää ö' äaaaaaaaaaa 
www vw, wwwwwww 00 wwwwwwwwwww vý wW vý vý Ln v, cn v2 v2 v2 v2 v2 v2 v2 Ln cn cn Gn u2 O0 c) O0O CD OO0OOOOOOOOOOOOO 
1 cq a -" `^ Uý ää ýI äMä., ... w ýn wwU 
H 
W 
a 
o .o 
d ý ý ö a1 w 
- N ä 
ý ö ö ö b O 
p 
p a N 
ý 
10 -9 
ý 
.9 
0 0 O, vi 
ofi 1 V 
a Ö Ö Ö O 
"y4 
y 
b 
a 
q 
I 
Y 
a , , 
ý+ Ö G M O N ~ 
41 q O N y N y U N y a+ U ä U vn c' w o c o cc 
O . 
m m Q 0) Ö Ö Ö 
ü 
- 
Q+ 
V 
p ca 03 
04 
b ö Ca Cý CÖ X 
U O 
UU' 
' ä ä to o 
ä Cý a 
$0 
s 
ý 
ý ý 0 a ý 
ý ` ' ý H E-» a w w ý w A w º 
U 
~ p, 
aN 
00 
en 
M 
00 
0t 
00 
l0 
00 
N ý C O' 
- 
'd O' N 00 O'. `T 
0 - 
. -4 N N N N 
N N N V] ýO I - N N 
"" V) 
00 
r- C) PO 
M .0 et .0 M 
00 O ýo a en 
. 
ý-ý 00 N rn r- 
en 
-4 -+ 
. 
-1 - 
: S, -. [- 
'o 
N 
en 
-, 000 
It ý rr f I r 
N 00 . - 
vl 
", 
O 
N rr 
M 
00 
ýD 
r. + 
O 
N 
is 
ýQ 
oo 
ýD 
'o 
`d 
0 
M 
M 
10 
O 
M 
c 
N 
N 
cl 
d 
en N rrr rr 
ýt 
Vj 
"-+ 
r! 1 
N 
-V" rý: 
M 
ýt 
V1 
00 
N 
M 
00 
d 
ON 
O 
M 
M 
r/ 1 
M 
M 
v1 
Cý 
O 
M 
It 
V1 
oö 
N 
d; 
!Q 
00 
r/1 
N 
v1 
ýf 
N 
""r 
v1 
OÖ 
qRt 
ý"'r 
N 
OÖ 
tn 
oö 
ý"' 
Wl 
00 
W! 
00 
ý"r 
et 
oÖ 
N 
t, 
oÖ 
O 
M 
O 
00 
M 
M 
O 
M 
v7; 
ýR 
M 
Vl 
V9 
ýR 
^' V'1 
00 
kn 
N 
(- 
00 
v1 
d 
N 
el 
V1 V1 V1 
00 ý1 Oý 
VIA V1 "i 
-i "i 
v1 !Q 
MN 
MM 
M 
V1 
N 
IIO 
N 
W) 
N 
en 
r- 
IR 
't 
N 
en 
oo 
N 
-1 
- 
l- 
14R 
N 
-7 
O 
4: r 
-I 
M 
W) 
ýO 
00 
M 
O 
00 
. -  M 
!Q 
M 
C 
l-ý 
C 
N 
v1 
l 
M 
t'ý 
lO 
v1 
d 
Ö 
ON 
t- 
O 
Ili 
OÖ 
ýB 
N 
f 
ýO 
N 
00 
00 
N 
et 
%0 
N 
00 
00 
N 
": 
00 
"1 
ON 
M 
V1 
l 
06 
- 
V1 
M 
M 
v1 
V) 
IT 
to 
-4 
e! 
vi 
Ö 
N 
O 
"-+ N 
ý1 
9 
N 
qt 
N 
v1 
C\ 
IR 
00 
.. 
ýO 
p 
O 
Oý 
M 
00 
vl 
Ö 
N 
N 
rrr rr 
.r 
qt 
ý 
-i 
I-T 
N 
M 
O 
It 
M 
M 
-i 
14, 
.r 
et 
-4 
It 
r 
V 
-c OÖ 00 N N M M at 
W) 'T 
a, 
as 
d' OOM 
ON 
[ý 
O 
ýc 
a 
N 
O 
10 
a 
N 
00 
V1 
a 
N 
rn 
O 
a 
v1 
N 
O 
00 
a 
N 
IO 
P. 
- 
N 
O 
%O 
P. 
N 
M 
%0 
a 
' 
N 
O 
0 
a 
r/1 
C 
O 
1%O 
a 
N 
10 
ON 
N 
10 
P. 
O 
%0 
lI 
00 
. 
in. 
O 
%ýD 
N 
00 
. --r 
a 
N 
.. ý 
cs 
a 
N 
ei 
g 
1ýO 
a 
ýO 
vl 
en 
O 
a 
oo 
N 
N 
O 
a 
en 
d 
U 
00 
00 
a 
< 
00 
O 
9 
a 
N 
rrr rr 
WWWWWwwW 
WWWW En wWWWWWW 52 (4 52 Ln cn VD u3 u2 u2 v2 u2 u2 v2 (n u2 
ö000000öö0ö ö> ö 
Iýýýýý 
ýI ýý I11111 
ii 
NI NI 
NI I __II 
I 
,ýI1N "" rr .. r. E. 
6, tCV7ý pÖQÖ Cý W QQ E-ý d¢ dQ-äUUÖ, Pý °ý ww 
.ý 
.ý 
Wn 
N 
CV 
U 0 
_N 
U O 
9 2 
,D 2 E 0 ä 
U 
~ 
eq 
w 
0 
w 
0 0 L Q, 
42 bA . 13 9ý Vvý v01 N k4 v. 
o R U) 'C 
' " ý' ö ö ö J 'ö ö 1 ö 
4. ) 
cy 
u -C2 -ti 10 10 112 
O o o 
v 
ö 
v 
0 
o u b v v v 
tz -E3 0 c2 
v v cý c o u 
o 
.E "o cu z2 a i 0 0 
a i 
Q Q . n . - Q Q Q d ä Ü Ü > 
ý 
d w 
vii >m ä Z) ýD ;D ZD E g E F 
00 N M M 
r 
.. " 00 
gr - 
00 
- 'n N .o0 N- NN 
.. " 
Z; ) 
N M 00 
M 
oo oo - 
IIIIIIIIIIIfIIIIIIIIIIIIIII 
II1IIIIIIIIIIIIIIIIIIIIIIII 
v1 Cý O "-ý "-ý ONCý "-ý "-ý V1 et V1 . -w 
O cý 00 O ýO h V) 
00 
t,: I-ý O 
`ti et V1 Vl ýI1 
" V1 ý7 ý/1 ý/i V1 U1 71, 
en 
Cý vl 00 N 00 C: 00 O .t 00 n 01 O lý n C4 en r- 
MNNNNNN W) eq 
NNNNN0- 
00 
^' "° "' ^ý "" 
06 
ý" ~~~~ 
00 
IIIIIIIIIIIIIIIIIIIIIIIIIII 
I11111I11 
IIIIIIIIIIIIIIIIII 
ý%D 
IN N 
-4 N 4) ci 4) 4) 4) 0 'y bb v0 b00üüü0üü0ü 
.N .N 
w 
e«; wwwwwww ý« wwk: ý= ä " ääääääw 'ý+ ý+ +. + r. + +. r. + a+ ý+ . `+ ý+ ý+ a. + a+ a+ A Lam'. 
bb 
aaaaaa 0) aaaaaaa Gý NNNNNNNvNNNNNNNN GJ N0 
aaaaaa a aEääa-ICJ -90 aEEEE a 
Iti ýý ää2 
ý' NM ýD 0N 
0 gt 
ON 
00 00 
%0 
00 000 000 
Q vi v 0% 
a, 
OÖO- v) r- cy, C) 0 
_A -ý 
O 
.w' . 
~r 
_A 
- 
--ý . 
N. 
ý -. . 
M. 
IIIIIIIIIIIIIIIIIIIIIIIIII 
IIIIIIIIIIIIIIIIIIIIIIIIII 
oo M Cý OO 't C; 41 t ey N? '4ý I": "-+ ýD OOQ; ýt N O; r+ 
ýc li VJ ec; ýo r oo ýn ý !neo od od c, ýQ lo eCC 
Mv1 'ct N 'ýt ", v1 00 N ýO V r+ eMO ýt V1 Oý 0O . -ý 
co 
NNN v» O "--i C 00 . -- 
N 'ýF t` O> M "-+ vm 00 00 
NNNNMMN (N MMMMMM er st e 'r1 -e Aill r- vl No 00 
18i 
I161111111111111111111116$ 
N 
IIIIIIIIIIIIIIIiiiIIIIiiII fNV 
'b ed .0 .v 'b '° 'd -° 'b 'b 'b 'd bb '° °o 'b 'b bbb 'b 'd 
UbUUUUUUpbbUQQUbUUUUÄUcayU 
-0 -0 -0 
,Ü 
-ci :Üb -u -Ö "C 
, 
'-0G 'ýC 
b 
"d -Ö 
b 
10 10 
b 
10 M "C 
b. 0 Cj "0 
il . 11 . 11 
.; U1 ýG NMNd' %0 [- ONM t- NM CN v) 0o o' Nm co . -- Nh1,0 
N 
ý-4 r+ 
1 c> 
ý-4 NNNNNNNNNNNNN 
00 N 
I 
I 
CN 
00 
00 
I 
I 
I 
N 
v b 
.ý 
0 0 M 
vý 
E 
a) 
"C 
aý 
bQ 
cd 
aý 
0 
U 
s 
vu 
E V 
'd a. ) 
C) b 
C) 
"d 
0 
ai 
cý 
cd 
GQ 
U 
z 
a 
w 
U 
4 S 
M_ 
O O 
ý 
g- 
O O 
S 
Ö Ö Ö Ö Ö Ö Ö Ö 
O 
000 
N 
N 
O ro) 
N 
N 
N 
M 
t 
V1 
N 
-4 N 
N 
c. 
rý 
N 
- 
N 
4n 
C? 
w 
00 
9 
w 
9 W O 
w 
O 
w w 
N 
N r". V'º 
"i 
V1 
M 
N 
M 
ý 
". i 
'ýt 
Pry 
M ý N 
z A. lý 00 Oý C N lý 
00 
ü 
7 
u 
b0 
d e N N 
etw, 
cý r4 
V 
Gn 
Ö 
N 
N 
N 
'. f 
N 
O\ N 
M 
M 
"-" 
N 
M 
N 
m 
V1 
N 
- 
M 
V 
O 
a 
ý v1 
ý 
M 
' 
O\ 
lý ýD 
Y1 
00 
M ýO M Oý 
ý 
O c h 
ýt 
M ýt N 
M 
e e 
V 
11 
Vlb m 
all 
N 
O 
- 
Oý 
10 
r- 
call, 
ýýo 
C 
'O 
C 
'O 
C 
u 
Ü 
N .0 
KA ý M 
v1 
xt 
N 
ýc '+ 
N 
r4 N fr M 
oO 
ö 
M 
o0 
ö 
M 
00 
ö 
M 
.. + 0 
ä 
CZ 
c O 
y 
ü 
c5 
Z Ö C) W 
M 
r-4 ö 0 0 
d ä w ä w ä c ä ä äN 
t" 
w 
w 
ö 
w 
ö ZD Ln Z) 
w o w ? w o 
1. z ý , > ý :ý 
c, 
ý 
: > > > 
p" 
ý 
ýj 
w 
ý 
w 
4 
v) Eý Ilt 
x 
!I 
Q 
p4 
¢ 
p4 
d 
p4 
d 
ä 
a 
N 
c3 
O H < vi yUj 
U U U 
p 
w 
cd 
p 
ed 
Ca 
O O O O 
v 
z 
p 
.ý 
p 
CU ce 
v 
ä 
v 
ö ä 
r+ 
y0, 
"Lý 
Ü 
w 
p C7 cý0 tad 
ý". ý 
c0 cd 
E. 
ýy y 
!ý 
Q 
4, ý 
ý0 
t/ý 
Gi 
cl 
tý 
F7 
p 
N 
D 
p 
to 
p 
p 
IA 
p 
p 
N 
V N p V U 
p 
ý+. 
u 
ý'i p 
p "m O O bA O A oA 
to 
w w w w x x x x 
0 Z 7 A 
O 
. -0 
N 
oý 
_ 
- 
O 
ýo 
M 
0o 
N 
a` 
8 
v- 
""" 
o 
N 
0 
NNOO -+ gS r+ $ v_1 y pN 
g$$'. D (N "- -$ p- 
-p 
ÖÖÖÖÖOOOSOOSOOOOÖOSÖSOOO 
ÖÖÖÖÖÖÖÖÖÖ CD ÖÖÖÖÖÖÖÖOÖGÖÖO 
lt et 
'O N ry '"ý OMO '° O 00 MOM eý cO 00 qf' N 00 v1 n0 
NO ýt NMn 00 00 O . "+ O O; O\ O> n O\ M <i 00 
NN 
^' 
NNMNNMMNNMNMNM fV NNMMNN 
O ýo e 00 e 00 n %I nn 00 en 00 00 O> n en en 00 ýO n 'O 0 Oý 
. -" o0000OOOO0ogqqc? gqqqqqq-; 9 
wwwwwwwwwwwwwwwwwwwwWwwww 'd V1 "ý 00 ýt O 00 00 V lý N 00 °% -+ --ý tý d ýO n v1 NM o0 V1 
V1 . -ý MMNMMNN r+ M 00 V1 NN Cý ýQ nMNMN 
CC Co' 
ed 
n et N- O> -' 
-Nen 
%0 -4 -4 -4 
Nn 
. -. .. + 
--ne- 
%0 :Z 
"I %, ° 00 00 "+ ýt V1 Cý O\ N Oý "-+ 00 
NNNN0 --ý IN 'ýt N .+ en O% O% ON (> NO l'ý C% 
NeN oÖ NM QK NM~ ^" V1 00 vi 
le 00 N 
ýt O\ . ""ý -+ nN-N-nnNNNMM 
O\ .ýO tt NNM et ý° ýO 'd ýC ýt ýO d; M V1 OOe v1 "" 
N 
00 00 t 00 00 00 enMMMMM V1 --Q (N -nN ýO 
-4 N 00 ý" M t! V1 ýo ýo 0 '° ýo 1G %° 1C - 41 ýo O v -4 -" Nt it 
vý --ý Oý ON VI VI Vi V'b vn V-ý V-1 
Md 
ýD ýC ýO NNM °1 ry 00 000 N 00 ý° 00 M ýC ýO ýD ýD ýO ýO ýD r+ OOO ýO ýO Y1 
1,0 10 
ee .r 'G O\ O\ Z lt -. e %0 - oö 00 00 00 llt M oö Oý -i OÖOOOOÖMi °ý O, Oý N v1 Oz e c; OO% - ý7 't7 MM et v1 VV . -4 v1 ýO ýO ýO MM ý1 M tt 
O 00 n . -+ NN en ý7 e. of 
%0 00 (> (> rlm rn m r4 1-4 Z 0% r-1 0% c> 0% aý 
CN "0 
M 
ýo 00 00 00 00 00 00 00 
- O: ,° ýc 'm 110 'O 00 Oý o> -m .4 "-4 CV 
aao a aaaaaaCo a, Co aaaaaaaa ao, a aN 
wwwwwwwwwwwwwww C/1 C/1 C/1 u2 Ul CD 
:DA :5AZA 
VJ C! 1 Cn w A vi C/2 V2 CwwN AAAAaAAOOOOOOAAa A] NAAA OOOOOAAN c) OOAAOOOOoOO CD C> ý51 > 
Aaaaaaaaiiii>> nt V) %M M 
r, 4 a''' 1r -1 1 -1 1- 
Nom 
ÄÄÄääää 
a 
111111111 
xaAAA CY 
0) 
ý1 Ä xý aaaaaaaÄÄÄ 
C) N 6) C) 'r0)) C) 6) d) NN E) N C) 
;ý 
Kn Gn 
00000000000 ey eo p N 1ý Fw Fý 4w4M Fr w ký 
aaaaaaaaaa2u° 0 0° oOOo o° oo NNNNNN EJ N 
. 
tea r" 0UUU 4123 
cJ c) tý cý c) v c) v c) v c) I-. `'' ) 
000000000oQQQ° en .Hw a sý 0a0aaaaoazv 00°oOoOO°°O ^' P4 a o ,o .oo .o .a .c .oöý, "ý 
0A 'A 
ä, .b ýö 
v<äöööö 
NNNVN 4) UNNVN 92. P. 9: 4 
vvvvvvvvvvvbO 
0) 0) V 
aL 4 . b4 b4 OOOOOOOOmOO -' 
aQO to to aaa to C7 ýt vq 
8c 
. 
ýa 
ä 
Vi Vl Vý V1 Vý y V1 
a=Z= ;jp. p. 
i3ý !Va V) V) Vf VJ oOOo00oooOa. pEF OOOOOOOOOOOW0w Fý rn m -9 M CU ce NddQQ°°U 
00) UUUUU 00) VV a0i x2U (L) 4. =00< *r- . 
ýq 
. 
wry 
0 
Co 0,0 to Co oA öA a0 oA oA oA o0 
0 a) 
ppÖöÖvÄmM 
u 
ed ea 
OOOOOOOOOOopQQ 
it i+ W i-, Fr it WH Ir it F fd 
-11 
1NNNy 
ýE yý v aý v aý aý v e, e, a, °ööö ý' Äonnn iäiäiää ai Vää4, www xxxxxxxxxxxxaaa. aZ2Z cý E-ý .. vvv 
mNO '° n 00 O\ O -"ý NM . -ý .+ In In O to 
O O\ In '° 
. -- NNNNMMMMnNNO . -+ .Cn 
xt -' 
ö0000öoco0000odo0ocococco 
vi 
M 
- 
r4 
\O 
e 
N 
e 
10 
N 
C> 
ýD 
N 
-+ e 
N 
C% 
t- 
N 
M 
M N 
"-, N 
N 
. -+ 
r+ M 
M 
N 
N 
fN 
N 
V) 
M 
N 
O, 
o0 
N 
N 
N 
N 
N 
1 
O 
tC N 
Co 
vi 
NN 
M 
N 
fV 
M 
N 
N 
N N 
pop 
r+ 
00 
0 
00 
0 ö 
e 
0 
VO 
o ä 
ýO 
o ö 
ýO 
r 
. - O. 
o 
.C N 
O 
O 
"-" 
C. 
o 
N 
N 
%0 
g 
e 
g 
U1 
9 
v'1 
9 
e 
9 
m 
9 
Qý 
9 
C> 
9 
w N w N w M w O w N 
6 
w [N w \O w N 
9 
w N w V1 w v1 w 00 
q 
w N w N w V1 w O w o0 w O w ni; w w w w w w 
.O o0 M ýt 
C 
N O\ N "-ý 000 
Z 
O 
"ý-ý 
0 
vi 
N-ý 
ýO 
Z 
-4 
. 
~-ý 
Cl 
O 
. 
ý" 
00 
12 
v1 
N 
ýO ýO ý'+ ýt 
N 
ýc 
N 
M 
4 
00 
i 
Ö 
N 
V1 
V) 
r+ Ö 
-+ 
O 
N 
"O 
vi 
'ýT 
OÖ 
.r 
O 
N 
. -r 
N 
N 
M 
%, m 
N 
" 
N 
Q% 
' 
N 
N 
N 
N 
M 
v1 
-1: 
- 
e 
M 
- 
- 
VM1 
N 
.- 
140 
N 
`ct 
N 
N 
et - 
0 
'1 
-+ o 
-, + 
O 
y-b 
M 
N M -e r- N e - V1 N ON - O - V1 CDN e! In O "1 00 -+ M ON M r" 
00 
vi 
l- 
kn 
t- 
V) 
--t 
h 
00 
lt 
M 
N 
O 
lt 
v 
N 
V' 
c> 
le 
v, 
N N 
ýA 
Q\ cý 
06 
N 
O4 
C 
In 
"-ý 
C 
v1 
"r 
C 
00 
""" 
v; 
'o %Q 
v; 
M 
%0 
v; 
00 
vi 
vi 
00 
vi 
r+ 
erb N N N N - 
v1ý 
v; 
cl 
. cý 
- 
Qý, 
-4 
Cý Cý 
- 
Cý 
-r 
O; 
-4 
cý 
N 
O 
v1 
lIO 
O 
O 
II1 
-i 
N 
M 
00 
00 
00 
00 
o0 
o0 
- 
cý 
-4 
G1 
. -4 cý 
- 
cý 
C'. 
(1 
Q'. 
N 
O'. 
N 
Q'. 
N 
--+ 
M 
lt 
n 
0 
ýo 
h 
0 
\o 
Vý 
0 
e 
In 
0 
\O 
N 
o 
e 
in 
O 
v 
V1 
o 
\O 
K) 
l- 
'p 
eý # 
oo 
00 
N 
V) 
"-ý 
et 
O> 
o'. 
V, 
O 
r- 
C 
00 
r' 
-+ 
C 
00 
I- 
"4 
00 
l- 
-0 
j/'1 
I; 
M 
rý 
i 
Y; 
M 
I- 
Vl 
v; 
M 
t- 
I1 
hi 
r 
I1 Vl 
N 
v1 
N 
d' 
vl 
of 
in 
'7 [- 
00 
M 
O 
M 
'. O 
a 
00 
M 
O 
M 
'. C 
414 
00 
M 
O 
M 
"0 
4 
00 
M 
O 
M 
'. O 
a 
00 
M 
O 
M 
\G 
a 
00 
M 
O 
M 
'. D 
a 
00 
M 
O 
M 
'. O 
a 
O\ 
N 
O 
C 
N 
N 
M 
O 
M 
'. O 
a 
O'. 
in 
N 
N 
in 
a 
"M 
- 
en 
h 
^5 O 
N1 
'. O 
a 
N 
e 
N 
N 
- 
a 
N 
e 
N 
N 
-4 a 
N 
e 
N 
N 
- 
a 
N 
00 
M 
N 
00 
M 
a 
N 
00 
M 
a 
N 
00 
en 
a 
O 
-4 N 
0 
'. D 
a 
O 
' -0 
N 
0 
'. O 
124 
O 
'~ N 
0 
%0 
a 
O 
~ 
N 
O 
'. C 
a. 
O 
N 
M 
\O 
a 
00 
t- 
e 
00 
le 
s 
ti 
c4 
zDA AUAOOOOOOAAAOOOOO OOOOO 
1-, i1 Uff fli . 11 ll li 1111111 0000000NQNNN 
xxxxxxxdzZ, P, äääýýýý 
UUUUUUU C7 Awxxaaa C7 c7 C7 c7 ¢d 
w 
N 
pý, 
U 
w ü P. Gü 
ü_ üyUOO00 
a ýy 
u 
U v.., 4 
Oý UVUV 
~N 
wQQ 
ýi 
l- I.. l- ºOn 
00000 Oý, 
ý, 
id cd e0 Rt 
'b 
¢OA' 
vOi vOi 
ööö 
A 
.., .-.. 
OO0O0OvÜ 
.Ü :00--- a+ "-" 
pO d4 
QQ0OO OOO ed ed ----. + r+ . -ý N 
aaaaaaa , ý, r. a 
öo 
:i Cd 2. ir+VVVVU 
(4 u2 
A'- MAI 
2 
o .ý ,kaaaaoOo0o ?, oOO05.5. ýi. 51 51 U 
!C RS CV LO RS fl fd fC Ö "q . O''ý .ý "O 
NHyH 110 
VUVU 
.0 
4- = 141 
CJ 
mi 0 o o\ 0000 rro AWxxäää 
tn W 
can vni uQQQQd 
I- 00 ON ýO "f' r'"1 I- 00 '" -Y cal ýt V1 eh V1 M V1 
O'1N 00 CN MM 
. -+ "--ý "-ý M '¬ O 00 lý Iý Iý ^' ý"ý ýi rn 
0 0 0 8 g o ö ö 
$ ä ö ö ö ö o o o ä ö ö ö 0 o d o d ö 0 0 0 0 0 0 0 0 0 0 ö o d ö 0 
oN0 
en 
O 
VI) 
o 
N 
q 
t-: 
n 
0 N W) 00 t. -: 00 0 0ý en - en 47: r- 4", M Ö 0 ON 00 00 N 
Q1 M 19 q 
- 
a 
- 
a 
M o N N 
a a 
oc M 
a 
^' N 
N 
N N fI Oý 
a 1 i a i a 
N 
O 
ýO 
O 
an 
O 
M 
O 
Cý 
9 
v1 
9 
N 
0 - "" 
an 
- 
. -- 
- 
N 
- 
.ý 
- 
.r 
- 
N 
0 
N 
9 
N 
9 
et 00 . -ý 00 00 N O 
W W W W W W W W W W W W W W W W W W 
W W W W W W 
Vl N rn It o0 et llý v1 N O0 Oý a ei M v1 Cý Oý l. (- ýD Oý qt 
fV N 00 Os 00 - M M M tt N vt v1 M "-+ W'1 M 
M 06 CV 
1-. 
-4 ýO "4 IN N N 10 
r 
- o 
N 
00 M 
N 
It! M 01 M 00 'T 
m 
- N V' 
M 
C 
"-+ 
O 
00 
M O 
N 
O 
O 
ý-+ ON 
00 
M 
an 
N 
M 
et 
v1 
NO 
NO ON '. O N 
M 
v1 . - 00 O\ 
0 M 
-.. 
cV 
en C14 
N 
IRT ýo 
Ö 
C4 
N 
-4 
M 
r- 
M 
-4 
I- 
Izr 
06 M 
W) 
O 
C4 -4 W-) 
O tn m M 
(: N en 
en Wt N M 
'n Cý '. G 00 '. O 'n '. O N an 00 - N N an '. O V1 N Kl an t? en ', 7 
tZt ,, t - -- H ý7 `Q "I ", C e C 10 Ö 
00 
ý N 
00 
et 
N 
en 
'. O 
qtt 
"4 N en en en 
en 
en 
an 
Vl 
ýO ef' 
Vl 
Oý 
IT 
00 
'q' 
10 n eý 
'ý! ' 
O 
ý7 
N 
en 
00 
en 
v1 
10 an N N N 
IT 
an 
It 
V1 
'. O 
an 
O 
o0 
O's 
I 
an 
'O 
00 
ýD 
I'D ý. O 
O 
'. D 
O 
%D 
O 
ýD 
O 
ýO 
O 
%0 
O O 
ýO 
O 
'n en en 
41 OR 
N '. 0 en en 
vi 1 vl v1 e . to 00 ýo 
N N 00 [ý lý M ON 00 D ýC ýO ýO ýO l v M ": V1 V1 
It 
N 
et 
N 
10 
"-+ 
ON 
-+ 
N 
en 
OÖ 
N 
N 
en 
N 
en 
M 
an 
M 
'n 
M 
an 
M 
an 
M 
Vl 
M 
an 
M 
'1 
M 
v1 
00 
en 
00 
en 
00 
m 
o 
'. O 
m 
mi' 
N 
N 
M 
N 
M 
N 
00 
N 
00 
N 
an 
0 
0% 
pa 
4 - 
N 
N 
N 
O 
d 
N 
N 
an 
N 
'n 
N 
an 
N 
an 
N 
an 
N 
an 
N 
an 
N 
an 
N 
O 'n an 
O 
r- 
U 
- 
U 
0 
00 
9 
00 00 O U 
ä 
00 " - 00 0 0 0 0 ö 0 ä 0 ä 
ä 
ä 
ö 
ä 
N 
° 
N 
ä ä a 00 
rý ä 9 ä aN ä ä ä ä ä ä ä ä ä ä ä w a . 
wwwWW 
ÖOOOO Z) OOOO ý' aaÖÖ OOOOOOOOOOOOOOOO 
da 10 
IIMNwwwwwww(ý., aa 
21 
U 
U 
0 
O 
cM 
%0 
y 
V) 
N 
.5 m 
U 
ý 
c U . 
cl 
U 
ý 
U 
M 
0 
a 
UU a 
0 
ý ý-"ý 
ö 
ä 
ýa 
ö 
ä 
ýa 
ö 
U 
.c 
ö 
h 
cý 
ä, ° d ý¢ ý¢ ., ý qqpq . 
00 0 
- ety 
v1 
v1 
- 
`ýt 
N 
ýt 
M 
RT 
O% ON N ýt M r- 00 O 
M -4 ". r NNNNM 
N ýD 1ý M Os O ON 
O ON ON - "., 00 lý [- 
ccccccccccocccccccccc 
ooo 
N 
CW) ; 
e 
Cý 
v1 
cfi 
m 
O 
N 
It 
^' N 
r- 
Q; 
ý1 
oho 
M 
o~o 
M 
OR 
M 
In 09 N wi 
Ö 
40 
M 
N 
N 
" 
( fV 
00 
0 Ci 
O 
"i N 
kn 
-: fV 
ý N` tea 
, N 
W 
Wi 
W 
Wn 
M 
W 
oo 
00 
W 
Cý 
O 
W 
N 
N 
W 
et 
N 
W 
M 
V1 
W 
v. 
Oý 
W 
. -. 
W 
M 
N 
W 
N 
N 
W 
N 
V1 
W 
ID 
W 
r+ 
00 
W 
N 
00 
W 
ý7 
Cý 
W 
ýO 
M 
W 
O 
Oý 
00 
00 
W 
N 00 
00 W) qt 00 N vi C-4 W) 
N PN - . -ý M ýt et - '. G 
N 
- M N - 00 10 -+ N 
vý ýC 
N 
.4 
N 
00 
. 
N N 
00 
M 
. -+ 
CC 
In 
N 
'. O 
`T 
- 
0ý 
M 
00 
N 
- M M 
M 
00 
O'. 
V-1 
C'. 
M 
N 
00 
M 
V) 
M 
N "0 
1 
[N 
M 
M In 
O 
M 
N Oý N M M 'It It V1 o0 O N O'. O N M ? ' 
In 
IC 
cý 
O 
`d 
N 
v1 
'ýr 
M 
In 
`ýf 
00 
ýt 
d 
lý 
"i' 
et 
In 
IT 
ý7 
t- 
IT 
ýi 
V'1 
N 
4 
. -' 
v1 
vi 
n 
14* 
v1 
00 
It 
. 
et 
-4 
en 
M 
ý 
M 
00 
M 
M 
oÖ 
M 
M 
In 
C 
In 
M 
ýD 
N 
'. O 
00 00 00 M M O'. O O -tt '. C Ch O'. 0% 01 M to 
vii IIi In 
in N 
'. D 
In 
'. O 
V1 
ýe 
V1 
d 
O 
ýt 
O 
l? 
"i 
d 
ri 
ýf 
O 
ý7 
Vl 
in 
M 
'n 
M 
In 
M 
In 
M 
00 
'R 
00 
It 
00 
"I: 
00 
It 
co 
N 
00 
N 
'. O 
In 
O 
10 
Ö 
\0 
Ö 
'. O 
'06 
IT 
00 
It7 
r- 
M 
oö 
M 
00 
M 
00 
M 
Ci 
1.4 In In 
'. C 
In In 
N 
M 
N 
M 
N 
M 
N 
M 
In 
M 
In 
M 
0 
N 
00 00 00 NNNN pp o0 aaC . -+ . -. N. 
ch 
00 OC0C 
UUU-. - 00 00 00 xN 00 00 00 00 rn rrý rn rn (r00 ) ono >>ý ý_ ýn ýn v4 al OOOO ýD ýo =N rrl 
ä ääa ö0aääää äääää CO as C00 
rn 
O 
Gn cn wwww 
ý]ýwwwwwww wwwwý'ý'ý"ý ý OOOv2v2v2v2v2v2 u2 unvncn cn OÖOO vwi vii O ýD ZD Z) Z) t) 
00000000000 >> 
00 00 00 
UUUxx3zz. Mz cn as mZUUUU1 
00 00 00 
¢dQUUU ýH aF ¢dddaaU 
aaauUUxxxH ¢¢ d¢ w 
oUVUVwäääNyV 
Gý+ GGü 
t7 tr 
ete7ý eFý7 
U+ 
'd "Cy 'd 'd 
ý7 ý7 00 
Fei Fei 
0;.. +i'NN to 
h 
. +. i Q0 
Nw^aý cd EF 0000Q CA 
U 
y ý, b 'ýa vvvv 
«N00 ýo a 9- >M Lö °qý 
4ýä 
äcä rý r, ý 
10 
ä0uvo pes. 'U'U'V (U 0 'U °a V 91 gý (L) v, vý H v, oA K oA a0 aý aý A. 
o00 EUU Cl UÜ Cr. ' Emd °QQ¢>>> >o 
y C7 C7 p-. 
owö 
~m ý° ~ r- 00 NNNNN M'0 
00 
00 0% 
00 
0 
C' -: - 
O'. ý4 Ij -t in c> 
cu MM 'lt NNNN V) NM 
ö 
O 
ý 
O 
S Ö O C C O C C O O O C 
O 
M 
Oý 
N 
N 
N M 
000 
" 
N 
N 
ýt 
N 
M 
N 
00 
M 
N 
en 
N 
M 
M 
oo 
N 
ri 
N 
ri 
N 
00 
00 
rn 
00 
M 
N 
oo 9 
Oý 
%0 9 
O0 
e 
9 W 
"-" 
9 
'1t 
N 
9 
ýO 
00 9 
-ii 
. -. 
f41 N 't N 
ed pý 
r` 
", ON 
r4 
en - .M -4 'n '! 1 N Vl N M 
en 
V) (> en 
cý 
0 
00 V) 
O\ 
vi 
vý"º 
N 
M 
O 
~ 
lID 
N 
O; 
- 
00 
N 
00 
In 
N 
vi 
ýt 
Výj 
vi 
N 
N 
et 
ý7; 
Ö 
M 
N 
vgl 
N 
t' 
ýt 
'/1 
11: 
O 
N 
o\ 
N 
vl 
M 
N 
In 
M 
N 
00 M 
C 
N 
N 
vý 
\ 
ej 
M 
N 
00 
V) 
rM 
N 
00 
vc v1 
"o 
O'. 
00 
et 
et 
00 
\O 
N 
N 
N 
ýt 
rý 
V) 
rý 
V) 
V) 
O; 
vi 
o0 
0 
rr 
09 
N 
t1: 
c 
O 
r`1 
ýý 
-4 le 
ä 
A 
Ö' 
A 
ä 
N 
le 
N 
°a 
M 
Q 
A 
Ö' 
ý 
0 
r- 
00 
Ö 
M 
_ 
O 
O\ 
ä 
M 
O_ 
O\ 
o°ý 
M 
lS 
n 
ä 
- 
I- 
1,0 
(: 
ä 
.. .4 N 
ýo 
O'. 
ä 
N 
1. e 
rA 00 
ä 
N 
N 
00 N 
ä 
M 
w 
P. 4 
w 
0 
0 
c 
w 
0 
0 
w 
° 
uU 
" 
c 
CY 
w N Z, 
0 
9 
a 
ö 
Ä 
4 
Gn 0 
Ä 
a 
M 
ö 
ä 
ar 
ö 
ö 
v/ 
0 
0 
vý 
c 
ö 
ý 
V 
] 
ý 
p y N 
in U) 
g2 w W w : 
z 
y 
ä 
U) 
eý 
u 
ä h 
Q 
O 
tj 
o 
ýq 
=. 
u 
v 
N 
r4 
O 
H 
Ihr 
end 
b 
Q 
O 
j 
o 
. '. 
U 
vý 
M 
r4 
O 
0y. 
y 
pýj 
ÄC 
b 
ý ;; 
ä 
Z 
y 
y 2 
u 
1 
O 
Ö 
O 
0 
cý 
... 
p 
0 
pý, 
j, 
taCd 
b 
- 
ý+ 
y 
.ý ý 
CI 
tý 
Ü 
w 
ö 
CI 
0 
Ä 
" 
ip 
x 
ý. 
O/ 
5 
N- 
° 
ö 
0 Q) 
1 
0n 
"Ö 
O 
ä 
'-' 
ö 
N 
w 
0. 
M 'S7 
O 
v 
uN 
U 
N 
-2 b 
O 
I. 
N 
Q 
fn 
O 
'. ý 
cn 
N 
O 
4 
?" 
o 
p 
H 
O 
vý 
n 
w c: 
Ö 
d 
._ 
r. 
u 
vý 
M 
p 
1112 
.n 
Ü 
le 
en 
O 
f d 
4J 
lß 
C7 
rq 
00 
OOCOOOOOOCCOOOOOO 
10 et et . -+ .rNNr ýO v1 Ob 00 00 OO ooo Co Ö0 09 09 M 'M^ ,N ri , Glý 
nj vi NN 
ýi NNNNMMNMi 
tN v1 lO r1 .0 'O 00 NNM 00 NeN 
ýO öe V1 
O 09999999a Q99999,99 
WWWWWWWWWWWWWWWWWWW 
CI "I: -i 00 ri 00C, 4 ei MvNM \O .- .-- -- Op N th - -4 .4 -g . -0 
0-1 2 
O\ 4n 
V) NNM 00 l- 
ý 
et t- 
ö0 
r- 
NA 
ep 
"NM 
%0 O v1 lt v1 N et ýO V) 
NN 
00 
'O 0M o0 Oý ýt NN 111: N 'D Itý v"1 '0 - 
pp oÖ NMÖ O\ O 00 
M (> O\ .i MN -m 
-4 . -4 -N of -MNM- "y NNN 
. "r V1 V1 OO 41 V1 V1 I/1 NN-l-N 
IO O """ OM 
000 
Öc 000 
14 
13 cý 0% OO V) vi ýO ýO NN V1 Vgl 
d" tt - ^"ý M Kl le le le of vi V1 M 
1.0 - et N 
C> O> v1 tN N1 V1 N V1 lit IN Oý vl 
NQ (D Mt 
NN ýO N -i ON IO O\O\ en h '0 
F Q: 
Sp ýO 
eh ýt U1 V1 O\ O\ 00 00 eC %ID "O e v1 V" 
e 
N [Ný, öN ý7 
Öý NN 
Cý N lq» .r o0 lý M 00 
. -+ vC M er - 00 
et 
N 
vi MN 1-4 
tf O0 
N 
M ý/1 M le vi MMM Izt r- 
N 00 
- (D Nm e 'O 
M V) 00 4 ^' mt (D 
O_ 0c0ý Ö ý""ý ýi (> 
00 0NMM9 Oý 
O\ 000 O ýD 00 Oý C) 
u C> 00 
C\ 00 t' 
oo O v1 00 e C> 
0N 'd' 
Oý °., es'., ý°ý ý". Oý waaOää 
ßr ßßi O0 
-4 ßr wasN 
WWWW WWýW 
ýn vWi W vý ur Ln V) En WW ýn tn 
cpÖ CD Öc0ZOÖO>pOÖ O O ý5 (D 
1 -9 NQý 
ä Q¢ Ua' HdAaO 
o 
ö 
U~ 
^, a d 
to . 
c. 3 
M" u 
C, ) 0 
NNä 
n 6ý e0 O0 O 
~ 
5 
wo N2 -0 
.5y 
w" 4". p 
N9 U cý o "p O b'. , 
O. 
Uy 10 O 
'G 070E0ur, 
p ß. ÖýÖOO 
ce3 NO ed NUv F" U. 
O 
rn OC.! E a' O cd ^, äu 
U OA OÖONNO 'ý, ýI 
>LA. E4U tip N :¢aI E-. ,dQ 
C7 O ? 'ý a" cn 
p 94 CLO -t 
00 ce 00 00 . -r . -r re) M 'D 10 MM V1 V1 00 ýO 
K! 1 I1- 
2MM0 ýQ O\ Oý 0O--NN O\ N 'O M 
00 en 
O 
O 
ý 
Ö 
O 
p 
N 
O 
p 
Ö 
O 
p 
Ö 
O 
p 
O 
p 
O 
O 
p 
O 
O 
p 
O 
O 
Ö 
O 
O 
Ö 
Q 
v 
Ö O O Ö 
S 
O 
Ö 
O O O 
M 
O 
N 
O, 
^" 
N 
,l 1, 
M mm 
00 
M 
'D 
O 
N 
v1 
N 
N 
O 
N 
00 
O 
ýD 
l' 
o0 
ei 
t- 
e 
nt 
0 
1 
t, 
' 
3 %0 
ti 
N 
O 
N 
N 
N 
r 
M 
O 
fV 
1 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 
N 
vi 
n 
OO 
O 
vi 
can 
'. O 
O\ 
vi 
et 
vi 
.O 
00 
M 
C\ 
ýt 
M 
lIO 
ýt 
ýt 
N 
10 
ý7 
O 
N 
Oý 
ý7 
Oý 
l- 
N 
vi 
Oý 
- 
1t 
et 
Ö 
- 
O 
2, 
N 
(> 
e 
"p 
"-r 
O 
M 
M 
m 
c1 
p 
"" 
e 
10 
z: 
O 
vi 
rý 
1 1 1 1 1 1 1 1 i 1 1 1 
1 1 1 1 1 
1 1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 1 1 
U 
U 
1 1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 1 1 .. r 
Oý 
a) 
ö 
(A 
O Cd 
U O 
ci 
ý:. 
'b 0 
ä 
;b 
a 
'b N 
ä 
a 
'd u 
ä 
b 
a 
'b U 
ä 
v 
a 
'b N 
ä 
v 
a 
'b N 
ä 
ö 
a 
'd u 
-C 
a 
'd u 
ä 
;b 
a 
'd c) 
ä 
lv 
a 
'd u 
ä 
b 
a 
b 
u 
ä 
v 
a 
b 
u 
v 
a 
b 
4) 
ä 
-d 
a 
b 
2 
ä 
-b 
a 
b 
N 
ä 
;y 
a 
b 
lli 
ä 
; vi 
a 
b 
N 
! EE b 
v 
a 
b 
N 
lE-1 Ä 
v 
a 
b 
^ 
° 
2 
a 
a) 
"ý 
l- 
2 N M 
N 
O 
`V 
In 
ýt 
M 
V'1 
'. O 
vi 
N 
v1 
00 
t! 1 
IN 
ýD 
00 
ýD 
Q> 
ýO 
N 
tý 
'D 
00 
N 
00 
ýt Cý 
N 
. 
ý. 
4 
.. r 
_ 
KA M 
N 
REFERENCES 
Abe, K., H. Niwa, et al. (1996). "Endoderm-specific gene expression in embryonic stem cells 
differentiated to embryoid bodies. " Exp Cell Res 229(1): 27-34. 
Aicher, A., C. Heeschen, et al. (2003). "Essential role of endothelial nitric oxide synthase for mobilization 
of stem and progenitor cells. " Nat Med 9(11): 1370-6. 
Alexander, R. W. and V. J. Dzau (2000). "Vascular biology: the past 50 years. " Circulation 102(20 Suppl 
4): IV 112-6. 
Allen, R. G and A. K. Balin (1989). "Oxidative influence on development and differentiation: an 
overview of a free radical theory of development. " Free Radic Biol Med 6(6): 631-61. 
Alvarez, R. J., S. J. Gips, et al. (1997). "17beta-estradiol inhibits apoptosis of endothelial cells. " Biochem 
Biophys Res Commun 237(2): 372-81. 
Amit, M., M. K. Carpenter, et al. (2000). "Clonally derived human embryonic stem cell lines maintain 
pluripotency and proliferative potential for prolonged periods of culture. " Dev 13iol 227(2): 
271-8. 
Anderson, D. J., F. H. Gage, et al. (2001). "Can stem cells cross lineage boundaries? " Nat Med 7(4): 
393-5. 
Ando, J., A. Ohtsuka, et al. (1993). "Wall shear stress rather than shear rate regulates cytoplasmic Ca++ 
responses to flow in vascular endothelial cells. " Biochem Biophys Res Commun 190(3): 716-23. 
Asahara, T., T. Murohara, et al. (1997). "Isolation of putative progenitor endothelial cells for 
angiogenesis. " Science 275(5302): 964-7. 
Assmus, B., V. Schachinger, et al. (2002). "Transplantation of Progenitor Cells and Regeneration 
Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). " Circulation 106(24): 3009-17. 
Aw, T. Y. (1999). "Molecular and cellular responses to oxidative stress and changes in oxidation-reduction 
imbalance in the intestine. " Am J Clin Nutr 70(4): 557-65. 
Badorff, C., R. P. Brandes, et al. (2003). "Transdifferentiation of blood-derived human adult endothelial 
progenitor cells into functionally active cardiomyocytes. " Circulation 107(7): 1024-32. 
Bain, G, D. Kitchens, et al. (1995). "Embryonic stem cells express neuronal properties in vitro. " Dev Biol 
168(2): 342-57. 
Banach, K., M. D. Halbach, et al. (2003). "Development of electrical activity in cardiac myocyte 
aggregates derived from mouse embryonic stem cells. " Am J Physiol Heart Circ Physio1284(6): 
H2114-23. 
Banks, R. E., M. J. Dunn, et al. (2000). "Proteomics: new perspectives, new biomedical opportunities. " 
Lancet 356(9243): 1749-56. 
Barbee, K. A., P. F. Davies, et al. (1994). "Shear stress-induced reorganization of the surface topography 
of living endothelial cells imaged by atomic force microscopy. " Circ Res 74(1): 163-71. 
Barberi, T., P. Klivenyi, et al. (2003). "Neural subtype specification of fertilization and nuclear transfer 
embryonic stem cells and application in parkinsonian mice. " Nat Biotechnol 21(10): 1200-7. 
Barja, G (1999). "Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, 
organ specificity, and relation to aging and longevity. " J Bioenerg Biomembr 31(4): 347-66. 
Barja, G (2002). "Rate of generation of oxidative stress-related damage and animal longevity. " Free 
Radic Biol Med 33(9): 1167-72. 
Bautch, V. L., W. L. Stanford, et al. (1996). "Blood island formation in attached cultures of murine 
236 
embryonic stem cells. " Dcv D 205(1): 1.12. 
Becker, K. and R. H. Schirmer (1995). "1,3-Bis(2-chloroethyl)-1-nitrosourea as thiol-carbamoylating 
agent in biological systems. " Methods Enzymol 251: 173-88. 
Beckman, K. B. and B. N. Ames (1998). "The free radical theory of aging matures. " Pbysiol 78(2): 
547-81. 
Bernal-Mizrachi, C., A. C. Gates, et al. (2005). "Vascular respiratory uncoupling increases blood pressure 
and atherosclerosis. " Nature 435(7041): 502-6. 
Berthiaume, F. and J. A. Frangos (1992). "Flow-induced prostacyclin production is mediated by a 
pertussis toxin-sensitive G protein. " FEBS Lett 308(3): 277-9. 
Birukov, K. G, N. Bardy, et al. (1998). "Intraluminal pressure is essential for the maintenance of smooth 
muscle caldesmon and filamin content in aortic organ culture. " Arterioscler Thromb Vasc Biol 
18(6): 922-7. 
Bjornson, C. R., R. L. Rietze, et al. (1999). "Turning brain into blood: a hematopoietic fate adopted by 
adult neural stem cells in vivo. " Science 283(5401): 534-7. 
Boheler, K. R., J. Czyz, et al. (2002). "Differentiation of pluripotent embryonic stem cells into 
cardiomyocytes. " Circ Res 91(3): 189-201. 
Bourassa, M. G., L. Campeau, et al. (1982). "Changes in grafts and coronary arteries after saphenous vein 
aortocoronary bypass surgery: results at repeat angiography. " Circulation 65(7 Pt 2): 90-7. 
Bradford, M. M. (1976). "A rapid and sensitive method for the quantitation of microgram quantities of 
protein utilizing the principle of protein-dye binding. " Anal Biochem 72: 248-54. 
Bradley, A., M. Evans, et al. (1984). "Formation of germ-line chimaeras from embryo-derived 
teratocarcinoma cell lines. " Nature 309(5965): 255-6. 
Brazelton, T. R., F. M. Rossi, et al. (2000). "From marrow to brain: expression of neuronal phenotypes in 
adult mice. " Science 290(5497): 1775-9. 
Bruneel, A., V. Labas, et al. (2005). "Proteomics of human umbilical vein endothelial cells applied to 
etoposide-induced apoptosis. " Proteomics 5(15): 3876-84. 
Bruneel, A., V. Labas, et al. (2003). "Proteomic study of human umbilical vein endothelial cells in 
culture. " Proteomics 3(5): 714-23. 
Brunini, T. M., A. C. Mendes-Ribeiro, et al. (2006). "Platelet nitric oxide synthesis in uremia and 
malnutrition: A role for 1-arginine supplementation in vascular protection? " Cardiovasc Res. 
Brunini, T. M., N. B. Roberts, et al. (2002). "Activation of L-arginine transport in peripheral blood 
mononuclear cells in chronic renal failure. " Pflugers Arch 445(1): 147-51. 
Brunini, T. M., M. M. Yaqoob, et al. (2003). "Increased nitric oxide synthesis in uraemic platelets is 
dependent on L-arginine transport via system y(+)L. " Pflugers Arch 445(5): 547-50. 
Brustle, 0., K. N. Jones, et al. (1999). "Embryonic stem cell-derived glial precursors: a source of 
myelinating transplants. " Science 285(5428): 754-6. 
Burkert, U., T. von Ruden, et al. (1991). "Early fetal hematopoietic development from in vitro 
differentiated embryonic stem cells. " New Biol 3(7): 698-708. 
Buttery, L. D., S. Bourne, et al. (2001). "Differentiation of osteoblasts and in vitro bone formation from 
murine embryonic stem cells. " Tissue Eng 7(1): 89-99. 
Cadenas, E. and K. J. Davies (2000). "Mitochondrial free radical generation, oxidative stress, and aging. " 
Free Radic Biol Med 29(3-4): 222-30. 
Cai, H. and D. Cx Harrison (2000). "Endothelial dysfunction in cardiovascular diseases: the role of 
oxidant stress. " Circ Res 87(10): 840-4. 
237 
Campbell, J. H. and G R. Campbell (1994). "The role of smooth muscle cells in atherosclerosis. " urr 
Opin Lipidol 5(5): 323-30. 
Carr, S., R. Aebersold, et al. (2004). "The need for guidelines in publication of peptide and protein 
identification data: Working Group on Publication Guidelines for Peptide and Protein 
Identification Data. " Mol Cell Proteomics 3(6): 531-3. 
Carroll, K., K. Ray, et al. (2000). "Two-dimensional electrophoresis reveals differential protein expression 
in high- and low-secreting variants of the rat basophilic leukaemia cell line. " Electrophoresis 
21(12): 2476-86. 
Cerdan, C., A. Rouleau, et at. (2004). "VEGF-A165 augments erythropoietic development from human 
embryonic stem cells. " Blood 103(7): 2504-12. 
Chadwick, K., L. Wang, et at. (2003). "Cytokines and BMP-4 promote hematopoietic differentiation of 
human embryonic stem cells. " Blood 102(3): 906-15. 
Chandel, N. S., E. Maltepe, et al. (1998). "Mitochondria] reactive oxygen species trigger hypoxia-induced 
transcription. " Proc Nat! Acad Sci USA 95(20): 11715-20. 
Chandra, J., A. Samali, et al. (2000). "Triggering and modulation of apoptosis by oxidative stress. " Free 
Radic Biol Med 29(3-4): 323-33. 
Chen, S. and R J. Lechleider (2004). "Transforming growth factor-beta-induced differentiation of smooth 
muscle from a neural crest stem cell line. " Circ Res 94(9): 1195-202. 
Chiariello, M., M. J. Marinissen, et al. (2001). "Regulation of c-myc expression by PDGF through Rho 
GTPases. " Nat Cell Biol 3(6): 580-6. 
Choi, K., M. Kennedy, et al. (1998). "A common precursor for hematopoietic and endothelial cells. " 
Development 125(4): 725-32. 
Clark, A. T., M. S. Bodnar, et al. (2004). "Spontaneous differentiation of germ cells from human 
embryonic stem cells in vitro. " Hum Mol Genet 13(7): 727-39. 
Clarke, D. L., C. B. Johansson, et al. (2000). "Generalized potential of adult neural stem cells. " Science 
288(5471): 1660-3. 
Conway, E. M., D. Collen, et al. (2001). "Molecular mechanisms of blood vessel growth. " Cardiovasc 
Res 49(3): 507-21. 
Corthals, Cl, Gygi, SP, Aebesold, R, Patterson, SD (2000). "Identification of proteins by mass 
spectrometry. " Proteome Research: Two-Dimensional Gel Electrophoresis and Identification 
Methods.: 197-227. 
Cossarizza, A., M. Baccarani-Contri, et al. (1993). "A new method for the cytofluorimetric analysis of 
mitochondrial membrane potential using the J-aggregate forming lipophilic cation 
5,5', 6,6'-tetrachloro-1,1', 3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). " Biochem 
Biophys Res Commun 197(1): 40-5. 
Cotgreave, I. A. and R. G Gerdes (1998). "Recent trends in glutathione biochemistry--glutathione-protein 
interactions: a molecular link between oxidative stress and cell proliferation? " Biochem Biophys 
Res Commun 242(1): 1-9. 
Cremona, 0., M. Muda, et al. (1995). "Differential protein expression in aortic smooth muscle cells 
cultured from newborn and aged rats. " EM Cell Res 217(2): 280-7. 
Cuzzocrea, S., D. P. Riley, et al. (2001). "Antioxidant therapy: a new pharmacological approach in shock, 
inflammation, and ischemia/reperfusion injury. " Pharmacol Rev 53(1): 135-59. 
Cybulsky, M. I. and M. A. Gimbrone, Jr. (1991). "Endothelial expression of a mononuclear leukocyte 
adhesion molecule during atherogenesis. " Science 251(4995): 788-91. 
238 
Daheron, L., S. L. Opitz, et al. (2004). "LIF/STAT3 signaling fails to maintain self-renewal of human 
embryonic stem cells. " Stem Cells 22(5): 770-8. 
Dani, C., A. G Smith, et al. (1997). "Differentiation of embryonic stem cells into adipocytes in vitro. " L 
Cell Sci 110 (Pt 11): 1279-85. 
Davies, K. J. (1999). "The broad spectrum of responses to oxidants in proliferating cells: a new paradigm 
for oxidative stress. " IUBMB Life 48(1): 41-7. 
Davies, M. J. (2005). "The oxidative environment and protein damage. " IIiochim ßiophys Acta 1703(2): 
93-109. 
Davies, P. F. (1995). "Flow-mediated endothelial mechanotransduction. " Physiol Rev 75(3): 519-60. 
Davies, P. F., K. A. Barbee, et al. (1997). "Spatial relationships in early signaling events of flow-mediated 
endothelial mechanotransduction. " Annu Rev Physiol 59: 527-49. 
Davies, P. F., D. C. Polacek, et al. (1999). "A spatial approach to transcriptional profiling: 
mechanotransduction and the focal origin of atherosclerosis. " Trends Biotechnol 17(9): 347-51. 
De Flora, S., A. Izzotti, et al. (1997). "Molecular epidemiology of atherosclerosis. " Faseb J 11(12): 
1021-31. 
De Vecchi, E., L. Lubatti, et al. (1998). "Protection from renal ischemia-reperfusion injury by the 
2-methylaminochroman U83836E. " Kidney Int 54(3): 857-63. 
Dembach, E., C. Urbich, et al. (2004). "Antioxidative stress-associated genes in circulating progenitor 
cells: evidence for enhanced resistance against oxidative stress. " Blood 104(12): 3591-7. 
Dewey, C. F., Jr., S. R. Bussolari, et at. (1981). "The dynamic response of vascular endothelial cells to 
fluid shear stress. " J Biomech Eng 103(3): 177-85. 
Dietrich, H., Y. Hu, et al. (2000). "Rapid development of vein graft atheroma in ApoE-deficient mice. " 
Am J Pathol 157(2): 659-69. 
Dimmeler, S., B. Assmus, et al. (1998). "Fluid shear stress stimulates phosphorylation of Akt in human 
endothelial cells: involvement in suppression of apoptosis. " Circ Res 83(3): 334-41. 
Dimmeler, S., I. Fleming, et al. (1999). "Activation of nitric oxide synthase in endothelial cells by Akt- 
dependent phosphorylation. " Nature 399(6736): 601-5. 
Doetschman, T. C., H. Eistetter, et al. (1985). "The in vitro development of blastocyst-derived embryonic 
stem cell lines: formation of visceral yolk sac, blood islands and myocardium. " J Embryol Exp 
Morphol 87: 27-45. 
Drab, M., H. Haller, et al. (1997). "From totipotent embryonic stem cells to spontaneously contracting 
smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. " Faseb J 11(11): 
905-15. 
D'Souza, S. L., A. G Elefanty, et al. (2005). "SCL/Tal-1 is essential for heniatopoietic commitment of the 
hemangioblast but not for its development. " Blood 105(10): 3862-70. 
Dunn, M. J. (1997). "Two-dimensional polyacrylamide gel electrophoresis for the separation of proteins 
for chemical characterization. " Methods Mol Biol 64: 25-36. 
Dunn, M. J. (2000). "Studying heart disease using the proteomic approach. " DrugDiscov Today 5(2): 
76-84. 
Dupont, A., D. Corseaux, et al. (2005). "The proteome and secretome of human arterial smooth muscle 
cells. " Proteomics 5(2): 585-96. 
Duran, M. C., S. Mas, et al. (2003). "Proteomic analysis of human vessels: application to atherosclerotic 
plaques. " Proteomics 3(6): 973-8. 
Dzau, V. J., G. H. Gibbons, et al. (1993). "Vascular biology and medicine in the 1990s: scope, concepts, 
239 
potentials, and perspectives. " Circulation 87(3): 705-19. 
Elliott, S. T., D. G. Crider, et at. (2004). "Two-dimensional gel electrophoresis database of murine R1 
embryonic stem cells. " Proteomics 4(12): 3813-32. 
Ema, M., P. Faloon, et al. (2003). "Combinatorial effects of Flkl and Tall on vascular and hematopoietic 
development in the mouse. " Genes Dev 17(3): 380-93. 
Evans, M. J. and M. H. Kaufman (1981). "Establishment in culture of pluripotential cells from mouse 
embryos. " Nature 292(5819): 154-6. 
Faloon, P., E. Arentson, et al. (2000). "Basic fibroblast growth factor positively regulates hematopoietic 
development. " Development 127(9): 1931-41. 
Faux, M. C. and J. D. Scott (1996). "More on target with protein phosphorylation: conferring specificity 
by location. " Trends Biochem Sci 21(8): 312-5. 
Fehling, H. J., G. Lacaud, et al. (2003). "Tracking mesoderm induction and its specification to the 
hemangioblast during embryonic stem cell differentiation. " Development 130(17): 4217-27. 
Feldmann, R. E., Jr., K. Bieback, et al. (2005). "Stem cell proteomes: a profile of human mesenchymal 
stem cells derived from umbilical cord blood. " Electrophoresis 26(14): 2749-58. 
Feraud, 0. and D. Vittet (2003). "Murine embryonic stem cell in vitro differentiation: applications to the 
study of vascular development. " Histol Histopathol 18(1): 191-9. 
Ferrari, G, G Cusella-De Angelis, et al. (1998). "Muscle regeneration by bone marrow-derived myogenic 
progenitors. " Science 279(5356): 1528-30. 
Fey, S. J. and P. M. Larsen (2001). "2D or not 2D. Two-dimensional gel electrophoresis. " Curr Opin 
Chem Biol 5(1): 26-33. 
Filomeni, Cz, G Rotilio, et al. (2005). "Disulfide relays and phosphorylative cascades: partners in 
redox-mediated signaling pathways. " Cell Death Differ. 
Foster, L. J., P. A. Zeemann, et al. (2005). "Differential expression profiling of membrane proteins by 
quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast 
differentiation. " Stem Cells 23(9): 1367-77. 
Frid, M. G, E. C. Dempsey, et al. (1997). "Smooth muscle cell heterogeneity in pulmonary and systemic 
vessels. Importance in vascular disease. " Arterioscler Thromb Vasc Biol 17(7): 1203-9. 
Frid, M. Q, E. P. Moiseeva, et al. (1994). "Multiple phenotypically distinct smooth muscle cell 
populations exist in the adult and developing bovine pulmonary arterial media in vivo. " Circ Res 
75(4): 669-81. 
Furchgott, R. F. and J. V. Zawadzki (1980). "The obligatory role of endothelial cells in the relaxation of 
arterial smooth muscle by acetylcholine. " Nature 288(5789): 373-6. 
Galasso, G, S. Schiekofer, et al. (2006). "Impaired angiogenesis in glutathione peroxidase-1-deficient 
mice is associated with endothelial progenitor cell dysfunction. " Circ Res 98(2): 254-61. 
Galli, R., U. Borello, et al. (2000). "Skeletal myogenic potential of human and mouse neural stem cells. " 
Nat Neurosci 3(10): 986-91. 
Gepstein, L. (2002). "Derivation and potential applications of human embryonic stem cells. " Circ Res 
91(10): 866-76. 
Gibbons, G H. and V. J. Dzau (1994). "The emerging concept of vascular remodeling. " N Engi J Med 
330(20): 1431-8. 
Girotti, A. W. (1998). "Lipid hydroperoxide generation, turnover, and effector action in biological 
systems. " J Lipid Res 39(8): 1529-42. 
Giulivi, C., A. Boveris, et al. (1995). "Hydroxyl radical generation during mitochondrial electron transfer 
240 
and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA. " Arch Biochem 
Biophys 316(2): 909-16. 
Griendling, K. K. and G. A. FitzGerald (2003). "Oxidative stress and cardiovascular injury: Part I: basic 
mechanisms and in vivo monitoring of ROS, " Circulation 108(16): 1912-6. 
Griendling, K. K. and G A. FitzGerald (2003). "Oxidative stress and cardiovascular injury: Part II: animal 
and human studies. " Circulation 108(17): 2034-40. 
Griendling, K. K., C. A. Minieri, et al. (1994). "Angiotensin II stimulates NADI! and NADPI! oxidase 
activity in cultured vascular smooth muscle cells. " Circ Res 74(6): 1141-8. 
Griendling, K. K., D. Sorescu, et al. (2000). "NAD(P)II oxidase: role in cardiovascular biology and 
disease. " Circ Res 86(5): 494-501. 
Griffith, 0. W. (1999). "Biologic and pharmacologic regulation of mammalian glutathione synthesis. " 
Free Radic Biol Med 27(9-10): 922-35. 
Gudi, S., J. P. Nolan, et al. (1998). "Modulation of GTPase activity of G proteins by fluid shear stress and 
phospholipid composition. " Proc Natl Acad Sci USA 95(5): 2515-9. 
Gudi, S. R., C. B. Clark, et al. (1996). "Fluid flow rapidly activates G proteins in human endothelial cells. 
Involvement of G proteins in mechanochemical signal transduction. " Circ Res 79(4): 834-9. 
Guevara, N. V., H. S. Kim, et al. (1999). "The absence of p53 accelerates atherosclerosis by increasing 
cell proliferation in vivo. " Nat Med 5(3): 335-9. 
Gussoni, E., Y. Soneoka, et al. (1999). "Dystrophin expression in the mdx mouse restored by stem cell 
transplantation. " Nature 401(6751): 390-4. 
Gygi, S. P., B. Rist, et al. (1999). "Quantitative analysis of complex protein mixtures using isotope-coded 
affinity tags. " Nat Biotechnol 17(10): 994-9. 
Haar, J. L. and G. A. Ackerman (1971). "A phase and electron microscopic study of vasculogenesis and 
erythropoiesis in the yolk sac of the mouse. " Anat Rec 170(2): 199-223. 
Hallmann, R., D. N. Mayer, et al. (1995). "Novel mouse endothelial cell surface marker is suppressed 
during differentiation of the blood brain barrier. " Dev Dvn 202(4): 325-32. 
Han, C. I., G R. Campbell, et al. (2001). "Circulating bone marrow cells can contribute to neointimal 
formation. " J Vasc Res 38(2): 113-9. 
Hart, Cl W. (1992). "Glycosylation. " Curr Opin Cell Biol 4(6): 1017-23. 
Hazell, L. J. and R. Stocker (1997). "Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of 
apolipoprotein B-100 of low-density lipoprotein. " FEBS Lett 414(3): 541-4. 
He, J. Q., Y. Ma, et al. (2003). "Human embryonic stem cells develop into multiple types of cardiac 
myocytes: action potential characterization. " Circ Res 93(1): 32-9. 
Heil, M. and W. Schaper (2004). "Influence of mechanical, cellular, and molecular factors on collateral 
artery growth (arteriogenesis). " Circ Res 95(5): 449-58. 
Hellstrom, M., M. Kalen, et al. (1999). "Role of PDGF-B and PDGFR-beta in recruitment of vascular 
smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. " 
Development 126(14): 3047-55. 
Hescheler, J., B. K. Fleischmann, et al. (1997). "Embryonic stem cells: a model to study structural and 
functional properties in cardiomyogenesis. " Cardiovasc Res 36(2): 149-62. 
Hidaka, K., J. K. Lee, et al. (2003). "Chamber-specific differentiation of Nkx2.5-positive cardiac 
precursor cells from murine embryonic stem cells. " Faseb J 17(6): 740-2. 
Hill, J. M., G Zalos, et al. (2003). "Circulating endothelial progenitor cells, vascular function, and 
cardiovascular risk. " N End J Med 348(7): 593-600. 
241 
Hillebrands, J. L., F. A. Matter, et al. (2001). "Origin of neointimal endothelium and alpha-actin-positive 
smooth muscle cells in transplant arteriosclerosis. " J Clin Invest 107(11): 1411-22. 
Hirashima, M., H. Kataoka, et al. (1999). "Maturation of embryonic stem cells into endothelial cells in an 
in vitro model of vasculogenesis. " Blood 93(4): 1253-63. 
Hirschi, K. K., S. A. Rohovsky, et al. (1998). "PDGF, TGF-beta, and heterotypic cell-cell interactions 
mediate endothelial cell-induced recruitment of IOTI/2 cells and their differentiation to a smooth 
muscle fate. " J Cell Biol 141(3): 805-14. 
Hissin, P. J. and R. Hilf (1976). "A fluorometric method for determination of oxidized and reduced 
glutathione in tissues. " Anal Biochem 74(1): 214-26. 
Hobbs, A. J. and L. J. Ignarro (1996). "Nitric oxide-cyclic GMP signal transduction system. " Methods- 
Enzymol 269: 134-48. 
Hohl, C., R. Oestreich, et al. (1987). "Evidence for succinate production by reduction of fumarate during 
hypoxia in isolated adult rat heart cells. " Arch Biochem Biophys 259(2): 527-35. 
Holycross, B. J., M. J. Peach, et al. (1993). "Angiotensin II stimulates increased protein synthesis, not 
increased DNA synthesis, in intact rat aortic segments, in vitro. " J Vasc Res 30(2): 80-6. 
Hristov, M., W. Erl, et al. (2003). "Endothelial progenitor cells: mobilization, differentiation, and 
homing. " Arterioscler Thromb Vasc Biol 23(7): 1185-9. 
Hu, Q., R. J. Noll, et al. (2005). "The Orbitrap: a new mass spectrometer. " J Mass Spectrom 40(4): 
430-43. 
Hu, Y., F. Davison, et al. (2002). "Smooth muscle cells in transplant atherosclerotic lesions are originated 
from recipients, but not bone marrow progenitor cells. " Circulation 106(14): 1834-9. 
Hu, Y., F. Davison, et al. (2003). "Endothelial replacement and angiogenesis in arteriosclerotic lesions of 
allografts are contributed by circulating progenitor cells. " Circulation 108(25): 3122-7. 
Hu, Y., M. Mayr, et al. (2002). "Both donor and recipient origins of smooth muscle cells in vein graft 
atherosclerotic lesions. " Circ Res 91(7): e13-20. 
Hu, Y., Z. Zhang, et al. (2004). "Abundant progenitor cells in the adventitia contribute to atherosclerosis 
of vein grafts inApoE-deficient mice. " J Clin Invest 113(9): 1258-65. 
Hu, Y., Y. Zou, et al. (1999). "Inhibition of neointima hyperplasia of mouse vein grafts by locally applied 
suramin. " Circulation 100(8): 861-8. 
Huber, L. A., K. Pfaller, et al. (2003). "Organelle proteomics: implications for subcellular fractionation in 
proteomics. " Circ Res 92(9): 962-8. 
Hubner, K., G Fuhrmann, et al. (2003). "Derivation of oocytes from mouse embryonic stem cells. " 
Science 300(5623): 1251-6. 
Humphery-Smith, I., S. J. Cordwell, et al. (1997). "Proteome research: complementarity and limitations 
with respect to the RNA and DNA worlds. " Electrophoresis 18(8): 1217-42. 
Imanishi, T., T. Hano, et al. (2005). "Angiotensin II accelerates endothelial progenitor cell senescence 
through induction of oxidative stress. " J Hypertens 23(1): 97-104. 
Inoue, M., E. F. Sato, et al. (2003). "Mitochondrial generation of reactive oxygen species and its role in 
aerobic life. " Curr Med Chem 10(23): 2495-505. 
Inui, K., R. 0. Oreffo, et al. (1997). "Effects of beta mercaptoethanol on the proliferation and 
differentiation of human osteoprogenitor cells. " Cell Biol Int 21(7): 419-25. 
Itskovitz-Eldor, J., M. Schuldiner, et al. (2000). "Differentiation of human embryonic stem cells into 
embryoid bodies compromising the three embryonic germ layers. " Mol Med 6(2): 88-95. 
Iwashina, M., M. Shichiri, et al. (1998). "Transfection of inducible nitric oxide synthase gene causes 
242 
apoptosis in vascular smooth muscle cells. " Circulation 98(12): 1212-8. 
Izzotti, A., S. De Flora, et al. (1995). "Cancer biomarkers in human atherosclerotic lesions: detection of 
DNA adducts. " Cancer Epidemiol Biomarkers Prey 4(2): 105-10. 
Jackson, K. A., S. M. Majka, et al. (2001). "Regeneration of ischemic cardiac muscle and vascular 
endothelium by adult stem cells. " J Clin Invest 107(11): 1395-402. 
Jackson, K. A., T. Mi, et al. (1999). "Hematopoietic potential of stem cells isolated from murine skeletal 
muscle. " Proc Natl Acad Sci USA 96(25): 14482-6. 
Jahn, M., J. W. Baynes, et al. (1999). "The reaction of hyaluronic acid and its monomers, glucuronic acid 
and N-acetylglucosamine, with reactive oxygen species. " Carbohydr Res 321(3-4): 228-34. 
Jenner, A. M., J. E. Ruiz, et al. (2002). "Vitamin C protects against hypochlorous Acid-induced 
glutathione depletion and DNA base and protein damage in human vascular smooth muscle 
cells. " Arterioscler Thromb Vasc Biol 22(4): 574-80. 
Jin, H., A. Aiyer, et al. (2006). "A homing mechanism for bone marrow-derived progenitor cell 
recruitment to the neovasculature. " J Clin Invest 116(3): 652-62. 
Kaiser, D., M. A. Freyberg, et al. (1997). "Lack of hemodynamic forces triggers apoptosis in vascular 
endothelial cells. " Biochem Biophys Res Commun 231(3): 586-90. 
Kannan, R. Y., H. J. Salacinski, et al. (2005). "Current status of prosthetic bypass grafts: a review. " L 
Biomed Mater Res B Appi Biomater 74(1): 570-81. 
Kaufman, D. S., E. T. Hanson, et al. (2001). "Hematopoietic colony-forming cells derived from human 
embryonic stem cells. " Proc Natl Acad Sci USA 98(19): 10716-21. 
Kehat, I., L. Khimovich, et al. (2004). "Electromechanical integration of cardiomyocytes derived from 
human embryonic stem cells. " Nat Biotechnol 22(10): 1282-9. 
Keller, G. (2005). "Embryonic stem cell differentiation: emergence of a new era in biology and medicine. " 
Genes Dev 19(10): 1129-55. 
Keller, G, M. Kennedy, et al. (1993). "Hematopoietic commitment during embryonic stem cell 
differentiation in culture. " Mol Cell Biol 13(1): 473-86. 
Keller, G. M. (1995). "In vitro differentiation of embryonic stem cells. " Curr Opin Cell Biol 7(6): 862-9. 
Kennedy, M., M. Firpo, et al. (1997). "A common precursor for primitive erythropoiesis and definitive 
haematopoiesis. " Nature 386(6624): 488-93. 
Kiechl, S. and J. Willeit (1999). "The natural course of atherosclerosis. Part I: incidence and progression. " 
Arterioscler Thromb Vasc Biol 19(6): 1484-90. 
Kim, S. C., R. Sprung, et al. (2006). "Substrate and functional diversity of lysine acetylation revealed by a 
proteomics survey. " Mol Cell 23(4): 607-18. 
Klaunig, J. E. and L. M. Kamendulis (2004). "The role of oxidative stress in carcinogenesis. " Annu Rev 
Pharmacol Toxicol 44: 239-67. 
Klose, J. (1975). "Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. 
A novel approach to testing for induced point mutations in mammals. " Human eg netik 26(3): 
231-43. 
Klose, J. (1999). "Fractionated extraction of total tissue proteins from mouse and human for 2-D 
electrophoresis. " Methods Mol Biol 112: 67-85. 
Klug, M. Q, M. H. Soonpaa, et al. (1996). "Genetically selected cardiomyocytes from differentiating 
embronic stem cells form stable intracardiac grafts. " J Clin Invest 98(1): 216-24. 
Kocka, M. M., B. A. Cambier, et al. (1994). "Foam cell replication and smooth muscle cell apoptosis in 
human saphenous vein grafts. " Hist patho y 25(4): 365-71. 
243 
Kolossov, E., B. K. Fleischmann, et al. (1998). "Functional characteristics of ES cell-derived cardiac 
precursor cells identified by tissue-specific expression of the green fluorescent protein. " JCe11 
Bio1143(7): 2045-56. 
Kramer, J., C. Hegert, et al. (2000). "Embryonic stem cell-derived chondrogenic differentiation in vitro: 
activation by BMP-2 and BMP-4. " Mech Dev 92(2): 193-205. 
Kreuzer, J., C. Viedt, et al. (2003). "Platelet-derived growth factor activates production of reactive oxygen 
species by NAD(P)H oxidase in smooth muscle cells through Gil, 2. " Faseb J 17(1): 38-40. 
Kubo, A., K. Shinozaki, et al. (2004). "Development of definitive endoderm from embryonic stem cells in 
culture. " Development 131(7): 1651-62. 
Lagasse, E., H. Connors, et al. (2000). "Purified hematopoietic stem cells can differentiate into 
hepatocytes in vivo. " Nat Med 6(11): 1229-34. 
Lan, Q., K. 0. Mercurius, et al. (1994). "Stimulation of transcription factors NF kappa B and AP 1 in 
endothelial cells subjected to shear stress. " Biochem Biophys Res Commun 201(2): 950-6. 
Lawson, K. A., N. R. Dunn, et al. (1999). "Bmp4 is required for the generation of primordial germ cells in 
the mouse embryo. " Genes Dev 13(4): 424-36. 
Lehoux, S. and A. Tedgui (1998). "Signal transduction of mechanical stresses in the vascular wall. " 
Hypertension 32(2): 338-45. 
Levenberg, S., J. S. Golub, et al. (2002). "Endothelial cells derived from human embryonic stem cells. " 
Proc Natl Acad Sci USA 99(7): 4391-6. 
Li, C., Y. Hu, et al. (1999). "Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) 
phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK 
pathways. " J Biol Chem 274(36): 25273-80. 
Li, C., Y. Hu, et al. (2000). "Ras/Rac-Dependent activation of p38 mitogen-activated protein kinases in 
smooth muscle cells stimulated by cyclic strain stress. " Arterioscler Thromb-Vasc Bi 20(3): 
E1-9. 
Li, J., X. Han, et al. (2001). "Vascular smooth muscle cells of recipient origin mediate intimal expansion 
after aortic allotransplantation in mice. " Am J Pathol 158(6): 1943-7. 
Liao, D. F., Z. G Jin, et al. (2000). "Purification and identification of secreted oxidative stress-induced 
factors from vascular smooth muscle cells. " J Biol Chem 275(1): 189-96. 
Libby, P. and D. I. Simon (2001). "Inflammation and thrombosis: the clot thickens. " Circulation 103(13): 
1718-20. 
Lopez, M. F. and S. Melov (2002). "Applied proteomics: mitochondrial proteins and effect on function. " 
Circ Res 90(4): 380-9. 
Loscalzo, J. (2003). "Proteomics in cardiovascular biology and medicine. " Circulation 108(4): 380-3. 
Mack, C. P. and G K. Owens (1999). "Regulation of smooth muscle alpha-actin expression in vivo is 
dependent on CArG elements within the 5' and first intron promoter regions. " Circ Res 84(7): 
852-61. 
Madsen, C. S., C. P. Regan, et al. (1998). "Smooth muscle-specific expression of the smooth muscle 
myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA 
sequence. " Circ Res 82(8): 908-17. 
Mahoney, W. M. and S. M. Schwartz (2005). "Defining smooth muscle cells and smooth muscle injury. " 3 
Clin Invest 115(2): 221-4. 
Maines, M. D. (1997). "The heure oxygenase system: a regulator of second messenger gases. " Annu Rev 
Pharmacol Toxicol 37: 517-54. 
244 
Maltsev, V. A., J. Rohwedel, et al. (1993). "Embryonic stem cells differentiate in vitro into 
cardiomyocytes representing sinusnodal, atrial and ventricular cell types. " Mech Dev 44(1): 
41-50. 
Manevich, Y., T. Sweitzer, et al. (2002). "1-Cys peroxiredoxin overexpression protects cells against 
phospholipid peroxidation-mediated membrane damage. " Proc Natl Acad Sci USA 99(18): 
11599-604. 
Mann, G. E., D. L. Yudilevich, et al. (2003). "Regulation of amino acid and glucose transporters in 
endothelial and smooth muscle cells. " Physiol Rev 83(1): 183-252. 
Mann, M., R. C. Hendrickson, et at. (2001). "Analysis of proteins and proteomes by mass spectrometry. " 
Annu Rev Biochem 70: 437-73. 
Marchetti, S., C. Gimond, et al. (2002). "Endothelial cells genetically selected from differentiating mouse 
embryonic stem cells incorporate at sites of neovascularization in vivo. " J Cell Sc' 115(Pt 10): 
2075-85. 
Mariano, F., B. Bussolati, et al. (2003). "Platelet-activating factor synthesis by neutrophils, monocytes, 
and endothelial cells is modulated by nitric oxide production. " Shock 19(4): 339-44. 
Martin, G R. (1981). "Isolation of a pluripotent cell line from early mouse embryos cultured in medium 
conditioned by teratocarcinoma stem cells. " Proc Nati Acad Sci USA 78(12): 7634-8. 
Matsuoka, Y., H. Kubota, et al. (2004). "Insufficient folding of type IV collagen and formation of 
abnormal basement membrane-like structure in embryoid bodies derived from 11sp47-null 
embryonic stem cells. " Mol Biol Cell 15(10): 4467-75. 
Matsuura, K., T. Nagai, et al. (2004). "Adult cardiac Sca-l-positive cells differentiate into beating 
cardiomyocytes. " J Biol Chem 279(12): 11384-91. 
Mayr, M., Y. L. Chung, et al. (2005). "Proteomic and metabolomic analyses of atherosclerotic vessels 
from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and 
energy metabolism. " Arterioscler Thromb Vasc Biol 25(10): 2135-42. 
Mayr, M., Y. Hu, et al. (2002). "Mechanical stress-induced DNA damage and rac-p38MAPK signal 
pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. " Faseb J 16(11): 
1423-5. 
Mayr, M., C. Li, et al. (2000). "Biomechanical stress-induced apoptosis in vein grafts involves p38 
mitogen-activated protein kinases. " Faseb J 14(2): 261-70. 
Mayr, M., R. Siow, et al. (2004). "Proteomic and metabolomic analysis of vascular smooth muscle cells: 
role of PKCdelta. " Circ Res 94(10): e87-96. 
Mayr, U., M. Mayr, et al. (2002). "Loss of p53 accelerates neointimal lesions of vein bypass grafts in 
mice. " Circ Res 90(2): 197-204. 
Mayr, U., M. Mayr, et al. (2005). "Proteomic dataset of mouse aortic smooth muscle cells. " Proteomics 
5(17): 4546-4557. 
McCloskey, K. E., D. A. Smith, et al. (2006). "Embryonic stem cell-derived endothelial cells may lack 
complete functional maturation in vitro. " J Vasc Res 43(5): 411-21. 
McGregor, E. and M. J. Dunn (2003). "Proteomics of heart disease. " Hum Mol Genet 12 Spec No 2: 
R135-44. 
McGregor, E., L. Kempster, et al. (2004). "F-actin capping (CapZ) and other contractile saphenous vein 
smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. " of Cell 
Proteomics 3(2): 115-24. 
McGregor, E., L. Kempster, et al. (2001). "Identification and mapping of human saphenous vein medial 
245 
smooth muscle proteins by two-dimensional polyacrylamide gel electrophoresis. " Protcomics 
1(11): 1405-14. 
Mehta, J. L., L. Y. Chen, et at. (1995). "Identification of constitutive and inducible forms of nitric oxide 
synthase in human platelets. " J Lab Clin Med 125(3): 370-7. 
Melov, S., P. Coskun, et al. (1999). "Mitochondrial disease in superoxide dismutase 2 mutant mice. " Pro 
Natl Acad Sci USA 96(3): 846-51. 
Mezey, E., K. J. Chandross, et al. (2000). "Turning blood into brain: cells bearing neuronal antigens 
generated in vivo from bone marrow. " Science 290(5497): 1779-82. 
Michelakis, E. D., V. Hampl, et al. (2002). "Diversity in mitochondrial function explains differences in 
vascular oxygen sensing. " Circ Res 90(12): 1307-15. 
Miller, F. J., Jr., D. D. Gutterman, et al. (1998). "Superoxide production in vascular smooth muscle 
contributes to oxidative stress and impaired relaxation in atherosclerosis. " Circ Res 82(12): 
1298-305. 
Mockett, R. J., R. S. Sohal, et al. (1999). "Overexpression of glutathione reductase extends survival in 
transgenic Drosophila melanogaster under hyperoxia but not normoxia. " Faseb J 13(13): 
1733-42. 
Molloy, M. P. (2000). "Two-dimensional electrophoresis of membrane proteins using immobilized pH 
gradients. " Anal Biochem 280(1): 1-10. 
Moncada, S., M. W. Radomski, et al. (1988). "Endothelium-derived relaxing factor. Identification as nitric 
oxide and role in the control of vascular tone and platelet function. " Biochem Pharmacol 37(13): 
2495-501. 
Monteoliva, L. and J. P. Albar (2004). "Differential proteomics: an overview of gel and non-gel based 
approaches. " Brief Funct Genomic Proteomic 3(3): 220-39. 
Muller, M., B. K. Fleischmann, et al. (2000). "Selection of ventricular-like cardiomyocytes from ES cells 
in vitro. " Faseb J 14(15): 2540-8. 
Murry, C. E., M. H. Soonpaa, et al. (2004). "Haematopoietic stem cells do not transdifferentiate into 
cardiac myocytes in myocardial infarcts. " Nature 428(6983): 664-8. 
Nakabeppu, Y., K. Sakumi, et al. (2006). "Mutagenesis and carcinogenesis caused by the oxidation of 
nucleic acids. " Biol Chem 387(4): 373-9. 
Nakajima, Y., V. Mironov, et al. (1997). "Expression of smooth muscle alpha-actin in mesenchymal cells 
during formation of avian endocardial cushion tissue: a role for transforming growth factor 
beta3. " Dev Dyn 209(3): 296-309. 
Nakano, T., H. Kodama, et al. (1994). "Generation of lymphohematopoietic cells from embryonic stem 
cells in culture. " Science 265(5175): 1098-101. 
Nakayama, N., J. Lee, et al. (2000). "Vascular endothelial growth factor synergistically enhances bone 
morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem 
cells in vitro. " Blood 95(7): 2275-83. 
Neumann, D., M. Zierke, et al. (1998). "Withdrawal of 2-mercaptoethanol induces apoptosis in a B-cell 
line via Fas upregulation. " J Cell Physiol 177(1): 68-75. 
Nir, S. G., R. David, et al. (2003). "Human embryonic stem cells for cardiovascular repair. " Cardiovasc 
Res 58(2): 313-23. 
Nishikawa, S. I., S. Nishikawa, et al. (1998). "Progressive lineage analysis by cell sorting and culture 
identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic 
lineages. " Development 125(9): 1747-57. 
246 
O'Farrell, P. H. (1975). "High resolution two-dimensional electrophoresis of proteins. " J Biol Chem 
250(10): 4007-21. 
Okabe, S., K. Forsberg-Nilsson, et al. (1996). "Development of neuronal precursor cells and functional 
postmitotic neurons from embryonic stem cells in vitro. " Mech Dev 59(1): 89-102. 
Olesen, S. P., D. E. Clapham, et at. (1988). "Haemodynamic shear stress activates a K+ current in 
vascular endothelial cells. " Nature 331(6152): 168-70. 
Ong, S. E., B. Blagoev, et al. (2002). "Stable isotope labeling by amino acids in cell culture, SILAC, as a 
simple and accurate approach to expression proteomics. " Mol Cell Proteomics 1(5): 376-86. 
Orlic, D., J. Kajstura, et al. (2001). "Bone marrow cells regenerate infarcted myocardium. " Nature 
410(6829): 701-5. 
Park, C., I. Afrikanova, et al. (2004). "A hierarchical order of factors in the generation of FLK1- and 
SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. " 
Development 131(11): 2749-62. 
Patton, W. F. (2000). "A thousand points of light: the application of fluorescence detection technologies to 
two-dimensional gel electrophoresis and proteomics. " Electrophoresis 21(6): 1123-44. 
Patton, W. F., H. Erdjument-Bromage, et al. (1995). "Components of the protein synthesis and folding 
machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. 
Identification by comparative protein phenotyping and microsequencing. " J Biol Chem 270(36): 
21404-10. 
Patton, W. F., M. G Pluskal, et al. (1990). "Development of a dedicated two-dimensional gel 
electrophoresis system that provides optimal pattern reproducibility and polypeptide resolution. " 
Biotechniques 8(5): 518-27. 
Peirce, M. J., R. Wait, et al. (2004). "Expression profiling of lymphocyte plasma membrane proteins. " 
Mol Cell Proteomics 3(1): 56-65. 
Perez-Campo, R., M. Lopez-Torres, et al. (1998). "The rate of free radical production as a determinant of 
the rate of aging: evidence from the comparative approach. " J Comp Physiol FBI 168(3): 149-58. 
Perkins, D. N., D. J. Pappin, et at. (1999). "Probability-based protein identification by searching sequence 
databases using mass spectrometry data. " Electrophoresis 20(18): 3551-67. 
Petersen, B. E., W. C. Bowen, et al. (1999). "Bone marrow as a potential source of hepatic oval cells. " 
Science 284(5417): 1168-70. 
Pittenger, M. F., A. M. Mackay, et al. (1999). "Multilineage potential of adult human mesenchymal stem 
cells. " Science 284(5411): 143-7. 
Podmore, I. D., H. R. Griffiths, et al. (1998). "Vitamin C exhibits pro-oxidant properties. " Nature 
392(6676): 559. 
Poli, G, Cz Leonarduzzi, et al. (2004). "Oxidative stress and cell signalling. " Curr Med Chem 11(9): 
1163-82. 
Poliard, A., A. Nifuji, et al. (1995). "Controlled conversion of an immortalized mesodermal progenitor 
cell towards osteogenic, chondrogenic, or adipogenic pathways. " J Cell Biol 130(6): 1461-72. 
Quaini, F., K. Urbanek, et al. (2002). "Chimerism of the transplanted heart. " N Engl J Med 346(1): 5-15. 
Rabilloud, T. (1999). "Solubilization of proteins in 2-D electrophoresis. An outline. " Methods Mol Biol 
112: 9-19. 
Rabilloud, T., M. Heller, et al. (2002). "Proteomics analysis of cellular response to oxidative stress. 
Evidence for in vivo overoxidation of peroxiredoxins at their active site. " J IIiol Chem 277(22): 
19396-401. 
247 
Rafii, S. (2000). "Circulating endothelial precursors: mystery, reality, and promise. " J Clin Invest 105(1): 
17-9. 
Ramsby, M. L. and U S. Makowski (1999). "Differential detergent fractionation of eukaryotic cells. 
Analysis by two-dimensional gel electrophoresis. " Methods Mol Biol 112: 53-66. 
Ratan, R. R., T. H. Murphy, et al. (1994). "Macromolecular synthesis inhibitors prevent oxidative 
stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein 
synthesis to glutathione. " J Neurosci 14(7): 4385-92. 
Rauscher, F. M., P. J. Goldschmidt-Clermont, et al. (2003). "Aging, progenitor cell exhaustion, and 
atherosclerosis. " Circulation 108(4): 457-63. 
Regan, C. P., I. Manabe, et al. (2000). "Development of a smooth muscle-targeted cre recombinase mouse 
reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. " Circ 
Res 87(5): 363-9. 
Remuzzi, A., C. F. Dewey, Jr., et al. (1984). "Orientation of endothelial cells in shear fields in vitro. " 
Biorheology 21(4): 617-30. 
Resing, K. A. (2002). "Analysis of signaling pathways using functional proteomics. " Ann NY Acad Sci 
971: 608-14. 
Resnick, N. and M. A. Gimbrone, Jr. (1995). "Hemodynamic forces are complex regulators of endothelial 
gene expression. " Faseb J 9(10): 874-82. 
Reubinoff, B. E., M. F. Pera, et at (2000). "Embryonic stem cell lines from human blastocysts: somatic 
differentiation in vitro. " Nat Biotechnol 18(4): 399-404. 
Reusch, P., H. Wagdy, et al. (1996). "Mechanical strain increases smooth muscle and decreases 
nonmuscle myosin expression in rat vascular smooth muscle cells. " Circ Res 79(5): 1046-53. 
Righetti, P. G. (1990). "Recent developments in electrophoretic methods. " J Chromatogr 516(1): 3-22. 
Risau, W., H. Sariola, et al. (1988). "Vasculogenesis and angiogenesis in embryonic-stem-cell-derived 
embryoid bodies. " Development 102(3): 471-8. 
Roepstorff, P. (1997). "Mass spectrometry in protein studies from genome to function. " Curr Opin 
Biotechnol8(1): 6-13. 
Rohwedel, J., V. Maltsev, et al. (1994). "Muscle cell differentiation of embryonic stem cells reflects 
myogenesis in vivo: developmentally regulated expression of myogenic determination genes and 
functional expression of ionic currents. " Dev Biol 164(1): 87-101. 
Ross, R. (1993). "The pathogenesis of atherosclerosis: a perspective for the 1990s. " Nature 362(6423): 
801-9. 
Ross, R. (1999). "Atherosclerosis--an inflammatory disease. " N En lg J Med 340(2): 115-26. 
Ross, R., J. Glomset, et al. (1977). "Response to injury and atherogenesis. " Am J Pathol 86(3): 675-84. 
Saiura, A., M. Sata, et al. (2001). "Circulating smooth muscle progenitor cells contribute to 
atherosclerosis. " Nat Med 7(4): 382-3. 
Sales, K. M., H. J. Salacinski, et al. (2005). "Advancing vascular tissue engineering: the role of stem cell 
technology. " Trends Biotechnol 23(9): 461-7. 
Salvioli, S., A. Ardizzoni, et al. (1997). "JC-1, but not DiOC6(3) or rhodamine 123, is a reliable 
fluorescent probe to assess delta psi changes in intact cells: implications for studies on 
mitochondrial functionality during apoptosis. " FERS Lett 411(1): 77-82. 
Sanchez-Ramos, J., S. Song, et at. (2000). "Adult bone marrow stromal cells differentiate into neural cells 
in vitro. " Exp Neurol 164(2): 247-56. 
Sata, M. (2003). "Circulating vascular progenitor cells contribute to vascular repair, remodeling, and 
248 
lesion formation. " Trends Cardiovasc Med 13(6): 249-53. 
Sata, M., A. Saiura, et at. (2002). "Hematopoietic stem cells differentiate into vascular cells that 
participate in the pathogenesis of atherosclerosis. " Nat Med 8(4): 403-9. 
Sauer, H. and M. Wartenberg (2005). "Reactive oxygen species as signaling molecules in cardiovascular 
differentiation of embryonic stem cells and tumor-induced angiogenesis. " Antioxid Redox Signal 
7(11-12): 1423-34. 
Sauer, H., M. Wartenberg, et al. (2001). "Reactive oxygen species as intracellular messengers during cell 
growth and differentiation. " Cell Physiol Biochem 11(4): 173-86. 
Schmitt, R. M., E. Bruyns, et al. (1991). "Hematopoietic development of embryonic stem cells in vitro: 
cytokine and receptor gene expression. " Genes Dev 5(5): 728-40. 
Schwartz, S. M. (1999). "The intima : Anew soil. " Circ Res 85(10): 877-9. 
Shen, J., F. W. Luscinskas, et al. (1992). "Fluid shear stress modulates cytosolic free calcium in vascular 
endothelial cells. " Am J Physiol 262(2 Pt 1): C384-90. 
Shevchenko, A., M. Wilm, et al. (1996). "Mass spectrometric sequencing of proteins silver-stained 
polyacrylamide gels. " Anal Chem 68(5): 850-8. 
Shimizu, K., S. Sugiyama, et al. (2001). "Host bone-marrow cells are a source of donor intimal smooth- 
muscle-like cells in murine aortic transplant arteriopathy. " Nat Med 7(6): 738-41. 
Shirota, T., H. He, et al. (2003). "Human endothelial progenitor cell-seeded hybrid graft: proliferative and 
antithrombogenic potentials in vitro and fabrication processing. " Tissue Eng 9(1): 127-36. 
Sies, H. (1991). "Oxidative stress: from basic research to clinical application. " Am J Med 91(3C): 
31S-38S. 
Sies, H. and E. Cadenas (1985). "Oxidative stress: damage to intact cells and organs. " Philos Trans R Soc 
Lond B Biol Sci 311(1152): 617-31. 
Simper, D., P. G. Stalboerger, et al. (2002). "Smooth muscle progenitor cells in human blood. " Circulation 
106(10): 1199-204. 
Sinha, S., B. R. Wanihoff, et al. (2006). "Assessment of Contractility of Purified Smooth Muscle Cells 
Derived from Embryonic Stem Cells. " Stem Cells. 
Siow, R. C., H. Sato, et al. (1999). "Herne oxygenase-carbon monoxide signalling pathway in 
atherosclerosis:, anti-atherogenic actions of bilirubin and carbon monoxide? " Cardiovasc Res 
41(2): 385-94. 
Smith, A. G (2001). "Embryo-derived stem cells: of mice and men. " Annu Rev Cell Dev Biol 17: 435-62. 
Smith, A. G, J. K. Heath, et al. (1988). "Inhibition of pluripotential embryonic stem cell differentiation by 
purified polypeptides. " Nature 336(6200): 688-90. 
Smith, P. G., T. Tokui, et al. (1995). "Mechanical strain increases contractile enzyme activity in cultured 
airway smooth muscle cells. " Am J Physiol 268(6 Pt 1): L999-1005. 
Sohal, R. S., R. G Allen, et al. (1986). "Oxygen free radicals play a role in cellular differentiation: an 
hypothesis. " J Free Radic Biol Med 2(3): 175-81. 
Song, J., J. Stastny, et al. (1985). "Effect of aging on human aortic protein composition. II. 
Two-dimensional polyacrylamide gel electrophoretic analysis. " Exp Mol Pathol 43(3): 297-304. 
Soria, B., E. Roche, et al. (2000). "Insulin-secreting cells derived from embryonic stem cells normalize 
glycemia in streptozotocin-induced diabetic mice. " Diabetes 49(2): 157-62. 
Spitkovsky, D., P. Sasse, et at. (2004). "Activity of complex III of the mitochondrial electron transport 
chain is essential for early heart muscle cell differentiation. " Faseb J 18(11): 1300-2. 
Stary, H. C. (1989). "Evolution and progression of atherosclerotic lesions in coronary arteries of children 
249 
and young adults. " Arteriosclerosis 9(1 Suppl): 119-32. 
Stastny, J., E. Fosslien, et al. (1986). "Human aortic intima protein composition during initial stages of 
atherogenesis. " Atherosclerosis 60(2): 131-9. 
Stastny, J. J. and E. Fosslien (1992). "Quantitative alteration of some aortic intima proteins in fatty streaks 
and fibro-fatty lesions. " Exp Mol Pathol 57(3): 205-14. 
Steinberg, D., S. Parthasarathy, et al. (1989). "Beyond cholesterol. Modifications of low-density 
lipoprotein that increase its atherogenicity. " N Engl J Med 320(14): 915-24. 
Stone, J. R. and M. A. Marletta (1994). "Soluble guanylate cyclase from bovine lung: activation with 
nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. " 
Biochemistry 33(18): 5636-40. 
Strong, J. P. (1995). "Natural history and risk factors for early human atherogenesis. Pathobiological 
Determinants of Atherosclerosis in Youth (PDAY) Research Group. " Clin Chem 41(1): 134-8. 
Strong, J. P., C1 T. Malcom, et al. (1992). "Early lesions of atherosclerosis in childhood and youth: natural 
history and risk factors. " J Am Coll Nutr 11 Suppl: 51 S-54S. 
Strong, J. P., M. C. Oalmann, et al. (1984). "Coronary heart disease in young black and white males in 
New Orleans: Community Pathology Study. " Am Heart J 108(3 Pt 2): 747-59. 
Syka, J. E., J. J. Coon, et al. (2004). "Peptide and protein sequence analysis by electron transfer 
dissociation mass spectrometry. " Proc Natl Acad Sci USA 101(26): 9528-33. 
Szmitko, P. E., P. W. Fedak, et al. (2003). "Endothelial progenitor cells: new hope for a broken heart. " 
Circulation 107(24): 3093-100. 
Tao, W., M. Wang, et al. (2004). "Comparative proteomic analysis of human CD34+ stem/progenitor cells 
and mature CD15+ myeloid cells. " Stem Cells 22(6): 1003-14. 
Taurin, S., V. Seyrantepe, et al. (2002). "Proteome analysis and functional expression identify mortalin as 
an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth 
muscle cells. " Circ Res 91(10): 915-22. 
Thomson, J. A., J. Itskovitz-Eldor, et al. (1998). "Embryonic stem cell lines derived from human 
blastocysts. " Science 282(5391): 1145-7. 
Tiwari, A., H. J. Salacinski, et al. (2001). "Tissue engineering of vascular bypass grafts: role of 
endothelial cell extraction. " Eur J Vasc Endovasc Surg 21(3): 193-201. 
Touyz, R. M. (2004). "Reactive oxygen species, vascular oxidative stress, and redox signaling in 
hypertension: what is the clinical significance? " Hypertension 44(3): 248-52. 
Tretter, L. and V. Adam-Vizi (2000). "Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key 
role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative 
stress. " J Neurosci 20(24): 8972-9. 
Trocino, R. A., S. Akazawa, et al. (1995). "Significance of glutathione depletion and oxidative stress in 
early embryogenesis in glucose-induced rat embryo culture. " Diabetes 44(8): 992-8. 
Tseng, H., T. E. Peterson, et al. (1995). "Fluid shear stress stimulates mitogen-activated protein kinase in 
endothelial cells. " Circ Res 77(5): 869-78. 
Tuan, R. S., G. Boland, et al. (2003). "Adult mesenchymal stem cells and cell-based tissue engineering. " 
Arthritis Res Ther 5(1): 32-45. 
Unlu, M., M. E. Morgan, et al. (1997). "Difference gel electrophoresis: a single gel method for detecting 
changes in protein extracts. " Electrophoresis 18(11): 2071-7. 
Vasa, M., S. Fichtlscherer, et al. (2001). "Increase in circulating endothelial progenitor cells by statin 
therapy in patients with stable coronary artery disease. " Circulation 103(24): 2885-90. 
250 
Vittet, D., M. H. Prandini, et al. (1996). "Embryonic stem cells differentiate in vitro to endothelial cells 
through successive maturation steps. " Blood 88(9): 3424-31. 
Wagner, E., S. Luche, et al. (2002). "A method for detection of overoxidation of cysteines: peroxiredoxins 
are oxidized in vivo at the active-site cysteine during oxidative stress. " Biochem 366(Pt 3): 
777-85. 
Wang, L., L. Li, et al. (2004). "Endothelial and hematopoietic cell fate of human embryonic stem cells 
originates from primitive endothelium with hemangioblastic properties. " Immunity 21(1): 31-41. 
Weber, C. A., C. A. Duncan, et al. (1990). "Depletion of tissue glutathione with diethyl maleate enhances 
hyperbaric oxygen toxicity. " Am J Physio1258(6 Pt 1): L308-12. 
Weber, D. S., Y. Taniyama, et al. (2004). "Phosphoinositide-dependent kinase 1 and p21-activated protein 
kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth 
factor-induced smooth muscle cell migration. " Circ Res 94(9): 1.219-26. 
Weindruch, R. and R. S. Sohal (1997). "Seminars in medicine of the Beth Israel Deaconess Medical 
Center. Caloric intake and aging. " N En lg J Med 337(14): 986-94. 
Wert Gd, G. and C. Mummery (2003). "Human embryonic stem cells: research, ethics and policy. " Hum 
Reprod 18(4): 672-82. 
White, C. W., R. F. Minunack, et al. (1986). "Accumulation of lung tissue oxidized glutathione (GSSG) as 
a marker of oxidant induced lung injury. " Chest 89(3 Suppl): 11IS-113S. 
Wiersma, J. A., M. Bos, et al. (1994). "High strength poly(meth)acrylamide copolymer hydrogels. " 
Polymer Bulletin 33: 615-622. 
Wilkins, M. R., R. D. Appel, et al. (2006). "Guidelines for the next 10 years of proteomics. " Proteomics 
6(1): 4-8. 
Wilkins, M. R., C. Pasquali, et al. (1996). "From proteins to proteomes: large scale protein identification 
by two-dimensional electrophoresis and amino acid analysis. " Biotechnology (N Y) 14(1): 61-5. 
Wilkins, M. R., J. C. Sanchez, et al. (1996). "Progress with proteome projects: why all proteins expressed 
by a genome should be identified and how to do it. " Biotechnol Genet Eng Rev 13: 19-50. 
Williams, M. D., H. Van Remmen, et al. (1998). "Increased oxidative damage is correlated to altered 
mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. " J Biol 
Chem 273(43): 28510-5. 
Williams, R. L., D. J. Hilton, et al. (1988). "Myeloid leukaemia inhibitory factor maintains the 
developmental potential of embryonic stem cells. " Nature 336(6200): 684-7. 
Wilm, M., A. Shevchenko, et al. (1996). "Femtomole sequencing of proteins from polyacrylamide gels by 
nano-electrospray mass spectrometry. " Nature 379(6564): 466-9. 
Wissler, R. W. (1992). "Theories and new horizons in the pathogenesis of atherosclerosis and the 
mechanisms of clinical effects. " Arch Pathol Lab Med 116(12): 1281-91. 
Wood, Z. A., E. Schroder, et al. (2003). "Structure, mechanism and regulation of peroxiredoxins. " Trends 
Biochem Sci 28(1): 32-40. 
Xiao, Q., L. Zeng, et at. (2006). "Stem Cell-derived Sca-l+ Progenitors Differentiate into Smooth Muscle 
Cells, which is Mediated by Collagen IV-Integrin {alpha} 1/{beta} 1/{alpha}v and PDGF 
Receptor Pathways. " Am J Physiol Cell Physiol. 
Xu, C., M. S. Inokuma, et al. (2001). "Feeder-free growth of undifferentiated human embryonic stem 
cells. " Nat Biotechnol 19(10): 971-4. 
Xu, Q. (2000). "Biomechanical-stress-induced signaling and gene expression in the development of 
arteriosclerosis. " Trends Cardiovasc Med 10(1): 35-41. 
251 
Xu, Q. (2006). "The impact of progenitor cells in atherosclerosis. " Nat Clin Pract Cardiovasc Mcd 3(2): 
94-101. 
Xu, Q., Z. Zhang, et al. (2003). "Circulating progenitor cells regenerate endothelium of vein graft 
atherosclerosis, which is diminished in ApoE-deficient mice. " Circ Res 93(8): e76-86. 
Yamane, T., S. Hayashi, et al. (1999). "Derivation of melanocytes from embryonic stem cells in culture. " 
Dev Dyn 216(4-5): 450-8. 
Yamashita, J., H. Itoh, et al. (2000). "Flkl-positive cells derived from embryonic stem cells serve as 
vascular progenitors. " Nature 408(6808): 92-6. 
Yan, J. X., R. Wait, et al. (2000). "A modified silver staining protocol for visualization of proteins 
compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass 
spectrometry. " Electrophoresis 21(17): 3666-72. 
Yang, Y., J. Y. Min, et al. (2002). "VEGF enhances functional improvement of postinfarcted hearts by 
transplantation of ESC-differentiated cells. " J Appl Physiol 93(3): 1140-51. 
Yates, J. R., 3rd, J. K. Eng, et al. (1995). "Method to correlate tandem mass spectra of modified peptides 
to amino acid sequences in the protein database. " Anal Chem 67(8): 1426-36. 
Yeh, E. T., S. Zhang, et al. (2003). "Transdifferentiation of human peripheral blood CD34+-enriched cell 
population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. " Circulation 
108(17): 2070-3. 
Yin, X., M. Mayr, et al. (2005). "Proteomic dataset of Sca-1(+) progenitor cells. " Proteomics 5(17): 
4533-45. 
Ying, Q. L., J. Nichols, et al. (2003). 'BMP induction of Id proteins suppresses differentiation and 
sustains embryonic stem cell self-renewal in collaboration with STAT3. " Cell 115(3): 281-92. 
Yurugi-Kobayashi, T., H. Itoh, et al. (2003). "Effective contribution of transplanted vascular progenitor 
cells derived from embryonic stem cells to adult neovascularization in proper differentiation 
stage. " Blood 101(7): 2675-8. 
Zandstra, P. W., C. Bauwens, et al. (2003). "Scalable production of embryonic stem cell-derived 
cardiomyocytes. " Tissue Eng 9(4): 767-78. 
Zeng, L., Q. Xiao, et al. (2006). "HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation 
toward endothelial cells. " J Cell Biol 174(7): 1059-69. 
Zhang, S. H., R. L. Reddick, et al. (1992). "Spontaneous hypercholesterolemia and arterial lesions in mice 
lacking apolipoprotein E. " Science 258(5081): 468-71. 
Zhang, Y., 0. Marcillat, et al. (1990). "The oxidative inactivation of mitochondrial electron transport 
chain components and ATPase. " J Biol Chem 265(27): 16330-6. 
Zhou, Q., G R. Hellermann, et al. (1995). "Nitric oxide release from resting human platelets. " Thromb 
Res 77(1): 87-96. 
Zou, Y., Y. Hu, et al. (1998). "Signal transduction in arteriosclerosis: mechanical stress-activated MAP 
kinases in vascular smooth muscle cells (review). " Int J Mol Med 1(5): 827-34. 
zur Nieden, N. I., G Kempka, et al. (2003). "In vitro differentiation of embryonic stem cells into 
mineralized osteoblasts. " Differentiation 71(1): 18-27. 
252 
I'm the happiest man in the world now! 
Masterpiece of Qiuru Xing 
253 
